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Abstract 
 Glioblastoma is a heterogeneous disease such that the receptors expressed vary based on 
tumor location. Working with Nemucore Medical Innovations, Inc., theranostic nanoemulsions 
were designed and manufactured to combat Glioblastoma and other brain diseases. Engineered 
targeting ligands incorporated in the nanoemulsions assisted in delivery to specific regions. 
Magnetic Resonance Imaging determined the bio-distribution in healthy rats across the Blood-
Brain Barrier. Statistical analysis was completed with T1 MRI data for 174 defined regions. A 3-
dimensional heat map program was created to integrate MRI imaging and statistical analysis. In 
conclusion, data demonstrates targeting ligands on the nanoemulsions alter pharmacodynamics 
in rat brains, shown by a fully integrated imaging system. 
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Executive Summary 
I. Introduction 
A. Glioblastoma 
Glioblastoma Multiforme (GBM) is the most aggressive malignant brain tumor found in 
adults (Angihotri et al., 2013). Annually, there are 18,000 newly diagnosed cases of GBM in the 
United States; of these new cases, less than 10% of the patients survive longer than five years 
(Tutt, 2011). Glioblastoma characteristics vary, in part due to the region of the tumor, giving rise 
to a need for targeted therapy based on lobe location. A theranostic treatment, combining both 
therapeutics and diagnostics into one modality, has the potential to solve this need (Kealar and 
Reineke, 2011). 
 
B. Current Gold Standard 
The current gold standard for treatment involves obtaining images with gadolinium-
enhanced MRI and using these images for radiation therapy (Hou et. Al., 2006). Temozolomide, 
a chemotherapeutic agent, is administered to the patient along with radiation therapy after a 
debulking surgery. Treatment analysis is completed on MRI machine software, which does not 
contain the capability to visually connect the statistical analysis with a visual interface. 
 
C. Applications to Other Neurological Diseases 
Other diseases of the brain have had receptors identified based on the location or function 
of the affected cells. Alzheimer’s has been investigated with rivastigmine as a treatment, but this 
molecule is unable to pass through the BBB (Wilson et. al., 2008); however, when combined 
with a targeted drug delivery system, the amount of drug able to reach the correct location would 
be much higher and may result in an improved therapeutic system. Other pathologies that this 
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method shows promise for include Parkinson’s and Post Traumatic Stress Disorder (PTSD) 
(Olanow et. al., 2006; Bremner et. al., 2000). 
 
II. Methods 
A. Nanoemulsions 
This project was built upon past research Nemucore Medical Innovations had completed 
on the NE drug delivery system (Ganta et al., 2014a; Ganta et. al. 2014b; Ganta et. al., 2015). 
NEs were targeted towards penetrating vasculature and glioblastoma cells by conjugating 
dermorphin, candoxin, or cereport to the NE surfaces. Receptors targeted were µ-opioid, α-7 
nicotinic acetylcholine (nACh), and B2-Bradykinin receptors, respectively. NEs incorporated 
chelated gadolinium to allow for visualization with MRI. Upon manufacturing, characterization 
of NE stability was performed over a time period of 21 days. Size, polydispersity index, and 
zeta-potential were measured using a Malvern SV90. NEs manufactured were stored at 4oC and 
used for in vivo testing. 
 
B. In Vivo Testing 
MRI scans were performed using healthy rats anesthetized with isoflurane administered 
continuously by a nose cone. NE’s were delivered systemically through a catheter in the tail 
vein, and cohorts (n=7) were run for non-targeted NE, as well as the three targets as identified 
above. Additional testing (n=5) was completed with a pretreatment of β-fulantrexamine, a µ-
opioid receptor antagonist (Martin et. al., 2008; Honore et. al., 1996), and dermorphin NEs to 
confirm µ-opioid receptor targeting. Scans collected for each rat included a pre-scan, and scans 
at the 20, 40, and 60 minute time points. 
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C. 3D Statistical Heat Map 
Currently, no software programs allow for drug distribution visualization with the 174 
defined regions of a rat brain. By using Northeastern University’s Rat Brain Atlas, an imaging 
analysis program was created. MRI data was analyzed with statistical means and displayed in 3D 
for visual analysis. 
Statistical analysis was completed using a custom Matlab program. Initial T1 signal values 
were assigned to each of the 174 ROIs, with each region having a varying voxel size based on the 
rat scanned. Normalization of scans with the pre-scan of each rat for T1 weighted means 
followed. Specificity Index (SPI) values were calculated to determine targeted NE accumulation 
per ROI based on gadolinium concentration as compared to non-targeted NEs. 
Visualization for the level of expression was completed through the development of a 
custom Matlab program. The visualization program takes in the SPI values for each of the 174 
ROIs and determines the 75th, 80th, 85th, 90th and 95th percentile cutoffs for the dataset. It then 
uses these cutoffs to assign color to the defined space(s) representing each region in the imaged 
3D brain or brain slice heat map. The 174 regions were defined as areas on 63 slices, each 
representing a slice of the rat brain with a thickness of 400 µm.  The visualization program was 
produced so that users have the ability to produce imaged slices individually, or all at once, for 
the visualization of the determined uptake across the entire brain. 
 
III. Results and Discussion 
A. Nanoemulsions 
CONFIDENTIAL |  
 
x 
Stability of the NEs was defined as: no significant change in the properties of the NEs 
occurred over the period of time measured. While small fluctuations did occur, these values are 
within ranges of similar NEs and do not affect the quality of the NEs or the tests completed with 
them [8-10]. Table 1 shows a representative 21-day stability testing table for a batch of 
dermorphin NEs. 
Table 1: Dermorphin Stability Testing Results 
Dermorphin NE Day 0 Day 7 Day 14 Day 21 
Size (nm) 150 153 153 149 
Polydispersity Index 0.061 0.108 0.073 0.095 
Zeta Potential (mV) -41±11 -44±13 -43±10 -43±9 
 
B. 3D Statistical Heat Map 
Processing of in vivo data using custom data processing and visualization programs 
resulted in a collection of heat-mapped slices of the rat brain. Using these heat maps the 
accumulation of NE in specific areas of the brain can be seen for different targeting ligands and 
compared to areas expressing the respective receptors. Figure 1 shows a sample of maps for 
different brain slices with various receptors and their corresponding heat maps at different time 
points. The dermorphin NE shows accumulation in the basal ganglia and hypothalamus, the 
candoxin NE shows accumulation in the cerebrum, and the cereport NE shows accumulation in 
the entorhinal cortex. 
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Figure 1: Sample brain slices demonstrating targeted nanoemulsion uptake for different receptors at 
varying time points 
 
When all the slices are put together, a full 3D heat map is created. An example of this can 
be seen in Figure 2. 
 
Figure 2: Full brain view of Dermorphin NE uptake at 40 minutes 
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IV. Conclusion 
In conclusion, this technology has the potential to revolutionize drug delivery to the brain. 
Instead of being satisfied with getting the drug across the BBB and into the brain, researchers will 
be able to go one step further in targeting medicines to the specific lobes of the brain where the 
drug is needed. With applications in Glioblastomas and other brain diseases, these theranostic 
nanoemulsions have great potential. The visualization program that was designed and created 
with this project brings health care professionals the ability to visualize uptake to investigate the 
effectiveness of different targeting ligands used to deliver drugs to highly specific ROIs. 
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1: Introduction 
18,000 patients are diagnosed with Glioblastoma Multiforme (GBM) in the United States 
each year (Tutt, 2011). Of these, less than 10% of the patients survive longer than five years 
(Tutt, 2011). GBM is a level IV cancer as classified by the World Health Organization, making it 
the most aggressive form of malignant brain tumor cancer in adult patients (Louis et al., 2007; 
Agnihotri et. al, 2013). GBM is composed of glial cells developing from a mutation in astrocytes 
in the central nervous system (CNS). These glial cells create tumors that can become a 
significant amount of total brain tissue that thrives off of the large network of vasculature that 
provides nutrients, enhancing growth (Behzadian et. al, 1998). 
Every case of Glioblastoma is different, and each patient is unique. A “one-size-fits all” 
approach will not be the future of cancer therapy; however, a theranostic approach shows great 
potential. Theranostics is the combination of therapeutics and diagnostics into a single modality 
(Kelkar, 2008). Ideally, a theranostic system will be able to provide feedback almost 
immediately, enhancing the quality and efficiency of clinical treatment. With this overall goal in 
mind, the objectives of this project are: to design a program to display a 3-dimensional (3D) heat 
map of Magnetic Resonance Imaging (MRI) T1 relaxation times in the brain, to design and 
synthesize targeting moieties, and to test for pharmacodynamics effects of the nanomedicines in 
vivo. Together, these objectives will lead to a nanoemulsion (NE) for the targeting and imaging 
of GBM in vivo, and a program to visualize these NEs. 
 
1.1: Current Gold Standard 
The current gold standard for the treatment of GBM is imaging the brain using an MRI, 
and using these images in resection surgery to better remove the tumor. Before going into 
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surgery, the GBM patient goes through a gadolinium-enhanced MRI to image the tumor, 
providing the surgeon knowledge on the location of the cancer (Hou et al, 2006). The MRI is 
able to show the differences in tissue types with gadolinium as an image-enhancing compound. 
The patient is then given an oral chemotherapy drug, Temozolomide (TMZ), which acts as a 
methylation agent. Due to the methylation of the DNA, cell death is trigged (Newlands et. al, 
1997). TMZ has been shown to be effective, but a large margin for improvement remains. The 
drug is mainly effective with patients under the age of 45, and of those positively affected by the 
treatment, survival was increased by about 18 months (Yaneva et. al, 2010)  
The main problems that arise while treating GBM is the lack of clear imaging, and the 
delivery of the therapeutic drugs across the Blood Brian Barrier (BBB) of the brain while 
minimizing the damage to the rest of the brain. Although MRI, the imaging method that has been 
used since 1985 for differentiation of tumors from healthy tissue (Grossman et.al, 2004), can 
show a high-resolution picture of the different tissues present, a high amount of “guess and 
check” is still done for the exact tumor location. Additionally, during chemotherapy and 
radiation treatments, highly accurate methods of quantifying the therapeutic extent of the drugs 
and exactly where the drugs are accumulating are not available. The second main problem is 
trying to get drugs past the BBB. The BBB is made up of endothelial cells that form tight 
junctions, which are permeable only to hydrophilic drugs or liquids. For a drug to be beneficial 
in treating GBM, it needs to be able to pass through the BBB easily while not affecting the 
surrounding healthy tissue. 
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1.2: Goals  
 This project consists of two main goals: to design and test a nanoemulsion drug delivery 
system and to design an interface to visualize in vivo data of the drug delivery system. The team 
began with designing a nanoemulsion that is capable of holding common chemotherapeutic 
drugs stable, that is able to contain a peptide used to target specific cells, and that contains an 
imaging agent. Once a functional nanoemulsion was made, it was tested in vivo, utilizing 
resources at Northeastern University to run MRI scans on healthy rat brains.  
Upon collection of this in vivo MRI data, the raw data needed to be analyzed to visualize 
uptake of the nanoemulsions in different areas of the brain. A 3D heat map that can show the 
accumulation of the nanoemulsions across sixty-three cross-sectional slices of the brain was 
designed. With the heat map showing nanoemulsion accumulation in specific areas of the brain, 
selective targeting of cells can be seen.  
 
1.3: Approach: Nanoemulsions 
One of Nemucore Medical Innovations’ (NMI) main areas of interest is the design of NEs 
for drug delivery. NEs used by the company are comprised of oil-in-water droplets with 
stabilizers, drugs, targeting peptides, and imaging agents (Mason, et al., 2006; Ledet et al., 
2013). A major goal of this project is to design and enhance qualities of the NEs to achieve 
greater targeting specificity against GBM. Three cell receptors were identified previously for this 
project: the Alpha-7 nicotinic Acetylcholine Receptor (Alpha-7 nAchR), the B2 Bradykinin 
Receptor (B2BR), and the Mu-Opioid Receptor (MOR) (Day, Lacarra, Sacks, & Sadraei, 2015, 
unpublished). Continued research was completed for these receptors, focusing on various ligands 
for better targeting. Once chosen, the targeting ligands were chemically synthesized and 
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implemented onto the surface of the NMI-800 NEs. Once created, the NEs were tested in vitro 
for stability, and in vivo for targeting effectiveness. 
NEs provide a novel way to combat the drug resistance found in GBM due to their 
designability and high level of customization (Ledet et al., 2013). NMI has previously identified 
drugs they wish to use against GBM, which can be incorporated into the final design once proof-
of-concept experiments have been completed to confirm correct targeting of intended receptors. 
With the proper knowledge of ligand shape and specificity, manufacturing, chemotherapeutics, 
stability measurements, and in vivo testing, an optimal line of NEs will be designed and 
synthesized by NMI. 
 
1.4: Approach: 3D Statistical Heat Map 
 Verifying the effectiveness of the designed drug delivery system required analysis of the 
location of the imaging medium, which is attached to the drug delivery vehicle, in vivo. There 
are currently no programs available which can accomplish this, therefore a custom one was 
created, addressing both NMI’s specific need and a functional gap in the industry. The program’s 
function is similar to that of a Positron Emission Tomography (PET) scan’s initial output, at least 
insofar as tracking an imaging marker’s position. Where this program’s functionality differs is in 
the data it outputs. The focus of this program is in producing sound statistical data; the similarity 
to PET functionality is merely a positive reapplication of the technology in use.  
 In the creation of this visualization program, the outputs from a custom statistical analysis 
program and the rat brain wireframe code, a product created by the preceding work on this 
project, were used. As such, this project is dependent on the established rat brain atlas program 
as well.  
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 The program’s function is to produce accurate specificity index and t-test heat map 
images. These can be made for all time points at which rats are tested in each of the 174 regions 
of interest across all 63 brain slices. One method of allowing for the clear visualization of this 
data, even in the 3D variant, is shown in Figure 3.  The program allows for the selection and 
display of individual slices of the 3D image for closer analysis, an example of such a slice can be 
seen below. This should be achievable in the same user-friendly manner as the data analysis and 
3D image production. A similar program, which can map the densities of different receptors that 
are studied, was also created, allowing for the comparison of where the NEs are found versus 
where the targeted receptor is expressed. 
 
Figure 3: Example of a heat map slice:  
1.5: Summary 
Throughout the following chapters of this report, the biology of Glioblastoma 
Multiforme, current diagnostics and treatment of brain cancers, the function and properties of 
NEs and other small molecule drug delivery systems, and techniques for visualization of data 
through heat mapping are explored. A detailed discussion of the approach of this and the theory 
behind this design is then be presented, followed by preliminary designs tested throughout this 
iterative design process. An in-depth look at the final designs will be explained next, followed by 
a discussion, some general conclusions, and ideas on possible directions of future research.  
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2: Literature Review 
2.1: Glioblastoma Multiforme 
 Glioblastoma Multiforme (GBM) is a form of malignant brain cancer present in adult 
patients. GBM is the most aggressive form of brain cancer with a classification of grade IV, the 
highest by the World Health Organization (WHO), due to its rapid proliferation, development in 
oligodendrocytes, and abnormal appearance under a microscope (Louis, 2007). There are 
12,000-18,000 patients per year diagnosed with GBM in the United States alone (Tutt, 2011). 
Due to the rapid attack on the body and the difficulty to treat, less than 10% of those patients 
diagnosed each year will survive 5 years (Tutt, 2011).  There are two types of Glioblastomas: 
primary and secondary. Primary glioblastoma expands quickly, making it the more aggressively 
invasive of the two types. Secondary glioblastomas are slower in their growth, starting off at a 
much lower grade tumor level, but as time passes this secondary type changes into an even more 
aggressive form (Ohgaki & Kleihues, 2007). 
To understand and characterize the morphology of Glioblastoma, the types of cells that 
make up the tumor are examined. Gliomas can form from a variety of different cell types, and 
therefore come from different parts of the brain. The three most common types of cell-derived 
gliomas are oligodendrogliomas, astrocytomas, and oligoastrocytomas (Behin et. al, 2003).  
Oligodendrogliomas are primary glial brain tumor cells that are categorized by the WHO as 
grade II and grade III tumors. They are a lower grade because they are far less aggressive and 
respond well to chemotherapy (Uddin, 2015). The WHO classifies astrocytomas, tumors that are 
derived from immortalized astrocytes, the supportive tissue in the brain, as grade IV tumor cells 
(Kennedy, 2015).  Oligoastrocytomas have very distinct regions of differentiation being both 
oligodendroglial and astrocytic in nature (Gupta 2005). The type of cell the glioblastoma is 
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comprised of affects the differing symptoms observed. Common symptoms include headache, 
drowsiness, or vomiting. All of these symptoms arise from the tumor pressure exerted onto the 
brain, often in areas that control motor function. This leads to patients experiencing weakness 
focused on one side of the body, visual changes, difficulty speaking, and encountering challenges 
when recalling both short and long term memory. Other symptoms include focal neurologic 
deficits, seizures, and headaches (Grossman et. al, 2004). 
Another quality of glioblastoma is angiogenesis, the formation of new blood vessels. 
Glioblastoma tumors contain greater vascularization than normal brain tissue. This allows the 
tumor to receive a very high amount of nutrition and oxygen to enable rapid growth. When 
hypoxia is experienced in the tumor, the secretion of vascular endothelial growth factors 
(VEGFs) is induced. These growth factors have been found to be present at a significantly 
greater concentration in stem cell-like glioma cells (SCLGC) compared to non-SCLGC cells, and 
lead to increased vascularization within the tumor (Bao et. al, 2006). 
The alignment of cells in a tumor allows for gaps for both oxygen and nutrition to enter 
the tumor area. This enhanced permeability and retention (EPR) effect is seen in many types of 
tumors. The permeability has been recognized as an exploitable characteristic for targeted drug 
delivery using diffusion. (Miura et. al, 2013). 
Tumors grow rapidly, in part due to the increased expression of various receptors. 
Epidermal growth factor receptor (EGFR), one of the receptors overexpressed that contributes to 
unregulated tumor growth, was been observed in 62.5% of the 40 tumors that were examined. 
EGFR is found on the extracellular protein ligands. Additionally, it was seen that of these, 40% 
of the tumors expressed EGFR amplification (Haas-Kogan et.al, 2005). The growth factors on 
the gliomas are tumor-specific in order to optimize the tumor’s success in the localized 
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environment and growth conditions (Nishikawa et. al, 1994).  In normal brain tissue, the Fn14 
gene is expressed, but only slightly. It has been found that Fn14 is overexpressed in traveling 
glioma cells (Tran et. al, 2003). Three of the many known receptors of the brain include the 
Alpha-7 nicotinic Acetylcholine Receptor (Alpha-7 nAchR), the B2 Bradykinin Receptor 
(B2BR), and the Mu-Opioid Receptor (MOR). Exploitation of the overexpression of these 
receptors on tumor cells opens up the possibility of targeted drug delivery (Ganta et. al., 2014a).  
 
2.2: Current Gold Standard of Treatment 
The current gold standard of treatment for Glioblastoma is to locate and excise the 
cancerous tissue. An MRI is taken of the patient’s brain to locate the tumor’s location in the 
brain prior to removal. Surgeons excise as much of the tumor as possible from the peripheral of 
the brain (Agnihotri et. al, 2013). Once the surgery has been successfully completed, the patient 
is treated with series of radiation and chemotherapy treatments. Temozolomide (TMZ) is the 
common oral chemotherapy that is given. TMZ acts by adding a methyl group to cell DNA, 
damaging DNA and triggering cell death. Even with these treatments being enacted in 
conjunction with one another there is only a 16.1% increase in the patient survival rate (Stupp et. 
al, 2005).  
A GLIADEL® wafer is placed at the site of resection upon the removal of the tumor’s 
mass. GLIADEL® is a biopolymer made of polycarboxyphenoxy-propane/sebacic acid 
anhydride containing 3.85% carmustine [BCNU]. This biopolymer wafer is designed to 
incrementally release the carmustine (a chemotherapeutic) into the site of resection for 2 to 3 
weeks (Domb et. al, 1999). Carmustine’s mechanism of action is not completely understood, but 
it is known that Carmustine is an alkylating agent that induces depolarization of mitochondrial 
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inner transmembrane potential, up-regulates Bax, down-regulates Bcl-2, activates caspase-3, and 
notably reduces collagen and thrombin-induced platelet aggregation (Zhang et. al., 2015). 
Despite the multiple treatment methods available, there has been little improvement in 
patient mortality rates since the “war on cancer” began in 1972. This is partially because 
chemotherapeutic drugs being developed are hydrophobic and cannot pass through the Blood 
Brain Barrier (BBB) to enter the brain. The BBB is a highly selective membrane with tight 
junctions formed by capillary endothelial cells (Hawkins et. al, 2005). When EGFR kinase 
inhibitors are given to patients only about 10-20% of patients demonstrate a positive response 
due to the inability of the drug to cross the BBB and reach the cancerous tissue it is indented for 
(Mellinghoff et. al, 2005). Clearly there is a need for a new type of treatment that can pass 
through the BBB and effectively attack the GBM tumors, a common discussion topic in drug 
delivery research. 
Many proposed treatment delivery methods involve circumventing the BBB. In order to 
bypass the BBB nanocarriers that can identify brain capillary endothelial cells and tumor cells 
have been proposed (Beduneau et. al, 2007). The primary areas in which there have been 
advances in the field of tumor drug delivery have been in targeting, increasing permeability, and 
improving retention effect (Maeda et. al, 2000). Nanocarriers have been specifically made to 
shield the drug from the body’s defense mechanisms, while still keeping the size appropriately 
small, typically in the 30-180 nanometer range.  
 
2.3: Biology of the Brain 
 Approaching the problem of creating a drug delivery system that can overcome the 
unique challenge of getting the drug through the circulatory system and into the brain tissue 
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starts with an understanding of the BBB. The BBB is made up of densely packed endothelial 
cells that surround the vasculature of the brain. This includes the astrocytes and extracellular 
matrix that actively interacts with the barrier on the luminal surface of the endothelial cells. The 
BBB maintains homeostasis in the brain environment. To accomplish this, the barrier has tight 
regulations on the transport of solutes and cells in and out of the central nervous system tissue 
(Bhaskar et al., 2010). 
The endothelial cells aid in the restricted permeability of the BBB through tight junctions 
between neighboring endothelial cells. There are different routes that materials can take in order 
to pass through the BBB as presented in Figure 4. The tight junctions allow small aqueous 
molecules such as oxygen and carbon dioxide to diffuse. In GBM tumors, these tight junctions 
are not as tight as in the normal lining, making the BBB more permeable, and therefore a higher 
amount of diffusion occurs. (Hawkins & Davis, 2005) 
 
Figure 4: Different mechanisms of nutrition and molecular transport through the Blood Brain Barrier.1 
The BBB allows necessary molecules such as glucose, amino acids, and nucleosides to 
pass through the barriers with the associated carrier proteins. Materials can also pass through the 
BBB by receptor-mediated transcytosis. This process is used when a larger molecule needs to be 
1 Ramos-Cabrer, Pedro, & Campos, Francisco. (2012). Liposomes and nanotechnology in drug development: focus on 
neurological targets. International Journal of Nanomedicine, 8, 951-960. 
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transported into the brain tissue, and is dependent on the receptors on the epithelial cells (Ramos 
& Campos, 2012). 
The ultimate goal when working with drug delivery to the brain is using the natural 
processes already there to deliver the drug where it is needed, i.e. bio-mimicry. This reduces the 
amount of invasive procedures such as intraparenchymal injections. Other procedures include 
disrupting the BBB with high-intensity focused ultrasound or inserting a long-term drug delivery 
device (Bhaskar et. al., 2010). 
A second barrier that needs to be considered is the blood cerebrospinal fluid (CSF) 
barrier. This is a primary barrier present in choroid plexus tissue (present in all ventricles in the 
brain) and is a thin layer of blood capillary and choroid plexus epithelial cells. The major 
difference between the BBB and the blood-CSF barrier is the exchange of specific compounds as 
demonstrated in Figure 5. Looking at calcium influx from the blood into the CSF, an example of 
the difference between these two barriers can be seen. Calcium influx is 10 times greater across 
the CSF barrier as compared to the BBB (Laterra et. al, 1999). This disparity in movement across 
the different barriers comes from the choroid plexus tissue, which is responsible for producing 
cerebrospinal fluid. This fluid is then circulated throughout the ventricles in the brain and 
surrounding subarachnoid layers that cover the entire brain (Johansson et. al, 1997).   
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Figure 5: Visualization of the Blood- CST Barrier and Molecular Transport.2 
Studies have been carried out to examine the mechanisms of penetration used in the 
blood-CSF barrier. It has been found that both facilitated diffusion and active transport occur 
from blood into CSF.  In regards to the diffusion from CSF into blood, active transport occurs at 
the blood-CSF barrier (Bhaskar et. al, 2010).  This is an area that is continuously being 
researched by drug development teams.  
 
2.4: Theranostics 
The field of theranostics is relatively new in the medical community, and there has been a 
surge of activity in research and application of theranostics due to the rising concept of 
personalized medicine. Personalized medicine is the tailoring and application of medicine based 
on the pathological features and the differing physical responses of each patient. Theranostics is 
the concept of combining modalities of therapy and diagnostics together, with the goal of 
increasing medical effectiveness (Kelkar & Reineke, 2011). Theranostics covers a wide range of 
imaging tools and methods to help detect the pharmaceutical delivery during administration. One 
2 Laterra J, Keep R, Betz LA, et al. Blood—Cerebrospinal Fluid Barrier. In: Siegel GJ, Agranoff BW, Albers RW, et al., 
editors. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Philadelphia: Lippincott-Raven; 1999. 
Available from: http://www.ncbi.nlm.nih.gov/books/NBK27998/ 
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such method of administration uses NEs, where the surface can be functionalized for imaging 
purposes and the interior payload can contain drugs.  
 
2.4.1: Diagnostics  
One of the main halves of theranostics is the diagnostic aspect, allowing for visualization 
of theranostic particle accumulation after administration to the patient. The field of diagnostics 
encompasses methods used to recognize and pinpoint the location of a morphological tissue or 
disease. Various imaging methods can be used based on the tissue to be imaged and studied. 
When imaging the brain for glioma location, Magnetic Resonance Imaging (MRI) is the common 
choice. One study examined the accuracy of the MRI technique and if the MRI accuracy could 
be increased by using Positron Emission Tomography (PET) with O-(2-[F]fluoroethyl)-L-
tyrosine (FET), an amino acid. 31 different patients were examined, and it was determined that 
when only using MRI, 96% sensitivity and 53% specificity were found. However, MRI with 
FET-PET exhibited 93% sensitivity and 94% specificity, displaying a significant increase in 
specificity (Pauleit et. al, 2005). 
Beyond MRI, fluorescence imaging techniques are another method in the application of 
theranostics on patients (Andersson-Engels et. al, 1997). Quantum dots comprise a fluorescence 
imaging method, and here the quantum dots are utilized for their optical properties, one of which 
is brightness (Zhang et. al, 2012). Computer-aided diagnosis (CAD) is being researched and 
improved with the intent of better medical imaging and radiology diagnostics. CAD is a tool 
used by radiology technicians as a second opinion to aid in making their final decision. This 
method is able to obtain lateral images, which may lead to an early diagnosis of disease (Doi, 
2007).  
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2.4.2: Therapeutics 
With the involvement of therapeutics, the diagnostic tools used take on an ability of 
duality, leading to theranostics. Past problems encountered when designing drugs and their 
delivery method are still issues when creating novel treatments, including systemic 
biodistribution, drug specificity towards target cells, first-pass clearance and metabolism of the 
drug and delivery method, bioavailability, systemic toxicity, and unfavorable side-effects from 
increased doses accounting for clearance rates (Torchilin, 2000). Using diagnostics in 
combination with therapy has eliminated or decreased many of these problems. Targeting 
theranostic particles often incorporate some form of targeting moiety on the surface that can 
selectively interact with biomolecules and receptors, such as an overexpressed receptor on tumor 
cells that is not seen on non-cancerous cells (Biotechnology, 2011). The specificity of the 
targeting aims to bring down the dosage administered because of a greater accumulation at the 
target location, allowing for less systemic toxicity. This brings the opportunity to lower the 
therapeutic threshold of a treatment for a patient while still achieving the effects desired. 
The basics of drug delivery have challenges associated, but additional challenges are 
encountered when theranostic methods are applied to the brain. A tightly-packed barrier of 
endothelial cells with narrow junctions (the BBB) acts as a protective wrapping of the brain. The 
BBB filters what is taken up from the blood to the brain and modulates molecule uptake. The 
selective permeability of the BBB has led to two main approaches of drug delivery to the brain, 
invasive and non-invasive (Pehlivan, 2013). Invasive methods of delivery often involve surgery 
where a portion of the skull is removed, allowing for direct delivery to the brain. This can be 
achieved by an injection of the therapeutic or by using a delivery device mechanism. Delivery of 
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the payload in an invasive manner takes time and results in a long healing process for the patient 
after surgery is completed. Non-invasive delivery methods are being developed and researched 
in the nanomedical field. Products, such as NEs, are showing promise as their advantages to both 
the health care provider and patient. 
 
2.5: Nanoemulsions 
Nanoemulsions (NEs) are emulsions where the suspension droplet dispersion is at the 
nano-scale. This size is made possible due to the properties of surfactants, which work to 
decrease the surface tension interaction of the two liquids. Since NEs often consist of a 
hydrophilic and hydrophobic component, surfactants are commonly amphiphilic particles, 
allowing for organization at the liquid interface. The sizes of NEs commonly range from 100nm 
to 500nm, however particles with sizes above and below this range do exist (Shah et. al, 2010).  
Oil and aqueous phases are prepared separately and then mixed together, after which they are run 
through a microfluidizer, exposing the solution to a high pressure, high stress environment. 
Inside the microfluidizer, the high-pressure forces the mixed phases to go through a small porous 
mesh, allowing for mechanical extrusion and size control by the mesh pore sizes. Other factors 
affecting the size of the droplets include the maximum pressure experienced, length of extrusion 
time, and number of extrusion repetitions. 
The current standard operation procedure for synthesizing NEs at NMI is a high shear 
microfluidization process where the two phases are thoroughly mixed before being introduced to 
the machine. The standard process includes a pressure of 25KPSI with 10 cycles experienced by 
the NE.  The size range obtained by this process is 100nm to 150nm, which has been shown to 
CONFIDENTIAL |  
 
16 
be an optimal size in the treatment of cancer (Ganta et. al, 2014). A range of NE research is 
currently being conducted at NMI. 
 
2.5.1: The Aqueous Phase 
 The basic components of NEs synthesized at NMI are egg lecithin and PEG2000DSPE, 
which together will self-assemble by surrounding hydrophobic components in water and leading 
to the formation of NE (Ganta et. al, 2014). Surfaces of NMI’s NEs consist primarily of 
surfactant, in this case the egg lecithin. Molecules found in egg lecithin include 
phosphatidylethanolamine (PE) and phosphatidylcholine (PC), both of which are amphiphilic 
surfactants. The next component is polyethylene glycol (PEG), which is conjugated to 1, 2-
distearoyl-sn-glycero-3-phosphoethanolamine. The combined conjugate is labeled as 
PEG2000DSPE, and the PE in the conjugate behaves the same as the PE found in the egg lecithin. 
This allows the PEG2000DSPE to also integrate itself as part of the surfactant layer during self-
assembly, and the PEG portion faces outwards. This PEG molecule helps to avert biomolecule 
and immune system adhesion, allowing for a longer circulation time of the NE (unpublished 
data, McCall, et. al, 2014).  
 
2.5.2: The Oil Phase 
Internal components of the NEs are dissolved in either safflower or flaxseed oil at NMI, 
both of which are obtained from commercial suppliers. The most prevalent fatty acid found in 
safflower oil is the linoleic acid, an omega-6 poly-unsaturated fatty acid (PUFA) (Babayan, 
1987). Linoleic acid itself is not observed at significant levels in the brain, but linoleic acid is a 
precursor for the creation of arachidonic acid that is seen at significant levels in astrocytes. This 
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was proven with rats on a diet of high amounts of linoleic acid. Correspondingly rats were 
observed to have highly significant levels of arachidonic acid in brain tissue (Dopeshwarkar et 
al., 1971). 
The main triglyceride material in flaxseed oil is α-linolenic acid, an Omega-3 PUFA 
(Vereshchagin & Novitskaya, 1965). Just as with the linolenic acid from safflower oil, α-
linolenic acid is a precursor, in this case for eicosapentaenoic acid (EPA) and for 
docosahexaenoic acid (DHA). α-linolenic acid is not found in large amounts in the brain, but 
both EPA and DHA are seen with significant amounts in brain tissue (Burdge & Calder, 2005). 
Drugs that are lipophilic can be added to the oil phase without modification, although 
some drugs do require modification to achieve effective loading in the NEs, such as the fatty acid 
derivative of TMZ (Cacaccio & Wrabel, 2014, unpublished). Use of either safflower or flaxseed 
oil has been observed to increase NE uptake to the brain; presumably the oil is used to assist in 
PUFA production in brain cells. NMI has expanded the functional potential of produced NEs 
through enhancing the oil for aid in causing more favorable distribution in vivo.  
 
2.5.3: Glioblastoma Research and Efforts at Nemucore  
NMI has assembled a strong foundational knowledge on the NEs with targeted delivery 
of chemotherapeutic drugs using NEs for breast and ovarian cancer (Ganta et al., 2014a; Ganta et 
al., 2014b). When research at NMI began on GBM, initial research showed that loading the NEs 
with safflower oil could enhance penetration of the BBB. Joseph Cacaccio and Eileen Wrabel , a 
previous team from the Biochemistry Department at Worcester Polytechnic Institute (WPI), 
worked with NMI over the 2013-2014 academic year on their Major Qualifying Project (MQP). 
This team was able to synthesize stable NEs. When loaded with chemotherapeutics, the NEs 
CONFIDENTIAL |  
 
18 
exhibited a greater toxicity to cells than the free chemotherapeutics. Cacaccio and Wrabel also 
established that the NEs are taken up through in vitro studies. Another important 
accomplishment by Cacaccio and Wrabel was the modification of TMZ. This allowed loading of 
the drug into the NEs, and a higher toxicity was seen using the NEs than with the free TMZ. 
They also began research on possible targeting ligands, isolating the Alpha-7 nicotinic 
Acetylcholine Receptor (Alpha-7 nAchR) and the Mu-Opioid Receptor (MOR) as candidates 
from literature research (Cacaccio & Wrabel, 2014, unpublished; McCall et al., 2014).  
 
2.5.4: Targeting and Imaging 
 To aid in the imaging capability of the NE, lanthanide gadolinium is chelated to 
diethylnetriamine penta-acetic acid (DTPA). This chelated compound is utilized as an imaging 
contrast enhancing agent and goes by the commercial name Magnevist (Oudkerk et. al 1995). 
This happens due to the adjacent protons’ T1 relaxation times shortening, making this compound 
useful in imaging GBM as the particle will gather in locations having new vasculature and free 
protons. Both of these qualities are found nearby and in GBM. At NMI, the chelated gadolinium 
is further conjugated to phosphatidylethanolamine (PE), allowing the PE-Gd-DTPA to be 
inserted into the NE membrane, with the PE in the membrane and the Gd-DTPA portion on the 
surface (Ganta et. al, 2014). 
 
Targeting: B2 Bradykinin, Alpha-7 nicotinic Acetylcholine, and Mu-Opioid Receptors  
Continued research at NMI has led to identifying the three main receptors for focus: the 
B2 Bradykinin receptor (B2BR), the α-7 homo-pentameter nicotinic acetylcholine receptor 
(α7nAChR), and the mu-opioid receptor (MOR). Previous research has been completed on 
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possible targeting ligands, as designing NEs, and testing NEs by a past MQP from the 
Biomedical Engineering Department of WPI (Day, Lacarra, Sacks, & Sadraei, 2015, 
unpublished). The chosen targeting ligands were conjugated to DSPE-PEG molecules to ensure 
incorporation of the targeting ligands with the NEs. To show that the targeting ligands are 
interacting with predicted and shown regions, a receptor-inhibiting drug can be used which 
should show statistically similar results when a non-targeted NE is used.  
When used for the purpose of targeting B2BR, Cereport has been reported as increasing 
the BBB permeability due to the activation of B2BR and further transient opening of the BBB 
(Bartus et. al, 2000). For inhibition of the B2BR receptor, Icatibant presents itself as a suitable 
drug. This pharmaceutical is a peptidominetic drug comprised of 10 amino acids and is an 
effective inhibitor of B2BR (Cockcroft et. al, 1994). Bradyzide, a pharmaceutical that has shown 
blockage of B2BR, could also be used (Burgess et. al 2000). 
In vivo, the main location of α7nAChR is in brain tissue, giving cause to this receptor as a 
viable NE target (Pohanka, 2012). Previous ligands used for the targeting of α7nAChR involve 
derivations and modifications to toxins from cobras and cone snails (Zhan et. al 2010). For the 
α7nAChR, nicotine, a parasympathomimetic alkaloid, has proven itself to be a strong agonist 
(Albuquerque et. al, 2009).  
 The MOR, is typically seen in both the brain and gastrointestinal tracts in mammals. A 
well-established agonist of MOR is dermorphin, a natural peptide opioid (Amiche et. al, 1988; 
Mizoguchi et. al, 2011; Broccardo et. al, 2003). An Opioid antagonist, Naloxone, is used to treat 
heroin overdose because it is such a strong competitive inhibitor of MOR. Additionally, 
naloxone has the added benefit of being the only known purely antagonist of opioid receptors to 
date, indicating that this pharmaceutical does not cause agonist effects (Evans et. al, 1974). 
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However, it has also been shown that naloxone has a relatively quick clearance time in rats 
(unpublished data). For this reason, β-funaltrexamine (β-FNA) is another option for MOR 
blocking, as this compound is able to completely block the receptors for at least week, and in 
some rats has been shown to block the receptors for up to 18 days (Martin, et. al, 1998).  
 
2.6: Clinical Imaging of the Brain 
 The diagnosis and treatment of conditions like Glioblastoma have long been reliant on 
the ability to communicate the contents of the brain to medical experts without the need for 
invasive techniques. Regarding imaging of the brain, two techniques stand out in particular, 
Positron Emission Tomography (PET) and MRI. 
PET scanning works by tracking of an ingested marker’s movement through the brain. 
This particle emits positrons as it travels through the body and can be used to track the activity of 
specific regions of the brain as they interact with the particle (Bailey, 2005). MRI presents a 
more detailed view of the structure of the imaged tissue but cannot track functional activity to the 
same extent without additional tracking methods utilized.  
 
2.7: Data Analysis  
 MRI imaging may be the current gold standard in clinical imaging of Glioblastoma, 
however processing the data from the machine remains a challenge. Upon running a single MRI 
scan, one receives several raw data files. These can easily be translated into an image, but need a 
significant amount of processing to be translated into numerical values related to each of the 174 
regions of the brain. Highly trained clinicians are able to look at MRI images on a macroscopic 
level and understand what is happening in the soft tissues by looking at the variation of 
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brightness seen among different tissues (Scherfler, 2006). Researchers, however, often need the 
data in an analyzed manner, typically numerical.  
Currently, moving data from raw MRI data to numerical form is a significant process that 
requires lots of time and resources while leaving a large margin for human error. A program that 
can quickly and accurately translate raw data into numerical values would enhance the quality 
and efficiency of translating raw MRI data into interpretable data for researchers.  
 
2.8: Rat Brain Atlas 
Dr. Craig Ferris and Dr. Praveen Kulkarni created the Atlas program to allow for 
effective visualization of sample brains. The program took 2-dimensional images of slices of rat 
brains and then utilized decimation and smoothing algorithms to produce a usable 3D map, or 
atlas, of the brain (Ferris et al., 2013). This brain atlas can be used to assist the analysis of MRI 
T1 response times in the brain by being applied in the definition of specific areas of the brain. 
The T1 response time data for each discrete region can then be analyzed separately (Day, 
Lacarra, Sacks, Sadraei, 2015). 
 
2.9: Matlab 
Matlab is a programming language commonly used across the engineering and scientific 
communities due to its ability to process and analyze large quantities of data effectively. As such 
it is an ideal candidate to analyze and manipulate the data procured from interaction with the Rat 
Brain Atlas program produced by Ferris and Kulkarni to obtain T1 relaxation data. Additionally, 
Matlab provides a robust visualization capacity which enables the visualization of results to be 
performed in the same virtual environment as they are produced, increasing simplicity and 
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reducing the risk of cross platform complications.  Further, Matlab makes it easier to ensure that 
visualization code meets medical standards. Specifically IEC 61508 and ISO 26262 are met due 
to the existence of for sale certification kits that allow programs to be tested for standard 
compliance prior to release (“Matlab: The Language of Technical Computing”, MathWorks) 
 
2.10: Statistical Analysis 
2.10.1: Specificity Index 
With raw T1 relaxation values in hand, data can be compiled from across a cohort, 
normalized, and analyzed by calculating the specificity index (SPI). Calculating the SPI can be 
done using the following equation: 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴𝑥!"# ! − 𝐴𝑥! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴𝑥!"# ! − 𝐴𝑥! !𝑛𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! − 𝐴! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! − 𝐴! !𝑚
 
In this equation, “Ax” is the targeted NE and “A” is the non-targeted NE. “Pre” represents the 
pre-scan that is done before NEs are injection, while “t” is the time point scan done 20, 40, or 60 
minutes after injection of the NE. “Voxels Section” refers to the number of voxels for that 
specific region of the brain, while “Voxels Total” refers to the total number of voxels in the 
animal. This part of the equation allows for the normalization of animals with differently sized 
brains and for sections of different sizes, where “n” is the number of animals in the targeted 
cohort, while “m” is the number of animals in the non-targeted cohort. When calculating the SPI 
of the non-targeted NEs, this equation becomes: 
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𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# !𝑛𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴! !𝑛
 
  The SPI is a relevant calculation because it allows for comparison of a targeted NE to the non-
targeted NE on a cohort level. 
 
2.10.2: Statistical Significance 
As with any life sciences project, the ability to determine the statistical significance of 
data gathered is crucial. In the scope of this project, statistical analysis is required to determine 
the significance of NE interactions in vivo. A paired t-test can be used to determine the statistical 
significance of data within a set, as well as between sets. Specifically, a t-test can compare the 
targeted NE data to the non-targeted NE data to determine the level of statistical significance 
between the cohorts. A high level of statistical significance will improve confidence that the NEs 
are accumulating differently when targeting is involved, and the data is not just overcrowded 
with noise. T-tests can be conducted using Matlab, Microsoft Excel, or most statistical analysis 
programs.  
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3: Project Strategy 
NMI has been researching and developing targeted NEs as therapies for cancer since 
founded in 2008. With a stable, size-controlled NE, the company has had preclinical animal trials 
for the targeted NEs for both breast and ovarian cancer, with plans to continue into Phase 1 
clinical trials in the near future.  
NMI has assembled a strong foundational knowledge on the NEs with targeted delivery 
of chemotherapeutic drugs using NEs for breast and ovarian cancer (Ganta et al., 2014a; Ganta et 
al., 2014b).  A previous team from the Biochemistry Department at WPI worked with NMI 
during the 2013-2014 academic year on their MQP and created stable NEs. When loaded with 
chemotherapeutics, the NEs exhibited a greater toxicity to cells than the free chemotherapeutics. 
Additionally, the team was able to show the modification of TMZ to allow for loading into the 
NEs, and a higher toxicity was seen using the NEs than with the free TMZ. Research was started 
on potential receptors to target, identifying α7nAChR and MOR as possibilities from literature 
(Cacaccio & Wrabel, 2014, unpublished; McCall et al., 2014).  
Continued research identified the B2BR as another potential target (unpublished data) 
because of the transient opening of the BBB when the receptor is activated (Chen et al., 2000). 
Using these receptors, NEs with targeting ligands were synthesized for animal trials for the 
summer of 2014. Results from this study were the basis of another MQP team working with 
NMI. This group, from the Biomedical Engineering Department at WPI, worked on analyzing 
the data and creating a Matlab statistical heat map program during the 2014-2015 academic year. 
A correlative database of the receptor expression was made using data from literature research, 
and a wire frame atlas of the brain was created. The targeting capability of NEs created was 
tested in vitro using flow cytometry and florescent imaging; however, the proposed statistical 
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heat map was not completed, and this is still desired by NMI (Day, Lacarra, Sacks, & Sadraei, 
2015, unpublished).  
 
3.1: Initial Client Statement 
Further research during the summer of 2015 at NMI led to the identification of other 
possible targeting molecules, based on inspiration from venomous animals and the mechanisms 
of attack the toxins use to penetrate the body. Supplementary examination of the mu-opioid 
receptor was completed, finding a targeted inhibitor drug to confirm that the NE was 
successfully targeting the chosen receptor. Further use of targeting ligands is now desired for 
increased confidence on the targeting capability of the NEs. Additionally, the Matlab statistical 
heat map program still needs to be created. As such, the initial client statement was given as:  
Nemucore Medical Innovations, Inc., as part of its NCI U54-funded Center for 
Cancer Nanotechnology Excellence (CCNE) research, has developed a series of 
nanomedicines which penetrate the Blood-Brain Barrier and enter the brain. 
Magnetic Resonance Imaging (MRI) can be used to track these nanomedicines in 
vivo. The focal points of this project are the following: 
o Designing and manufacturing experimental nanomedicines, as well as testing 
novel nanomedicines in vitro for uptake and potential cytotoxicity.  
o Creating a Matlab program capable of exhibiting gathered MRI drug delivery data in 
order to visualize drug distribution and intensity in vivo.  
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3.2: Objectives 
 The overall objectives of this project are to work with NMI’s technology of targeted NEs 
to target highly specific regions of the brain, and to create a 3D heat map of the brain to track the 
locations of the NEs in vivo. 
 
3.2.1: Nanoemulsion Objectives 
 NMI’s advanced NE technology has many aspects for this multi-functional NE to work 
as designed. As research is done to continue to improve this technology, there are a few areas 
this project will focus on. The overall objective will be to have functional NEs. To achieve this, 
smaller objectives have been determined and ranked. 
The primary objectives, listed in order of importance, are as follows: the ability to cross 
the blood brain barrier, the ability to be imaged, and the ability to target specific regions of 
interest in the brain. These objectives will be measured through MRI scanning and a 3D heat 
map coloration scale.  
The secondary objective of the NE design is to be able to target highly specific receptors 
throughout the brain. This will involve the use of different peptides to target different receptors. 
Comparison to non-targeted NEs will show if the targeting is effective. The ability to target 
specific receptors in the brain allows the dosage of the drug to be decreased, and in turn for the 
overall toxicity of the drug to decrease. 
The tertiary objective of this project is to load the NEs with a chemotherapeutic drug to 
kill the Glioblastoma cells. The overarching goal is to be able to eliminate Glioblastoma in a 
patient, so therefore the NEs need to be toxic towards cancerous cells. 
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3.2.2: Heat Map Objectives 
 The primary objective of the produced 3D heat map is to display the regions of 
comparatively high drug uptake among all of the tested rats. This will be accomplished by 
plotting the regions in a 3D model of the subject brains and noting areas of high signal increase 
through the use of a heat map color gradient. By displaying the regions of high NE uptake, it is 
identifiable if the NEs are targeting the intended regions. It is essential to portray locations of 
drug accumulation in order to verify the objectives of the NEs, ensuring project progress. The 
non-primary objectives for the heat map are intended to improve the ability of the user to access 
and understand the information it portrays. This ensures any user with a basic understanding of 
MRI technology and imaging could use the program and be able to understand the images 
created. 
The secondary objective is the addition of functionality to the visualization program, in 
such that individual slices of the heat mapped wireframe are selectable for individual viewing, 
allowing greater in depth analysis. In order to increase the ability for a doctor to watch the drug 
take effect on the tumor, there must be a simplified but informational image available. The 
tertiary objective is the optimization of the software’s usability. This can be achieved through 
limiting the required input from an untrained user to non-technical tasks such as the selection of 
slices (by index number, not by location in the wireframe x, y, z coordinate system). 
 
3.3: Constraints 
As with any project, there are some constraints this project will have to work around in 
order to be successful. Both the NE and heat map aspects of this project have some constraints. 
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There are some general project constraints as well, including time and money. Animal work 
takes time, is expensive, and involves many different collaborators to be successful. Since NMI 
is funding this project, the money is less of a constraint than time, since only one academic year 
is given to complete the above objectives while NMI will be providing any needed supplies. 
 
3.3.1: Nanoemulsion Constraints 
 As research is done to improve the NE technology, there are a few constraints to consider 
during the design process. First, it is important that the NEs stay within an identified size range, 
such as 120 nm to 160 nm, in order to retain storage stability. Second, the NE must be able to 
cross the BBB, for if it cannot reach the targeted region of the brain tissue, the design will be 
considered ineffective. A third constraint is the feasibility of manufacturing. Even though a 
peptide is designed, not all configurations are relatively easy to make, much less feasible. Some 
chemical reactions in producing selective peptides require more time and delicate, exact 
procedures. Additionally, all peptides designed will need to be PEGylated in order to be 
successfully incorporated into the NE surface. 
 
3.3.2: Heat Map Constraints 
 The main constraints limiting the heat map program are as follows. Outliers in the MRI 
signal response data can result in the false reporting of NE accumulation in a region as being 
lower or higher than is true over the cohort tested. Due to the safety protocols in place at 
Northeastern University, the team members do not handle or carry out the experimentation with 
the rats, and it is therefore out of the team’s control how the data is recorded. Errors in the 
manual alignment of the established rat brain structure and the actual MRI image of the rat brain 
could result in false reporting of the location of signal intensities, and therefore drug 
CONFIDENTIAL |  
 
29 
concentration location. The program that allows for MRI scan and rat brain atlas alignment, 
Atlas, is not capable of correctly aligning the two automatically. This makes manual alignment 
mandatory. Finally, the heat map must be made using the previously defined Rat Brain Atlas 
Wireframe in Matlab, eliminating the possibility for use of other programing languages,  
 
3.4: Design Standards 
 NMI is a private pharmaceutical development company; therefore, the company’s goal is 
to get their medicines on the market for patients to use. With this end goal in mind, it is 
important that everything they do is completed and recorded correctly so they will eventually be 
able to gain approval from the United States Food and Drug Administration (FDA). It is also 
pertinent that all current standards are followed, as outlined in the following sections. 
 
3.4.1: Nanoemulsion Standards 
 As of 2014, there have been no official regulations regarding nanomedicines, as they are 
being assessed case-by-case (Tinkle, 2014). However, guidance was issued in 2014 regarding the 
application of nanotechnology and confirming whether or not a product is considered 
nanotechnology. A main consideration of that is the size, ranging from 1 nm - 100 nm. While the 
intended size of the produced NE will be greater than 100 nm, they will still be under 1 µm in 
size, categorizing them as nanotechnology ("Guidance," 2014). Recommendations have been put 
forth for the regulation of nanomedicines due to their potential (Tinkle, 2014). The authors 
mention controls needed and evaluations to be done in order to establish that the product is 
therapeutic, reproducible, and safe. Manufacturing should be controlled since the NE synthesis 
involves a variety of complex processes. The product should be evaluated in terms of 
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pharmacokinetics and pharmacodynamics to ensure that properties of the NE are true to what the 
producers state, are therapeutic within safety ranges, and that the NE are characterized 
completely (Tinkle, 2014). The quality and stability of the NE are also important aspects (Tinkle, 
2014). Manufacturing of the NEs will need to be done following Title 21, Section 820 of the 
United States Code of Federal Regulations, which outlines current Good Manufacturing 
Processes (cGMP) for medical devices, and Title 21, Section 211 of the United States Code of 
Federal Regulations, which outlines cGMPs for drugs. Further cGMP standards can be found in 
section 7.1. 
 
3.4.2: Programing Standards 
 The primary engineering standard applying to the Matlab Code is IEC 61508 
(International Electrotechnical Commission standard 61508). IEC 61508 defines standards of 
hazard exposure and risk of physical harm to human patients involved in the use and data 
collection of medical imaging software. Our program is in compliance with this standard due to 
the separation acquired data from any identifying features of each patient. NMI will need to store 
and data that applies to the patient population in a separate xml file in the format outlined by the 
Dublin Core Metadata Initiative xml schema. The Initiative xml schema guidelines are open to 
the public intended to allow the more effective storage and sharing of metadata. 
 
3.5: Revised Client Statement 
Since the initial client statement, NMI has kept a clear and focused image of the in vivo 
experimental portion. The MRI T1 visualization, by brain location and region, has a primary 
success / fail objective, and decisions for continued improvements of the program have been left 
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to the group with input from NMI. Therefore, the revised client statement is similar to the first, 
although clarifications are made connecting the targeting experiments and image analysis in 
order to expose the necessary connection between the two. With both, targeting specificity can 
be proven for continued research in the future. The final client statement is as follows: 
Nemucore Medical Innovations, Inc., as part of its NCI U54-funded Center for Cancer 
Nanotechnology Excellence (CCNE) research, has developed a series of nanomedicines 
which penetrate the Blood-Brain Barrier and enter the brain. With the Nanoemulsion 
technology so far developed by Nemucore Medical Innovations, Inc., the aim is to create 
an inclusive imaging and analysis program to prove the targeting specificity of 
Glioblastoma Multiforme treatment and improve therapeutic diagnosis. A Matlab 
program able of visualizing MRI drug delivery data to show the distribution by intensity 
and location will be created. Upon designing and manufacturing novel Nanomedicines, 
in vivo MRI studies will be completed to improve the statistical power of the MRI data in 
showing specific targeting in the rat brain. 
 
3.6: Project Management 
 Timely completion of this project will require careful planning and the guidance of many 
different mentors. A Gantt Chart of the tasks to be completed and the timeline of deadlines can 
be seen in Appendix A. Dr. Timothy Coleman, Dr. Niravkumar Patel, and Dr. Aleksandr Piroyan 
of NMI will provide insight and guidance with the biochemistry aspect of this project. Laurie 
Cote of NMI will provide guidance with the computer science aspect of this project. Dr. Craig 
Ferris and Dr. Praveen Kulkarni of Northeastern University will provide insight into the biology 
and function of the brain, as well as aiding with the completion of the MRI scans. Dr. Kwonmoo 
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Lee of WPI will advise the team on the design aspect of this project, as well as the use of 
medical imaging. 
 
4: Design Considerations 
Following the establishment of a project strategy, analysis was conducted in order to 
create preliminary designs for both the nanoemulsions and the visualization program for in vivo 
studies. These designs take into account and meet specifications, needs, and wants of recipients 
and prospective users. 
 
4.1: Nanoemulsions Needs Assessment 
4.1.1: Nanoemulsion Objectives 
As the nanoemulsions will be used for imaging as well as drug delivery later on, it is 
important to consider objectives relating to the delivery, biocompatibility, manufacturing, and 
stability of them. In order to understand which of these objectives are the main focuses of the 
project, each objective was ranked on a 1-5 scale (5 being the most important) based on NMI’s 
desired product. Table 1 displays the ranking for the objectives. 
Table 2: Nanoemulsion Objectives 
Objective Score 
High uptake by cells 4 
Non-Toxic 4 
Ease of Manufacturing 3 
Stability over Time 5 
Low Cost 2 
 
As can be seen above, the highest-ranking objectives are a consistent stability, high 
cellular uptake, and non-toxicity to the animals. The lower objectives are ease of manufacturing 
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and low cost. By following these objectives, nanoemulsions can be manufactured consistently 
with optimal properties that can be used for both initial research and future pre-clinical studies. 
 
4.1.2: Nanoemulsion Functions 
After defining the core objectives in designing and synthesizing the nanoemulsions, it is 
important to also define the desired functions of the nanoemulsions. Below in Table 2 it can be 
seen the exact functions and specification that should be met by the designed nanoemulsions. 
Table 3: Nanoemulsion Functions and Specifications 
Function Specification 
Consistent Size 150 nm with Polydispersity Index (PDI) <0.1 
Negatively Charged NE surface -20 to -50 mV +/- <10mV 
Stability over a long time <10 nm size change over 3-4 weeks 
Fluorescence capability for uptake studies Rhodamine loading onto NEs 
Targeting Capability Target ligands based on chosen receptors 
MRI compatibility Attachment of imaging agents to the surface 
 
In order to justify the specifications of the defined functions, it is important to look at 
research previously accomplished at NMI as well as at other institutions. It has been established 
by NMI that a size of ~150nm is ideal with a polydispersity index (PDI) <0.1 (Ganta et al., 
2014). This allows for a feasible combination of components, a stable particle, and passage 
through loose junctions and fenestrations. The particles should have a negative surface charge of 
-20 to -50 mV ± 10mV to avoid aggregation and cell detection. As nanoemulsions may need to 
be stored between manufacturing and use, they need to be stable for periods of time. For this 
project, “stable” will be defined as <10 nm size change over 3 weeks (Cacaccio & Wrabel, 2014, 
unpublished; Day, Lacarra, Sacks, & Sadraei, 2015, unpublished). When testing uptake of the 
nanoemulsions in the brain, some form of tracking is needed. Therefore, the ability to connect 
different imaging agents (Gadolinium for MRI imaging, Rhodamine for flow cytometry uptake 
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studies) to the outside of the nanoemulsion for uptake in the brain is needed. Lastly, the ability to 
manufacture and attach different targeting agents, allows for a selective receptor mediated 
endocytosis uptake of the nanoemulsions in specific areas of the brain making the direction of 
the nanoemulsions controlled which is essential to the design. 
 
4.1.3: Nanoemulsion Design Standards 
Currently there are no design standards or regulations set in place by the Federal Food 
and Drug Administration (FDA) regarding nanomedicines. Instead, the FDA has turned to 
evaluating each nanomedicine on a case-by-case basis, with the main consideration being the 
active principle ingredient (API) (Lai et al., 2013, Sainz et al., 2015). Biologics with peptides fall 
into the category of biological medicinal product regulations, but when used at the nanoscale 
level of medicine, other parameters need to be examined (Bowman, 2010, Sainz, 2015).  The 
FDA has joined with the Alliance for NanoHealth (ANH) in creating seven priorities in 
nanomedicine analysis challenges: biodistribution, mass transport, imaging methods, math 
models, computational models, and standardized analytical methods for manufacturing (Sanhai 
et al., 2008).  Scientists in the field hope for a database comprised of nanoemulsion 
characteristics depending on the materials used, as a knowledge source such as this would 
contribute greatly to the standardization of nanoemulsions (Chan, 2006). With the small size of 
nanomedicines and their potential for targeting ligands, therapeutic loading, and imaging agents 
it is important to ensure the distribution and cytotoxicity of the nanoemulsions to be used are 
within safe ranges.  
The Nanotechnology Characterization Laboratory has created guidelines for assays of 
nanoemulsions in regards to safety assessment (U.S. Institutes of Health, 2015). Of these safety 
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assessments, they are categorized by characteristics. These include size, surface characteristics, 
stability, zeta potential, efficacy of therapeutics and imaging, distribution, and targeting among 
others (www.ncl.cancer.gov). The functions listed previously can be quantified by using 
experimental procedures detailed in the Materials & Methods section.  
 
4.1.4: Conceptual Nanoemulsion Designs 
 NMI has been working on the development of their theranostic nanoemulsions since it 
was founded in 2010. While this project focuses specifically on development of the NMI-800 
series nanoemulsions, the general concept and some of the specifications have already been 
established by NMI. Figure 6 shows the nanoemulsions concept as established by NMI. The 
nanoemulsions are composed of a flaxseed oil core containing chemotherapeutic agents, a lipid 
layer, targeting ligands, and imaging agents. The oil core allows for the stabilization of the 
therapeutic and uptake by the brain. PEG-ylated binding ligands allow for uptake by selective 
cells. PEG-ylated Gd+DTPA allows for imaging in vivo.  
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Figure 6: A Representative Schematic of a Nanoemulsion. 
Targeting with Receptors: Bradykinin, Alpha-7, and Mu-Opioid Receptors  
This project focuses specifically on the development and testing of different binding 
ligands. NMI has requested that the team focuses on the use of the Mu-Opioid Receptor (MOR), 
the Alpha-7 nicotinic Acetylcholine Receptor (α7nAChR), and the B2 Bradykinin Receptor 
(B2BR). NMI has chosen these receptors due to completed research showing expression in the 
brain, and because of previous work done on this project (Cacaccio & Wrabel, 2014, 
unpublished; Day, Lacarra, Sacks, & Sadraei, 2015, unpublished). The chosen targeting ligands 
were conjugated to DSPE-PEG molecules to ensure incorporation of the targeting ligands with 
the NEs.  
The MOR is typically seen in both the brain and gastrointestinal tracts in mammals. A 
well-established agonist of MOR is dermorphin, a natural peptide opioid (Amiche et. al, 1988; 
Mizoguchi et. al, 2011; Broccardo et. al, 2003).  In vivo, the main location of α7nAChR is in 
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brain tissue, giving cause to this receptor as a viable NE target (Pohanka, 2012). Previous ligands 
used for the targeting of α7nAChR involve derivations and modifications to toxins from cobras 
and cone snails (Zhan et. al 2010). When used for the purpose of targeting B2BR, Cereport has 
been reported as increasing the BBB permeability due to the activation of B2BR and further 
transient opening of the BBB (Bartus et. al, 2000).  
    
Targeting Ligands: Dermorphin, Candoxin, and Cereport 
 Previous work at NMI has explored the efficacy of the peptides Dermorphin, Candoxin, 
and Cereport (Cacaccio & Wrabel, 2014, unpublished; Day, Lacarra, Sacks, & Sadraei, 2015, 
unpublished). Targeting of the MOR can be done with the Dermorphin peptide, seen in figure 7.  
 
 
 Figure 7: Dermorphin  
The α7nAChR can be targeted with Candoxin, seen in figure 8.  
 
Figure 8: Candoxin 
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The B2BR antagonist Cereport can be used for targeting of this receptor. The structure of 
Cereport can be seen in figure 3.1 
 
Figure 9: Cereport 
Imaging with Gadolinium  
To aid in the imaging capability of the NE, the lanthanide gadolinium is chelated to 
diethylnetriamine penta-acetic acid (DTPA). This chelated compound is utilized as an imaging 
contrast enhancing agent and goes by the name Magnevist (Oudkerk et. al 1995). This happens 
due to the adjacent protons’ T1 relaxation times shortening, making this compound useful in 
imaging GBM as the particle will gather in locations having new vasculature and free protons. 
Both of these qualities are found nearby and in GBM. At NMI, the chelated gadolinium is further 
conjugated to phosphatidylethanolamine (PE), allowing the PE-Gd-DTPA to be inserted into the 
NE membrane, with the PE in the membrane and the Gd-DTPA portion on the surface (Ganta et. 
al, 2014). While gadolinium is known to be a toxic heavy metal, it has been established that in 
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such small doses in chelated form, it is harmless (Cacaccio & Wrabel, 2014, unpublished; Day, 
Lacarra, Sacks, & Sadraei, 2015, unpublished; Ganta et. al., 2014a, Ganta et. al., 2014b). 
 
Levels of Imaging Particles and Targeting Peptides 
 NMI has a standard of 300 binding peptides and 300 particles of imaging agent per 
nanoemulsion (Ganta et. al. 2014a; Ganta et. al., 2014b.) The T1 relaxation time measured will 
directly correlate to the Gadolinium concentration that is present, and therefore indicate how 
many nanoemulsions are present. Knowing how much chemotherapeutic is in each nanoemulsion 
(measured by a high performance liquid chromatography (HPLC) assay), it then becomes 
possible to know how much drug is being delivered. Figure 10 represents this relationship 
visually. 
 
Figure 10: Relationship of T1 Relaxation Time to Drug Concentration 
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4.1.5: Alternative Nanoemulsion Design Features 
 As NMI has been developing the NE technology for several years, many engineering 
decisions were pre-defined for the team. However, as part of this project, the tem did consider a 
few alternative design features to enhance the properties o the NE. In the creation of the targeting 
ligands, a short spacer sequence was added onto the end. This short sequence is intended to aid 
in keeping the peptide oriented out from the NE surface, and has been shown to enhance cell 
uptake (Stefanick et al., 2013a, Stenfanick et al., 2013b). This design feature was accepted by 
NMI and incorporated into the NEs used in this project.  
 Another alternative design feature that the team considered was the use of different 
targeting ligands. Four alternative ligands were developed and accepted by NMI. They were not 
ale to be tested during this project due to time limitations and a focus on the original targeting 
peptides, but these four have been designed and manufactured, and are currently in stock at NMI 
awaiting lipidation. These peptides are: ARIB (figure 11), DCandoxin (figure 12), and two 
others. The latter two peptides and sequences are proprietary materials.   
Toxins from snakes and cone snails have been used in previous research for identifying 
various receptors of the nervous system to target. Of these, there are toxins that target nicotinic 
acetylcholine receptors (nAChR), known as alpha-Conotoxins (alpha-Ctxs) (Whiteaker, 2007). 
In a study completed by Whiteaker, an alpha-Ctx was derived from C. arenatus, and various 
alpha-Ctxs and analogues were analyzed (Whiteaker, 2007).  Of those studied, ARIB [V11L, 
V16A] was shown to be highly selective for alpha-7 receptors, with an IC50 of 0.356nM when 
tested for blocking of Xenopus oocyte-expressed nAChRs. The next most highly selective 
modified ligand was ARIB [V11L, V16D]. It was decided to select ARIB [V11L, V16A] to 
attach to DSPE-PEG-MAL for use in the NEs. A tail of CKKK amino acids was added to the N-
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terminus, and it is important to note the di-sulfide bridge between the third and ninth residue, as 
well as between the fourth and seventeenth residue.  
 
Figure 11: ARIB 
The next ligand chosen was D-CDX, or the D-amino acid version of Candoxin, a known 
nACh toxin from the malayan krait, a highly venomous snake (Nirthanan, 2003). Nemucore has 
previously used candoxin as a targeting ligand to study the alpha-7 receptor with their NEs 
(Cacaccio & Wrabel, 2014, unpublished; Day, Lacarra, Sacks, & Sadraei, 2015, unpublished). 
One group of researchers synthesized the retro-inverse form of CDX, and performed 
competition-binding studies. The percentage of D-CDX to cross the BBB was twice as great as 
the amount of CDX to cross the BBB (Wei, 2015). In vivo imaging studies demonstrated the 
capability of D-CDX to cross the BBB was much greater than that of CDX when conjugated to 
liposomes. (Wei, 2015). For these reasons, the retro-inverse form of CDX was chosen as a 
targeting ligand.  
 
Figure 12: DCandoxin 
 Additionally, two more ligands were chosen as targeting ligands for liposomal use. These 
ligands target lipoprotein receptors, which appear in high density in the brain, and cross the 
BBB. The second of the two ligands is the retro-inverse form of the first ligand. The D-isomer 
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has been shown to survive significantly longer in serum than the first ligand and accumulates to a 
greater degree in the brain. Due to these ligands’ ability to cross the BBB with high efficacy, 
they were chosen as ligands to be conjugated for experimentation. Due to confidentiality the 
names of the ligands, sources, and diagrams of the ligands have been omitted.  
 
4.2: Programming Needs Assessment 
In order to be effective, the finished program must meet specific criteria. The user 
interface must be simple and well explained with a user guide and through in-program prompts 
such that any user with no previous Matlab or programming experience could operate it easily 
and efficiently. The final visual must be clear and easy to understand, with differences between 
the specificity indexes being clearly communicated in the gradation of coloration across the 
display. 
 
4.2.1: Objectives 
 The visualization program is intended for use by individuals with a focus on biology, as 
opposed to those who are necessarily well versed in programing. As such, the program needed to 
be optimized for user friendliness by limiting the required interaction with the user through 
simple and critical steps. The program additionally needed to be able to import, read, and 
interpret large quantities of data without crashing and within a reasonable time frame. Finally the 
program required imaging functionality from its base language, Matlab, in order to be able to 
effectively produce the 3D brain model. 
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4.2.2: Functions 
 The program’s ability to process data and the ability to produce images are ranked above 
optimizing it for user friendliness, as they are important for the actual functionality of the 
program, as opposed to reducing time consumption during its use. 
Table 4: Programming Functions and Specifications 
Function Specification 
Take in and manipulate data Written in a language capable of accepting and manipulating 
excel files 
Produce an image based on 
acquired data 
Written in a programming language with image creation 
capability 
Automate program Program only requires data and conditions to effectively 
produce the 3D brain map 
 
4.2.3: Decisions 
In order for the program to be capable of carrying out its critical functions (data analysis 
and image creation), it was decided to create the program in the Matlab programming language. 
Matlab is a standard data analysis program in the engineering field due to its ability to process 
large data sets that other data analysis tools, such as Microsoft excel, cannot. Matlab additionally 
has an inbuilt suite of image creation and manipulation tools. These advantages were determined 
to more than reconcile Matlab’s perceived lack of user friendliness. This characteristic was 
addressed through the implementation of a user manual and text based prompts in the usage of 
the program. 
 
4.2.4 Alternative Designs 
 Following the identification of the selected programming language the team produced 
and presented to the sponsor two conceptual approaches to the creation of a three dimensional 
Heatmap of the rat brain. The first conceptual method was the production of a program that 
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would produce a 3D model of the rat brain by producing colored surface objects (3-dimensional, 
rotatable images) to represent each region of the brain. These regions would then be assembled 
together to form the whole rat brain for comparison of uptake across the areas of the brain, with 
the functionality of Matlab’s “slice” command giving the ability to view the internal segments of 
the rat brain model from any angle. The second conceptual method was the application of 
coloration to each of the wireframe slices. This would be accomplished by defining each of the 
regions as they appear in the wireframe so that they could be reproduced as flat colored images 
by Matlab’s fill3 () function. The primary difference between these two approaches is the form 
taken by the produced 3-dimensional heatmap, as the required data analysis and definition of 
regions (the processes for which are described in sections and respectively) remain the same. The 
surface production approach would create a volumetric heat mapped model of the brain which 
could then be analyzed through the use of Matlab’s “slice” command to view its internal 
components. In contrast the wireframe coloration would produce a representative model of the 
brain, with stacked 2-dimensional heat mapped slices of the brain forming a 3-dimensional 
structure with empty space between the slices to allow the visualization of the brain’s shape. The 
surface approach would provide a more understandable visualization of the brain, as it would 
depict a full rat brain instead of a series of slices. The wireframe approach however depicts the 
same data with the same degree of efficiency as the surface approach, with the additional 
advantage of  requiring less memory to produce due to the computational disadvantages of the 
surface objects used in the alternate approach. Despite the less visually pleasing nature of the 
wireframe approach, it was ultimately selected due to its parity with the surface approach in 
terms of communicating the data coupled with its lower system requirements. 
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5: Materials and Methods 
 With the previously outlined needs, objectives, and goals in mind, the following 
procedures were developed and enacted. All work was done following NMI’s standard operating 
procedures (SOPs), and is disclosed appropriately according to NMI’s confidentiality agreement. 
 
5.1: Materials 
L-α-phosphatidylethanolamine transphosphatidylated (Egg, Chicken) (ePE)  were 
purchased from Avanti Polar Lipids (Alabaster, AL). Egg phosphotidylcholine (Lipoid® E80) 
was received from Lipoid GmbH (Ludwigshaffen, Germany). 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy-(polyethyleneglycol)-2000] (mPEG2000-DSPE) and 1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000] 
(ammonium salt) (DSPE-PEG2000-MAL) were purchased from Laysan Bio Inc., (Arab, AL). 
Dermorphin, Candoxin, Cereport were purchased from A1 BioTech, (Richmond, VA). All other 
chemicals and solvents used were of the highest available grade. 
 
5.2: Nanoemulsions 
5.2.1: Manufacturing 
Synthesis of lipidated gadolinium chelate (Gd-DTPA-ePE) 
The lipidated gadolinium (III) chelate was synthesized by a revised method used by NMI. 
A solution of 1 g (1.377 mmol) of L-α-phosphatidylethanolamine transphosphatidylated (egg 
PE) and 300 µL of triethylamine in 10 mL of chloroform was added dropwise to a solution of 
diethylenetriaminepentaacetic dianhydride (DTPA) (4.0 g, 11.197 mmol) dissolved in 200.0 mL 
of dimethylsulfoxide (DMSO). The mixture was stirred for 3 hours under nitrogen atmosphere at 
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25oC after which the chloroform was removed by gas nitrogen stream, and the reaction mixture 
was stirred overnight at 25oC. The mixture was dialyzed (3.5 kDa MWCO) for 2 hours against 
15% DMSO, then for 2 hours against 7.5% DMSO, and for 2 hours against 3.75% DMSO in 
water. For the remaining 66 hours of dialysis, the mixture was dialyzed against DI-water. The 
mixture was lyophilized for 72 hours to obtain 1.35 g (1.226 mmol) of intermediate DTPA-PE. 
The crude intermediate so obtained was dissolved in 75 mL of DMSO. The solution of 0.485 g 
(1.839 mmol) of gadolinium (III) chloride in 3.0 mL of DI-water was added dropwise to the 
DTPA-PE solution. The solution was stirred overnight at 25oC. Then the reaction mixture was 
purified by dialysis against 5% DMSO for 2 hours and then a pure DI-water for 70 hours. The 
solution was lyophilized and 1.41 g (1.124 mmol) of Gd-DTPA-ePE was obtained. 
 
Synthesis of Lapidating Targeting Ligands  
Synthesis of DSPE-PEG2000-Demorphin 
55.3 mg (0.0188 mmol) of DSPE-PEG2000-MAL was dissolved in 40ml of 50 mM 
HEPES buffer. 29.1 mg (0.0226 mmol) of free peptide was added to the solution above. Reaction 
mixture was stirred for 4 hours at room temperature and then 20 hours at 4oC. The next day the 
mixture was dialyzed at 25oC against DI water using MWCO 6-8K dialysis membrane for 72 
hours with frequent water change. Dialyzed solution was frozen and freeze-dried for 72 hours. 
The yield of the product was 56.7 mg (71.3%) of white powder. 
 
Synthesis of DSPE-PEG2000-Candoxin 
13.3 mg (0.0045 mmol) of DSPE-PEG2000-MAL was dissolved in 10ml of 50 mM 
HEPES buffer. 13.4 mg (0.0054 mmol) of free peptide was added to the solution above. Reaction 
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mixture was stirred for 4 hours at room temperature and then 20 hours at 4oC. The next day the 
mixture was dialyzed at 25oC against DI water using MWCO 6-8K dialysis membrane for 72 
hours with frequent water change. Dialyzed solution was frozen and freeze-dried for 72 hours. 
The yield of the product was 20.1 mg (82.2%) of white powder. 
 
Synthesis of DSPE-PEG2000-Cereport 
29.1 mg (0.0099 mmol) of DSPE-PEG2000-MAL was dissolved in 20ml of 50 mM 
HEPES buffer. 19.7 mg (0.0119 mmol) of free peptide was added to the solution above. Reaction 
mixture was stirred for 4 hours at room temperature and then 20 hours at 4oC. The next day the 
mixture was dialyzed at 25oC against DI water using MWCO 6-8K dialysis membrane for 72 
hours with frequent water change. Dialyzed solution was frozen and freeze-dried for 72 hours. 
The yield of the product was 31.9 mg (70.1%) of white powder. 
 
Preparation of Theranostic Nanoemulsion  
Nanoemulsion formulation with gadolinium and targeting ligand on the surface was 
prepared by high shear homogenization method using lab scale LV1 Microfluidizer 
(Microfluidics Corporation, Newton, MA). Aqueous phase of the nanoemulsion formulation was 
prepared by dissolving egg lecithin (2.4% w/v), and PEG2000DSPE (0.3% w/v) in 4 ml of 
glycerol-water, to which the appropriate amount of targeting ligand such that 300 molecules 
were on the surface of each droplet was added. The sample was vortexed for one minute and 
stirred for 2 h to achieve complete dissolution of all components. Oil phase consisted solely of 
flaxseed oil for initial testing. Aqueous and oil phases were heated (60°C, 2 min), mixed and 
then homogenized at 25,000 psi for 10 cycles to obtain the nanoemulsion formulations. 
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Corresponding non-targeting nanoemulsions were prepared in the same manner without any 
targeting ligand added.  
 
Nanoemulsion Characterization by Particle size and zeta potential analysis  
 Particle size distribution of nanoemulsions were determined with dynamic light scattering 
method using a Zetasizer ZS (Malvern, UK).  The samples were diluted in deionized water and 
the droplet size was determined at 90o angle and at 25oC temperature using refractive index of 
1.45. PDI was used as a measure for calculating particle size distribution. The zeta potential 
value of nanoemulsion was determined with Zetasizer ZS based on the electrophoretic mobility 
of the nanoemulsion droplets. 
 
5.2.2: Use of Nanoemulsions 
In vivo Imaging of Healthy Rat Brains 
Variable TR images were acquired using RARE pulse sequence (TE=12.5 and TR: 450, 
800, 1400, 2200, 6000, msec.) Images were acquired with a field of view [FOV] 3cm2, data 
matrix = 128×128×20 slices, thickness = 1 mm. T1 measurements were computed using 
Paravision 5.1 software (Bruker, Billerica, Massachusetts) by fitting absolute signal at particular 
TR.  Isoflurane was constantly supplied throughout the imaging session using a nose cone to 
maintain a respiratory rate between 40 and 60 breaths per minute. During image acquisition, the 
respiratory rate was monitored continuously using a small animal heating and monitoring system 
(SA Instruments, Stony Brook, NY). After the first baseline scan (pre-dose scan) of whole brain, 
rats were administered a total dose by tail vein injection of targeted nanoemulsion enriched in 
Gd+ (n=7).  An additional cohort of animals was also injected with a non-specific Gd+-enriched 
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nanoemulsion (n = 7) as a control. The injection volume was determined using the following 
equation, which is derived during the manufacturing of the nanoemulsions:  
1𝑚𝑙0.0159𝑚𝑚𝑜𝑙 𝐺𝑑𝑘𝑔 𝑋 0.072𝑚𝑚𝑜𝑙
𝐺𝑑𝑚𝑙1𝑘𝑔 𝑋 𝑅 𝑘𝑔 = 𝑉 𝑚𝑙 
where R represents the mass of the rat in kilograms, and V represents the volume of injection in 
milliliters.  
In a subsequent study rats (n = 5) were pretreated via an intracerebroventricular (ICV) 
injection with 40 nano-moles (1.227mg B-FNA in 1ml of 0.9% saline; 16µl of solution) of the 
selective MOR antagonist B-funaltrexamine hydrochloride (B-FNA) (Tocris Bioscience, Bristol, 
England) (Martin et al., 1998). Three to four days later they were tested with the targeted 
nanoemulsion. After dosing, MR scans were commenced to capture post dosing time points of 
20min, 40min and 60min. 
 
MRI Alignment and Data Analysis 
Each healthy rat brain scan at 0min, 20min, 40min and 60min was registered to a 3D 
segmented and annotated Rat Brain Atlas (Ekam Solutions LLC, Boston MA.). The alignment 
process was facilitated by an interactive graphic user interface EVA. The affine registration 
involved translation, rotation, and scaling in all 3 dimensions independently. The matrices that 
transformed the subject’s anatomy to the atlas space were used to embed each slice within the 
atlas. All transformed pixel locations of the anatomy images were tagged with the segmented 
atlas regions, creating a fully segmented representation of each subject. T1 parameter values for 
each ROI were computed based on each segmented map.  
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Percent Change 
% Change decrease in T1 values at each time point and in each major regions and 
specific regions was calculated at 20min, 40min and 60min time point as described: 
 % 𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝑇1 𝑣𝑎𝑙𝑢𝑒 
= (𝑇1 𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 1 𝑝𝑟𝑒𝑠𝑐𝑎𝑛 −  𝑇1 𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 1 𝑎𝑡 𝑝𝑜𝑠𝑡 𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡)(𝑇1 𝑖𝑛 𝑟𝑒𝑔𝑖𝑜𝑛 1 𝑝𝑟𝑒𝑠𝑐𝑎𝑛)  𝑥100 
 
Statistical student’s t tests were performed on % change of T1 value for the 174 brain regions of 
each subject. T-test statistics using a 95% confidence level, 2-tailed distributions, and 
heteroscedastic variance assumptions were performed. 
 
Specificity Index 
With raw T1 relaxation values in hand, data can be compiled from across a cohort and 
normalized by calculating the specificity index (SPI). Calculating the SPI can be done using the 
following equation: 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴𝑥!"# ! − 𝐴𝑥! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴𝑥!"# ! − 𝐴𝑥! !𝑛𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! − 𝐴! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! − 𝐴! !𝑚
 
In this equation, “Ax” is the targeted NE and “A” is the non-targeted NE. “Pre” represents the 
pre-scan that is done before NEs are injection, while “t” is the time point scan done 20, 40, or 60 
minutes after injection of the NE. “Voxels Section” refers to the number of voxels for that 
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specific region of the brain, while “Voxels Total” refers to the total number of voxels in the 
animal. This part of the equation allows for the normalization of animals with differently sized 
brains and for sections of different sizes, where “n” id the number of animals in the targeted 
cohort, while “m” is the number of animals in the non-targeted cohort. When calculating the 
specificity of the non-targeted NEs, this equation becomes: 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴!"# !𝑛𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴! ! +⋯+ 𝑉𝑜𝑥𝑒𝑙𝑠 𝑆𝑒𝑐𝑡𝑖𝑜𝑛!𝑉𝑜𝑥𝑒𝑙𝑠 𝑇𝑜𝑡𝑎𝑙! 𝐴! !𝑛
 
 
Statistical Significance 
A paired t-test was completed using Microsoft Excel software to determine the statistical 
significance of results between cohorts 
 
5.3: Programming 
To accurately convey results to the parties whom they would concern, a visual aid in the 
form of a heat mapped brain was produced to make SPI and T-test data more understandable and 
accessible. This was achieved by plotting out the locations in the 3D brain model that 
corresponded to each of the 174 regions of interest. Regions are then assigned coloration based 
on the SPI value or the level of statistical significance. This coloration assignment tool was also 
used to display the theoretical locations of receptors throughout the brain, to allow for 
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comparison between the hypothesized targeting behavior and the behavior that was observed 
experimentally. 
 
5.3.1: Quality Control 
To ensure that the visualization code worked as intended, the coloration and mathematic 
analysis code needed to be run through quality control procedures. This ensured that the 
individual components of the visualization process worked as intended, and were therefore 
capable of producing an accurate end image. The coloration code was tested by feeding in a 
series of data sets in which only single regions met the criteria for coloration. The resulting 
images were then analyzed to confirm the region intended to meet the criteria was colored, and 
was the sole region assigned color. This procedure was undertaken for all 174 regions of interest 
across all 63 imaged brain slices. 
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6: Design Verification 
 Previous results from NMI and raw results from experiments completed show promise 
towards the success of this project. This section is a presentation of the raw results for the 
project, leading to a positive go-ahead for the remainder of the project.  
 
6.1: Nanoemulsions 
 Each batch of nanoemulsion is tested to ensure that the batch was manufactured within 
the required limits. The batch is then monitored for up to three weeks to ensure the stability of 
the nanoemulsions. Stability testing of nanoemulsions includes testing the size, polydispersity 
index (PDI), and zeta potential of a small aliquot from each batch. Results can be seen in tables 
4-7. At the time of testing with the non-targeted nanoemulsion, the nanoemulsion was mostly 
frozen during transportation to the testing site. A check-up stability test was done with a sample 
retrieved after MRI scans were completed to ensure no significant damage was done to the NEs.  
Table 5: Stability Measurements for Non-targeted Nanoemulsion 
Non-targeted Nanoemulsion Day 0 Day 6 
Size (nm) 140.2 155.2 
PDI 0.078 0.121 
Zeta Potential (mV) -60.8 -52.0 
Zeta Potential Standard Deviation 9.65 13.4 
 
 
Table 6: Stability Measurements for Dermorphin Nanoemulsion 
Dermorphin Nanoemulsion Day 0 Day 7 Day 14 Day 21 
Size (nm) 150.1 143.0 143.0 149.2 
PDI 0.061 0.108 0.073 0.095 
Zeta Potential (mV) -40.5 -44.4 -43.1 -42.8 
Zeta Potential Standard Deviation 10.5 12.5 9.52 9.41 
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Table 7: Stability Measurements for Candoxin Nanoemulsion 
Candoxin Nanoemulsion Day 0 Day 7 Day 14 Day 21 
Size (nm) 142.2 149.7 147.9 153.9 
PDI 0.061 0.129 0.093 0.087 
Zeta Potential (mV) -49.2 -38.1 -39.6 -39.5 
Zeta Potential Standard Deviation 12.4 10.5 10.0 9.48 
 
Table 8: Stability Measurements for Cereport Nanoemulsion 
Cereport Nanoemulsion Day 0 Day 7 Day 14 Day 21 
Size (nm) 137.1 139.9 146.3 144.0 
PDI 0.065 0.108 0.099 0.126 
Zeta Potential (mV) -52.2 -48.3 -34.7 -44.0 
Zeta Potential Standard Deviation 13.0 14.1 9.66 11.6 
 
6.2: MRI Raw Results 
 Upon running MRI scans, the output is a large number of data files that need to be 
processed to obtain T1 relaxation times (in milliseconds). Reaching the T1 values involves both 
the manual alignment of the scans to the rat brain atlas, and the use of a custom Matlab code 
(Day, Lacarra, Sacks, & Sadraei, 2015, unpublished). Dr. Praveen Kulkarni of Northeastern 
University developed this code and alignment method. A guide for the completion of this 
alignment process can be found in Appendix B. Completion of this process outputs a Comma 
Separated Values (CSV) file for each time point scan for the animal with data for each of the 174 
regions of the brain. This data includes the number of voxels for the region, the mean T1 
relaxation time, and the standard deviation. This data then needs to be further processed to look 
at the difference in relaxation times for the time points as compared to the pre-scans, and to 
combine with other animals of the same treatment to take advantage of the power of having a full 
cohort of animals. This analysis can be done using Microsoft Excel (Appendix C) or with the 
statistical analysis code the team developed, described in section 6.3. 
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6.3: Statistical Analysis Program 
 A statistical analysis program, seen in Appendix E, was developed to automate the data 
processing, shorten the time needed to process data, and minimize the possibility of human error. 
This process was previously done in Microsoft Excel many times, giving the team data that could 
be used to cross-check the output of the program. A guide for the processing of this data in 
Microsoft Excel can be seen in Appendix C. The program was tested, and found to output the 
same values as when the data was processed in Microsoft Excel, leaving the team confident in 
the validity of this program. This output can then be fed into the 3D heat mapping program. A 
guide for use of this statistical analysis program can be found in Appendix D. 
 
6.4: Heat Map Quality Control 
 In order to verify that the data processing and image production component of the Heat 
Map generating program was correct, a quality control procedure was developed and 
implemented. The data processing component was run with Microsoft Excel files containing 
primarily zero values in the regions accessed by the program. A value of 1 was placed in the 
index location of the region the excel file was intended to be used to test. Files with data entered 
in this manner were produced for all 174 ROIs. The heat mapping function was run testing each 
individual region on each individual slice and results were compared against the original labeled 
Rat Brain Atlas slices. A test was considered successful when the area lighting up red on the heat 
mapped slice matched the index of the “1” on the excel sheet. The marking locations and file 
indices of slices that demonstrated errors in either area were corrected and retested. Examples of 
the plotting methodology can be found in Appendix F. Completion of this process gave the team 
confidence in the integrity of the mapping program.  
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7: Final Design Validation 
As the medical technology developed and researched in this project is expected to have 
far reaching effects, there are many different areas that are expected to be impacted. These 
factors will affect different areas such as economic, environmental, ethical, political, safety and 
health, societal, and sustainability concerns. These areas are explored below.  
 
7.1: Engineering, Industry, and Manufacturing Standards Met  
7.1.1: Nanoemulsion Standards 
NMI is developing NEs with the ultimate goal of being used to treat humans. To get to 
that point, FDA approval will be needed. Currently, there are no design standards or regulations 
from the FDA regarding nanomedicines. Instead, the FDA evaluates each nanomedicine on a 
case-by-case basis. As described in section 4.3.1, the individual components of the NE will be 
examined. Another area the FDA will assess is compliance to the regulations outlined in the 
United States Code of Federal Regulations. Specifically, compliance to Title 21, Section 211: 
current good manufacturing processes (cGMP) for finished pharmaceuticals (21 CFR 211) will 
be assessed.  
 21 CFR 211.22 explains the responsibilities of quality control unit. This regulation states 
that a quality control until that has the ability to approve or reject finished product must be 
established, that this unit must have adequate lab space, that this unit is responsible for approving 
or rejecting procedures, and that everything this unit does must be in writing. Nemucore is 
continually testing each batch of NE to ensure all specifications are met. 
 21 CFR 211.25 and 21 CFR 211.28 describe the qualifications and responsibilities of the 
personnel engaged in the process. With these regulations, anyone involved in the manufacturing 
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process must have adequate training, must be dressed with the appropriate personal protective 
equipment, and must follow appropriate hygiene habits. At NMI, everyone is trained and then 
observed to ensure they are competent in their abilities. Proper hygiene and adhesion to safety 
protocols are enforced and monitored by an outside supervisor. 
 21 CFR 211.63 states that equipment used in the manufacturing process must be of the 
proper design, size, and location. 21 CFR 211.65 states that equipment should be constructed so 
that it can be used properly, and 21 CFR 211.67 describes that equipment must be cleaned and 
maintained properly. Section 21 CFR 211.68 states that all electronic equipment should be 
routinely calibrated and inspected. At NMI, all equipment in the lab is placed to maximize 
efficiency. All equipment is routinely inspected, tested, calibrated, and maintained as necessary.  
21 CFR 211.100 says that all procedures should be written out and followed exactly, and 
that any deviations from them need to be recorded and justified. NMI maintains a strict set of 
standard operation procedures (SOPs). These SOPs are followed at all times, and new ones are 
designed as necessary. The SOPs include the exact equipment that is to be used, meeting 21 CFR 
211.105. The SOPs in place also provide guidelines for maintaining sterility and disposing of 
contaminated components, meeting 21 CFR 211.113. 
21 CFR 211.160 provides some general requirements for laboratories. This includes the 
establishment of specifications for the product(s). NMI has a set of specifications the NEs must 
fit to be considered acceptable, and each batch is tested to ensure these specifications are met. 
These tests are typically carried out weekly for three weeks upon the NEs being manufactured, 
confirming the stability of the NEs and meeting 21 CFR 211.166. 
 All of the animals used for the MRI studies were purchased through Charles River 
laboratories and maintained following protocols set in place by Northeastern University. The 
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housing at Northeastern University meets all required standards, ensuring the 21 CFR 211.173 is 
met. 
 NMI has a custom program, Pharma-Designs, that is used to track all information on each 
batch of NE. This includes lot numbers, and supplier information for every component that is 
incorporated along the way. Printed reports can then easily be produced as needed, and all 
information is backed-up onto a server indefinitely.  This system meets 21 CFR 211.180, 21 CFR 
211.184, 21 CFR 211.186, 21 CFR 211.188, and 21 CFR 211.194.  
 
7.1.2: Programming Standards 
The primary engineering standard applying to the Matlab Code is IEC 61508 
(International Electrotechnical Commission standard 61508). It is important to note that this is 
only in regard to the intended future use of the program and heat map. IEC 61508 defines 
standards of hazard exposure and risk of physical harm to human patients involved in the use and 
data collection of medical imaging software. The imaging method (MRI) and cohort based data 
analysis used in this project ensure that patients are safe from both physical harm and the 
exposure of personal medical information. 
In an effort to ensure all patients are properly protected, the team has recommended to 
NMI that any data which applies to the patient population be stored in a separate xml file in the 
format outlined by the Dublin Core Metadata Initiative xml schema. The Initiative xml schema 
guidelines are open to the public intended to allow the more effective storage and sharing of 
metadata. 
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7.2: Economic Impact 
 With the development of the custom program created in Matlab, the economical factor is 
relatively low. Matlab can be obtained through a license, a cost that customers would have to 
plan for. Currently the 3D statistical heat map is open source, but if NMI continues to develop 
the software there is potential for the program to be patented. Once the patent is obtained, NMI 
would be able to sell the software to obtain a profit.  
 Regarding the nanoemulsions, the cost of manufacturing involves differing factors. One 
of these factors is the maintenance of microfluidizer machine, which includes machine parts 
replacements and personnel maintenance. Additionally there is the cost of obtaining the 
components as well as the processing. Customized proteins can be costly, and after they arrive at 
NMI further modification of the tail end of the protein is needed to allow for proper integration 
with the nanoemulsions. 
 The specific targeting capabilities of the NEs will enable them to be strong 
chemotherapeutic agents. The customizable targeting can enable a lower cost of 
chemotherapeutics to patients, as a lower amount of drug will need to be delivered to the tumor 
to cause significant results. The chemotherapeutic nanoemulsions are also projected to be less 
destructive to the body because of their targeting capabilities, which would decrease medical 
costs for both the patient care facilities and the patients.  
 
7.3: Environmental Impact 
 The environment can be affected through manufacturing, distribution, and use of a 
product. With the NEs, strict care is taken in the chemical synthesis of the components and of the 
final NEs to ensure proper disposal of all waste. Waste removal follows standard laboratory care, 
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and little waste is created during the manufacturing of the NEs. Shipping costs of the final 
products will include standard boxes, insulating styrofoam containers, and refrigerating agents 
such as cold packs. These materials together will ensure the NEs remain cool, as they should be 
refrigerated at all times. Patient care facilities are expected to dispose of any additional materials 
as they would biohazardous materials.  
 With the 3D statistical heat map, one does not have to worry about shipping the software 
as it can be downloaded. The use of the Matlab code should not greatly affect the amount of 
energy used by a computer. The general use of a computer on a daily basis will require more 
power than the use of the created software, and so the impact of the software should not be great 
on the environment.  
 
7.4: Ethical Impact 
 For the current status of the project, there were some ethical considerations. Animals 
were used for the testing of NEs. The rats were cared for properly with humane treatment 
standards. When this endeavor reaches clinical trials, further considerations will have to be made 
before it can be approved by a Board of Review. There would be greater regulations and a larger 
emphasis on all cytotoxic effects. For example, if a component of the NEs causes an adverse 
effect on the patient, there is the ethical trade-off of treatment versus detrimental health risks. 
This sort of trade-off can be seen in current cancer treatments, such as chemotherapy and 
radiotherapy. The safety of the NEs will be a prime area of interest in all future clinical studies.  
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7.5: Political Impact 
 Currently this theranostic treatment is a novel guided therapy, with no concrete 
predecessor in the United States Patent and Trademark Office. As such, the path to patenting this 
viable technology will be a landmark in medicine if it is registered as the first. Collaborators 
from Northeastern University will be included due to their contribution of the Rat Brain Atlas 
and completion of rat MRI cohorts.  
 In the future, as it is projected for this treatment to be refined and accepted by society, 
healthcare providers will impact the way policies are handled as patients are treated. Insurance 
companies, healthcare practitioners and pharmaceutical companies are likely to be involved in 
the use and regulation of this product. At this time the product is still in the beginning stages, but 
as more research is completed federal funding may enter the picture as well as larger 
corporations as their interest increases. The government will assist in the regulation of 
manufacturing, distribution, and use of all theranostic devices used.   
 
7.6: Safety and Health Impact 
 In this continuation of a previous project, no additional testing was completed on human 
cells lines or with human subjects. The visual statistical analysis the coded program outputs 
creates no health concerns for the user. In the future, as the theranostic treatment will be used for 
real analysis of NE performance in humans, there will be more thought needed. The NEs 
targeting capability will need to be confirmed through monitoring, as well as potential systemic 
cytotoxic effects through inappropriate payload delivery. The therapy will follow FDA standards 
and regulations, ensuring that the biocompatibility and efficacy of the NEs are not only 
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acceptable, but exceed all current expectations. Patient safety will be, as always, the primary 
concern with the application of this therapeutic system.  
 
7.7: Societal Impact 
 The overarching goal of this project is to create a theranostic drug delivery system with 
visualization capabilities for glioblastoma multiforme, one of the most aggressive forms of 
cancer. However, this method of combining the therapy with the real-time imaging of an MRI to 
confirm targeting opens the door for other potential uses. By attaching Gd+ to the nanoemulsions, 
the visualization accuracy rivals that of PET scans, and the cost of an MRI is typically less. With 
the application of the imaging technology used here, theranostic treatments could be developed 
for other brain pathologies, aggressive diseases, or cancers found in the body.  
 With theranostic NEs as a viable treatment option in the future, patients will reap the 
benefits from this enhanced form of chemotherapy and recover at a quicker rate. Not as much 
time will be spent in the hospital trying to regain strength and the lessening of physical strain 
will lead to a lower emotional and mental strain. In this way both the mental and physical health 
of cancer patients undergoing this treatment will be improved.  
 
7.8: Sustainability 
 The 3D statistical heat map allows for an interface that is sustainable, workable, and 
improvable for years to come. Matlab is a relatively common and simple programming language, 
and the Matlab platform is compatible across different operating systems. Additionally, if the 
program was desired to be in a different programming language, the logic and theory behind the 
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script could be translated into another language. The capabilities of the program allow for better 
end results as it evolves based on user preference.  
 With the nanoemulsions, there is not much recyclability as there is with other materials. 
During the process of synthesizing components of the NEs, it may be necessary to revisit and 
examine steps and materials to see if there are alternative materials that may lead to a better 
result.  
 
7.9: Manufacturability 
 Currently, nanoemulsions are made in-house at NMI. This is a day-long process, and 
requires extensive preparation in gathering all of the components. Once prepared, batches are 
known to be stable for at least three weeks. The NMI lab is fully equipped to handle the current 
manufacturing needs; however, in the future when the project is scaled up and larger batches are 
needed, a scaled-up manufacturing space and procedure that meets all GMP standards will 
become necessary.   
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8: Discussion 
 
8.1: Nanoemulsions 
 Nanoemulsions were characterized by examining the sizes and Zeta potentials of the 
particles. While the sizes were in the range of 130-160 nm, publications NMI has been a part of 
in the past have shown nanoemulsions to be used for cancer therapy in the range of 130 – 150 
nm with a PDI of 0.1 or lower. Additionally, previous Zeta potentials were in the range of -
40mV to -50mV with standard deviations up to ±13mV (Ganta et al., 2014A; Ganta et al., 
2014B; Ganta et al., 2015), and the Zeta potentials of these NEs were in the range of -30mV to -
50mV, with standard deviations up to ±13mV. While the results are not exactly the same at every 
measurement, the ranges are similar to that of values previously published by NMI for different 
purposes, and therefore considered a success. 
 
8.1.1: Dermorphin Nanoemulsions 
 Mapping of the MOR shows high levels of receptor to be present in the Basal Forebrain 
and the Thalamus. A full map of the MOR can be found in Appendix G. With the Dermorphin 
NE, it was expected that accumulation of nanoemulsion would be seen in these MOR rich areas. 
While not every ROI matched up perfectly, there was some significant NE accumulation in these 
areas. Appendix K shows the complete voxel-weighted SPI results for all three time points of the 
cohort (n=7) tested with the Dermorphin NE, as compared to the cohort (n=7) of animals treated 
with the non-targeted NE.  
 
CONFIDENTIAL |  
 
65 
8.1.2: Dermorphin Nanoemulsions upon Blocking of the Mu-Opioid Receptor 
The proof-of-concept experiment that was done was to treat the animals with a 
component that would block the receptor, therefore out-competing the nanoemulsions. It was 
decided that if the nanoemulsions were indeed being targeted to the receptor they were designed 
for, which was now blocked, the nanoemulsions would have the same effect as the non-targeted 
nanoemulsions. Originally, naloxone was identified as a MOR antagonist (Wand et. al., 2011; 
Usenko et. al., 2002). Upon further research and analysis of the results of an experiment where 
animals were dosed via the tail vein catheter with Naloxone (2mg/kg in 0.9% saline) 10 minutes 
before the nanoemulsion injection, it was discovered that naloxone was cleared from the brain in 
about 40 minutes (Glass et. al., 1994), and therefore was washing out before the completion of 
the MRI scans. These results can be found in Appendix M. 
Further research identified β-funaltrexamine hydrochloride (B-FNA) as an irreversible 
MOR antagonist, with slight Kappa-opioid receptor (KOR) agonistic properties (Martin et. al., 
1998). This proof-of-concept experiment was then repeated with B-FNA as the MOR blocker, as 
described in section 5.1.2.  
The results from testing dermorphin NE on a cohort (n=5)  that had been pretreated ICV 
with 40 nano-moles of B-FNA in 0.9% saline did not match the non-targeted NE results as 
predicted, but did show a difference in where the NE was accumulating in the brain. NEs appear 
to accumulating in the Diencephalon, an area with some MORs, but not area where the 
unblocked dermorphin NEs or the non-targeted NEs accumulate. The Olfactory Bulb, an area 
with some MORs present, shows NE accumulation without B-FNA blocking, but shows no NE 
accumulation when B-FNA is present. A full map of these voxel-weighted SPI results at 20, 40, 
and 60 minutes can be seen in Appendix L. 
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After ICV treatment of B-FNA, the animals were given 3 to 4 days to recover before use 
in this experiment. As B-FNA is a MOR antagonist, it is possible that there was a slight up-
regulation of MOR receptors over this time period. These new MORs would be unblocked, and 
therefore provide a location for the dermorphin NEs to bind. As a KOR agonist, it is likely that 
the KOR was affected by the B-FNA. Further research will be required to understand KOR 
expression in the brain, investigate dermorphin’s avidity for the KOR, and to determine if KORs 
or Delta-opioid receptors (DORs) may be proving alternate binding site for the dermorphin NEs. 
 
8.1.3: Candoxin Nanoemulsions 
 A receptor map of the Alpha-7 receptor, which can be found in Appendix H, shows high 
levels of the Alpha-7 receptor to be expressed in the Frontal Lobe, Hippocampal Formation, 
Amygdaloidal Nuclear Complex, and the Tectum. Analysis of the Candoxin NE SPI values over 
the 20, 40, and 60 minute time points (seen in Appendix N) show accumulation in the Frontal 
Lobe, Limbic Lobe, Insular Cortex, Thalamus, and Epithalmus. It seems as though many NEs 
are limited in where they are able to reach. While these results are not exactly as hypothesized, 
further analysis of how the NEs are being transported through the brain may explain these results 
more clearly. 
 
8.1.4: Cereport Nanoemulsions 
 Analysis of the B2BR location throughout the brain shows this to be a very prevalent 
receptor. Particularly high areas of receptor include the Diencephalon (Hypothalamus, Pituitary, 
and Thalamus), the Hippocampal Formation, the Amygdaloidal Nuclear Complex, the Limbic 
Lobe, and the Basal Ganglia. The cohort (n=7) that was tested with the Cereport NEs, showed 
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NE accumulation in the Diencephalon, Hippocampal Formation, Amygdaloidal Nuclear 
Complex, and Cerebral Peduncle. While not perfect, these results are very promising toward the 
future of these Cereport NEs. Full results of the SPI values for this cohort as compared to the 
non-targeted NE cohort (n=7) across the 20, 40, and 60 minute time points can be found in 
Appendix O. 
 
8.2: Entry into the Brain 
An original hypothesis of this project was that the NEs were entering the brain by 
adsorptive transcytosis through the BBB. It was thought that the lipid core of the NE was 
recognized as a natural fat by the brain, allowing it to pass though. Further analysis of results, 
particularly those of the non-targeted NE (found in Appendix J), have challenged this theory. 
Research of the flow of CFS through the brain has shown to be similar to the locations of the 
non-targeted NEs. Specifically, the CFS enters through the brain stem in the center, flows around 
the front, up over the top, and then flows out through the Metencephalon, Mesencephalon, and 
the Medulla Oblongata. An increased amount of non-targeted NE can be seen in the 
Metencephalon, Mesencephalon, and the Medulla Oblongata, right where the CSF would 
accumulate. Since it is known that the blood-CSF barrier is easier to cross than the BBB, it is 
possible that the NEs are entering the CNS through the blood-CSF barrier and then entering the 
brain. An easy location for this entry could be the Choroid Plexus, the region of the brain that 
produces CSF. Permeability is enhanced at this region to allow for easier passage of necessary 
nutrients and large molecules. Given the research that was completed in this study, a final 
conclusion on how the NEs are entering the brain cannot be drawn; however, future research 
should take this possibility into account and explore it further. 
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Figure 13: Brain Vasculature and CSF.  Image depicts the major brain vasculature, in red, and CSF, in 
blue. Location of the Choroid Plexus is indicated by the yellow. 
 
8.3: Statistical Calculations Program 
The statistical code is a program to efficiently calculate and process the T1-relaxation 
times into usable SPI and t-test values for the heat map program. This program was written using 
Matlab and provides a user friendly interface with which users can provide input files for 
processing. The code removes the need to perform the calculations by hand and is more efficient, 
accurate, and reliable than the previous method using Microsoft Excel, as it does not allow for 
user error in copying, pasting, and equation actions.  
 
8.3.1: Motivation for Development 
After the images from the MRI are processed by the atlas and the T1-relaxation times are 
received, the SPI value needs to be calculated. For each rat, there are about 5,000 data points to 
evaluate and calculate. Once these data points are analyzed and the SPI values and respective t-
test are calculated, they must be organized into the 174 regions of the rat brain. This formatted 
data sheet is then sent to be processed through the Heat Map program. Originally all of these 
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calculations were completed in multiple Excel sheets. This process not only took 4 hours per rat, 
but also lent itself to human error in data calculations. The statistical code was developed in 
order to create a system to be able to process the MRI data and go from MRI scan to heat map 
quickly and efficiently. Utilizing this program, a cohort can be processed in about two minutes, 
with no errors. The added benefits of having this code made are the reduction of needed training 
to carry out the statistical calculations, the reduction of time needed, and the increased accuracy. 
In addition, if there are changes that are needed in the equations in the future the changes can be 
easily reflected in the code.  
 
8.3.2: General Code Structure  
The code is written in an object-oriented style. Many different aspects of the data files are 
represented as “objects” within the code. Each object contains properties which define its 
characteristics, as well as methods that define which part of the analysis the object is responsible 
for. When combined, these objects produce spreadsheets containing SPI values for each cohort. 
The program is designed in a hierarchical structure. At the top of the hierarchy are the 
objects responsible for rendering the user interface. The user provides a “manifest” file which 
provides details about each data file. For each file, the manifest specifies the location of the file 
on disk, the treatment the file belongs to, and the time point of the file. The program reads in the 
manifest file and passes the collection of data files to the “SPI analysis” object. The SPI analysis 
object organizes each data file into its own “treatment file” object. The treatment file objects 
each contain a unique list of “rat” objects, each of which represent a rat within the cohort. The 
SPI analysis object uses each of these objects in the hierarchy to perform calculations on the data 
and produce the resulting output file.  
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8.3.3: Accuracy Against Excel Calculations 
Once the code was written, the data points were compared with the Microsoft Excel 
calculated values to ensure that the calculations were being carried out correctly. The numbers 
matched between the user done and code completed calculations. It is also important to note that 
Matlab’s “format long” parameter keeps values to the 15th significant digit after the decimal 
point, unlike Microsoft Excel which only keeps the 15th significant digit overall. Therefore, the 
values from the statistical code are equivalent to those calculated using Microsoft Excel. 
 
8.3.4: Troubleshooting 
Upon completion of the code, there was an issue that came up with compatibility between 
the computer that the code was written and originally run on and the computers at Nemucore. 
The difference was in the versions of Matlab on the computers which affected the User Interface. 
The User Interface was written using a 2015 version of Matlab, but the computers at Nemucore 
have the student’s 2014 version of Matlab. This problem lead to the code having to be changed 
in order to accommodate for the older version so that the company can use the program after this 
project is completed. 
The final issue faced was ensuring the output was compatible with the next step in the 
project pathway. The regional data input for the heat map program had to be structured in a 
specific way in order to make sure that the correct coloring was placed in the correct regions of 
the brain. Since the program’s output was the input for the heat map program, code had to be 
added to include the necessary formatting function.  
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8.3.5: Final Product 
With these issues fixed and the code now downloaded and functional on Nemucore’s 
computers, the company has the ability to process the T1 relaxation times into SPI and t-test data 
in about two minutes. The steps and exact guide on how to use this program are outline in a user 
guide, which can be found in Appendix D. A print-out of the code with all necessary comments 
can be seen in Appendix E. 
 
8.4: 3D Heat Map 
 In order to allow the visualization of the data produced by the data analysis program, the 
task of producing of a 3D heat mapping program was set. The criteria for this program included 
taking in data previously outputted from the statistical analysis code, analyzing data to determine 
cut-off values for categorizing NE uptake for each region, and imaging the uptake for each 
discrete region of the brain using a white to red gradient, all with minimal input from the user. 
 
8.4.1: Development Process 
Upon the start of the project, Nemucore gave a client statement of utilizing the wireframe 
Rat Brain Atlas developed previously (Day, Lacarra, Sacks, & Sadraei, 2015, unpublished) to 
develop a 3D heat map to demonstrate NE uptake across the brat brain. To begin, a simple 
example program demonstrating the function of the intended code was produced, which placed 
colored circles into each region to denote NE uptake. This result was approved by Nemucore, 
and a program that applied color to each brain region instead of labeling them with colored 
circles was put into production. This program was also designed to produce a user friendly 
interface to allow for continued use with individuals not fully versed in Matlab code.  
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8.4.2: Program Components and Functional Process 
 The main feeder program, “UseableMapFeedSPI,” calls the data storage file 
“plotable.mat,”  which contains the wireframe rat brain atlas produced previously (Day, Lacarra, 
Sacks, & Sadraei, 2015, unpublished), as well as the region coloring function “slicemap” that 
comprises the majority of the program’s functionality. The feeder program, 
“UseableMapFeedSPI” loads the storage file and consults the user for input. The input prompt 
asks for the file to pull SPI data from, slice identifier number, and which time point the user 
wants to image. The “UseableMapFeedSPI”  program then calculates the cutoff points for heat 
map coloration and sends the SPI values, the cutoff values, and region defining points for the 
specified slice number to the  “slicemap” function to overlay the relevant slice of the wireframe 
on the colored regions and produce a heat mapped slice image. The “UsableMapFeedSPI” 
program can be found in Appendix Q. The “slicemap” function can be found in Appendix R. 
The variant of this program, which is used to produce a heat mapped model of the entire 
brain, also contains a call to the “plotable.mat” file and the “slicemap” function. This feeder 
program, “UseableMapFeedSPIALLATONCE,” loads the storage file and asks the user for the 
input file and the time point. The “UseableMapFeedSPIALLATONCE” then calculates the SPI 
cutoff values, and sends the SPI values, cutoff values, and region defining points for the regions 
of each of the 63 slices to the ”slicemap” function. The “slicemap” function then overlays all 63 
slices of the wire frame over the colored regions and procures a full 3D heat map of the data. 
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The “slicemap” Function 
The “slicemap” coloration function contains a call to the fill3 () function in the Matlab 
imaging library. It takes in the region defining points, the SPI value for the region, and the cutoff 
values. The function then determines if the SPI value is above, below, or equal to each of the 
cutoff values and assigns coloration to the region accordingly. Output from the program is seen 
in a slice with regions colored based on a scale, representing no significant signal to high 
significant signal.  
 
8.4.3: Issues faced 
 The most significant challenge in the process of producing the 3D heat map was in 
defining each of the regions based on the locations of points in the wireframe. This was carried 
out through the use of the analysis tools provided in Matlab’s figure viewing window, primarily 
the line following tool. This tool was used to highlight individual points that occupied important 
positions for the definition of each of the regions and display the x, z, and y coordinates of said 
points. These coordinates were then recorded for each defining point for each region. This 
process was at high risk for error, as mistakes in the entry of a point location could throw off the 
shape and location of a displayed slice in the final program. Additionally, this process had a 
limited accuracy due to distortion present in the original wireframe, causing some of the 
produced images to appear to be deformed. 
 The next large issue in the construction of the program involved converting the code into 
a user friendly state. Matlab is sensitive to changes in capitalization, which can lead to difficulty 
in recognizing and calling the correct variables. Various variables had originally been defined 
similarly to previous code received from NMI’s partners at NEU, but were found to be 
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inconsistent. This resulted in a debugging process which involved addressing each line of code 
that returned an error message. By capitalization of some called variables, and initializing 
common capitalization variants of other variables, the issue was resolved. 
 
8.4.4: Final Product Use  
 The use of the final product was streamlined to minimize the required input from the 
user. This expansion of use demonstrates the capability of this program to be used without 
intensive training. Someday, this may be applied so that other researchers and clinical 
practitioners will be able to effectively use this technology.  To run, ensure all required files are 
in the same folder as the program.  The files required include the source file for the data, the 
coloring function “slicemap”, the “plotable.mat” storage object, and the feeder program itself, 
either “UseableMapFeedSPI” or “UseableMapFeedSPIALLATONCE.”. With these, the user 
simply needs to run the feeder program and enter the desired data source, slice number, and time 
point to produce an image when prompted. A user guide, found in Appendix P, contains specific 
details for successful use of the program. The raw code for these programs can be found in 
Appendix Q.  
 
8.4.5: Interpretation of the Heat Maps 
The produced images indicate which areas of the brain have an accumulation of NEs as 
compared to that of the non-targeted NEs through the calculation of the SPI. The colored regions 
are those in the top quartile of SPI values, or those that had the most increase of accumulation 
from the non-targeted NE to the targeted NE. A yellow to red scale which increases every 5th 
percentile from 75% up is used to demonstrate different SPI values. A white area indicates that 
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the SPI value for that region was not in the top quartile. The heat map images indicate in a visual 
manner where the targeted NE is accumulating as opposed to the non-targeted NE on a cohort 
basis, leading to easy interpretation by those less familiar with the 174 ROIs, but knowledgeable 
about the geography of the brain.  
 
8.5: The Receptor Mapping Program 
 To analyze the effectiveness of different targeting ligands in reaching the desired 
receptors, the 3D heat mapping program was expanded to create 3D maps of the Mu-Opioid, 
Alpha-7, and B2 Bradykinin, receptors. These maps, which can be produced as single slices as 
well as the entire brain, function the same way as the SPI heat mapping program. Receptors were 
mapped on a teal scale, with dark teal being low levels of receptors and bright teal being high 
levels of receptors. Tan was used to represent a region with no receptor. The receptor values that 
are represented in these heat maps come from autoradiography studies that were found in 
literature. The receptors were classified numerically as outlined in Table 9 to allow them to be 
read by the feeder program “receptorMap” and mapped onto the rat brain atlas using the 
“slicemap” program. 
Table 9: Receptor Expression Conversion 
Receptor Expression Alphabetical Value Numerical Value 
None N/A 0 
Patchy P 1 
Low L 1 
Medium to Low M-L 2 
Medium M 3 
Medium to High M-H 4 
High H 5 
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 The Mu-Opioid Receptor map can be found in Appendix G, the Alpha-7 Receptor map 
can be found in Appendix H, and the B2 Bradykinin Receptor map can be found in Appendix I. 
The “receptorMap” feeder program can be found in Appendix S.   
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9: Conclusions and Recommendations 
 
In conclusion, this technology has the potential to revolutionize drug delivery to the 
brain. Instead of being satisfied with just getting the drug across the BBB and into the brain, 
researchers will be able to go one step further in targeting medicines to the specific lobes of the 
brain where the drug is needed. With applications in Glioblastomas and other brain diseases, 
these theranostic nanoemulsions have great potential to revolutionize neuro-medicine. The 
ability to cross the BBB and reach specific lobes of the brain via systemic delivery will allow 
many current therapeutics to be used without the need for an invasive brain surgery.  
 The visualization program that was designed and created with this project brings health 
care professionals the ability to visualize uptake to investigate the effectiveness of different 
targeting ligands used to deliver drugs to highly specific ROIs. Many current heat maps only 
allow for visualization of the surface of the brain. The ability to examine 400µm thick cross-
sectional slices of the frontal plane from anywhere along the length of the brain provides 
increased accessibility to areas not on the surface of the brain. This program also allows for 
quantitative analysis of the 174 ROIs, opening up the ability to perform statistical analysis on the 
results. 
 
9.1: Limitations 
As this technology continues to be explored, there are a few limitations to be aware of. 
The nanoemulsions have been tested to be stable for up to 21 days. Beyond that, there are no 
guarantees. This short “shelf-life” would make clinical use a challenge, for new nanoemulsions 
would have to be made just before use. The possibility of freezing for storage may be an option, 
but extensive studies would be needed to make this an option. A batch of non-targeted 
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nanoemulsions was accidently frozen, and when thawed the stability testing was still in an 
acceptable range, showing promise for this. When freezing, it would be important to ensure that 
ice crystals did not form and burst the nanoemulsions, but use of a cryo-protectant such as 
Dimethyl Sulfoxide (DMSO) would introduce toxic side effects to the drug. Freezing to increase 
shelf-life may be a possibility, but shelf-life would currently remain as a limitation to this 
technology. 
Economics are another major limitation of this technology. Nanoemulsions can be 
customized with the drugs and targets that the patient needs most, but the customization of the 
drugs can become very expensive very fast. Additionally, MRI scanning is expensive and time 
consuming, and requires a highly trained technician and access to a machine. While money 
should never limit a patient receiving the care they need, this technology will need to become 
more economic to reach its full potential. 
 
9.2: Other Applications of this Technology 
 While this project set out with GBM as the primary target for the theranostic system 
developed, there are additional applications of this technology. Various brain diseases, such as 
Alzheimer’s, Parkinson’s, and PTSD could one day benefit from this application of medical 
technology. Alzheimer’s has been investigated using rivastigmine, which inhibits 
acetylcholinesterase and butyrylchinesterase, as a therapeutic treatment. This molecule is unable 
to pass through the BBB (Wilson, et al., 2008), however, when combined with a targeted drug 
delivery system, the amount of drug able to reach the intended location would be much higher 
and therefore result in an improved therapeutic system. One of the receptors targeted in this 
project, the α7nAChR, has also been identified as a target for slowing the progression of 
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Parkinson’s disease (Quik, et al., 2015). Parkinson’s is often treated with levodopa, which helps 
to continuously produce dopaminergic stimulation, but this can cause dyskinesia, or impairment 
of intended movement (Olanow, et al., 2006; Quik, et al., 2015). By targeting the α7nACh 
receptors, the dyskinesia effects can be reduced (Quik, et al., 2015). Additionally, levodopa 
could be loaded into a theranostic delivery modality to allow for increased systemic delivery 
time and for a greater amount of total levodopa to reach the target site. A longer-term release of 
the levodopa would also aid in reducing the dyskinesia experienced (Olanow, et al., 2006).  
 There have been two receptors identified as having abnormal function in patients with 
PTSD, serotonin and GABAA (Liu, et al, 2013; Randall, et al., 1995).  One of the serotonin 
receptors, 5-HT1A, has been shown through research to be involved in anxiety and in regulating 
mood (Luo, et al., 2011). As 5-HT1A is effected over a variety of areas in the brain by PTSD 
(Liu, et al., 2011; Liu, et al., 2013; Luo, et al., 2011; Wang, et al., 2009), this receptor, if targeted 
with a theranostic, could lead to an opening of improved treatment, therapy, and research of 
serotonin-PTSD effects. Benzodiazepines (BZDs) work with the GABAA receptors to increase 
the inhibitory effect of the GABA neurotransmitter. This in turn leads to an inhibition of anxiety, 
an increase in sedation and relaxation of muscle, and cognitive effects (Ravindran & Stein, 
2009). Various BZDs are used as a supplemental treatment of PTSD, usually to treat irritability, 
hyper-awareness, and sleep disturbance, but there is still a need to further research this class of 
molecules with the GABAA receptor (Mohamed & Rosenheck, 2008; Ravindran & Stein, 2009). 
Using theranostic agents with a BZD conjugated to the surface could be used to expand the 
research of the GABAA receptor and the role of BZDs in treating PTSD.  
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9.3: Future work 
 As the project continues and NMI grows as a company, there are many actions to 
continue this project and move it closer to reaching the ultimate goal of curing patients. While 
some items can be done in the immediate future, others will occur further along in the 
pharmaceutical development process. Immediately, the team suggests the testing of the four new 
targeting peptides that have been designed and made. These peptides were designed with the 
goal of being testing in the project, however various delays and the use of the original peptides 
prevented the team from testing the new peptides. With the peptides already in stock at NMI, this 
would be a good place for a future team to pick-up. Section 4.1.5 provides an outline of these 
peptides.  
 The NMI-800 nanoemulsion is not currently loaded with any chemotherapeutic agent. 
NMI has shown the possibility of loading nanoemulsions with a variety of different 
chemotherapeutic agents; however, the challenge of finding the optimal drug(s) for the NMI-800 
series nanoemulsions remains open. Future teams may want to look at the creation of the 
nanoemulsions with different drugs for both stability and effectiveness. These nanoemulsions 
can then be taken into pre-clinical and clinical trials by NMI as promising data is acquired.  
As outlined in section 9.2, there is great potential for this technology to have many 
applications in other brain diseases. While section 9.2 provides a brief outline of some of these 
possibilities, a great deal of research will be needed to bring this project to these different 
applications. Teams will be able to look at different receptors to target, targeting ligands, and 
drugs to deliver to the specific areas of the brain. 
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10: Glossary 
 
Alpha-7 nicotinic Acetylcholine Receptor (α7nAChR) – a type of nAchR that is a homo-
pentamer composed of five α-7 subunits. It is located in the brain, spleen, and lymph nodes and 
its activation increases Ca2+ permeability. It is located on the endothelial cells of the blood-brain 
barrier, and has been shown to be involved in angiogenesis and cancer mediation/proliferation. 
β-funaltrexamine (B-FNA) - an alkylating antagonist of the opioid receptor that is selective for 
Mu Opioid Receptors, so much so that by binding to the Mu Opioid Receptors it is a valid 
indicator of the receptor locations.  
Blood Brain Barrier (BBB) - the mechanism that controls the passage of molecules from the 
blood into the cerebrospinal fluid and the tissue spaces surrounding the cells of the brain and thus 
protects the brain from the effects of substances harmful to it. The endothelial cells lining the 
walls of the brain capillaries are more tightly joined together at their edges than those lining 
capillaries supplying other parts of the body, which allows the passage of solutions and fat-
soluble compounds but excludes particles and large molecules. 
B2 Bradykinin Receptor (B2BR) – a G-protein coupled receptor for Bradykinin. Activation of 
this receptor induces vasodilation, as well as increasing vascular permeability. It is expressed 
throughout most tissues in the brain to varying degrees. 
Central Nervous System (CNS) - The part of the nervous system consisting of the brain and the 
spinal cord. This are is highly protected from the rest of the body. 
Cerebral Spinal Fluid (CSF) - A clear, colorless bodily fluid found in the brain and spine that 
provides mechanical and immunological protection to the brain. 
Computer-Aided Diagnostics (CAD) - The use of computer software to improve diagnostics 
through obtaining lateral images which allow for early diagnostics of a disease. 
Current Good manufacturing Processes (cGMP) - A set of regulations set in place by the 
United States Food and Drug Administration outlining standards that must be met during a given 
manufacturing process. 
Delta-Opioid Receptor (DOR)- a class of opioid receptors found in the olfactory bulb, cerebral 
cortex, nucleus accumbens and the caudate putamen. DOR receptors are located presynaptically 
on primary afferents where they inhibit the release of neurotransmitters. Through both spinal and 
supraspinal sites, the receptor is involved in the antinociceptive/analgesic actions of some 
opioids. (McDonald & Lambert, 2005) 
Diethylenetriaminepentaacetic acid (DTPA) - A linker used to attach Gd+ to the PEG-ylated 
surface of the nanoemulsion. 
Enhanced Permeability and Retention (EPR) Effect- The property by which molecules of 
certain sizes tend to accumulate in tumor tissue much more than in normal tissue. 
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Epidermal Growth Factor Receptor (EGFR) - A cell surface receptor that binds to epidermal 
growth factor. 
Food and Drug Administration (FDA) - A branch of the United States government that 
regulates the manufacturing quality and safety of food, drugs, and medical devices with the goal 
of protecting public health. 
Flow Cytometry- a laser-based technology in which cells are passed single-file through a light 
beam that is set to excite fluorescent markers, while a detector analyzes fluorescent signals 
emitted from the cells. This system allows high throughput quantitative analysis of cells through 
the use of fluorescent markers. 
Gadolinium (Gd+DTPA) – An imaging agent that can be attached to the surface of the 
nanoemulsions which will alter the T1 relaxation time of the MRI and therefore enable imaging 
of the nanoemulsions in vivo. 
Glioblastoma Multiforme (GBM) - A glioma consisting chiefly of undifferentiated anaplastic 
cells frequently arranged radially about an irregular focus of necrosis, usually occurring in the 
cerebrum of adults. Also called grade IV astrocytoma. 
Good Manufacturing Practices (GMP) - An industry recognized standard for manufacturing of 
drugs that ensures the drugs are made in an acceptable sterile manner. 
Intracerebroventricular (ICV) - A type of injection that involves opening up the skull and 
delivering the drug directly to the brain. 
Kappa-Opioid Receptor (KOR) - a class of opioid receptors that does not cause respiratory 
depression. KOR agonists display an anti-opioid action attenuating analgesia elicited by 
endogenously released or exogenously administered MOR agonists. This action is caused by a 
distinct distribution of KOR receptors on primary cells located within the nucleus raphe magnus, 
a group of cell bodies situated in the midbrain. (McDonald & Lambert, 2005) 
Magnetic Resonance Imaging (MRI) - diagnostic medical imaging technologies that uses 
strong magnets and pulses of radio waves to manipulate the natural magnetic properties in the 
body to generate a visible image.  
Mu-Opioid Receptor (MOR) – a class of opioid receptors that distinguish themselves from 
other classes by their high affinity for enkaphalins and low affinity for dynorphins. They are 
primarily found in the tissue of the CNS, with their secondary location in the intestines. They are 
G protein-coupled receptors with opioids as their primary antagonist. 
Nanoemulsion (NE) - A nano-sized droplet of oil contained in water, with a surfactant 
phospholipid monolayer creating a barrier between the immiscible liquids, creating a micelle-like 
structure. They are created through a high stress, mechanical-extrusion process that creates 
droplets of uniform size. 
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Nemucore Medical Innovations, Inc. (NMI) - clinical development company dedicated to the 
development and commercialization of life-saving molecularly targeted therapeutics for the 
treatment of multi-drug resistant cancers. 
Nontargeted (NT, A) - Having no receptor ligands on the surface, but still incorporating all 
other aspects of the drug delivery system, see Targeted for definition.  
Normalization- The normal distribution is one of the key distributions providing the basis for 
probability statistics, so that when a particular distribution is not normal, some transformation of 
the data may be attempted so as to achieve a normal distribution—for example charting the 
logarithms of values instead of the values themselves. This is known as normalizing the 
distribution. 
Polydispersity index (PDI) - A measure for calculating particle size distribution. 
Positron Emission Tomography (PET) - An imaging system that detects gamma ray emission 
from radioactive tracers. 
Rat Brain Atlas (RBA) - a 3D, segmented, annotated atlas was developed from high resolution 
anatomical MRI images obtained from male adult rats. The output file delineates each region 
uniquely. They are suitable for further numerical analyses such as constructing pixel image data 
set (of any size) or surface mesh. 
Region of Interest (ROI) - A specific geometrically defined area of the brain that serves a 
specific function based off of its location 
Stem Cell-Like Glioma Cells (SCLGCs) - Cells within a glioma population that share 
characteristics with neural stem cells. These cells promote tumor angiogenesis through vascular 
angiogenesis growth factor. 
Subsystem of Brain - A grouping of region of interests that comprise a larger area of the brain 
that has a multitude of functions.  
Specificity Index (SPI) - the condition of being peculiar to a particular individual, region, or 
group of organisms. 
T1-weighted image - A basic pulse sequences in MRI and demonstrates differences in the T1 
relaxation times of tissues, used with softer tissue types. 
Temozolomide (TMZ) – An alkylating agent used as a first-line chemotherapeutic for 
Glioblastoma Multiforme. 
Theranostic – development of more specific individualized therapies for various diseases, and to 
combine diagnostic and therapeutic capabilities into a single agent. 
Three-Dimensional (3D) - The quality of having defined dimensions along the x-axis, y-axis, 
and z axis.  
Transcytosis- A mechanism for transcellular transport in which a cell encloses extracellular 
material in an invagination of the cell membrane to form a vesicle, then moves the vesicle across 
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the cell to eject the material through the opposite cell membrane by the reverse process. 
Transcytosis is also known as vesicular transport.  
Targeted- The process whereby a newly synthesized molecule is directed to its correct location 
within the cell. Receptor targeting is determined by short sequences of ligands on the surface, 
which direct it to the correct destination 
T-test - A test to calculate the probability that mean values for a particular measurement are 
significantly different in two sets of data. 
Vascular Endothelial Growth Factor (VEGF) - A signal protein produced by cells that 
stimulates vasculogenesis and angiogenesis. 
Voxel - short for ‘volume element’, the volume of tissue in a body that is represented by a pixel 
in a cross-sectional image. 
World Health Organization (WHO) - a specialized agency of the United Nations that focuses 
on international public health. 
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Appendix A: Project Timeline 
 
Task	Name	 Duration	 Start	 Finish	
Overall	MQP	Project	 176	days	 Thu	8/27/15	Thu	4/28/16	
			Weekly	meetings	with	TPC	 161	days	 Wed	9/9/15	Wed	4/20/16	
			Bi-weekly	Call	with	Dr.	Ferris/Praveen	 161	days	 Wed	9/9/15	Wed	4/20/16	
			Bi-Weekly	Meeting	with	Prof.	Lee	 151	days	 Mon	9/21/15	
Mon	
4/18/16	
			A-term	1:	Introduction	 17	days	 Thu	8/27/15	Fri	9/18/15	
						Background	Reading	 123	days	 Thu	8/27/15	Sat	2/13/16	
									NMI's	Technology	and	research	that	has	already	been	done	 7	days	 Thu	8/27/15	Fri	9/4/15	
									2014	BME	MQP	and	2013	Biochem	MQP	 7	days	 Thu	8/27/15	Fri	9/4/15	
									BBB	structure,	function,	and	penetraton	 5	days	 Mon	9/7/15	 Fri	9/11/15	
									Brain	Diseases	 5	days	 Mon	9/14/15	 Fri	9/18/15	
									Brain	anatomy	and	physiology	 5	days	 Mon	9/14/15	 Fri	9/18/15	
									What	is	MRI	and	how	we	can	use	it	 5	days	 Mon	9/14/15	 Fri	9/18/15	
									Current	Matlab	heat	map	programs	 12	days	 Thu	8/27/15	Fri	9/11/15	
						Discussion	of	Overall	Problem	 3	days	 Wed	9/16/15	 Fri	9/18/15	
						Formal	Hypothesis	and	Outline	of	Experiments	 1	day	 Fri	9/18/15	 Fri	9/18/15	
			A-term	2:	Specific	Literature	Search	 21	days	 Fri	9/18/15	 Fri	10/16/15	
						Specific	Literature	Review	 21	days	 Fri	9/18/15	 Fri	10/16/15	
									Glioblastoma	receptors	expressed	 5	days	 Mon	9/21/15	 Fri	9/25/15	
									Irreversible	blocking	of	receptors	 5	days	 Mon	9/21/15	 Fri	9/25/15	
									Drugs	used	for	glioblastomas	and	other	brain	diseases	 5	days	 Mon	9/21/15	 Fri	9/25/15	
									Matlab	functions	to	go	from	MRI	to	visual	data	 10	days	 Mon	9/21/15	 Fri	10/2/15	
									Using	the	rat	brain	atlas	 6	days	 Fri	9/18/15	 Fri	9/25/15	
						Write	Literature	Review	and	Introduction	 20	days	 Mon	9/14/15	 Fri	10/9/15	
			A-term	3:	Phase	1a	Experimentation	for	MQP	 15	days	 Mon	9/28/15	 Fri	10/16/15	
						Lab	Training	 3	days	 Mon	9/28/15	
Wed	
9/30/15	
						Make	new	A2	nanoemulsions	 2	days	 Mon	9/28/15	 Tue	9/29/15	
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						MRI	with	A2	and	B-FNA	 3	days	 Wed	9/30/15	 Fri	10/2/15	
						Alignment	of	Scans	in	Atlas	 1	day	 Mon	9/28/15	
Mon	
9/28/15	
						Statistical	Analysis	of	Data	 1	day	 Mon	9/28/15	
Mon	
9/28/15	
						Intro,	lit	review,	project	strategy	chapters	due	 0	days	 Thu	10/15/15	
Thu	
10/15/15	
						Review	Data	and	Alter	Plan	 7	days	 Fri	10/16/15	Mon	10/26/15	
			B-Term:	Phase	2a	Experimentation	for	MQP	 38	days	 Tue	10/27/15	
Thu	
12/17/15	
						Data	Collection	Phase	1	 38	days	 Tue	10/27/15	
Thu	
12/17/15	
									Make	new	nanoemulsions:	A2,	A3,	and	A4	 19	days	 Tue	10/27/15	 Fri	11/20/15	
									Run	MRIs		 25	days	 Mon	11/2/15	 Fri	12/4/15	
									Alignment	of	Scans	with	Atlas	 1	day	 Tue	10/27/15	
Tue	
10/27/15	
									Statistical	Analysis	of	MRI	results	 1	day	 Tue	10/27/15	
Tue	
10/27/15	
						Mapping	of	63	brain	slices	 1	day	 Tue	10/27/15	
Tue	
10/27/15	
						Break	down	of	Statistical	Analysis	Code	 1	day	 Tue	10/27/15	
Tue	
10/27/15	
						Review	Literature	Review	and	Add	or	Remove	Sections	 25	days	 Tue	10/27/15	
Mon	
11/30/15	
						Meet	with	Susan	to	Discuss	Intellectual	Property	 0	days	 Thu	12/10/15	
Thu	
12/10/15	
						Review	and	finalize	first	4	chapters	of	paper	 9	days	 Mon	12/7/15	
Thu	
12/17/15	
						Intro,	lit	review,	project	strategy,	alternative	design,	design	
verification	chapters	due	 1	day	
Thu	
12/17/15	
Thu	
12/17/15	
						Review	Data	and	Establish	Future	Experimental	Plan	 1	day	 Mon	12/21/15	
Mon	
12/21/15	
			C-Term1:	Phase	2b	Experimentation	for	MQP	 23	days	 Thu	1/14/16	Sat	2/13/16	
						Data	Collection	Phase	II	 23	days	 Thu	1/14/16	Sat	2/13/16	
									Comparison	of	and	Scientific	analysis	of	all	MRI	data	up-to-
date	 16	days	 Thu	1/14/16	Thu	2/4/16	
									Begin	work	on	new	statistical	analysis	code	 22	days	 Thu	1/14/16	Fri	2/12/16	
									Quality	Control	of	63	mapped	out	slices	 17	days	 Thu	1/14/16	Fri	2/5/16	
			C-Term	2:	Phase	III	Experiments	 20	days	 Mon	2/8/16	Fri	3/4/16	
						Creation	of	receptor	maps	 12	days	 Mon	2/8/16	 Tue	2/23/16	
						Prepare	fresh	batches	of	Nanoemulsions	(A2,	A3,	and	A4)	 5	days	 Mon	 Fri	2/26/16	
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2/22/16	
						Finish	up	MRI	experiments	(clean,	complete	cohorts)	 5	days	 Mon	2/29/16	 Fri	3/4/16	
						Use	new	Statistical	code	and	3D	heat	map	to	analyze	data	 5	days	 Mon	2/29/16	 Fri	3/4/16	
						Fine	tune	Matlab	code	for	optimization	and	user	friendliness	 9	days	 Tue	2/23/16	Fri	3/4/16	
						Write	Final	Methodology	 20	days	 Mon	2/8/16	 Fri	3/4/16	
						Meet	with	Susan	to	Discuss	Intellectual	Property	 1	day	 Wed	3/2/16	 Wed	3/2/16	
						Draw	Conclusions	 5	days	 Mon	2/29/16	 Fri	3/4/16	
						Review	Methods,	Results,	Conclusions	 5	days	 Mon	2/29/16	 Fri	3/4/16	
			D-Term:	Complete	Writing	and	Presentation	 34	days	 Mon	3/14/16	 Thu	4/28/16	
						Write	Results	Section	 6	days	 Mon	3/14/16	
Mon	
3/21/16	
						Write	Discussion	and	Conclusions	 6	days	 Mon	3/21/16	
Mon	
3/28/16	
						Review	Intellectual	Property	with	Susan	 0	days	 Tue	3/29/16	Tue	3/29/16	
						Review	and	Edit	Entire	Paper	 14	days	 Mon	3/14/16	 Thu	3/31/16	
						Create	Presentation	 11	days	 Fri	4/1/16	 Fri	4/15/16	
						Edit	and	Practice	Presentation	 6	days	 Wed	4/13/16	
Wed	
4/20/16	
						PROJECT	PRESENTATION	DAY	 1	day	 Thu	4/21/16	Thu	4/21/16	
						Final	Paper	Edits	with	Tim	and	Susan	 4	days	 Fri	4/22/16	 Wed	4/27/16	
						FINAL	PAPER	DUE	TO	WPI	 1	day	 Thu	4/28/16	Thu	4/28/16	
						Review	Entire	Project	and	Discuss	Future	Projects	 0	days	 Fri	4/29/16	 Fri	4/29/16	
						Create	poster	for	Nemucore	 11	days	 Fri	4/29/16	 Fri	5/13/16	
Write	up	publication(s)	 176	days	 Thu	8/27/15	Thu	4/28/16	
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Appendix B: MRI Alignment in Atlas Step-through 
   
1) Extract all files from the Zip Folder given. There will be one main folder from the Zip 
Folder, with as many folders as there were animals in the cohort inside. Each of these 
folders will contain numbered folders for as many scans were done. Identify which ones 
are the: Pre-Scan and important time markers, such as 20, 40, & 60 minutes. When the 
numbered folders are opened, there you will see the “method” file, to be used in step 3.  
In this case, Scan 3 was the Pre-Scan, and Scans 4, 5, & 6 were 20, 40, & 60 minutes respectively. Not all 
Scans extracted will be needed. In this case, Scans 1 & 2 were not part of the protocol and so not analyzed. 
 
2) Before extracting data from the files, set up an organized system of files. Create one 
master folder, such as “Analyzed Data”. In this folder, create a folder for the Pre-Scan, 
and all important time points.  Inside each of those folders create two more folders, 
“Signal Intensity” & “T1 Map”, and inside each “T1 Map” folder create a “ROI” folder.  
 
Note: Time Points 1, 2, 3 are arbitrary. Often they will mean 20, 40, 60 minutes. It is completely acceptable 
to label folders as “20 Minutes”, “40 Minutes”, and “60 Minutes” if preferred. Be consistent with labeling 
as you go.  
 
3) Open Matlab R2014a by going to the Start Menu and navigating to the program or by 
using the Search Bar. In the program, open the ‘ExtractT1’ folder. Run the 
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extractTvalNC.m program for all rats involved in order to obtain information from the 
Pre-Scan and important time points. For each, choose the appropriate Rat folder, then 
Scan Folder, then choose the “method” file. Each run of the program will create an 
additional folder within each rat folder, with 10 files. 5 files will be “.spr”, and 5 files 
will be “.sdt.” Files should be Signal Intensity, Std dev of signal intensity, std dev of T1 
relaxation time, std dev of the fit, and T1 relaxation time.  
In each _Tmap_scan# folder created, 10 files will be created. Files that will be used from each scan 
include signal_intensity.sdt, signal_intensity.spr, T1_relaxation_time.sdt, and T1_relaxation_time.spr. 
 
4) Return to the “Analyzed Data” folder. Now it is time to sort the “.sdt” and “.spr” files 
extracted. For each Time Point Folder (or 20 Minutes, 40 Minutes, 60 Minutes), copy & 
paste the corresponding Signal Intensity and T1 Relaxation Time files. Sort the Signal 
Intensity files into the Signal Intensity folder, and the T1 Relaxation Time files into the 
T1 Map folder. Be sure that the files are being sent to the correct Time Point folder, as 
the files “.sdt” and “.spr” are not labeled by time in their names.  
Left: View of the inside of the T1 Map folder. Right: View of the inside of the Signal Intensity folder.  
5) Open up Atlas Software by navigating through the Start Menu or using the Search Bar. 
Once open, click on ‘File’ menu, choose ‘Load Atlas’ option, and select Rat_Atlas.nii. 
Choose Orientation of Axial: S-I for both image and headers. If the atlas loads with solid-
colors for the sections of the brain, go to the ‘View’ menu, and choose the option ‘Show 
Atlas Contours.’ If the outlines are dim, go to the ‘Image’ tab, ‘Brightness controls’ 
section, and then using the ‘Scan’ slider bar to make the Atlas outline more visible.  
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Image of the ‘File’ drop-down menu, with the ‘Load Atlas’ option in an orange box; Image of the Atlas 
sidebar displaying Image controls; Image of the ‘View’ menu in Atlas, with the ‘Show Atlas Contours’ 
option in an orange box. 
Image of the Atlas window after loading the Rat Atlas, with the atlas contours shown.  
 
6) Click on the ‘File’ menu, choose ‘Load Scan’ option, and navigate to the “Analyzed 
Data”, “Pre-Scan”, “Signal Intensity” folder. Select the file for the first rat. (Signal 
Intensity is done before the T1 Relaxation Time because Signal Intensity provides a 
clearer image for alignment). Choose Orientation of Axial: I-S for the image. You may 
need to adjust the brightness of the scan. This can be done by going to the ‘Image’ tab, 
‘Brightness controls’ section, and then using the ‘Scan’ slider bar. Contrast can be 
adjusted in the same way.  
7) Load all the remaining Pre-Scan, Signal Intensity files for all rats in the cohort as 
described in the previous step.  
Image of scans & Rat Atlas loaded correctly. All four rats were loaded together. Note that this image is 
before the alignment was completed.  
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8) Beginning with one scan, adjust the position for optimal alignment with the atlas. DO 
NOT MOVE THE ATLAS. Begin to move the scan so it aligns well with the atlas. Go to 
the ‘Transform’ tab and use the following commands’ slider bars as indicated.  
a. Rotation – ‘PA’, ‘RL,’ slider bar 
b. Translation – ‘DV’, ‘RL’ slider bar.  
c. Scale as needed (typical appropriate range is 0.91 to 1.03). It is best if all the scale 
slider bars (‘RL, ‘DV’, & ‘PA’) are at the same value/ 
Note - you can zoom in on the pictures by holding the Right button and moving the 
mouse. This can help with aligning the scan to the atlas. It is desirable for the white 
portion of the brain to end at the outline of the rat atlas. The black area indicates the 
CSF surrounding the brain, and the next area of white is the rat skull.  
Left: Image of the ‘Transform’ side bar with the slider options. Note that PA = Posterior / Anterior, DV = 
Dorsal / Ventral, and RL = Right / Left. Right: an aligned rat brain with the ‘Transform’ side bar, show the 
changes of the scan alignment. 
9) Confirm that the location of the scan to the atlas is well aligned by going to the ‘Slice’ tab 
and moving the Coronal and Axial sliders. This will allow the entire brain alignment to 
be checked against the atlas. Adjust the location under the ‘Transform’ tab as necessary 
for better alignment.  
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Left: Image of the ‘Slice’ side bar, showing the slider options for the different views. DO NOT click the 
‘Lock’ button to the ‘Unlocked’ position, as this will cause the view of the scan and atlas to not show the 
same slice. Right: an aligned rat brain with the ‘Slice’ side bar, displaying some of the different views 
available to check the alignment. 
10) Repeat steps 8 & 9 for all remaining Pre-Scans loaded. They can be accessed by the 
‘Image’ tab, and choosing scans from the ‘Select’ drop-down menu. The drop-down 
menu can be seen in the figure after step 7.  
11) Once everything is set, click on the ‘File’ menu, chose the option ‘Save Configuration’, 
and save the configuration with an appropriate name in the Signal Intensity folder of the 
Pre-Scan.  
Left: Image of the ‘Save Configuration’ option in the ‘File’ drop-down menu. Right: Image of what files 
should be in the “Signal Intensity” folder after saving the configuration. Note that the configuration should 
be an ‘.xml’ file. 
12) Click on the ‘File’ menu and choose the option ‘Unload Images.’ This will unload both 
the scans and the Rat Atlas.   
Image of the ‘Unload Images’ option in the ‘File drop-down menu.  
13) Repeat steps 6-12 with the Signal Intensity files for the other time points. When the last 
configuration has been saved, unload the images.  
14) Load the Rat Atlas as done previously. Load all T1 Relaxation Time files for the Pre-
Scan by navigating to the correct folder and loading as done in step 6. However, do not 
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align these files! Save the configuration in the T1 Map folder in the Pre-Scan folder. 
Unload the configuration, and do the same for all relevant time points. Unload the last 
configuration. 
15) Find the Configuration files (.xml) recently created in their respective folders. Right click 
on the configuration file, and choose the option “Edit with Notepad++”. Open both the 
Signal Intensity and T1 Relaxation Time configurations for the Pre-Scan in this way.  
16) For each rat, copy the matrix numbers in between <Matrix> to <Matrix> in the Signal 
Intensity file.  
Top: Image of the T1 Relaxation Scans Configuration with no alignment performed. Middle: Image of the 
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Signal Intensity Pre-Scan Alignment with co-ordinates. Co-ordinates to be copied are highlighted in gray 
for the first rat. Bottom: Image of the T1 Relaxation Scan Configuration with all correct values from the 
Signal Intensity Pre-Scan Alignment for each rat. 
17) Replace the numbers between <matrix> to <matrix> with the copied numbers for the 
correct rat in the T1 Relaxation Times configuration. See previous image.  
18) Repeat steps 18 & 19 for all rats in the Signal Intensity and T1 Relaxation Time files. 
Save the changes after ensuring correct copy & pasting.  
19) Repeat steps 17-20 for all relevant time point scans.  
20) Go to the Atlas program, click on the ‘File’ menu, and choose the ‘Load Configuration’ 
option.  Select T1 Relaxation Time Configuration for the Pre-Scan time point. Confirm 
that the Atlas is lined up well with the Scans by going to the ‘Slice’ tab and moving 
sliders. Adjust if necessary.  
Left: Image of the ‘Load Configuration’ option on the ‘File’ drop-down menu. Right: Image of the T1 
Relaxation scan with the Rat Atlas. View is of the ‘Slice’ side bar. Note how the difficulty in determining 
the brain edges with T1 Relaxation scans versus with Signal Intensity scans. This is why Signal Intensity 
scans are used for alignment, and those co-ordinates are then used with the T1 Relaxation scans. 
21) Under the “Registration” Menu, choose “Export Map Files.” When asked for a folder to 
save the files in, navigate to the ROI folder in the T1 Map folder of the scan.  
Left: Image of the ‘Registration’ drop-down menu with the option ‘Export Map Files’ highlighted. Right: Image 
of files in the ROI folder after exporting Map Files. 
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22) Unload Images when completed by going to the ‘File’ drop-down menu and selecting 
‘Unload Images.’ 
23) Complete steps 22-24 for all Time Point Configurations.  
24) Open Matlab, and run pixstat.m (found in folder Pixstat). Copy the folder T1Map 
location to the bar when prompted by the program. Save the output file appropriately 
(Pre_T1) in the T1 Map folder. The output file should be a ‘.csv’ file, and will be 
openable by Excel.  
Left: Image depicting how to input the T1 Map location into the prompt bar of the pixstat.m program. 
Right: Image showing an updated view of the T1 Map folder. Note the Excel file.  
 
25) Repeat for all time points.  
26) Voxels, Mean, and STDEV will be listed for each rat at that time point. Values for Mean 
and STDEV are in milliseconds. 
 
27) Continue with further analysis in Excel or through a statistical Matlab code.   
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Appendix C: Voxel Weighted Specificity Index on Microsoft Excel Step-Through 
 
Step 1: Open Microsoft Excel and create 11 sheets in the workbook. Label accordingly based on 
the nanomedicine being tested. 
 
Step 2: Insert T1 relaxation time data for each animal in the cohort for the specified 
nanomedicine for the pre-scan. 
 
Step 3: Insert T1 relaxation time data for each animal in the cohort for the specified 
nanomedicine for the time point. Be sure the tab matches the time point and nanoemulsion.
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Step 4: Subtract the time point T1 value from the pre-scan T1 value for each animal in the 
cohort.
 
Step 5: Insert voxel data for each animal in the cohort. This comes from the CSV files.
 
Step 6: Use the “SUM” function on Excel to find the total number of voxels for each animal.
 
Step 7: Find the voxel weight for each ROI of each animal by dividing the number of voxels for 
the ROI by the total number of voxels for the animal.
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Step 8: Multiply the pre - time point T1 values from step 4 by the voxel weight values from step 
7 for each ROI of each animal in the cohort.  
 
Step 9: Calculate the average number of voxels for each ROI across the cohort. 
  
Step 10: Repeat steps 2 through 9 for the rest of the times points, and for the non-targeted 
nanoemulsion. 
Step 11: Use the “Paste Transpose” function in Microsoft Excel to move the results from step 8 
to the “SPI” sheet for the time point. 
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Step 12: Calculate the SPI by dividing the average of the time point scans by the average of the 
pre-scans. 
 
Step 13: Run a t-test comparing the targeted array to the non-targeted array. 
 
Step 14: Copy and paste the VALUES calculated in steps 12 and 13 to the beginning of the sheet 
(by the ROI labels). 
 
CONFIDENTIAL |  
 
112 
Step 15: Use the “VLOOKUP” function in Microsoft Excel to sort the SPI and T-test data by the 
22 larger ROIs. 
 
Step 16: Repeat steps 11 through 15 for the other timepoints. 
Step 17: On the “Voxels” tab, copy and paste (using both the “Values” and “Transpose” 
functions in Microsoft Excel) the information from step 9 in. Then, use Microsoft Excel’s 
“VLOOKUP” function to sort by the 22 largers ROIs. 
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Step 18: Move the data from step 14 and step 17 into the “Sorted” tab. 
 
Step 19: Use Microsoft Excel’s “QUARTILE” function to calculate the top quartile for the SPI 
values (over all three time points). 
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Step 20: Use Microsoft Excel’s “Conditonal formatting” to highlight the SPI and T-test data as 
desired. 
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Appendix D: Statisical Analysis Code Walk Through 
 
Software Requirements  
In order to run this program the following software is needed:  
• A licensed version of Matlab  
• The MATLAB Statistics and Machine Learning Toolbox 
 This software has been tested on both Windows and Linux operating systems, but should also be 
compatible with the Mac OSX operating system as well.  
Running the Program  
First, open the following files in MATLAB:  
• SPIGenerator.m  
• SelectionMenu.m  
• ReportOption.m  
• RatAnalysis.m  
• TreatmentFile.m  
• Rat.m  
Then, simply run SPIGenerator.m  
If the software dependencies above are properly installed, the user will be presented with the following 
interface: 
 
Loading the manifest file 
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 A manifest file must then be loaded into the software. Press the 'Browse' button in the top right corner of 
the interface. A file browser window will appear. Navigate to the manifest XML file and press 'open'. For 
more information regarding the manifest file, see the section on creating a manifest file. 
 
 
After opening the manifest file, click the load button: 
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The manifest file will then be loaded into the program. This process typically takes a few seconds to 
complete.  
Generating Reports  
When the manifest file has finished loading, a list of report options will appear. A CSV report will be 
generated for all options that are checked. Uncheck any reports that do not need to be generated. Finally, 
click Generate Reports.  
Wait as each report is generated. This process usually takes about a minute for each report, but 
performance will vary widely depending on the speed of the computer and scale of the data. As each 
report is finished generating, a message will appear next to each checkbox indicating that it has finished: 
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Generated reports are saved in the same directory as the MATLAB code files.  
The Manifest File  
The manifest file is an XML document that is provided to the Treatment Analyzer. It is a configuration 
file that tells the program the following information:  
• The name of the untargeted treatment (e.g. A)  
• The name of the targeted treatment (e.g. A2, A3, BFNA)  
• The Rat MRI CSV files associated with each treatment  
• The time that each treatment file was taken at (e.g. 15 minutes, 30 minutes, 45 minutes, etc)  
The following is an example of a simple manifest file:  
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Creating a manifest file 
The content of the manifest file is formatted as XML.  
Creating a manifest file is simple. Start with an empty XML file. The file may have any name as long as it 
uses the XML file extension.  
All XML documents must have a root element. This example will use as the root:  
 
Inside the root element, add tags for the targeted and untargeted sections. It does not matter if the targeted 
section is placed before the untargeted section or vice versa. Both arrangements are equally acceptable.  
 
Next, add a name property to the targeted and untargeted sections. This is used to specify the name of the 
treatment and must be included.  
 
Inside each of the targeted and untargeted sections, add tags that point to the location on the computer that 
the input CSV data is saved at.  
For instance, if there are three CSV files saved at the following locations on disk for the BFNA treatment:  
• C:/Users/person/Desktop/file1.csv  
• C:/Users/person/Documents/file2.csv  
• C:/Users/person/Documents/Example/file3.csv  
Then add three <path> entries under the targeted section:  
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Each <path> tag must also have a time attribute specifying the time slice for which the data was collected. 
It does not matter how the path elements are ordered in the manifest file.  
 
Finally, repeat the previous steps for the untargeted section.  
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Appendix E: Statistical Analysis Raw Code 
 
SPI Generator 
%Run to run the rest of the code. 
import RatAnalysis 
import TreatmentFile 
import SelectionMenu 
import ReportOption 
import Brain 
 
%This turns off the warning about modified variable names in a Matlab 
%table. 
warning('off','MATLAB:table:ModifiedVarnames'); 
%use high precision numbers with many significant digits 
format long; 
 
selectionMenu = SelectionMenu(); 
Rat 
%Handle class define objects that references the data contained in the object. 
% Copying the object creates another reference to the same data. 
classdef Rat<handle 
    %Represents a particular rat with many regions in it 
    properties 
        ratName; 
        ratData; 
    end 
    methods 
        %Constructor for the representation of a Rat. A constructor is a 
        %template for the object. Where you specify how to create a new 
        %object- what makes up your object. 
        function obj = Rat(ratName, ratData) 
            obj.ratName = ratName; 
            obj.ratData = ratData; 
        end 
 
        %Sums all of the voxels in all regions of the specific rat that the 
        %object represents 
        function voxels = totalVoxels(obj) 
            %obj.ratData(1,:) is the first row (Number of Voxels) in the 
            %table of data for a rat. We then convert this row into an 
            %array(list) and sum all of the values. Voxels returns with 
            %total number of voxel in a rat. 
            voxelRow = obj.ratData(1,:); 
            voxels = Rat.nansum(table2array(voxelRow)); 
        end 
 
        %Returns a percentage representing the percentage of voxels in the 
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        %specified region 
        function ratio = roiVoxelPct(obj, roi) 
            %number of voxels in the ROI 
            roiVoxels = obj.regionVoxels(roi); 
            totalVoxels = obj.totalVoxels(); 
            ratio = roiVoxels/totalVoxels; 
        end 
 
        %Retrieves the number of voxels in a given region of the rat 
        function voxels = regionVoxels(obj, roi) 
            try 
                voxels = obj.ratData{1,roi}; 
            catch 
                voxels = 0; 
            end 
        end 
 
        %Retrieves the mean value in a given region of the rat 
        function mean = regionMean(obj, roi) 
            try 
                mean = obj.ratData{2,roi}; 
            catch 
                mean = 0; 
            end 
        end 
 
        %Retrieves the standard devation value in a given region of the rat 
        function stdDev = regionStdDev(obj, roi) 
            try 
             stdDev = obj.ratData{3,roi}; 
            catch 
                stdDev = 0; 
            end 
        end 
    end 
    %Static method: 
    % 
    % An object is essentially a blueprint for something. For example, an 
    % object representing a vehicle is kind of like a schematic: 
    % We might create my car object by saying 
    % DeannasCar = Car('2010','Toyota','Camry',Gray') if we wanted to 
    % programatically create my gray 2010 Toyota Camry. 
    % The object (or blueprint) might also have some methods defined for it: 
    % leftBlinker, rightBlinker, accelerate, brake, repaint... etc. 
    % 
    % So hypothetically, if we wanted to repaint my car we could just call 
    % DeannasCar.repaint('Red'), and now the car is red. Hopefully in 
    % this example, it's also clear that when we call DeannasCar.repaint('Red'), 
    % It doesn't make every other car in the world red as well. 
    % Only Deanna's car will get repainted. 
    % 
    % Sometimes, though, we want to be able to define methods that don't 
    % really need the blueprint to be constructed in order to run. To continue 
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    % With the example, sometimes we want to be able to make a method that belongs to 
    % the Car class even though we haven't actually created a specific 
    % instance of a car object to run it on (like DeannasCar). 
    % That's where static methods come in. We can make a static method like 
    % numberOfWheels. We do this because in this example, we can 
    % pretty safely make the generalization that all cars have 4 wheels. 
    % We can call this method by simply doing Car.numberOfWheels(). 
    % Note that we don't do DeannasCar.numberOfWheels() -- we do 
    % Cars.numberOfWheels because the static numberOfWheels() 
    %isn't meant to be run on a specific car -- this is a method 
    %that is defined for ALL cars in general. 
    methods (Static) 
        %Sometimes in the table of data, we get a stray entry at the end of 
        %a row that is not actually a number (NaN = Not a Number). For 
        %example, when we read in a CSV with the values, "1,2,3,4,5," 
        %Matlab actually interprets this as a table with the values 
        % "1,2,3,4,5,NaN" because of the trailing comma at the end. 
        %This causes problems when we try to sum the entire row because 
        %MatLab doesn't know how to sum numbers with something that's not a 
        %number. We circumvent this by creating a quick method that treats 
        %all NaN values as 0 and sums the rest of the numbers. 
        function y = nansum(x) 
            nans = isnan(x); 
            x(nans) = 0; 
            y = sum(x); 
        end 
    end 
end 
Rat Analysis 
classdef RatAnalysis<handle 
     %properties for the RatAnalysis objec. Containers.Map-a Map object is a data structure 
     %that allows you to retrieve values using a corresponding key. Keys (sections (20,40,60)) 
can 
     %be real numbers or text strings and provide more flexibility for data 
     %access than array indices, which must be positive integers. Values (TreatmentFile objects)) 
can 
     %be scalar or nonscalar arrays. 
    properties 
        manifestPath; 
        targetedFiles = containers.Map('keyType','double','ValueType','any'); 
        untargetedFiles = containers.Map('keyType','double','ValueType','any'); 
        numRats = 5; 
    end 
 
    methods 
        %Reads in the manifest file and parses each of the files into 
        %separate TreatmentFile objects 
        function obj = parseManifestFile(obj) 
            %Try and catch are used to handle when things don't work as 
            %expected in the code. Everything in the "try" section gets 
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            %run, and if it fails, execution jumps to the catch section 
            %where we can specify w hat kind of error message to produce, or 
            %how we should recover from the error (if at all). 
            try 
                %XMLread is a method that allows us to parse an XML file. 
                %We use it since the manifest file is in XML format. 
                xmlDoc = xmlread(obj.manifestPath); 
                %Grab the set of targeted treatment files.Tagname in 
                %manifest is anything in < >. 
                tFiles = xmlDoc.getElementsByTagName('targeted'); 
                %Grab the set of untargeted treatment files. 
                utFiles = xmlDoc.getElementsByTagName('untargeted'); 
                obj.parseFileSet(tFiles, true); 
                obj.parseFileSet(utFiles, false); 
 
            catch ME 
                switch ME.identifier 
                    case 'MATLAB:xml:FileNotFound' 
                        err = ['ERROR: The path you specified for the '... 
                            ,'manifest file: "%s" either does not exist or the ' ... 
                            ,'program does not have permission to read the file. ' ... 
                            ,'Please check to make sure that everything ' ... 
                            ,'is spelled properly.']; 
                        error(err,obj.manifestPath); 
                    otherwise 
                        error(getReport(ME)); 
                end 
            end 
        end 
 
        %The manifest file contains a section for both targeted and 
        %untargeted treatment files. This method takes in one of those sets 
        %and parses each file within the treatment set. 
        function obj = parseFileSet(obj, tagSet, targeted) 
            try 
                %getElementsByTagName- built in function. getting all 
                %similar path tags in a set 
                pathEls = tagSet.item(0).getElementsByTagName('path'); 
                treatmentName = char(tagSet.item(0).getAttribute('name')); 
                %for all of the path tags in set 
                for i=1:pathEls.getLength() 
                    %get the path items in order they appear. starts 
                    %counting at 0 
                    fileEl = pathEls.item(i - 1); 
                    %Gets the path to the file that this element in the 
                    %manifest is referencing 
                    filePath = char(fileEl.getTextContent()); 
                    %Gets the time slice that this file represents 
                    timeString = char(fileEl.getAttribute('time')); 
                    time = str2double(timeString); 
                    if isnan(time) 
                        error(['ERROR: Non-number time provided in manifest ' ... 
                            ,'file: "%s". Please use an integer when ' ... 
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                            , 'specifying the "time" field in the ' ... 
                            , 'manifest file.'], timeString); 
                    end 
 
                    %parse the data from this file into a TreatmentFile object 
                    treatmentFile = TreatmentFile(filePath, targeted, treatmentName, time); 
                    %separate untargeted and targeted rat files into separate 
                    %arrays 
                    if(targeted) 
                        obj.targetedFiles(time) = treatmentFile; 
                    else 
                        obj.untargetedFiles(time) = treatmentFile; 
                    end 
                end 
            %Try and catch are used to handle when things don't work as 
            %expected in the code. Everything in the "try" section gets 
            %run, and if it fails, execution jumps to the catch section 
            %where we can specify what kind of error message to produce, or 
            %how we should recover from the error (if at all). Below, an 
            %error message gets generated if the "targeted" or "untargeted" 
            %sections of the manifest file fail to be read in correctly. 
            catch ME 
                switch ME.identifier 
                    case 'MATLAB:nonStrucReference' 
                        err = ['ERROR: Could not find %s section in the '... 
                            , 'manifest file. Make sure that it exists '... 
                            , 'and that it is spelled correctly.']; 
                        if targeted 
                            error(err, 'targeted'); 
                        else 
                            error(err, 'untargeted'); 
                        end 
                    otherwise 
                        error(getReport(ME)); 
                end 
            end 
        end 
 
        %Generates either the numerator or the denominator value for the 
        %targeted equation 
        %prescan refers to the prescan file and compare scan refers to the 
        %other file that is being compared to the prescan file - same 
        %treatment 
        function [sum, ratValues]  = weightedROIDiff(obj, targeted, roiID, compareTime) 
            if targeted 
                dataSet = obj.targetedFiles; 
            else 
                dataSet = obj.untargetedFiles; 
            end 
 
            sum = 0; 
            %prescan data will be filled in here 
            preScan = dataSet(0); 
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            %time file data willl be filled in here 
            compareScan = dataSet(compareTime); 
 
            ratValues = zeros(1,obj.numRats); 
            for i=1:obj.numRats 
                %start with the first rats in each file. loops through rest 
                preScanRat = preScan.ratCollection(i); 
                compareScanRat = compareScan.ratCollection(i); 
                %calling voxel percentage 
                roiPct = compareScanRat.roiVoxelPct(roiID); 
 
                %retreives values and solves one rat at a time, but as it 
                %loops it will sum the values leaving you with the 
                %numerator or denominator of the overall equation. 
                compareScanMean = compareScanRat.regionMean(roiID); 
                preScanMean = preScanRat.regionMean(roiID); 
 
                preScanRatVal = roiPct * preScanMean; 
                compareScanRatVal = roiPct * compareScanMean; 
                ratValue = preScanRatVal - compareScanRatVal; 
                ratValues(i) = ratValue; 
                sum = sum + ratValue; 
            end 
        end 
 
        %Generates the targeted equation value for the roi. Compares the 
        %prescan treatment file against the treatment file corresponding to compareTime 
        function [spi, testVal] = targetedSPI(obj, roiID, compareTime) 
            [targetedResult, targetedValues] = obj.weightedROIDiff(true, roiID, compareTime); 
            [untargetedResult, untargetedValues] = obj.weightedROIDiff(false, roiID, 
compareTime); 
            [~,testVal] = ttest2(targetedValues, untargetedValues,'Tail','both'); 
            spi = targetedResult/untargetedResult; 
        end 
 
        %Generates the targeted equation value for the roi. Compares the 
        %prescan treatment file against the treatment file corresponding to compareTime 
        function [spi, testVal] = untargetedSPI(obj, roiID, compareTime) 
            [preScanResult, preScanValues] = obj.weightedROIMean(roiID, 0); 
            [compareScanResult, compareScanValues] = obj.weightedROIMean(roiID, compareTime); 
            [~,testVal] = ttest2(preScanValues, compareScanValues,'Tail', 'both'); 
            spi = preScanResult/compareScanResult; 
        end 
 
        %Generates either the numerator or denominator for the untargeted 
        %SPI value 
        function [sum, ratValues] = weightedROIMean(obj, roiID, time) 
            sum = 0; 
            dataSet = obj.untargetedFiles(time); 
 
            ratValues = zeros(1,obj.numRats); 
            for i=1:obj.numRats 
                treatmentRat = dataSet.ratCollection(i); 
CONFIDENTIAL |  
 
127 
                roiPct = treatmentRat.roiVoxelPct(roiID); 
                meanVal = treatmentRat.regionMean(roiID); 
                ratValue = roiPct * meanVal; 
                ratValues(i) = ratValue; 
                sum = sum + ratValue; 
            end 
        end 
 
        function tbl = outputSPItable(obj, treatmentFile) 
            regionTable = treatmentFile.regionTable; 
            numRegions = width(regionTable); 
            tbl = cell(numRegions,3); 
 
            for i=1:numRegions 
               if(treatmentFile.targeted) 
                   [SPI, testVal] = obj.targetedSPI(i, treatmentFile.time); 
               else 
                   [SPI, testVal] = obj.untargetedSPI(i, treatmentFile.time); 
               end 
 
               tbl{i,2} = SPI; 
               tbl{i,3} = testVal; 
               tbl{i,1} = regionTable{1,i}; 
            end 
 
            tbl = cell2table(tbl); 
            tbl.Properties.VariableNames = {'ROI_ID','SPI','T_Test'}; 
            tbl.Properties.RowNames = regionTable.Properties.VariableNames; 
            fileName = treatmentFile.generateFileName(); 
            writetable(tbl, fileName, 'WriteRowNames', true); 
        end 
    end 
end 
Report Option 
classdef ReportOption < handle 
    %REPORTOPTION Summary of this class goes here 
    %   Detailed explanation goes here 
 
    properties 
        checkbox; 
        ratAnalysis; 
        treatmentFileSet; 
        statusText; 
        index; 
        panel; 
        reportName; 
    end 
 
    methods 
        function obj = ReportOption(ratAnalysis, treatmentFileSet, index) 
            obj.ratAnalysis = ratAnalysis; 
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            obj.treatmentFileSet = treatmentFileSet; 
            obj.index = index; 
            obj.reportName = treatmentFileSet(0).treatmentName; 
 
            obj.panel = uipanel('BorderType','none'); 
            setpixelposition(obj.panel,[0.5,0.5,1,0.1]); 
            obj.checkbox = uicontrol('Style','checkbox','String',obj.reportName, ... 
                       'Value',1); 
 
            obj.statusText = uicontrol('Style','text',... 
                'String','DONE',... 
                'ForegroundColor', [0,0.9,0.4], ... 
                'FontWeight', 'bold', ... 
                'Visible', 'off'); 
        end 
 
        function value = getCheckboxValue(obj) 
            value = get(obj.checkbox, 'Value'); 
        end 
 
        function obj = setBoxPosition(obj, panelHeight) 
            offset = panelHeight - (100 + (obj.index * 30)); 
            setpixelposition(obj.checkbox, [20,offset,150,30]); 
            setpixelposition(obj.statusText, [200, offset - 10, 100, 30]); 
        end 
 
        function obj = showStatusText(obj, bool) 
            if(bool) 
                set(obj.statusText, 'Visible', 'on'); 
            else 
                set(obj.statusText, 'Visible', 'off'); 
            end 
            drawnow; 
        end 
    end 
 
end 
Selection Menu classdef SelectionMenu<handle 
    properties 
        fig; 
        ratAnalysis; 
 
        browseButton; 
        browsePathText; 
        loadButton; 
        ratCountBox; 
        ratCountText; 
        ratCountButton; 
        generateButton; 
        reportOptions; 
    end 
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    methods 
        function obj = SelectionMenu() 
            obj.ratAnalysis = RatAnalysis(); 
            obj.fig = figure(); 
            obj.makeUIPanel(); 
 
            %Put buttons/components in the correct position to begin 
            obj.resizeui(); 
        end 
 
        %Creates the initial panel with UI controls 
        function obj = makeUIPanel(obj) 
            %Make an empty window with no controls 
            %Hide the toolbars at the top of the menu 
            set(obj.fig, 'MenuBar', 'none'); 
            set(obj.fig, 'Toolbar', 'none'); 
            set(obj.fig, 'ResizeFcn', @obj.resizeui); 
 
            %Add some text next to the browse button to show the selected 
            %path 
            obj.browsePathText = uicontrol(obj.fig,'Style','edit',... 
                'String','No manifest file selected',... 
                'Enable', 'off'); 
 
            %Add a button to browse for the manifest file 
            obj.browseButton = uicontrol(obj.fig,'Style','pushbutton', ... 
                'String','Browse', ... 
                'Callback', @obj.browseManifest); 
 
            %Add a button to load the manifest file 
            obj.loadButton = uicontrol(obj.fig,'Style','pushbutton', ... 
                'String','Load', ... 
                'Enable', 'off', ... 
                'Callback', @obj.loadManifest); 
 
            %Add a button to generate the reports 
            obj.generateButton = uicontrol(obj.fig,'Style','pushbutton', ... 
                'String','Generate Reports', ... 
                'Enable', 'off', ... 
                'Callback', @obj.generateSelectedReports); 
 
            %Add a button to generate the reports 
            obj.ratCountBox = uicontrol(obj.fig,'Style','edit', ... 
                'String','5'); 
 
            %Add a button to generate the reports 
            obj.ratCountText = uicontrol(obj.fig,'Style','text', ... 
                'String','Number of rats:'); 
 
            %Add a button to generate the reports 
            obj.ratCountButton = uicontrol(obj.fig,'Style','pushButton', ... 
                'String','Set', ... 
                'Callback', @obj.validateRatCountBox); 
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        end 
 
        %When called, opens the file browser so the user can navigate to 
        %the manifest file 
        function obj = browseManifest(obj, ~, ~, varargin) 
            [fileName,filePath] = uigetfile('*.xml','Select the manifest file'); 
            fullName = strcat(char(filePath), char(fileName)); 
            set(obj.browsePathText,'String',fullName); 
            set(obj.loadButton,'Enable', 'on'); 
            obj.ratAnalysis.manifestPath = fullName; 
        end 
 
        function obj = loadManifest(obj, ~, ~, varargin) 
            obj.ratAnalysis.parseManifestFile(); 
            obj.generateReportList(); 
            obj.resizeui(); 
        end 
 
        function obj = validateRatCountBox(obj, ~, ~, varargin) 
            input = get(obj.ratCountBox, 'String'); 
            value = str2double(input); 
            %Value is invalid 
            if isnan(value) || value < 0 
                set(obj.ratCountBox, 'String', '5'); 
                value = 5; 
            end 
            obj.ratAnalysis.numRats = value; 
        end 
 
        function generateReportList(obj) 
            %Initialize the list of report options 
            obj.reportOptions = ReportOption.empty(0,2); 
            obj.reportOptions(1) = ReportOption(obj.ratAnalysis, obj.ratAnalysis.untargetedFiles, 
1); 
            obj.reportOptions(2) = ReportOption(obj.ratAnalysis, obj.ratAnalysis.targetedFiles, 
2); 
            set(obj.generateButton,'Enable', 'on'); 
        end 
 
        %This function is run whenever the panel is resized. 
        function resizeui(obj, ~, ~, varargin) 
           % Get figure width and height 
           figPos = get(obj.fig, 'Position'); 
           figWidth = figPos(3); 
           figHeight = figPos(4); 
 
           setpixelposition(obj.browseButton,[figWidth-140, figHeight-100, 60, 40]); 
           setpixelposition(obj.browsePathText, [20,figHeight-95, figWidth-100, 25]); 
           setpixelposition(obj.loadButton, getpixelposition(obj.browseButton) + [60 0 0 0]); 
           setpixelposition(obj.generateButton, [figWidth-200, 40, 160, 40]); 
 
           setpixelposition(obj.ratCountBox, [figWidth-120, figHeight - 150, 60, 30]); 
           setpixelposition(obj.ratCountText, [figWidth-180, figHeight - 150, 60, 30]); 
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           setpixelposition(obj.ratCountButton, [figWidth-60, figHeight - 150, 40, 30]); 
 
           for i=1:length(obj.reportOptions) 
               opt = obj.reportOptions(i); 
               opt.setBoxPosition(figHeight); 
           end 
        end 
 
        function obj = generateSelectedReports(obj, ~, ~, varargin) 
            brain = Brain(obj.ratAnalysis); 
            for i=1:length(obj.reportOptions) 
                opt = obj.reportOptions(i); 
                opt.showStatusText(false); 
            end 
 
            for i=1:length(obj.reportOptions) 
                opt = obj.reportOptions(i); 
                checked = opt.getCheckboxValue(); 
 
                if(checked) 
                    brain.generateOutputTable(opt.treatmentFileSet); 
                    opt.showStatusText(true); 
                else 
                    opt.showStatusText(false); 
                end 
            end 
        end 
    end 
 
end 
Treatment File 
classdef TreatmentFile<handle 
    properties 
        path; 
        regionTable; 
        ratCollection; 
        time; 
        targeted; 
        treatmentName; 
        rowsPerRat = 4; 
    end 
 
    methods 
        %constructor for TreatmentFile. Therefore you need path and time 
        %to have a TreatmentFile. 
        %ratCollection-creates an empty list that will later be filled in 
        %with the rat data 
 
        function obj = TreatmentFile(path, targeted, treatmentName, time) 
            obj.path = path; 
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            obj.ratCollection = []; 
            obj.time = time; 
            obj.targeted = targeted; 
            obj.treatmentName = treatmentName; 
 
            %constructors can also call methods that help for setup (fill in ratCollection). This 
            % will Parse all of the CSV data for the treatment file and populate 
            % the list of rats. 
            obj.parseCSV(); 
        end 
 
        %make the csv file data usable and interpret that data for use in 
        %Matlab 
        function obj = parseCSV(obj) 
            %Parse the CSV data as a MATLAB table. readtable is a built in 
            %function. readtable(location, whether or not read Row Names, 
            %yes or no) 
            treatmentData = readtable(obj.path,'ReadRowNames',true); 
 
            %Separate and remove the ROI table from the rest of the table 
            obj.regionTable = treatmentData(1:1,:); 
            treatmentData(1,:)=[]; 
 
            %number of rows left in table. for loop starts at 1, goes up by 
            %4 (rowsperRat) each time, and then stops at numRows 
            numRows = height(treatmentData); 
            for i = 1:obj.rowsPerRat:numRows 
                %Grab every four rows of the table so that we can put this 
                %data into a rat object. 
                ratSubTable = treatmentData(i:i+3,:); 
 
                %Get the name of the rat, for example: 
                %'NEMU_BFNA_A3_R9_yV1_T1_relaxation_time' 
                ratName = ratSubTable.Properties.RowNames{1}; 
 
                %Make a new rat object. The first parameter represents the 
                %name of the rat, and the second parameter is a table 
                %containing the number of voxels, mean, and std dev values 
                %as rows 
                ratData = ratSubTable(2:end,:); 
                newRat = Rat(ratName,ratData); 
 
                %Add the newly parsed rat into the list of rats for this 
                %treatment file 
                obj.ratCollection = [obj.ratCollection; newRat]; 
            end 
        end 
 
        %Generates a name for the report to be generated 
        function filename = generateFileName(obj) 
            filename = sprintf('%s pre-%d.csv', obj.treatmentName, obj.time); 
        end 
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    end 
end 
 
Brain 
classdef Brain<handle 
    %Represents a brain of a rat and contains the different groupings and 
    %sections 
 
    properties 
        groupings; 
        ratAnalysis; 
    end 
 
    methods 
        function obj = Brain(ratAnalysis) 
            obj.ratAnalysis = ratAnalysis; 
 
            %Define the sections of the brain 
            olfactoryBulb = Section('Olfactory Bulb', {57,53,59}); 
            olfactoryAreas = Section('Olfactory Areas', {152,20,102,103}); 
            limbicLobe = Section('Limbic Lobe', {31,125,126}); 
            insularCortex = Section('Insular Coretex', {64}); 
            occipitalLobe = Section('Occipital Lobe', {156,157}); 
            temporalLobe = Section('Temporal Lobe', {150, 52, 23, 50, 114}); 
            parietalLobe = Section('Parietal Lobe', {116, 130, 131, 132, 133, 134, 135, 136, 
137}); 
            frontalLobe = Section('Frontal Lobe', {166,88,75,63,115,55,79,80}); 
            hippocampalFormation = Section('Hippocampal Formation', 
{25,26,27,28,29,48,170,40,41}); 
            amygdaloidNucComplex = Section('Amygdaloid Nuclear Complex', 
{24,30,15,68,61,35,83,49}); 
            basalGanglia = Section('Basal Ganglia', 
{42,44,162,165,153,16,17,58,167,146,174,111,51,139}); 
            basalForebrainSect = Section('Basal Forebrain', {33,145,78,151}); 
            septum = Section('Septum', {91,39}); 
            hypothalamus = Section('Hypothalamus', 
{18,73,104,149,138,94,22,43,100,81,86,143,164,77,89,119}); 
            pituitary = Section('Pituitary', {19,92}); 
            thalamus = Section('Thalamus', 
{14,34,71,76,82,98,120,158,161,163,168,169,118,109,85,72,127}); 
            epithalamus = Section('Epithalamus', {60, 101}); 
            cerebellum = Section('Cerebellum', 
{2,3,4,5,6,9,10,12,13,1,65,140,36,99,37,38,54,69,84,105}); 
            pons = Section('Pons', 
{106,7,112,45,154,74,129,93,110,107,108,56,96,8,11,70,148,87}); 
            tectum = Section('Tectum', {62,147}); 
            cerebralPeduncle = Section('Cerebral Peduncle', {21,90,141,142,124,171,67,95,32,128, 
... 
                117,47,121,66,144,159,160,122,123,97,46,113,155,172,173}); 
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            %Define the groupings of the brain 
            cerebralCortex = Grouping('Cerebral Cortex', 
{olfactoryBulb,olfactoryAreas,limbicLobe, ... 
                
insularCortex,occipitalLobe,temporalLobe,parietalLobe,frontalLobe,hippocampalFormation}); 
            basalForebrain = Grouping('Basal Forebrain', 
{amygdaloidNucComplex,basalGanglia,basalForebrainSect,septum}); 
            diencephalon = Grouping('Diencephalon', 
{hypothalamus,pituitary,thalamus,epithalamus}); 
            metencephalon = Grouping('Metencephalon',{cerebellum,pons}); 
            mesencephalon = Grouping('Mesencephalon',{tectum, cerebralPeduncle}); 
            medullaOblongata = Grouping('Medulla Oblongata', {}); 
 
            %Set the groupings of the brain 
            obj.groupings = {cerebralCortex, basalForebrain, diencephalon, ... 
                metencephalon,mesencephalon, medullaOblongata}; 
        end 
 
        function obj = generateOutputTable(obj, treatmentFileSet) 
            row = 0; 
            regionTable = treatmentFileSet(0).regionTable.Properties.VariableNames; 
            treatmentName = treatmentFileSet(0).treatmentName; 
            outputTable = cell2table(cell(174,13)); 
            outputTable.Properties.VariableNames = {'A','Section','ROI_ID', 'ROI',... 
                'Approx_Voxels','NA','SPI_20', 'SPI_40', 'SPI_60', 'Quartile', ... 
                'T_test_20', 'T_test_40', 'Ttest_60'}; 
            for i = 1:length(obj.groupings) 
                grouping = obj.groupings{i}; 
                for j = 1:length(grouping.sections) 
                    section = grouping.sections{j}; 
                    for k = 1:length(section.regions) 
                        region = section.regions{k}; 
                        %Fill in the grouping name 
                        outputTable{row + k,1} = {grouping.name}; 
                        %Fill in the section name 
                        outputTable{row + k,2} = {section.name}; 
                        %Fill in the region ID 
                        outputTable{row + k,3} = {region}; 
                        %Fill in region name 
                        regionName = regionTable(region); 
                        outputTable{row + k,4} = regionName; 
 
                        [twentySPI, twentyTest] = obj.getTreatmentSetSPI(treatmentFileSet, 
region, 20); 
                        [fortySPI, fortyTest] = obj.getTreatmentSetSPI(treatmentFileSet, region, 
40); 
                        [sixtySPI, sixtyTest] = obj.getTreatmentSetSPI(treatmentFileSet, region, 
60); 
 
                        %Fill out SPI 20,40,60 
                        outputTable{row + k,7} = {twentySPI}; 
                        outputTable{row + k,8} = {fortySPI}; 
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                        outputTable{row + k,9} = {sixtySPI}; 
 
                        %Fill out T-Test 20,40,60 
                        outputTable{row + k,11} = {twentyTest}; 
                        outputTable{row + k,12} = {fortyTest}; 
                        outputTable{row + k,13} = {sixtyTest}; 
                    end 
                    row = row + length(section.regions); 
                end 
                fileName = sprintf('VoxelWeighted_SPI_%s.csv',treatmentName); 
                writetable(outputTable, fileName, 'WriteRowNames', true); 
            end 
        end 
 
        function [SPI, testVal] = getTreatmentSetSPI(obj, treatmentFileSet, roiID, time) 
                treatmentFile = treatmentFileSet(time); 
                if(treatmentFile.targeted) 
                    [SPI, testVal] = obj.ratAnalysis.targetedSPI(roiID, time); 
                else 
                    [SPI, testVal] = obj.ratAnalysis.untargetedSPI(roiID, time); 
                end 
        end 
    end 
 
end 
Grouping 
classdef Grouping 
    %Represents a grouping of sections within the brain% 
 
    properties 
        name; 
        sections; 
    end 
 
    methods 
        function obj = Grouping(name, sections) 
            obj.name = name; 
            obj.sections = sections; 
        end 
    end 
 
end 
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Appendix F: Quality Control Images 
To ensure that the Matlab program was mapping correctly to the 3D rat brain atlas, a 
quality control process was completed. This process involved using an excel sheet of all “0”s and 
one “1” to map out a singular region. Each region of each slice was tested. A sample of one 
region from each slice can be found below. 
Slice 1: 
   
Slice 2:  
 
Slice 3: 
 
Slice 4: 
 
Slice 5: 
 
 
 
 
 
Slice 6:  
 
Slice 7: 
 
Slice 8: 
 
Slice9: 
 
Slice 10: 
 
 
 
 
 
Slice 11: 
 
Slice 12: 
 
Slice 13: 
 
Slice 14: 
 
Slice 15: 
 
 
 
 
 
CONFIDENTIAL |  
 
137 
Slice 16: 
 
Slice 17: 
 
Slice 18: 
 
Slice 19: 
 
Slice 20: 
 
Slice 21: 
 
 
 
 
 
Slice 22: 
 
Slice 23: 
 
Slice 24: 
 
Slice 25: 
 
Slice 26: 
 
Slice 27: 
 
 
 
 
Slice 28: 
 
Slice 29: 
 
Slice 30: 
 
Slice 31: 
 
Slice 32: 
 
Slice 33: 
 
 
 
 
 
CONFIDENTIAL |  
 
138 
Slice 34: 
 
Slice 35: 
 
Slice 36: 
 
Slice 37: 
 
Slice 38: 
 
Slice 39: 
 
 
 
 
 
Slice 40: 
 
Slice 41: 
 
Slice 42: 
 
Slice 43: 
 
Slice 44: 
 
Slice 45: 
 
 
 
 
 
Slice 46: 
 
Slice 47: 
 
Slice 48: 
 
Slice 49: 
 
Slice 50: 
 
Slice 51: 
 
 
 
 
 
CONFIDENTIAL |  
 
139 
Slice 52: 
 
Slice 53: 
 
Slice 54: 
 
Slice 55: 
 
Slice 56: 
 
Slice 57: 
 
Slice 58: 
 
Slice 59: 
 
Slice 60: 
Slice 61: 
 
Slice 62: 
 
Slice 63: 
  
CONFIDENTIAL |  
 
140 
Appendix G: Mu-Opioid Receptor Map 
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Appendix H: Alpha-7 Receptor Map 
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Appendix I: B2 Bradykinin Receptor Map 
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Appendix J: Non-Targeted Nanoemulsion Results 
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Appendix K: Dermorphin Nanoemulsion Results 
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Appendix L: Dermorphin Nanoemulsion Blocked with β-Funaltrexamine Results 
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Appendix M: Dermorphin Nanoemulsions Blocked with Naloxone Results  
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Appendix N: Candoxin Nanoemulsion Results 
 
 
Slice Number 20 minutes 40 Minutes 60 Minutes 
1 
   
2 
   
3 
   
4 
   
5 
   
6 
   
CONFIDENTIAL | 190 
 
7 
   
8 
   
9 
   
10 
   
11 
   
12 
   
13 
   
CONFIDENTIAL | 191 
 
14 
   
15 
   
16 
   
17 
   
18 
   
19 
   
20 
   
CONFIDENTIAL | 192 
 
21 
   
22 
   
23 
   
24 
   
25 
   
26 
   
27 
   
CONFIDENTIAL | 193 
 
28 
   
29 
   
30 
   
31 
   
32 
   
33 
   
34 
   
35 
   
CONFIDENTIAL | 194 
 
36 
   
37 
   
38 
   
39 
   
40 
   
41 
   
42 
   
CONFIDENTIAL | 195 
 
43 
   
44 
   
45 
   
46 
   
47 
   
48 
   
49 
   
50 
   
CONFIDENTIAL | 196 
 
51 
   
52 
   
53 
   
54 
   
55 
   
56 
   
57 
   
CONFIDENTIAL | 197 
 
58 
   
59 
   
60 
   
61 
   
62 
   
63 
   
 
  
CONFIDENTIAL | 198 
 
Appendix O: Cereport Nanoemulsion Results 
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Appendix P: How to Use the 3D Heat Mapping Program 
 
1. Move the file containing the SPI values into the same folder as the program. 
a. This folder should also contain the slicemap.m and plotable.mat files. 
2. Select the mapping program for the number of slices (all or single) you intend to produce maps 
of. They are labeled appropriately. 
3. When prompted by the program enter the name of the file you are imaging the SPI values from 
(ex. “A3_SPI.xls”), as well as the slice number (1-63), and time point (20, 40, or 60). 
4. Rotate the image into the preferred orientation and save as the preferred file type. 
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Appendix Q: “UseableMapFeedSPI” Program 
 
clear all 
0 
clc 
%MapFeedSPI 
%Slice_points 
%filename =input('enter the filename you wish to image from\n','s'); 
filename = 'VoxelWeighted_SPI_A3.csv'; 
Slicenum = input('enter the index number of the slice you wish to 
image:\n'); 
Y = Slicenum*3; 
Timepoint = input('enter the timepoint you intend to image from\n 
Options: 20, 40, 60 \n'); 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
load('plotable.mat') 
if Timepoint ==20; 
valstor = xlsread(filename,'G2:G175'); 
end 
if Timepoint ==40; 
valstor = xlsread(filename,'H2:H175'); 
end 
if Timepoint ==60; 
valstor = xlsread(filename,'I2:I175'); 
end 
%valstor = xlsread(filename,'A2:A175');%BradyNUMconvert.xlsx / 
muNUMconvert.xlsx / alphaNUMconvert.xlsx 
lenstor = length(valstor)+1; 
specval = zeros(1,175); 
for i = 1:lenstor-1; 
specval(i+1)=valstor(i); 
end 
valstor2 = xlsread(filename,'G2:G175'); 
lenstor = length(valstor2)+1; 
specval2 = zeros(1,175); 
for i = 1:lenstor-1; 
specval2(i+1)=valstor2(i); 
end 
3 
percentile = prctile(specval2,[75,80,85,90,95]); 
low = percentile(1); 
medLOW =percentile(2); 
MED = percentile(3); 
medHIGH = percentile(4); 
HIGH = percentile(5); 
%Index locations for regions, list to avoid having to repetitively 
find 
%them 
GL=2;% 
EPI=3;% 
Gr=4;% 
TT=5;% 
AO=6;% 
PIRC=7;% 
PirR=8;% 
Cg=9;% 
CG=Cg; 
RSC=10;% 
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RSR=11;%Retrosplenial Rostral Ctx 
Ins=12;% 
V1=13;%Visual 1 Ctx 
V2=14;%Visual 2 Ctx 
Te=15;% 
Ent=16;%Entorhinal Ctx 
Au=17;% 
Ect=18;%Ectorhinal Ctx 
PRh=19;% 
Pt=20;%Parietal Ctx 
S1BF=21;% 
S1FL=22;% 
S1HL=23;% 
S1J=24;% 
S1Sh=25;%Primary Somatosensory Ctx Shoulder 
S1Tr=26;%Primary Somatosensory Ctx Trunk 
S1UL=27;%Primary Somatosensory Ctx Upper Lip 
S2=28;% 
VO=29;% 
MO=30;%Medial Orbital Ctx 
LO=31;% 
IL=32;% 
PrL=33;% 
FrA=34;%Frontal Association Ctx 
M1=35;% 
M2=36;% 
CA1D=37;% 
CA1V=38;%CA1 Hippocampus Ventral 
CA2=39;%CA2 
CA3D=40;%CA3 Dorsal 
CA3V=41;%CA3 Hippocampus Ventral 
DS=42;% 
VS=43;% 
DgD=44;% 
DGv=45;% 
4 
BA=46;% 
Ce=47;% 
AA=48;% 
LA=49;%Lateral Amygdaloid Nucleus 
La=49; 
I=50;%Intercalated ADygdaloid Nucleus 
Co=51;% 
Me=52;% 
EA=53;% 
DLS=54;%Dorsal Lateral Striatum 
DMS=55;%Dorsal Medial Striatum 
VLS=56;%Ventral Lateral Striatum 
VMS=57;% 
Tu=58;% 
AcbC=59;% 
AcbSh=60;% 
AcbSH=60;% repeat for capitalization-KC 
GP=61;% 
VP=62;% 
STh=63; 
Sth =63;%Subthalamic Nucleus 
ZIR=64;%Zona Incerta 
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PR=65;%Prerubral Field 
EN=66;% 
SI=67;%Substantia Innominata 
Cl=68;% 
ST=69;% 
LS=70;%Lateral Septal Nucleus 
TS=71;%Triangular Septal Nucleus 
MS=72;%Medial Septum 
DB=73;%Diagonal Band of Broca 
AHA=74;% 
LH=75;% 
Lh=75; 
PM=76;%Premammillary Nucleus 
SUM=77;%Supramammillary Nucleus 
SCh=78;%Suprachiasmatic Nucleus 
PVA=79;% 
Arc=80;%Arcuate Nucleus 
DM=81;% 
PHD=82;%Posterior Hypothalamic Area 
MCPO=83;%Magnocellular Preoptic Nucleus 
MM=84;%Medial Mammillary Nucleus 
SO=85;% 
VMH=86;% 
LPO=87;%Lateral Preoptic Area 
MPA=88;%Medial Preoptic Area 
Rch=89;%Retrochiasmatic Nucleus 
AI=90;% 
AL=90; 
Al=90; 
NL=91;% 
A=92;% 
CM=93;% 
5 
LD=94;%Lateral Dorsal Thalamic Nucleus 
LP=95;%Lateral Posterior Thalamic Nucleus 
MD=96;%Medial Dorsal Thalamic Nucleus 
PF=97;%Parafascicular Thalamic Nucleus 
Re=98;% 
Va=99; VA=99;%Ventral Anterior Thalamic Nucleus 
VL=100;%Ventrolateral Thalamic Nucleus 
VM=101;%Ventromedial Thalamic Nucleus 
VPL=102;%Ventral Posteriolateral Thalamic Nucleus 
VPM=103;%Ventral Posteriolmedial Thalamic Nucleus 
Pa=104;% 
PO=105; 
Po=105;%Posterior Thalamic Nucleus 
MG=106;% 
LG=107;%Lateral Geniculate 
Rt=108;% 
HB=109;%Habenula Nucleus 
Hb=HB; 
Pi=110;%Pineal Gland 
oneCb=111;%1st Cerebellar Lobule 
twoCb=112;%2nd Cerebellar Lobule 
threeCb=113;%3rd Cerebellar Lobule 
fourCb=114;%4th Cerebellar Lobule 
fiveCb=115;%5th Cerebellar Lobule 
sixCb=116;%6th Cerebellar Lobule 
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sevenCb=117;%7th Cerebellar Lobule 
eightCb=118;%8th Cerebellar Lobule 
nineCb=119;%9th Cerebellar Lobule 
tenCb=120;%10th Cerebellar Lobule 
Int=121;%Interposed Nucleus 
Sim=122;%Simple Lobule Cerebellum 
Cop=123;%Copula of the Pyramis 
Pfl=124;%Paraflocculus Cerebellum 
PFI=Pfl; 
Crus1=125;%Crus 1 of Ansiform Lobule 
Crus2=126;%Crus 2 of Ansiform Lobule 
Fl=127;%Flocculus Cerebellum 
FL=Fl; 
Lat=128;%Lat (Lateral Cerebellar Nucleus) 
Sl=129;%Medial Cerebellar Nucleus Fastigial 
PMI=130;%Paramedian Lobule 
Pn=131;%Pontine Nuclei 
fiveN=132;%Motor Trigeminal Nucleus 
Pr5=133;%Principal Sensory Nucleus Trigeminal 
Prs=Pr5; 
DMTg=134;%Dorsomedial Tegmental AreaTz 
Tz=135;%Trapezoid Body 
LL=136;%Lemniscal Nucleus 
RtTfg=137;%Reticulotegmental Nucleus 
RtTg=RtTfg; 
Olv=138;%Olivary Nucleus 
Poi=139;%Periolivary Nucleus 
POI=Poi; 
PnC=140;%Pontine Reticular Nucleus Caudal 
6 
PnO=141;%Pontine Reticular Nucleus Oral 
Gig=142;%Gigantocellular Reticular Nucleus Pons 
PB=143;%Parabrachial Nucleus 
fiveR=144;%Root of Trigeminal Nerve 
sevenN=145;%Facial Nucleus 
LC=146;%Locus Ceruleus 
SubC=147;%Sub Coeruleus Nucleus 
MnR=148;%Median Raphe Nucleus 
IC=149;%Inferior Colliculus 
Su=150;% 
APT=151;%Anterior Pretectal Nucleus 
MPT=152;%Medial Pretectal Area 
SNC=153;%Substantia Nigra Compacta 
SNR=154;% 
RP=155;% 
VTA=156;% 
Ip=157;% 
IP=57; 
PAG=158;% 
%=159;%Central Gray 
Rt=108; 
mRt=160;%Reticular Nucleus Midbrain 
PTg=161;%Pedunculopontine Tegmental Area 
DR=162;%Dorsal Raphe 
RLi=163;% 
IO=164;%Inferior Olivary Complex 
Sol=165;%Solitary Tract Nucleus 
VCA=166;%Cochlear Nucleus 
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Ve=167;%Vestibular Nucleus 
RMg=168;%Raphe Magnus 
Rob=169;%Raphe Obscurus Nucleus 
PCRt=170;%PCRt 
DPGi=171;%DPGi 
PrCN=172;%Precuniform Nucleus 
PrCn=172;%Copied for capitalization-KC 
V=173;%Ventricle 
WM=174;% 
Dgd = DgD; 
DGd = Dgd; 
Error using input 
Cannot call INPUT from EVALC. 
Error in UsableMapFeedSPI (line 9) 
Slicenum = input('enter the index number of the slice you wish to 
image:\n'); 
slice1 
if Slicenum == 1; 
Y=3; 
%GL 2 
GLx=[1295,1295,1310,1392,1449,1501,1527,1530,1518,1488,1440,1375,1331]; 
7 
GLz=[1315,1200,1136,1003, 968, 
991,1085,1168,1231,1282,1320,1340,1335]; 
%EPI 3 
EPIx=[1350,1423,1478,1506,1486,1463,1415,1333,1304,1313,1332]; 
EPIz=[1326,1299,1251,1156,1012,998 ,1003,1123,1276,1303,1323]; 
%Gr 4 
Grx=[1338,1337,1338,1373,1416,1455,1472,1459,1409,1341]; 
Grz=[1305,1300,1224,1105,1046,1032,1069,1204,1268,1307]; 
%%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=1 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice2 
if Slicenum == 2; 
Y=6; 
Grx=[1333,1335,1413,1453,1471,1463,1426,1392,1357,1345]; 
Grz=[1298,1225,1003,1003,1082,1185,1261,1294,1305,1304]; 
GLx=[1296,1342,1396,1477,1529,1547,1520,1471,1416,1388,1343,1318,1313,1301,12
91]; 
GLz=[1317,1343,1349,1315,1238,1107,1000, 953, 934, 
944,1003,1052,1124,1143,1149]; 
EPIx=[1314,1307,1329,1370,1422,1471,1492,1520,1494,1431,1358]; 
EPIz=[1296,1265,1130,1003, 962, 986,1002,1084,1226,1309,1319]; 
%receptorMap(specval(2), GLx, GLz, Y) 
CONFIDENTIAL | 213 
 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=2 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 3 
if Slicenum == 3; 
8 
Y=9; 
Grx=[1373,1339,1334,1372,1397,1436,1456,1471,1465,1423,1376]; 
Grz=[1307,1288,1261,1003, 960, 978,1010,1082,1205,1280,1306]; 
GLx=[1291,1295,1397,1432,1475,1524,1548,1549,1503,1458,1405,1342]; 
GLz=[1317,986 , 892, 883, 911,1003,1112,1212,1300,1337,1356,1348]; 
EPIx=[1325,1311,1336,1353,1406,1435,1465,1492,1515,1515,1503,1412,1353]; 
EPIz=[1313,1251,1003,965 , 922, 922, 942, 
996,1069,1178,1238,1325,1330]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=3 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice4 
if Slicenum == 4; 
Y=12; 
Grx=[1354,1354,1359,1376,1404,1441,1476,1489,1486,1462,1439,1383]; 
Grz=[1289, 993, 949, 922, 912, 941,1000,1066,1152,1246,1284,1310]; 
GLx=[1291,1387,1434,1480,1544,1570,1552,1521,1462,1332,1291]; 
GLz=[1321,1361,1357,1336,1251,1137,994 , 909, 866, 864, 881]; 
EPIx=[1312,1334,1331,1363,1462,1516,1534,1539,1519,1477,1389,1359,1327]; 
EPIz=[1263,1003,917, 892 , 905, 
976,1046,1155,1232,1296,1333,1332,1306]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=4 
%l = 1; %enter whatever slice you want 
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hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
9 
slice5 
if Slicenum == 5; 
Y=15; 
Grx=[1355,1341,1365,1356,1368,1397,1458,1463,1498,1497,1462,1380]; 
Grz=[1306,1242,1108, 993, 922, 900, 925,1003,1134,1225,1287,1321]; 
GLx=[1294,1300,1400,1457,1499,1538,1573,1574,1553,1519,1469,1435,1351,1291]; 
GLz=[1321,1350,1365,1360,1337,1286,1183,1089,1003, 903, 846, 827, 851, 
834]; 
EPIx=[1320,1312,1332,1332,1327,1339,1397,1462,1492,1516,1542,1528,1469,1390,1
336]; 
EPIz=[1312,1273,1164,1003, 911, 886, 868, 887, 920, 
997,1134,1233,1322,1347,1329]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=5 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice6 
if Slicenum == 6; 
Y=18; 
Grx=[1345,1335,1367,1368,1399,1443,1463,1484,1506,1497,1463,1383]; 
Grz=[1293,1224,1108, 875, 855, 882, 917,1002,1146,1227,1291,1314]; 
GLx=[1291,1282,1352,1385,1410,1514,1557,1576,1574,1559,1525,1477,1418,1328]; 
GLz=[1320, 798, 816, 763, 769, 
888,1003,1082,1152,1240,1308,1355,1370,1349]; 
EPIx=[1321,1307,1332,1333,1325,1338,1384,1454,1499,1546,1544,1529,1477,1400,1
339]; 
EPIz=[1312,1257,1164, 993, 881, 851, 829, 851, 
920,1081,1180,1236,1319,1347,1331]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=6 
%l = 1; %enter whatever slice you want 
10 
hold all 
for t = 1:plotable{l,2}%slice31 
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plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice7 
if Slicenum == 7; 
Y=21; 
EPIx = 
[1324,1307,1332,1332,1325,1340,1383,1457,1496,1534,1554,1533,1487,1447,1386,1
339]; 
EPIz = [1312,1257,1164,1003, 857, 821, 802, 841, 
885,1000,1144,1238,1309,1337,1346,1331]; 
Grx=[1352,1380,1462,1489,1510,1491,1487,1482,1458,1409,1378,1367,1345,1352]; 
Grz=[1291,1313,1291,1246,1137,1003,1000, 920, 875, 839, 
852,1003,1222,1291]; 
GLx=[1291,1333,1418,1493,1537,1564,1582,1567,1538,1513,1445, 
1383,1295]; 
GLz=[1320,1351,1370,1344,1292,1228,1137,1003, 894, 847, 786, 762, 
777]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=7 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice8 
if Slicenum == 8; 
Y=24; 
Grx=[1368,1350,1356,1364,1379,1406,1451,1488,1504,1513,1492,1441,1405]; 
Grz=[1297,1236,1003, 877, 842, 823, 852, 926, 
998,1158,1236,1303,1315]; 
GLx =[1291,1295,1320,1374, 
1470,1528,1568,1589,1589,1571,1536,1487,1451,1396,1329]; 
GLz =[1308, 760,746 , 744, 786, 841, 
931,1046,1139,1217,1284,1336,1353,1355,1335]; 
EPIx=[1353,1320,1308,1336,1333,1375,1461,1526,1557,1555,1533,1491,1411,1397]; 
EPIz=[1322,1292,1242,1109, 785, 775, 822, 
913,1003,1136,1238,1304,1334,1333]; 
11 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(GL), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=8 
%l = 1; %enter whatever slice you want 
hold all 
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for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice9 
if Slicenum == 9; 
Y=27; 
Grx =[1355,1366,1399,1450,1494,1526,1533,1511,1462,1438,1408,1375]; 
Grz =[1175, 818, 805, 832, 907,1002,1082,1174,1254,1279,1288,1273]; 
GLx=[1295,1358,1445,1522,1571,1594,1598,1555,1487,1394,1330,1295]; 
GLz=[1308,1334,1335,1294,1228,1140,1023, 875, 781, 733, 727, 747]; 
EPIx=[1324,1328,1345,1413,1474,1530,1560,1567,1541,1513,1451,1407,1394,1361,1
343]; 
EPIz=[1200, 769, 759, 768, 817, 898, 
998,1075,1214,1257,1303,1315,1314,1305,1286]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=9 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice10 
if Slicenum == 10; 
Y=30; 
12 
Grx=[1375,1364,1360,1398,1430,1510,1522,1524,1509,1479,1427,1417,1389]; 
Grz=[1203,1003, 805, 785, 808, 921, 
993,1111,1161,1222,1254,1254,1231]; 
GLx=[1292,1294,1318,1396,1478,1546,1595,1599,1587,1555,1511,1420]; 
GLz=[1303, 725, 712, 721, 764, 841,1005,1099,1162,1232,1278,1318]; 
EPIx=[1331,1326,1353,1388,1445,1482,1544,1566,1565,1550,1524,1471,1392,1365]; 
EPIz=[1155, 773, 752, 748, 781, 808, 
916,1000,1137,1192,1230,1273,1295,1276]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
l=10 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
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slice11 
if Slicenum == 11; 
Y=33; 
Grx=[1392,1382,1359,1382, 
1406,1430,1505,1532,1531,1516,1480,1433,1421]; 
Grz=[1229,1003, 830, 776, 773, 791, 899, 
992,1090,1168,1226,1252,1251]; 
GLx=[1559,1594,1601,1579,1524,1445,1354,1295,1295,1310,1345,1445,1504]; 
GLz=[864 , 977,1092,1182,1259,1299,1307,1263, 719, 705, 702, 731, 
779]; 
EPIx=[1358,1346,1320,1331,1363,1397,1447,1475,1539,1561,1569,1529,1448,1405,1
372]; 
EPIz=[1213,1000, 812, 769, 743, 739, 764, 794, 
887,1000,1101,1215,1277,1279,1253]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
13 
l=11 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice12 
if Slicenum == 12; 
Y=36; 
%AO - 6 
AOx = [1454,1472,1499,1570,1602,1601,1545,1526,1502,1484,];%6 
AOz = [ 908, 786, 770, 868,1005,1050,1069,1057,1017,1000,]; 
%Gr-4 
Grx=[1526,1490,1454,1464,1399,1363,1372,1376,1394,1423,1465,1519]; 
Grz=[1057,1003, 908, 788, 773, 795, 993,1110,1155,1180,1171,1113]; 
%GL-2 
GLx=[1291,1336,1389,1431,1486,1555,1585,1600,1585,1548,1526,1490,1454,1464,14
99,1440,1365,1316,1291]; 
GLz=[1223,1266,1288,1293,1273,1206,1133,1051,1065,1070,1057,1003, 908, 
788, 770, 726, 697, 703, 719]; 
%3 
EPIx=[1526,1490,1454,1464,1494,1394,1357,1331,1321,1341,1363,1405,1467,1520,1
557,1581,1548]; 
EPIz=[1057,1003, 908, 788, 765, 734, 733, 753, 
795,1169,1224,1251,1230,1186,1134,1064,1070]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
%receptorMap(specval(6),AOx,AOz,Y) 
slicemap (specval(6), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
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l=12 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 13 
if Slicenum == 13; 
Y=39; 
%AO14 
AOx=[1518,1648,1642,1620,1607,1577,1492,1468,1497,1497,1427,1413,1429]; 
AOz=[ 767, 919, 975,1003,1055,1057,1024,1000, 938, 911, 843, 802, 
777]; 
%Gr- 
Grx=[1515,1444,1363,1330,1322,1351,1376,1470,1497,1497,1427,1413,1429]; 
Grz=[ 764, 718, 743, 792, 881, 997,1019,1003, 938, 911, 843, 802, 
777]; 
%GLGLx=[ 
1290,1295,1320,1399,1444,1363,1330,1322,1351,1364,1416,1525,1584,1592,1573,15
28,1423,1324]; 
GLz=[1138, 719, 692, 697, 718, 743, 792, 881, 
997,1017,1056,1069,1100,1109,1181,1210,1204,1142]; 
%EPIEPIx=[ 
1607,1577,1492,1470,1376,1416,1525,1584,1595]; 
EPIz=[1055,1057,1024,1003,1019,1056,1069,1100,1109]; 
%FrA-34 
FrAx=[1291,1284,1324,1423,1528,1573,1618,1634,1692,1714,1723,1704,1674,1628,1
538,1450,1367]; 
FrAz=[1223,1138,1142,1204,1210,1181,1006,1024,1031,1062,1113,1226,1275,1313,1
343,1335,1296]; 
%receptorMap(specval(2), GLx, GLz, Y) 
slicemap (specval(2), low,medLOW, MED, medHIGH, HIGH, GLx, GLz, Y); 
%receptorMap(specval(3), EPIx, EPIz, Y) 
slicemap (specval(3), low,medLOW, MED, medHIGH, HIGH, EPIx, EPIz, Y); 
%receptorMap(specval(4), Grx, Grz, Y) 
slicemap (specval(4), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
%receptorMap(specval(6),AOx,AOz,Y) 
slicemap (specval(6), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
%receptorMap(specval(34),FrAx,FrAz,Y)%FrA 
slicemap (specval(34), low,medLOW, MED, medHIGH, HIGH, FrAx, FrAz, Y); 
l=13; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice14 
if Slicenum == 14; 
Y=42; 
Grx=[1295,1295,1342,1444,1400,1376,1378,1403,1466,1460]; 
Grz=[ 859, 728, 681, 696, 723, 763, 818, 868, 944, 995]; 
%receptorMap(specval(4), Grx, Grz, Y)%Gr 
CONFIDENTIAL | 219 
 
slicemap (specval(Gr), low,medLOW, MED, medHIGH, HIGH, Grx, Grz, Y); 
AOx=[1460,1466,1403,1378,1376,1400,1444,1476,1564,1634,1633,1580,1519]; 
AOz=[995 , 944, 868, 818, 763, 723, 696, 707, 773, 870, 
947,1003,1014]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(AO), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
FrAx=[1297,1331,1443,1474,1539,1608,1691,1742,1759,1761,1691,1650,1629,1616,1
616,1546,1465,1295]; 
15 
FrAz=[1305,1343,1370,1372,1363,1336,1280,1221,1176,1119, 952, 945, 
991,1000,1112,1134,1141,1118]; 
%receptorMap(specval(34),FrAx,FrAz,Y)%FrA 
slicemap (specval(FrA), low,medLOW, MED, medHIGH, HIGH, FrAx, FrAz, 
Y); 
MOx=[1295,1295,1345,1351,1360,1384,1449,1465]; 
MOz=[1118, 859, 907, 982,1003,1061,1116,1141]; 
%receptorMap(specval(30), MOx, MOz, Y)%MO 
slicemap (specval(MO), low,medLOW, MED, medHIGH, HIGH, MOx, MOz, Y); 
VOx=[1461,1449,1384,1351,1345,1445];%plot before MO and LO 
VOz=[998 ,1116,1061, 982, 907, 990]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
LOx=[1461,1449,1468,1546,1616,1612,1549,1514]; 
LOz=[998 ,1116,1140,1134,1112,1003,1021,1015]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
WMx=[1444,1476,1564,1634,1633,1580,1519,1549,1629,1650,1657,1600,1547,1476]; 
WMz=[ 696, 707, 773, 870, 947,1003,1014,1021, 991, 945, 881, 794, 744, 
707]; 
%receptorMap (specval(174), WMx, WMz, Y) 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
l=14; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice15 
if Slicenum == 15; 
Y=45; 
M2x=[1295,1295,1681,1757,1758,1724,1673,1597,1466]; 
M2z=[1230,1230,1304,1252,1002,1062,1111,1142,1137]; 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
LOx=[1472,1449,1441,1449,1502,1526,1589,1650,1714,1758,1724,1673,1597]; 
LOz=[1143,1100,1003, 967,1004,1012,1003, 940, 
932,1002,1062,1111,1142]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
AOx=[1355,1490,1515,1614,1610,1574,1542,1474,1393,1350]; 
AOz=[872 , 998,1009, 969, 844, 782, 749, 711, 710, 774]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(6), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
PirRx=[1613,1610,1574,1542,1474,1422,1410,1478,1587,1649,1668]; 
PirRz=[ 968, 844, 782, 749, 711, 703, 646, 666, 747, 826, 890]; 
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%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
16 
slicemap (specval(8), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
TTx=[1295,1330,1368,1410,1422,1393,1368,1350,1355,1295]; 
TTz=[720 , 668, 646, 646, 711, 710, 731, 774, 872, 821]; 
%receptorMap(specval(5), TTx, TTz, Y)%TT 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
MOx=[1295,1335,1338,1356,1392,1449,1466,1295]; 
MOz=[ 821, 851, 934,1003,1068,1110,1137,1117]; 
%receptorMap(specval(30), MOx, MOz, Y)%MO 
slicemap (specval(MO), low,medLOW, MED, medHIGH, HIGH, MOx, MOz, Y); 
VOx=[1449,1441,1449,1392,1356,1338,1335,1414]; 
VOz=[ 967,1003,1100,1068,1003, 934, 851, 930]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
PrLx = [1293,1466,1282]; 
PrLz = [1230,1137,1117]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
slicemap (specval(33), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, Y); 
l=15; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice16 
if Slicenum == 16; 
Y=48; 
Cgx=[1295,1326,1472,1461,1295]; 
Cgz=[1320,1361,1135,1137,1222]; 
%receptorMap(specval(9), Cgx, Cgz, Y)%Cg 
slicemap (specval(9), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
M2x=[1326,1480,1509,1542,1614,1522,1425,1406]; 
M2z=[1361,1136,1138,1246,1352,1386,1395,1394]; 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
M1x=[1617,1542,1509,1566,1818,1824,1783,1709]; 
M1z=[1353,1246,1138,1117,1094,1143,1245,1305]; 
%receptorMap(specval(35), M1x, M1z, Y)%M1 
slicemap (specval(35), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
Insx=[1569,1818,1760,1729,1729,1679,1638]; 
Insz=[1115,1094, 924, 887, 940,1048,1086]; 
%receptorMap(specval(12), Insx, Insz, Y)%Ins 
slicemap (specval(12), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
LOx=[1569,1638,1679,1729,1729,1664,1647,1607,1532,1474,1444,1463,1514]; 
LOz=[1115,1086,1048, 940, 887, 887, 913, 938, 953, 
941,1049,1136,1134]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
MOx=[1295,1333,1358,1405,1449,1444,1295]; 
17 
MOz=[ 803, 834, 922, 997,1038,1049,1031]; 
%receptorMap(specval(30), MOx, MOz, Y)%MO 
slicemap (specval(MO), low,medLOW, MED, medHIGH, HIGH, MOx, MOz, Y); 
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l=16; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
VOx=[1348,1418,1474,1449,1407,1358]; 
VOz=[ 848, 914, 941,1038,1000, 922]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
PrLx=[1295,1295,1444,1461]; 
PrLz=[1222,1031,1049,1137]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
slicemap (specval(33), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, Y); 
TTx=[1295,1295,1368,1437,1440,1386,1368,1400,1348,1330]; 
TTz=[ 803, 700,700 , 632, 694, 697, 730, 809, 848, 835]; 
%receptorMap(specval(5), TTx, TTz, Y)%TT 
slicemap (specval(5), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
PirRx=[1669,1669,1437,1440,1488,1565,1572,1561,1577,1590,1579,1552,1506,1477,
1434,1430,1403,1348,1418,1474,1524,1532,1607,1647]; 
PirRz=[888 , 700, 632, 694, 702, 735, 756, 771, 774, 796, 840, 858, 
861, 859, 841, 806, 808, 848, 914, 941, 953, 953, 938, 913]; 
%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
slicemap (specval(8), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
ENx=[1436,1517,1542,1534,1558,1577,1590,1579,1552,1506,1477,1434,1430]; 
ENz=[ 796, 814, 797, 783, 771, 774, 796, 840, 858, 861, 859, 841, 
809]; 
%receptorMap(specval(66), ENx, ENz, Y)%EN 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
WMx=[1444,1517,1542,1507,1451,1428]; 
WMz=[ 799, 814, 797, 770, 765, 777]; 
%receptorMap(specval(174), WMx, WMz, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
AOx=[1403,1368,1366,1488,1567,1572,1559,1534,1507,1451,1428,1444]; 
AOz=[ 808, 730, 697, 702, 737, 756, 770, 783, 770, 765, 777, 799]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(AO), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
end 
slice17 
if Slicenum == 17; 
Y=17*3; 
AOx=[1405,1442,1431,1441,1507,1545,1540,1570,1569,1532,1479,1437,1395,1377]; 
AOz=[ 778, 774, 755, 740, 741, 768, 760, 742, 714, 671, 648, 
648,666 ,697 ]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(6), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
ILx=[1291,1381,1391,1426,1431,1278]; 
18 
ILz=[790 , 827, 897, 987,1018,1013]; 
%receptorMap(specval(32), ILx, ILz, Y)%IL 
slicemap (specval(32), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, Y); 
l=17; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
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plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
VOx=[1487,1436,1426,1391,1383,1514,1635,1640,1518,1491,1480,1485]; 
VOz=[1042, 985, 987, 897, 829, 858, 844, 844, 924, 956, 993,1040]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(29), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
LOx=[1487,1479,1491,1518,1640,1722,1760,1723,1628,1546]; 
LOz=[1042,1003, 956, 924, 844, 787, 826, 890,1000,1066]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
M2x=[1331,1497,1511,1534]; 
M2z=[1365,1126,1132,1384]; 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
PrLx=[1295,1295,1468,1435,1433]; 
PrLz=[1013,1229,1104,1048,1020]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y); 
TTx=[1295,1295,1459,1462,1437,1395,1377,1405,1361,1347]; 
TTz=[ 790, 650, 599, 644, 648, 666, 697, 778, 797, 815]; 
%receptorMap(specval(5), TTx, TTz, Y)%TT 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
PirRx=[1446,1408,1361,1347,1495,1528,1635,1724,1600,1459,1479,1532,1569,1570,
1586,1596,1566,1516,1486,1440]; 
PirRz=[ 767, 776, 797, 815, 857, 859, 844, 784, 600, 599, 648, 671, 
714, 742, 746, 797, 829, 834, 832, 811]; 
%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
WMx=[1555,1513,1468,1433,1545]; 
WMz=[1114,1134,1104,1041,1097]; 
%receptorMap(specval(174), WMx, WMz, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WM2x=[1445,1521,1545,1507,1441,1431]; 
WM2z=[ 768,786 , 768, 741, 740, 755]; 
%receptorMap(specval(174), WM2x, WM2z, Y)%WM 
slicemap (specval(174), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, 
Y); 
M1x=[1534,1511,1552,1553,1855]; 
M1z=[1384,1132,1123,1118,1114]; 
%receptorMap(specval(35), M1x, M1z, Y)%M1 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
Cgx=[1331,1331,1497,1485,1295]; 
Cgz=[1295,1365,1126,1118,1229]; 
%receptorMap(specval(9), Cgx, Cgz, Y)%Cg 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
19 
Insx=[1855,1760,1723,1628,1546,1566,1553]; 
Insz=[1114, 826, 890,1000,1066,1091,1118]; 
%receptorMap(specval(12), Insx, Insz, Y)%Ins 
slicemap (specval(12), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
Clx=[1553,1545,1430,1431,1422,1426,1449,1483,1546,1566]; 
Clz=[1118,1097,1040,1018,1003, 987, 999,1039,1066,1091]; 
%receptorMap(specval(68), Clx, Clz, Y)%Cl 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
ENx=[1443,1440,1486,1566,1596,1586,1558,1545,1521,1505,1446]; 
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ENz=[ 768, 811, 832, 829, 797, 746, 742, 768, 786, 785, 767]; 
%receptorMap(specval(66), ENx, ENz, Y)%EN 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
end 
slice18 
if Slicenum == 18; 
Y=3*18; 
M2x=[1330,1503,1511,1505,1409]; 
M2z=[1382,1103,1107,1398,1411]; 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
M1x=[1511,1505,1712,1784,1841,1552]; 
M1z=[1107,1398,1328,1281,1223,1089]; 
%receptorMap(specval(35), M1x, M1z, Y)%M1 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
S1Jx=[1546,1879,1897,1891,1843,1552]; 
S1Jz=[1074, 898,1002,1115,1219,1089]; 
%receptorMap(specval(24), S1Jx, S1Jz, Y)%S1j 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y); 
%QCcolor (S1Jx,S1Jz,18*3) 
l=18; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
Insx=[1578,1584,1879,1876,1798,1729,1633]; 
Insz=[1040,1059, 898, 882, 738, 884,1003]; 
%receptorMap(specval(12), Insx, Insz, Y)%Ins 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y); 
LOx=[1520,1526,1549,1638,1682,1737,1759,1798,1729,1633,1578]; 
LOz=[1012, 954, 911, 810, 772, 738, 683, 738, 884,1003,1040]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
VOx=[1434,1419,1436,1538,1615,1682,1638,1549,1526,1520,1506,1461]; 
VOz=[ 936, 860, 800, 811, 805, 772, 810,911 , 954,1012,1000, 943]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
ILx=[1295,1424,1434,1419,1436,1356,1295]; 
20 
ILz=[ 946, 957, 936, 860, 800, 783, 763]; 
%receptorMap(specval(32), ILx, ILz, Y)%IL 
slicemap (specval(IL), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, Y); 
PrLx=[1295,1295,1424,1453,1488]; 
PrLz=[1218, 946, 957,1062,1096]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y); 
Cgx=[1295,1328,1503,1488,1295]; 
Cgz=[1328,1383,1103,1096,1218]; 
%receptorMap(specval(9), Cgx, Cgz, Y)%Cg 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
TTx=[1295,1289,1330,1371,1398,1369,1370,1411,1346]; 
TTz=[ 763, 712, 621, 589, 642, 688, 715, 731, 782]; 
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%receptorMap(specval(5), TTx, TTz, Y)%TT 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
AOx=[1369,1405,1447,1510,1542,1554,1532,1485,1438,1391,1370]; 
AOz=[ 688, 645, 629, 637, 659, 708, 714, 702, 720, 726, 715]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(AO), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
Tux=[1371,1434,1538,1510,1447,1399]; 
Tuz=[ 589, 558, 570, 639, 629, 638]; 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, Y); 
PirRx=[1346,1473,1538,1605,1689,1737,1759,1684,1543,1510,1542,1554,1589,1589,
1560,1429,1390,1385]; 
PirRz=[ 782, 807, 811, 805, 772, 738, 683, 630, 574, 639, 659, 708, 
712,755 , 781, 785, 774, 750]; 
%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
AcbSHx=[1438,1450,1492,1459,1429,1390,1385,1406]; 
AcbSHz=[ 720, 735, 747, 784, 785, 774, 750, 733]; 
%receptorMap(specval(60), AcbSHx, AcbSHz, Y)%AcbSh 
slicemap (specval(AcbSH), low,medLOW, MED, medHIGH, HIGH, AcbSHx, 
AcbSHz, Y); 
ENx=[1492,1522,1551,1532,1589,1589,1560,1493,1459]; 
ENz=[ 747, 751, 738, 714, 712, 755, 781, 787, 784]; 
%receptorMap(specval(66), ENx, ENz, Y)%EN 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
WMx=[1492,1522,1551,1532,1485,1438,1450,1506]; 
WMz=[ 747, 751, 738, 714, 702, 720, 735, 750]; 
%receptorMap(specval(174), WMx, WMz, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WM2x=[1431,1487,1549,1551,1522,1513,1453,1436]; 
WM2z=[ 978,1037,1076,1090,1107,1108,1062,1005]; 
%receptorMap(specval(174), WM2x, WM2z, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
WM3x=[1339,1318,1345,1390,1375]; 
WM3z=[ 578, 544, 523, 545, 573]; 
%receptorMap(specval(174), WM3x, WM3z, Y)%WM 
slicemap (specval(174), low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, 
Y); 
Clx=[1436,1487,1544,1582,1576,1515,1461,1426,1431]; 
Clz=[1005,1037,1074,1055,1041,1009, 943, 944, 978]; 
21 
%receptorMap(specval(68), Clx, Clz, Y)%Cl 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
end 
slice19 
if Slicenum == 19; 
Y=57; 
l=19 
AOx=[1420,1395,1369,1368,1394,1450,1506,1529,1556,1551,1486,1440,1444]; 
AOz=[ 714, 716, 698, 675, 637, 613, 620, 636, 670, 699, 680, 691, 
706]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(AO), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
ILx=[1295,1429,1436,1295]; 
ILz=[ 917, 925, 783, 757]; 
%receptorMap(specval(32), ILx, ILz, Y)%IL 
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slicemap (specval(IL), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, Y); 
VOx=[1426,1424,1431,1459,1490,1531,1534,1557,1700,1577]; 
VOz=[ 783, 838, 891, 891, 963, 998, 951, 906, 758, 790]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
LOx=[1700,1805,1732,1668,1580,1571,1532,1534,1557]; 
LOz=[ 758, 690, 859, 949,1021,1011, 997, 951, 906]; 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
M2x=[1484,1511,1504,1331]; 
M2z=[1115,1123,1398,1383]; 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
PrLx=[1295,1469,1432,1429,1295,]; 
PrLz=[1195,1086,1003, 925, 917]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL) 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y); 
TTx=[1295,1378,1411,1372,1368,1394,1360,1295]; 
TTz=[757 , 774, 718, 697, 675, 637, 588, 530]; 
%receptorMap(specval(5), TTx, TTz, Y)%TT) 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
PirRx=[1393,1439,1520,1568,1601,1595,1551,1556,1529,1571,1762,1692,1577,1426,
1378]; 
PirRz=[ 748, 768, 771, 765, 734, 691, 699,670 , 636, 539, 716, 759, 
790, 783, 774]; 
%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
WMx=[1436,1432,1481,1513,1560,1566,1541,1493,1455, 1438]; 
WMz=[ 963,1003,1114,1125,1100,1067,1053,1037,1003, 955]; 
%receptorMap(specval(174), WMx, WMz, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WM2x=[1440,1486,1539,1552,1524,1452]; 
WM2z=[ 691, 680, 696, 719, 729, 713]; 
%receptorMap(specval(174), WM2x, WM2z, Y)%WM 
22 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
WM3x=[1330,1374,1394,1372,1338,1311]; 
WM3z=[572 , 562, 524, 505, 506, 542]; 
%receptorMap(specval(174), WM3x, WM3z, Y)%WM 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
M1x=[1504,1849,1559,1511]; 
M1z=[1398,1232,1098,1123]; 
%receptorMap(specval(35), M1x, M1z, Y)%M1 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
Cgx=[1295,1331,1484,1469,1295]; 
Cgz=[1283,1383,1115,1086,1195]; 
%receptorMap(specval(9), Cgx, Cgz, Y)%Cg 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
Insx=[1582,1934,1805,1732,1668,1608,1580]; 
Insz=[1034, 884, 690, 859, 949,1002,1021]; 
%receptorMap(specval(12), Insx, Insz, Y)%Ins 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y); 
ENx=[1462,1520,1568,1601,1595,1547,1552,1508,1496]; 
ENz=[ 766, 771, 765, 734, 691, 703, 719, 728, 725]; 
%receptorMap(specval(66), ENx, ENz, Y)%EN 
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slicemap (specval(66), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
Clx=[1459,1430,1436,1455,1493,1536,1582,1571,1535,1490]; 
Clz=[ 891, 892, 963,1003,1037,1053,1034,1011,1000, 963]; 
%receptorMap(specval(68), Clx, Clz, Y)%Cl 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
Tux=[1360,1571,1529,1506,1450,1394]; 
Tuz=[ 588, 539, 636, 620, 613, 637]; 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, Y); 
S1Jx=[1849,1559,1566,1541,1934]; 
S1Jz=[1232,1098,1067,1053, 884]; 
%receptorMap(specval(24), S1Jx, S1Jz, Y)%S1j 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y); 
AcbShx=[1393,1420,1444,1508,1462,1431]; 
AcbShz=[ 748, 714, 706, 728, 766, 768]; 
%receptorMap(specval(60), AcbShx, AcbShz, Y)%AcbSh 
slicemap (specval(60), low,medLOW, MED, medHIGH, HIGH, AcbShx, AcbShz, 
Y); 
l=19; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice20 
if Slicenum == 20; 
23 
Y=60; 
l=20 
AOx=[1361,1385,1427,1470,1469,1439,1385,1356]; 
AOz=[ 728, 740, 698, 619, 612, 607, 637, 680]; 
%receptorMap(specval(6), AOx, AOz, Y)%AO 
slicemap (specval(6), low,medLOW, MED, medHIGH, HIGH, AOx, AOz, Y); 
AcbCx=[1480,1472,1534,1559,1533]; 
AcbCz=[ 765, 693, 711, 709, 740]; 
%receptorMap(specval(59), AcbCx, AcbCz, Y)%AcbC 
slicemap (specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, 
Y); 
Cgx=[1295,1326,1484,1482,1295]; 
Cgz=[1345,1394,1114,1085,1192]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(9), Cgx, Cgz, Y)%Cg 
ILx=[1295,1434,1435,1425,1440,1387,1364,1295]; 
ILz=[ 917, 925, 901, 853, 781, 742, 735, 725]; 
%receptorMap(specval(32), ILx, ILz, Y)%IL 
slicemap (specval(IL), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, Y); 
Insx=[1638,1956,1915,1828,1758,1736,1690,1620]; 
Insz=[1000, 871, 746, 639, 700, 794, 896, 982]; 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y); 
%receptorMap(specval(12), Insx, Insz, Y)%Ins 
VOx=[1435,1425,1452,1481,1616,1676,1547,1515,1503,1480,1455,1447]; 
VOz=[ 901, 853, 790, 793, 737, 723, 865, 929, 882, 862, 876, 912]; 
%receptorMap(specval(29), VOx, VOz, Y)%VO 
CONFIDENTIAL | 227 
 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, Y); 
LOx=[1515,1547,1679,1758,1736,1690,1620,1579,1541]; 
LOz=[ 929, 865, 723, 700, 794, 896, 982, 980, 964]; 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, Y); 
%receptorMap(specval(31), LOx, LOz, Y)%LO 
ENx=[1571,1552,1488,1470,1545,1637,1626,1612,1481,1452,1476,1533]; 
ENz=[ 692, 674, 659, 619, 589, 614, 693, 737, 793, 790, 760, 740]; 
%receptorMap(specval(66), ENx, ENz, Y)%EN 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
Clx=[1515,1541,1586,1620,1638,1625,1544,1496,1448,1455,1480,1503]; 
Clz=[ 929, 964, 982, 982,1000,1020,1028,1000, 914, 876, 862, 882]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
%receptorMap(specval(68), Clx, Clz, Y)%Cl 
M2x=[1326,1484,1513,1505,1385]; 
M2z=[1394,1114,1134,1398,1411]; 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
Tux=[1470,1439,1406,1373,1412,1482,1524,1618,1587,1509,1465,1443]; 
Tuz=[629 , 607, 618, 561, 504, 470, 474, 511, 552, 531, 537, 568]; 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, Y); 
PrLx=[1295,1482,1443,1434,1288]; 
PrLz=[1192,1085, 995, 925, 917]; 
%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y); 
24 
AcbShx=[1470,1484,1486,1458,1474,1476,1457,1385,1427,1467]; 
AcbShz=[ 619, 650, 663, 673, 694, 760, 792, 740, 698, 626]; 
slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, AcbShx, 
AcbShz, Y); 
%receptorMap(specval(60), AcbShx, AcbShz, Y)%AcbSh 
TTx=[1295,1295,1361,1356,1385,1407,1369,]; 
TTz=[ 650,728 , 728, 680, 637, 620, 549,]; 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, Y); 
%receptorMap(specval(5), TTx, TTz, Y)%TT 
S1Jx=[1582,1736,1798,1864,1922,1952,1963,1956,1638,1625,1600,1623,1620]; 
S1Jz=[1091,1204,1285,1232,1151,1078, 993, 
871,1000,1020,1029,1041,1067]; 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y); 
%receptorMap(specval(24), S1Jx, S1Jz, Y)%S1j 
PirRx=[1616,1758,1825,1607,1589,1623,1637,1636,1614]; 
PirRz=[ 737, 700, 637, 508, 554, 580, 614, 693, 737]; 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
VPx=[1469,1443,1465,1509,1587,1623,1637,1629,1545]; 
VPz=[ 609, 568, 537, 531, 552, 580, 614, 615, 589]; 
slicemap (specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(62), VPx, VPz, Y)%VP 
WMx=[1435,1493,1544,1598,1623,1620,1513,1485,1482,1449]; 
WMz=[ 901, 997,1028,1027,1041,1067,1134,1113,1083,1003]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(174), WMx, WMz, Y)%WM 
WM2x=[1458,1487,1552,1571,1559,1534,1474]; 
WM2z=[ 673, 665, 674, 692, 709, 711, 693]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
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%receptorMap(specval(174), WM2x, WM2z, Y)%WM 
WM3x=[1339,1370,1385,1367,1342,1311,1316]; 
WM3z=[ 559, 551, 521, 497, 493, 521, 544]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, Y); 
%receptorMap(specval(174), WM3x, WM3z, Y)%WM 
M1x=[1509,1511,1582,1736,1798,1677]; 
M1z=[1397,1134,1091,1204,1285,1349]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(35), M1x, M1z, Y)%M1 
%l = 1; %enter whatever slice you want 
%%Slicefeed(l); 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
%BREAKBREAKBREAKBREAKBREAKBREAK 
end 
slice21 
if Slicenum == 21; 
25 
Y=21*3; 
Cgx=[1295,1471,1463,1295]; 
Cgz=[1356,1149,1095,1113]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, 
Y);%receptorMap(specval(), x, z, Y) 
PrLx=[1295,1295,1419,1431,1461,]; 
PrLz=[1113, 884, 892,1003,1093]; 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y);%receptorMap(specval(33), PrLx, PrLz, Y)%PrL 
ILx=[1295,1295,1396,1440,1413,1419]; 
ILz=[884 , 725, 741, 781, 824, 892]; 
slicemap (specval(IL), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, 
Y);%receptorMap(specval(), x, z, Y) 
VOx=[1419,1413,1430,1463,1558,1497,1481,1443]; 
VOz=[ 863, 824, 774, 793, 756, 819, 869, 847]; 
slicemap (specval(VO), low,medLOW, MED, medHIGH, HIGH, VOx, VOz, 
Y);%receptorMap(specval(29), VOx, VOz, Y)%VO 
LOx=[1481,1497,1558,1635,1750,1590,1539,1516]; 
LOz=[ 869, 819, 756, 716, 673, 829, 899, 950]; 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, 
Y);%receptorMap(specval(31), LOx, LOz, Y)%LO 
S1Jx=[1642,1986,1985,1961,1905,1835,1734,1694,1581,1645,1655,1633]; 
S1Jz=[1016, 910,1000,1097,1196,1265,1323,1232,1113,1088,1057,1054]; 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y);%receptorMap(specval(24), S1Jx, S1Jz, Y)%S1j 
M1x=[1480,1622,1730,1694,1581,1504,1494]; 
M1z=[1404,1368,1325,1232,1113,1164,1164]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, 
Y);%receptorMap(specval(), x, z, Y) 
M2x=[1494,1471,1295,1307,1359,1478]; 
M2z=[1164,1149,1356,1375,1410,1401]; 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, 
Y);%receptorMap(specval(36), M2x, M2z, Y)%M2 
WMx=[1494,1592,1645,1655,1627,1584,1545,1489,1452,1426,1425,1465,1473]; 
WMz=[1164,1103,1088,1057,1051,1058,1049,1000, 945, 872, 
994,1096,1149]; 
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slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(), x, z, Y) 
WM2x=[1545,1491,1496,1569,1569]; 
WM2z=[ 711, 686, 666, 687, 703]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, 
Y);%receptorMap(specval(), x, z, Y) 
WM3x=[1368,1383,1361,1336,1306,1304]; 
WM3z=[ 479, 503, 536, 542, 532, 498]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, 
Y);%receptorMap(specval(), x, z, Y) 
Clx=[1426,1443,1467,1516,1557,1629,1629,1584,1545,1491,1452]; 
Clz=[ 872, 847, 852, 950, 980, 998,1055,1058,1049, 999, 945]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, 
Y);%receptorMap(specval(68), Clx, Clz, Y)%Cl 
Insx=[1516,1539,1590,1760,1846,1887,1955,1986,1642,1626,1557]; 
Insz=[ 950, 899, 829, 672, 621, 660, 781, 912,1016, 998, 980]; 
26 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y);%receptorMap(specval(Ins), Insx, Insz, Y) 
TTx=[1297,1382,1385,1388,1312,1311]; 
TTz=[ 725, 739, 630, 611, 612, 687]; 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, 
Y);%receptorMap(specval(5), TTx, TTz, Y)%TT 
Tux=[1388,1409,1441,1486,1543,1596,1622,1572,1525,1457,1406,1384,1336,1311]; 
Tuz=[ 611, 574, 536, 515, 512, 533, 467, 443, 438, 452, 478, 522, 562, 
601]; 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, 
Y);%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
AcbCx=[1440,1495,1522,1491,1492,1459,1429,1431]; 
AcbCz=[ 781, 749, 705, 686, 671, 665, 683, 773]; 
slicemap (specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, 
Y);%%receptorMap(specval(), x, z, Y) 
AcbShx=[1431,1429,1459,1492,1524,1500,1406,1385,1382,1396,]; 
AcbShz=[ 773, 683, 665, 671, 664, 583, 578, 630, 739, 741,]; 
slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, AcbShx, 
AcbShz, Y);%receptorMap(specval(60), AcbShx, AcbShz, Y)%AcbSh 
ENx=[1440,1479,1631,1642,1628,1500,1524,1569,1569,1545,1523,1495]; 
ENz=[ 781, 791, 718, 626, 577, 583, 664, 687, 703, 711, 700, 749]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, 
Y);%receptorMap(specval(66), ENx, ENz, Y)%EN 
VPx=[1409,1500,1628,1601,1543,1486,1441,1409]; 
VPz=[ 574, 583, 570, 534, 512, 515, 536, 574]; 
slicemap (specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, 
Y);%receptorMap(specval(62), VPx, VPz, Y)%VP 
PirRx=[1622,1800,1846,1760,1635,1642,1628,1601]; 
PirRz=[ 467, 580, 621, 672, 716, 626, 577, 534]; 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y);%receptorMap(specval(8), PirRx, PirRz, Y)%PirR 
%QCcolor (Insx,Insz,21*3) 
l=21; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
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slice22 
if Slicenum == 22; 
Y=22*3; 
Cgx=[1295,1474,1447,1295 ]; 
Cgz=[1346,1146,1096,1113 ]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, 
Y);%receptorMap(specval(), x, z, Y) 
PrLx=[1295,1447,1381,1386,1295]; 
PrLz=[1113,1096, 993, 895, 884]; 
27 
slicemap (specval(PrL), low,medLOW, MED, medHIGH, HIGH, PrLx, PrLz, 
Y);%receptorMap(specval(), x, z, Y) 
ILx=[1295,1386,1383,1370,1333,1295]; 
ILz=[ 884, 895, 811, 751, 758, 737]; 
slicemap (specval(IL), low,medLOW, MED, medHIGH, HIGH, ILx, ILz, 
Y);%receptorMap(specval(), x, z, Y) 
TTx=[1295,1333,1370,1366,1391,1316]; 
TTz=[ 737, 758, 751, 677, 613, 612]; 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, 
Y);%receptorMap(specval(), x, z, Y) 
Tux=[1316,1390,1451,1511,1570,1621,1652,1512,1458,1410,1371,1320]; 
Tuz=[ 612, 608, 531, 500, 491, 519, 449, 418, 432, 461, 533, 588]; 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, 
Y);%receptorMap(specval(), x, z, Y) 
PirRx=[1652,1720,1831,1881,1837,1784,1675,1664,1621]; 
PirRz=[ 440, 496, 537, 586, 630, 649, 657, 591, 519]; 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y);%receptorMap(specval(), x, z, Y) 
LOx=[1675,1778,1711,1625,1630]; 
LOz=[ 657, 647, 719, 774, 733]; 
slicemap (specval(LO), low,medLOW, MED, medHIGH, HIGH, LOx, LOz, 
Y);%receptorMap(specval(), x, z, Y) 
Insx=[1778,1837,1881,1969,2003,1883,1739,1648,1625,1711]; 
Insz=[ 647, 630, 586, 725, 879, 919, 930, 838, 774, 719]; 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y);%receptorMap(specval(), x, z, Y) 
S1Jx=[1739,1731,1723,1912,2000,2007,1883]; 
S1Jz=[ 930,1000,1051,1160,1003, 884, 919]; 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y);%receptorMap(specval(), x, z, Y) 
S1FLx=[1723,1909,1841,1788,1664]; 
S1FLz=[1051,1162,1272,1304,1108]; 
slicemap (specval(S1FL), low,medLOW, MED, medHIGH, HIGH, S1FLx, S1FLz, 
Y);%receptorMap(specval(), x, z, Y) 
M1x=[1664,1788,1717,1485,1501,1518,1581,1658]; 
M1z=[1108,1304,1339,1403,1184,1190,1145,1113]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, 
Y);%receptorMap(specval(), x, z, Y) 
M2x=[1501,1483,1391,1319,1295,1474]; 
M2z=[1184,1402,1412,1397,1346,1146]; 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, 
Y);%receptorMap(specval(36), M2x, M2z, Y)%M2 
WMx=[1474,1447,1379,1385,1445,1507,1583,1650,1689,1700,1674,1719,1723,1660,15
81,1518]; 
WMz=[1146,1092,1000,899 ,1000,1057,1082,1070,1032, 985, 934, 
967,1051,1112,1145,1190]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, 
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Y);%receptorMap(specval(), x, z, Y) 
WM2x=[1545,1556,1559,1545,1520,1500,1509]; 
WM2z=[ 707, 677, 658, 650, 670, 703, 723]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, 
Y);%receptorMap(specval(), x, z, Y) 
WM3x=[1335,1307,1304,1317,1361,1373]; 
WM3z=[ 540, 523, 496, 483, 478, 511]; 
28 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, 
Y);%receptorMap(specval(), x, z, Y) 
DMSx=[1388,1442,1507,1583,1607,1577,1527,1512,1520,1383]; 
DMSz=[ 897, 997,1057,1082,1078,1003, 899, 820, 797, 811]; 
slicemap (specval(DMS), low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, 
Y);%receptorMap(specval(), x, z, Y) 
DLSx=[1607,1577,1527,1512,1511,1552,1629,1644,1624,1666,1700,1689,1650]; 
DLSz=[1078,1003, 899, 820, 799, 787, 797, 831, 847, 891, 
985,1032,1070]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y);%receptorMap(specval(), x, z, Y) 
Clx=[1666,1719,1733,1749,1739,1648,1624,1634,1646]; 
Clz=[ 933, 967, 999, 965, 930, 838, 847, 891, 906]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, 
Y);%receptorMap(specval(), x, z, Y) 
AcbCx=[1383,1371,1423,1518,1500,1509,1545,1557,1580,1591,1578,1552,1510]; 
AcbCz=[ 811, 755, 690, 668, 703, 723, 707, 679, 698, 727, 764, 787, 
801]; 
slicemap (specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, 
Y);%receptorMap(specval(), x, z, Y) 
AcbShx=[1371,1423,1518,1545,1572,1636,1586,1517,1450,1391,1366]; 
AcbShz=[ 754, 690, 672, 650, 611, 575, 561, 564, 579, 613, 677]; 
slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, AcbShx, 
AcbShz, Y);%receptorMap(specval(), x, z, Y) 
ENx=[1545,1572,1636,1664,1674,1630,1625,1564,1578,1591,1580,1556,1559]; 
ENz=[650 ,611 , 575, 591, 658, 733, 794, 783, 764, 727, 698, 
677,658 ]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, 
Y);%receptorMap(specval(), x, z, Y) 
VPx=[1390,1451,1511,1570,1621,1664,1586,1517,1450]; 
VPz=[ 608, 531, 500, 491, 519, 585, 561, 564, 579]; 
slicemap (specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, 
Y);%receptorMap(specval(), x, z, Y) 
S1FLx=[1660,1723,1912,1841,1788]; 
S1FLz=[1112,1051,1160,1272,1304]; 
slicemap (specval(S1FL), low,medLOW, MED, medHIGH, HIGH, S1FLx, S1FLz, 
Y);%receptorMap(specval(), x, z, Y) 
%QCcolor (S1FLx,S1FLz,3*22) 
l=22; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 23 
if Slicenum == 23; 
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Y=23*3; 
29 
Cgx=[1295,1307,1341,1472,1456,1416,1366,1295]; 
Cgz=[1343,1381,1405,1178,1124,1082,1054,1035]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, 
Y);%receptorMap(specval(Cg), Cgx, Cgz, Y) 
WMx=[1472,1456,1416,1366,1295,1295,1422,1447,1546,1597,1683,1725,1753,1731,17
61,1778,1760,1724,1504]; 
WMz=[1178,1124,1082,1054,1035, 935,1000,1043,1095,1096,1065,1024, 937, 
868, 892, 983,1041,1080,1191]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, 
Y);%receptorMap(specval(WM), WMx, WMz, Y) 
WM2x=[1498,1531,1551,1552,1533,1492]; 
WM2z=[ 723, 713, 683, 659, 653, 695]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, 
Y);%receptorMap(specval(WM), WM2x, WM2z, Y) 
WM3x=[1336,1371,1357,1317,1305]; 
WM3z=[ 526, 498, 463, 470, 511]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, 
Y);%receptorMap(specval(WM), WM3x, WM3z, Y) 
Vx=[1383,1394,1437,1404]; 
Vz=[ 958, 967, 826, 881]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, 
Y);%receptorMap(specval(V), Vx, Vz, Y) 
LSx=[1295,1302,1371,1437,1383,1295,]; 
LSz=[ 707, 675, 699, 824, 958, 936]; 
slicemap (specval(LS), low,medLOW, MED, medHIGH, HIGH, LSx, LSz, 
Y);%receptorMap(specval(LS), LSx, LSz, Y) 
TTx=[1302,1321,1398,1376,1375]; 
TTz=[ 675, 586, 590, 643, 699]; 
slicemap (specval(TT), low,medLOW, MED, medHIGH, HIGH, TTx, TTz, 
Y);%receptorMap(specval(TT), TTx, TTz, Y) 
Tux=[1323,1393,1449,1594,1704,1651,1619,1530,1469,1420,1398]; 
Tuz=[ 588, 470, 424, 402, 437, 513, 480, 461, 483, 540, 590]; 
slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, Tux, Tuz, Y); 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
l=23; 
PirRx=[1651,1704,1748,1793,1846,1915,1842,1704,1664,1663]; 
PirRz=[ 513, 437, 488, 493, 519, 598, 644, 654, 590, 540]; 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y);%receptorMap(specval(PirR), PirRx, PirRz, Y) 
Insx=[1704,1710,1790,1793,2025,2000,1921,1842]; 
Insz=[ 654, 771, 879, 908, 890, 743, 601, 644]; 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y);%receptorMap(specval(Ins), Insx, Insz, Y) 
S1ULx=[1793,1779,1778,1995,2026]; 
S1ULz=[ 908, 943, 987,1067, 894]; 
slicemap (specval(S1UL), low,medLOW, MED, medHIGH, HIGH, S1ULx, S1ULz, 
Y);%receptorMap(specval(S1UL), S1ULx, S1ULz, Y) 
S1Jx=[1778,1995,1913,1741,1760]; 
S1Jz=[ 987,1067,1202,1063,1041]; 
slicemap (specval(S1J), low,medLOW, MED, medHIGH, HIGH, S1Jx, S1Jz, 
Y);%receptorMap(specval(S1J), S1Jx, S1Jz, Y) 
S1FLx=[1741,1913,1788,1674,1724]; 
S1FLz=[1063,1202,1311,1104,1080]; 
slicemap (specval(S1FL), low,medLOW, MED, medHIGH, HIGH, S1FLx, S1FLz, 
Y);%receptorMap(specval(S1FL), S1FLx, S1FLz, Y) 
30 
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M1x=[1674,1788,1637,1496,1509]; 
M1z=[1104,1311,1367,1398,1188]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, 
Y);%receptorMap(specval(M1), M1x, M1z, Y) 
M2x=[1472,1341,1391,1457,1496,1509]; 
M2z=[1178,1405,1412,1409,1398,1188]; 
slicemap (specval(M2), low,medLOW, MED, medHIGH, HIGH, M2x, M2z, 
Y);%receptorMap(specval(36), M2x, M2z, Y)%M2 
DMSx=[1419,1420,1447,1546,1597,1636,1566]; 
DMSz=[ 949, 997,1043,1095,1096,1082, 924]; 
slicemap (specval(DMS), low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, 
Y);%receptorMap(specval(DMS), DMSx, DMSz, Y) 
DLSx=[1636,1566,1728,1753,1725,1683]; 
DLSz=[1082, 924, 863, 937,1024,1065]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y);%receptorMap(specval(DLS), DLSx, DLSz, Y) 
VMSx=[1411,1566,1535,1437,1437]; 
VMSz=[ 944, 924, 783, 824,826]; 
slicemap (specval(VMS), low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, 
Y);%receptorMap(specval(VMS), VMSx, VMSz, Y) 
VLSx=[1535,1566,1728,1616,1602]; 
VLSz=[ 783, 926, 863, 696, 740]; 
slicemap (specval(VLS), low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, 
Y);%receptorMap(specval(VLS), VLSx, VLSz, Y) 
Clx=[1779,1790,1705,1677,1683,1731,1761]; 
Clz=[943 , 879, 745, 768, 820, 868, 892]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, 
Y);%receptorMap(specval(Cl), Clx, Clz, Y) 
ENx=[1677,1705,1704,1666,1629,1605,1616,1651]; 
ENz=[ 766, 745, 654, 592, 593, 621, 696, 748]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, 
Y);%receptorMap(specval(EN), ENx, ENz, Y) 
AcbCx=[1396,1427,1481,1547,1602,1629,1664,1662,1519,1420,1376]; 
AcbCz=[ 730, 673, 629, 611, 620, 593, 590, 541, 521, 544, 643]; 
slicemap (specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, 
Y);%receptorMap(specval(AcbC), AcbCx, AcbCz, Y) 
VPx=[1420,1519,1662,1619,1530,1469]; 
VPz=[ 544, 521, 541, 480, 461, 483]; 
slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, 
Y);%receptorMap(specval(VP), VPx, VPz, Y) 
%%Slicefeed(l); 
%l = ; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice24 
if Slicenum == 24; 
Y=24*3; 
31 
Cgx=[1295,1336,1473,1455,1364,1295]; 
Cgz=[1370,1402,1187,1130,1061,1042];slicemap (specval(Cg), low,medLOW, 
MED, medHIGH, HIGH, Cgx, Cgz, Y); 
WMx=[1473,1455,1364,1295,1295,1342,1379,1465,1552,1660,1786,1821,1799,1734,15
18]; 
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WMz=[1187,1130,1061,1042, 942, 950, 980,1075,1105,1086, 836, 
923,1007,1086,1192];slicemap (specval(WM), low,medLOW, MED, medHIGH, 
HIGH, WMx, WMz, Y); 
WM2x=[1502,1538,1546,1497,1482,1488]; 
WM2z=[733 , 704, 673, 686, 711, 731];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
WM3x=[1342,1380,1374,1317,1307]; 
WM3z=[ 512, 480, 448, 457,491];slicemap (specval(WM), low,medLOW, MED, 
medHIGH, HIGH, WM3x, WM3z, Y); 
Vx=[1409,1381,1405,1436]; 
Vz=[1003, 982, 884, 829];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
LSx=[1381,1405,1436,1428,1376,1333,1295,1295]; 
LSz=[ 982, 884, 829,775 , 627, 604, 602, 942];slicemap (specval(LS), 
low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
Tux=[1300,1330,1356,1383,1387,1462,1562,1657,1705,1737,1686,1589,1530,1465,14
11,1379,1333]; 
Tuz=[600 , 578, 536, 525, 478, 408, 389, 389, 414, 469, 545, 468, 
461,486 , 556, 631, 604];slicemap (specval(Tu), low,medLOW, MED, 
medHIGH, HIGH, Tux, Tuz, Y); 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
l=24; 
PirRx=[1686,1769,1788,1866,1914,1828,1737]; 
PirRz=[ 545, 660, 636, 617, 583,492 , 469];slicemap (specval(PirR), 
low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, Y); 
Insx=[1769,1788,1866,1914,2018,2034,2035,1822,1836,1762,1769]; 
Insz=[ 660, 636, 617, 583, 740, 801, 891, 927, 856, 743, 660];slicemap 
(specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
S1Jx=[1809,1990,1963,1909,1733]; 
S1Jz=[1005,1089,1156,1228,1083];slicemap (specval(S1J), low,medLOW, 
MED, medHIGH, HIGH, S1Jx, S1Jz, Y); 
S1FLx=[1637,1754,1909,1733]; 
S1FLz=[1129,1339,1228,1083];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
M1x=[1637,1754,1503,1516]; 
M1z=[1129,1339,1399,1190];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
M2x=[1503, 1516,1486,1476,1226,1374]; 
M2z=[1399, 1190,1198,1187,1402,1411];slicemap (specval(M2), 
low,medLOW, MED, medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
DMSx=[1427,1409,1465,1552,1660,1598,1522]; 
DMSz=[ 949,1011,1075,1105,1086, 906, 940];slicemap (specval(DMS), 
low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, Y); 
DLSx=[1595,1658,1728,1766,1792,1782,]; 
DLSz=[ 907,1084,1047,1003, 930, 829];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
VMSx=[1427,1595,1571,1431,1436,1427]; 
32 
VMSz=[ 949, 907, 756, 787, 829, 949];slicemap (specval(VMS), 
low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, Y); 
VLSx=[1596,1571,1621,1627,1672,1712,1730,1736,1775]; 
VLSz=[ 907, 756, 709,629 ,660 , 732, 737, 773, 821];slicemap 
(specval(VLS), low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
Clx=[1821,1775,1736,1730,1760,1762, 1836]; 
Clz=[ 923, 821, 773, 737, 708, 743, 856];slicemap (specval(Cl), 
low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
ENx=[1739,1672,1627,1666,1742,1768,1760]; 
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ENz=[ 737, 660, 629, 587, 588, 637, 708];slicemap (specval(EN), 
low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
AcbCx=[1401,1428,1519,1571,1621,1635,1559,1439]; 
AcbCz=[ 737, 775, 784, 756, 709, 619, 608, 668];slicemap 
(specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, Y); 
WM2x=[1502,1538,1546,1497,1482,1488]; 
WM2z=[733 , 704, 673, 686, 711, 731];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
AcbShx=[1404,1378,1376,1409,1545,1681,1738,1666,1627,1559,1439,1401]; 
AcbShz=[ 742, 684, 627, 561, 521, 540, 588, 587, 629, 608, 668, 
737];slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, 
AcbShx, AcbShz, Y); 
VPx=[1411,1545,1681,1589,1530,1465]; 
VPz=[556 , 521, 540, 468, 461, 486];slicemap (specval(VP), low,medLOW, 
MED, medHIGH, HIGH, VPx, VPz, Y); 
MSx=[1295,1336,1295]; 
MSz=[888 , 757, 684];slicemap (specval(MS), low,medLOW, MED, medHIGH, 
HIGH, MSx, MSz, Y); 
DBx=[1376,1333,1295,1295]; 
DBz=[ 627, 604,602 ,684];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%l = ; %enter whatever slice you wa 
S1ULx=[1799,1822,2034,2017,1990]; 
S1ULz=[1007, 934, 892,1003,1089];slicemap (specval(S1UL), low,medLOW, 
MED, medHIGH, HIGH, S1ULx, S1ULz, Y); 
%QCcolor (S1ULx,S1ULz,3*24) 
l=24; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice25 
if Slicenum == 25; 
Y=25*3; 
DLSx=[1614,1809,1828,1768,1716,1684,1655]; 
33 
DLSz=[910 , 817, 893,1033,1076,1087,1003];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
%receptorMap(specval(), x, z, Y) 
%QCcolor (DLSx,DLSz,25*3) 
Cgx=[1295,1328,1463,1415,1369,1295]; 
Cgz=[1365,1403,1199,1102,1075,1059];slicemap (specval(Cg), low,medLOW, 
MED, medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1295,1415,1465,1480,1518,1750,1806,1832,1850,1830,1828,1789,1768,1632,15
37,1474,1418,1359,1344,1295]; 
WMz=[1059,1102,1199,1213,1204,1100,1049,1000, 898, 824, 893, 
999,1033,1112,1121,1099,1046, 993, 991, 982];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(), x, z, Y) 
WM2x=[1482,1508,1526,1498,1463,1474]; 
WM2z=[ 737, 725, 690, 673, 715, 741];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
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%receptorMap(specval(), x, z, Y) 
WM3x=[1337,1391,1397,1441,1437,1386,1327,1308]; 
WM3z=[ 573, 549, 516, 476, 438, 423, 453, 524];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1459,1407,1384,1421,1461]; 
Vz=[ 813, 884,1006,1049, 815];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
LSx=[1295,1344,1381,1407,1460,1448,1409,1295]; 
LSz=[ 982, 991,1007, 884, 813, 774, 729, 729];slicemap (specval(LS), 
low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
%receptorMap(specval(), x, z, Y) 
Tux=[1330,1391,1397,1441,1437,1438,1658,1716,1736,1687,1679,1616,1538,1479,14
33,1406]; 
Tuz=[ 573, 549, 516, 476, 438, 415, 388, 425, 468, 528, 504, 463, 467, 
496, 560, 604];slicemap (specval(Tu), low,medLOW, MED, medHIGH, HIGH, 
Tux, Tuz, Y); 
%receptorMap(specval(58), Tux, Tuz, Y)%Tu 
PirRx=[1694,1799,1881,1912,1882,1837,1736]; 
PirRz=[ 535, 641, 610, 585, 538, 501, 468];slicemap (specval(PirR), 
low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[1815,1881,1917,2037,2045,1853,1874,1869,1795,1785]; 
Insz=[ 623, 610, 588, 812, 889, 920, 858, 818, 723, 690];slicemap 
(specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[1853,2045,1965,1816]; 
S1ULz=[ 920, 889,1142,1033];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
S1Jx=[1816,1750,1869,1901,1975]; 
S1Jz=[1033,1100,1272,1248,1148];slicemap (specval(S1J), low,medLOW, 
MED, medHIGH, HIGH, S1Jx, S1Jz, Y); 
%receptorMap(specval(), x, z, Y) 
S1FLx=[1872,1771,1720,1639,1750]; 
34 
S1FLz=[1271,1336,1354,1148,1100];slicemap (specval(S1FL), low,medLOW, 
MED, medHIGH, HIGH, S1FLx, S1FLz, Y); 
%receptorMap(specval(), x, z, Y) 
M1x=[1720,1505,1516,1639]; 
M1z=[1354,1405,1204,1148];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(), x, z, Y) 
M2x=[1516,1463,1333,1505]; 
M2z=[1204,1199,1404,1405];slicemap (specval(M2), low,medLOW, MED, 
medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
DMSx=[1684,1614,1450,1421,1474,1554,1632]; 
DMSz=[1087, 910, 941,1049,1099,1122,1112];slicemap (specval(DMS), 
low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, Y); 
%receptorMap(specval(), x, z, Y) 
%DLSx=]; 
%DLSz=[]; 
VMSx=[1614,1450,1460,1456,1512,1583]; 
VMSz=[ 912, 941, 813, 797, 787,748];slicemap (specval(VMS), 
low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, Y); 
%receptorMap(specval(), x, z, Y) 
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VLSx=[1583,1614,1809,1761,1694,1646,1614]; 
VLSz=[ 748, 912, 817, 715, 625, 598, 712];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
Clx=[1852,1874,1869,1795,1786,1761,1769,1795,1830]; 
Clz=[ 901, 858, 818, 723, 690, 715, 762, 797, 824];slicemap 
(specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
%receptorMap(specval(), x, z, Y) 
ENx=[1761,1786,1796,1756,1652,1697,1735]; 
ENz=[ 715, 690, 618, 577, 594, 624, 697];slicemap (specval(EN), 
low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbCx=[1456,1512,1583,1614,1635,1550,1489,1441,1409,1448]; 
AcbCz=[ 797, 787, 748, 712, 617, 608, 627, 668, 729, 774];slicemap 
(specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbShx=[1413,1397,1405,1433,1501,1569,1698,1750,1646,1629,1550, 
1489,1441]; 
AcbShz=[ 731, 678, 626, 560, 526, 515, 542, 577, 598, 614, 608, 627 , 
668];slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, 
AcbShx, AcbShz, Y); 
%receptorMap(specval(), x, z, Y) 
VPx=[1435,1501,1569,1699,1678,1616,1538,1479]; 
VPz=[ 554, 526, 515, 538, 501, 463, 467, 496];slicemap (specval(VP), 
low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(), x, z, Y) 
MSx=[1295,1328,1295]; 
MSz=[1407, 813, 729];slicemap (specval(MS), low,medLOW, MED, medHIGH, 
HIGH, MSx, MSz, Y); 
%receptorMap(specval(), x, z, Y) 
DBx=[1295,1404,1406,1337,1295]; 
35 
DBz=[ 678, 628,604 , 573, 587];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
%l = ; %enter whatever slice you wa 
%QCcolor (S1ULx,S1ULz,3*24) 
l=25; 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice26 
if Slicenum ==26 ; 
Y=26*3; 
Cgx=[1295,1331,1459,1415,1295]; 
Cgz=[1372,1400,1206,1121,1076];slicemap (specval(Cg), low,medLOW, MED, 
medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(), x, z, Y) 
M2x=[1333,1459,1508,1515]; 
M2z=[1404,1206,1219,1408];slicemap (specval(M2), low,medLOW, MED, 
medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
M1x=[1508,1515,1688,1616]; 
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M1z=[1219,1408,1370,1172];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(), x, z, Y) 
S1FLx=[1688,1616,1747,1868]; 
S1FLz=[1370,1172,1114,1283];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1Jx=[1747,1868,1971,1820]; 
S1Jz=[1114,1283,1164,1046];slicemap (specval(S1J), low,medLOW, MED, 
medHIGH, HIGH, S1Jx, S1Jz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[1971,1820,1882,2065]; 
S1ULz=[1164,1046, 874, 847];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[1882,2065,1981,1929,1838,1818,1809]; 
36 
Insz=[ 874, 847, 547,583 ,605 ,631 ,663 ];slicemap (specval(Ins), 
low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
PirRx=[1981,1929,1838,1818,1804,1736,1696,1779]; 
PirRz=[ 547,583 ,605 ,631 , 603, 565, 510, 403];slicemap 
(specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, Y); 
%receptorMap(specval(), x, z, Y) 
Tux=[1696,1779,1523,1454,1342,1411]; 
Tuz=[ 510, 403, 376, 405, 554, 582];slicemap (specval(Tu), low,medLOW, 
MED, medHIGH, HIGH, Tux, Tuz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1295,1390,1430,1440,1373,1295]; 
WMz=[ 574, 544, 500, 427, 410, 430];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(), x, z, Y) 
WM2x=[1451,1545,1540,1513,1443]; 
WM2z=[ 740, 705, 677, 673, 722];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WM2x, WM2z, Y); 
%receptorMap(specval(), x, z, Y) 
WM3x=[1294,1382,1470,1541,1633,1753,1840,1841,1865,1842,1812,1706,1613,1509,1
453,1412]; 
WM3z=[1013,1036,1115,1137,1128,1064, 901, 810, 
901,1003,1059,1142,1170,1219,1202,1122];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, Y); 
%receptorMap(specval(), x, z, Y) 
DBx=[1295,1371,1411,1335,1295]; 
DBz=[659, 659, 582, 554, 572];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1460,1412,1382,1429]; 
Vz=[ 850, 911,1036,1073];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
LSx=[1295,1371,1381,1456,1460,1412,1382,1295]; 
LSz=[659, 659, 716, 820, 850, 911,1036,1013];slicemap (specval(LS), 
low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
%receptorMap(specval(), x, z, Y) 
MSx=[1295,1333,1295]; 
MSz=[911 , 820, 716];slicemap (specval(MS), low,medLOW, MED, medHIGH, 
HIGH, MSx, MSz, Y); 
%receptorMap(specval(), x, z, Y) 
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DMSx=[1425,1452,1610,1695,1557,1470]; 
DMSz=[1071, 929, 912,1101,1138,1115];slicemap (specval(DMS), 
low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, Y); 
%receptorMap(specval(), x, z, Y) 
DLSx=[1615,1841,1840,1798,1753,1695]; 
DLSz=[ 907, 810, 901,1004,1064,1101];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
%receptorMap(specval(), x, z, Y) 
VLSx=[1610,1841,1716,1640,]; 
VLSz=[ 912, 810, 607, 582,];slicemap (specval(VLS), low,medLOW, MED, 
medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
VMSx=[1455,1452,1610,1584]; 
37 
VMSz=[ 815, 929, 912, 748];slicemap (specval(VMS), low,medLOW, MED, 
medHIGH, HIGH, VMSx, VMSz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbCx=[1584,1614,1528,1447,1414,1420,1456,1515]; 
AcbCz=[ 750, 629, 619, 647, 688, 766, 820, 804];slicemap 
(specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbShx=[1420,1381,1371,1411,1573,1716,1738,1640,1614,1528,1447,1414]; 
AcbShz=[ 766, 716, 659, 582, 517, 539, 567, 582, 629, 619, 647, 
688];slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, 
AcbShx, AcbShz, Y); 
%receptorMap(specval(), x, z, Y) 
VPx=[1434,1573,1718,1639,1545,1486]; 
VPz=[558 , 517, 541, 463, 459, 487];slicemap (specval(VP), low,medLOW, 
MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(), x, z, Y) 
ENx=[1680,1736,1804,1809,1774,1712]; 
ENz=[ 577,565, 603 , 663, 694, 598];slicemap (specval(EN), low,medLOW, 
MED, medHIGH, HIGH, ENx, ENz, Y); 
%receptorMap(specval(), x, z, Y) 
Clx=[1774,1809,1816,1867,1896,1864,1837]; 
Clz=[ 694, 665, 715, 753, 839, 896, 786];slicemap (specval(Cl), 
low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
%receptorMap(specval(), x, z, Y) 
%QCcolor (VMSx,VMSz,26*3) 
l=26; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice27 
if Slicenum == 27; 
Y=27*3; 
M1x=[1483,1584,1643,1487]; 
M1z=[1238,1201,1391,1418];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(), x, z, Y) 
STx=[1482,1484,1431,1388,1357,1499]; 
STz=[ 786, 738, 664, 646, 733, 784];slicemap (specval(ST), low,medLOW, 
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MED, medHIGH, HIGH, STx, STz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbCx=[1488,1484,1476,1499,1554,1631,1682,1570, 1487]; 
AcbCz=[ 810, 738, 707, 657, 610, 598, 612, 788, 819];slicemap 
(specval(AcbC), low,medLOW, MED, medHIGH, HIGH, AcbCx, AcbCz, Y); 
%receptorMap(specval(), x, z, Y) 
38 
LSx=[1393,1295,1295,1376,1420,1488,1485,1400,1357,1364]; 
LSz=[ 647, 647,1049,1049,1071, 820, 775, 784, 733, 678];slicemap 
(specval(LS), low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1420,1452,1488,]; 
Vz=[1071,1101, 820,];slicemap (specval(V), low,medLOW, MED, medHIGH, 
HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1295,1407,1452,1491,1772,1869,1866,1848,1812,1733,1643,1552,1503,1376,12
95]; 
WMz=[1092,1123,1217,1239,1115, 953, 754, 
920,1003,1095,1141,1153,1144,1049,1049];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(), x, z, Y) 
WM2x=[1629,1552,1422,1391,1407,1550]; 
WM2z=[ 649, 709, 763, 742, 713, 686];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
%receptorMap(specval(), x, z, Y) 
WM3x=[1295,1295,1319,1358,1429,1395]; 
WM3z=[551 , 449, 431, 430, 483, 526];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM3x, WM3z, Y); 
%receptorMap(specval(), x, z, Y) 
Cgx=[1295,1321,1450,1430,1367,1295]; 
Cgz=[1378,1408,1213,1149,1104,1092];slicemap (specval(Cg), low,medLOW, 
MED, medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(), x, z, Y) 
M2x=[1321,1450,1489,1487,1421]; 
M2z=[1408,1213,1234,1418,1423];slicemap (specval(M2), low,medLOW, MED, 
medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
S1FLx=[1643,1582,1693,1773,1889,1763,1643]; 
S1FLz=[1391,1200,1161,1110,1272,1353,1391];slicemap (specval(S1FL), 
low,medLOW, MED, medHIGH, HIGH, S1FLx, S1FLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[1773,1852,2051,1965,1889]; 
S1ULz=[1110,1003,1010,1200,1272];slicemap (specval(S1UL), low,medLOW, 
MED, medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
S2x=[1859,2051,2084,1906,1877,1869]; 
S2z=[ 986,1010, 843, 862, 884, 953];slicemap (specval(S2), low,medLOW, 
MED, medHIGH, HIGH, S2x, S2z, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[1906,2084,2079,2011,1966,1885,1861,1917]; 
Insz=[ 858, 843, 715, 550, 584, 600, 636, 806];slicemap (specval(Ins), 
low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
PirRx=[1861,1885,1966,2014,1968,1892,1738,1708,1727,1767,1809,1861]; 
PirRz=[ 623, 600, 584, 552, 487, 423, 368, 509, 536, 553, 560, 
623];slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, 
PirRz, Y); 
%receptorMap(specval(), x, z, Y) 
CONFIDENTIAL | 241 
 
Clx=[1861,1917,1906,1875,1863,1818]; 
Clz=[ 623, 806, 858, 880, 747, 667];slicemap (specval(Cl), low,medLOW, 
MED, medHIGH, HIGH, Clx, Clz, Y); 
39 
%receptorMap(specval(), x, z, Y) 
ENx=[1861,1809,1767,1748,1773,1802,1821]; 
ENz=[ 623, 560, 553, 585, 611, 649, 661];slicemap (specval(EN), 
low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
%receptorMap(specval(), x, z, Y) 
AcbShx=[1481,1452,1414,1459,1553,1656,1727,1767,1682,1631,1554,1499]; 
AcbShz=[ 705, 698, 654, 600, 553, 532, 536, 553, 612, 598, 610, 
657];slicemap (specval(AcbSh), low,medLOW, MED, medHIGH, HIGH, 
AcbShx, AcbShz, Y); 
%receptorMap(specval(), x, z, Y) 
VPx=[1425,1388,1439,1551,1659,1692,1727,1656,1553,1459]; 
VPz=[ 660, 646, 562, 472, 468, 481, 536, 532, 553, 600];slicemap 
(specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(), x, z, Y) 
VLSx=[1667,1862,1852,1821,1742,1691,1618,1623]; 
VLSz=[ 894, 777, 727, 661, 574, 603, 730, 763];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
VMSx=[1667,1623,1618,1570,1488,1475,1595]; 
VMSz=[ 894, 763, 730, 788, 820, 950, 933];slicemap (specval(VMS), 
low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, Y); 
%receptorMap(specval(), x, z, Y) 
DMSx=[1664,1733,1570,1503,1454,1473,1595]; 
DMSz=[ 896,1095,1154,1144,1100, 955, 933];slicemap (specval(DMS), 
low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, Y); 
%receptorMap(specval(), x, z, Y) 
DLSx=[1664,1862,1848,1812,1733]; 
DLSz=[ 896, 777, 920,1003,1095];slicemap (specval(DLS), low,medLOW, 
MED, medHIGH, HIGH, DLSx, DLSz, Y); 
%receptorMap(specval(), x, z, Y) 
MSx=[1295,1317,1317,1295]; 
MSz=[ 956, 956, 647, 647];slicemap (specval(MS), low,medLOW, MED, 
medHIGH, HIGH, MSx, MSz, Y); 
%receptorMap(specval(), x, z, Y) 
DBx=[1393,1295,1295,1400,1451]; 
DBz=[ 647, 647,550 , 523, 550];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
%QCcolor (M1x,M1z,27*3) 
l=27; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice28 
if Slicenum == 28; 
Y=28*3; 
40 
Cgx=[1295,1321,1448,1430,1351,1295]; 
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Cgz=[1372,1408,1217,1152,1106,1105];slicemap (specval(Cg), low,medLOW, 
MED, medHIGH, HIGH, Cgx, Cgz, Y); 
M2x=[1321,1448,1471,1468]; 
M2z=[1408,1217,1238,1423];slicemap (specval(M2), low,medLOW, MED, 
medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
M1x=[1471,1468,1609,1567]; 
M1z=[1238,1423,1404,1211];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
S1HLx=[1609,1567,1653,1717]; 
S1HLz=[1404,1211,1183,1370];slicemap (specval(S1HL), low,medLOW, MED, 
medHIGH, HIGH, S1HLx, S1HLz, Y); 
S1FLx=[1653,1717,1894,1781]; 
S1FLz=[1183,1370,1279,1116];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
S1ULx=[1894,1781,1858,2059]; 
S1ULz=[1279,1116,1003,1006];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
S2x=[1858,2059,2094,1913,1881]; 
S2z=[1003,1006, 862, 877, 899];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
Insx=[2094,1913,1869,2040]; 
Insz=[ 862, 877, 633, 564];slicemap (specval(Ins), low,medLOW, MED, 
medHIGH, HIGH, Insx, Insz, Y); 
PirRx=[1869,2040,2014,1941,1777,1694,1685,1746]; 
PirRz=[ 633, 564, 503, 424, 350, 348, 493, 549];slicemap 
(specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, Y); 
Tux=[1694,1685,1642,1595,1512,1487]; 
Tuz=[ 348, 493, 481, 436, 431, 416];slicemap (specval(Tu), low,medLOW, 
MED, medHIGH, HIGH, Tux, Tuz, Y); 
MCPOx=[1642,1595,1512,1487,1497]; 
MCPOz=[ 481, 436, 431, 416, 481];slicemap (specval(MCPO), low,medLOW, 
MED, medHIGH, HIGH, MCPOx, MCPOz, Y); 
DBx=[1487,1497,1457,1421,1407]; 
DBz=[ 416, 481, 516, 499, 461];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
Slx=[1457,1520,1566,1518,1469]; 
Slz=[ 516, 488, 488, 559, 567];slicemap (specval(S1J), low,medLOW, 
MED, medHIGH, HIGH, Slx, Slz, Y); 
LPOx=[1469,1457,1421,1399,1295,1295,1366,1395,1389]; 
41 
LPOz=[ 567, 516, 500, 597, 683, 725, 725, 718, 667];slicemap 
(specval(LPO), low,medLOW, MED, medHIGH, HIGH, LPOx, LPOz, Y); 
MPAx=[1295,1399,1421,1407,1366,1295]; 
MPAz=[ 683, 597, 500, 461, 522, 544];slicemap (specval(MPA), 
low,medLOW, MED, medHIGH, HIGH, MPAx, MPAz, Y); 
STx=[1481,1395,1389,1408,1513,1554,1546]; 
STz=[ 814, 718, 667, 624, 633, 712, 759];slicemap (specval(ST), 
low,medLOW, MED, medHIGH, HIGH, STx, STz, Y); 
LSx=[1295,1425,1466,1489,1422,1295]; 
LSz=[1087,1087,1003, 829, 753, 753];slicemap (specval(LS), low,medLOW, 
MED, medHIGH, HIGH, LSx, LSz, Y); 
MSx=[1295,1295,1326]; 
MSz=[745 ,1003, 917];slicemap (specval(MS), low,medLOW, MED, medHIGH, 
HIGH, MSx, MSz, Y); 
WM1x=[1295,1326,1380,1450,1626,1533,1366,1295]; 
WM1z=[795 , 795, 780, 733, 652, 682, 725, 725];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM1x, WM1z, Y); 
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WM2x=[1295,1384,1529,1623,1767,1822,1861,1871,1892,1858,1779,1696,1469,1448,1
430,1402,1351,1295]; 
WM2z=[1070,1070,1155,1147,1078,1003, 904, 763, 
819,1003,1115,1169,1236,1217,1152,1121,1106,1106];slicemap 
(specval(WM), low,medLOW, MED, medHIGH, HIGH, WM2x, WM2z, Y); 
WM3x=[1295,1366,1395,1337,1295]; 
WM3z=[ 544, 522, 469, 424, 423];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WM3x, WM3z, Y); 
Vx=[1425,1462,1503,1494,1466]; 
Vz=[1087,1116, 888, 834,1003];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
VPx=[1537,1752,1746,1685,1611,1566,1518,1469,1442,1519]; 
VPz=[ 674, 585, 549, 493, 476, 488, 559, 567, 601, 638];slicemap 
(specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
DMSx=[1464,1507,1611,1665,1703,1623,1537]; 
DMSz=[1123, 927, 911, 885,1116,1147,1155];slicemap (specval(DMS), 
low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, Y); 
DLSx=[1699,1665,1870,1882,1822,1767]; 
DLSz=[1118, 885, 779, 897,1003,1078];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
VMSx=[1504,1663,1638,1537,1556,1547,1483,1503]; 
VMSz=[ 926, 886, 645, 686, 728, 764, 810, 888];slicemap (specval(VMS), 
low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, Y); 
VLSx=[1670,1638,1753,1820,1870]; 
VLSz=[887, 645, 585, 665, 779];slicemap (specval(VLS), low,medLOW, 
MED, medHIGH, HIGH, VLSx, VLSz, Y); 
Clx=[1882,1929,1869,1820,1840,1892]; 
42 
Clz=[ 897, 840, 637, 665, 726, 819];slicemap (specval(Cl), low,medLOW, 
MED, medHIGH, HIGH, Clx, Clz, Y); 
ENx=[1820,1869,1834,1746,1764]; 
ENz=[665 , 633, 584, 549, 619];slicemap (specval(), low,medLOW, MED, 
medHIGH, HIGH, ENx, ENz, Y); 
%QCcolor (DMSx,DMSz,3*28) 
l=28; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice29 
if Slicenum == 29; 
Y=29*3; 
Cgx=[1295,1295,1352,1392,1449,1314]; 
Cgz=[1398,1108,1108,1120,1217,1416];slicemap (specval(Cg), low,medLOW, 
MED, medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(), x, z, Y) 
M2x=[1449,1314,1464,1469]; 
M2z=[1217,1416,1440,1237];slicemap (specval(M2), low,medLOW, MED, 
medHIGH, HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
M1x=[1464,1469,1552,1597]; 
M1z=[1440,1237,1211,1412];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
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%receptorMap(specval(), x, z, Y) 
S1HLx=[1552,1597,1721,1653]; 
S1HLz=[1211,1412,1381,1184];slicemap (specval(S1HL), low,medLOW, MED, 
medHIGH, HIGH, S1HLx, S1HLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1FLx=[1721,1653,1781,1901]; 
S1FLz=[1381,1184,1116,1290];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[1781,1901,2072,1869]; 
S1ULz=[1116,1290,1022, 965];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
S2x=[2072,1869,1901,1921,2118]; 
S2z=[1022, 965, 827, 820,848 ];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[1901,1921,2118,2110,2056,1890]; 
Insz=[ 827, 820,848 , 685, 560, 622];slicemap (specval(Ins), 
low,medLOW, MED, medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
PirRx=[2056,1890,1747,1685,1696,1805,1906]; 
43 
PirRz=[ 560, 622, 545, 490, 340, 334, 374];slicemap (specval(PirR), 
low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, Y); 
%receptorMap(specval(), x, z, Y) 
Tux=[1685,1696,1516,1546,1630,1655]; 
Tuz=[ 490, 340, 410, 424, 422, 480];slicemap (specval(Tu), low,medLOW, 
MED, medHIGH, HIGH, Tux, Tuz, Y); 
%receptorMap(specval(), x, z, Y) 
MCPOx=[1516,1546,1630,1655,1584,1529]; 
MCPOz=[ 410, 424, 422, 480, 478, 454];slicemap (specval(MCPO), 
low,medLOW, MED, medHIGH, HIGH, MCPOx, MCPOz, Y); 
%receptorMap(specval(), x, z, Y) 
DBx=[1529,1490,1456,1516]; 
DBz=[ 454, 483, 438, 410];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
Slx=[1529,1490,1515,1582]; 
Slz=[454 , 483, 544, 478];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, Slx, Slz, Y); 
%receptorMap(specval(), x, z, Y) 
LPOx=[1375,1498,1513,1501,1469,1459,1355,1335]; 
LPOz=[ 721, 648, 613, 486, 461, 524, 644, 716];slicemap (specval(LPO), 
low,medLOW, MED, medHIGH, HIGH, LPOx, LPOz, Y); 
%receptorMap(specval(), x, z, Y) 
MPAx=[1469,1459,1355,1335,1295,1295,1343,1353]; 
MPAz=[ 461, 524, 644, 716, 716, 531, 504, 463];slicemap (specval(MPA), 
low,medLOW, MED, medHIGH, HIGH, MPAx, MPAz, Y); 
%receptorMap(specval(), x, z, Y) 
STx=[1559,1534,1501,1431,1388,1373,1416,1511,1538]; 
STz=[ 919, 679, 649, 666, 694, 783, 854, 910, 936];slicemap 
(specval(ST), low,medLOW, MED, medHIGH, HIGH, STx, STz, Y); 
%receptorMap(specval(), x, z, Y) 
LSx=[1373,1416,1511,1538,1527,1491,1418,1370,1215]; 
LSz=[ 783, 854, 910, 936, 997,1059,1098,1079,1079];slicemap 
(specval(LS), low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
%receptorMap(specval(), x, z, Y) 
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TSx=[1373,1295,1295]; 
TSz=[783 , 783, 910];slicemap (specval(TS), low,medLOW, MED, medHIGH, 
HIGH, TSx, TSz, Y); 
%receptorMap(specval(), x, z, Y) 
WM1x=[1292,1370,1518,1631,1785,1859,1874,1894,1898,1812,1763,1686,1554,1483,1
447,1429,1352, 
1295]; 
WM1z=[1077,1079,1146,1140,1057, 933, 696, 
738,889 ,1082,1132,1173,1211,1240,1218,1157,1108, 1108];slicemap 
(specval(WM), low,medLOW, MED, medHIGH, HIGH, WM1x, WM1z, Y); 
%receptorMap(specval(), x, z, Y) 
WM2x=[1537,1531,1548,1550]; 
WM2z=[ 676, 838, 912,689];slicemap (specval(WM), low,medLOW, MED, 
medHIGH, HIGH, WM2x, WM2z, Y); 
%receptorMap(specval(), x, z, Y) 
WM3x=[1183,1185,1295,1295]; 
WM3z=[783 ,718, 718, 783];slicemap (specval(WM), low,medLOW, MED, 
medHIGH, HIGH, WM3x, WM3z, Y); 
%receptorMap(specval(), x, z, Y) 
WM4x=[1295,1343,1353,1460,1426,1390,1295]; 
44 
WM4z=[531 , 504, 463, 433, 402, 391, 406];slicemap (specval(WM), 
low,medLOW, MED, medHIGH, HIGH, WM4x, WM4z, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1418,1490,1528,1491,1421]; 
Vz=[1098,1138,1006,1059,1102];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
VPx=[1538,1735,1677,1582,1515,1513,1498]; 
VPz=[ 682, 536, 488, 478, 544, 613, 648];slicemap (specval(VP), 
low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(), x, z, Y) 
DMSx=[1490,1551,1695,1723,1536]; 
DMSz=[1138, 923, 882,1109,1147];slicemap (specval(DMS), low,medLOW, 
MED, medHIGH, HIGH, DMSx, DMSz, Y); 
%receptorMap(specval(), x, z, Y) 
DLSx=[1695,1723,1822,1882,1882]; 
DLSz=[ 882,1109,1003, 846, 783];slicemap (specval(DLS), low,medLOW, 
MED, medHIGH, HIGH, DLSx, DLSz, Y); 
%receptorMap(specval(), x, z, Y) 
GPx=[1560,1539,1607,1603]; 
GPz=[ 868, 694, 603, 779];slicemap (specval(GP), low,medLOW, MED, 
medHIGH, HIGH, GPx, GPz, Y); 
%receptorMap(specval(), x, z, Y) 
VMSx=[1607,1603, 1560,1548,1695,1679]; 
VMSz=[ 603, 779, 868 , 912, 882, 553];slicemap (specval(VMS), 
low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, Y); 
%receptorMap(specval(), x, z, Y) 
VLSx=[1695,1679,1738,1771,1848,1881,1882]; 
VLSz=[ 882, 553, 539, 601, 650, 726, 783];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
Clx=[1901,1922,1930,1887,1856,1894,1901]; 
Clz=[ 827, 818, 741, 632, 678, 738, 827];slicemap (specval(Cl), 
low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
%receptorMap(specval(), x, z, Y) 
ENx=[1848,1890,1879,1842,1787,1747,1771]; 
ENz=[ 650, 622, 592, 566, 565,545 , 601];slicemap (specval(EN), 
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low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
%receptorMap(specval(), x, z, Y) 
%QCcolor (Cgx,Cgz,3*29) 
l=29; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice30 
if Slicenum == 30; 
45 
Y=30*3; 
DBx =[1574,1505,1489,1498,1545,1587,1593]; 
DBz =[ 388, 423, 423, 474, 496, 473, 438];slicemap (specval(DB), 
low,medLOW, MED, medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
%QCcolor (DBx,DBz,3*30) 
Cgx=[1295,1442,1426 ,1295]; 
Cgz=[1398, 1224,1161,1116];slicemap (specval(Cg), low,medLOW, MED, 
medHIGH, HIGH, Cgx, Cgz, Y); 
%receptorMap(specval(), x, z, Y) 
M2x=[1295,1442,1425]; 
M2z=[1398,1224,1442];slicemap (specval(M2), low,medLOW, MED, medHIGH, 
HIGH, M2x, M2z, Y); 
%receptorMap(specval(36), M2x, M2z, Y)%M2 
M1x=[1442,1425,1552,1503]; 
M1z=[1224,1442,1433,1214];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(), x, z, Y) 
S1HLx=[1552,1503,1652,1723]; 
S1HLz=[1433,1214,1181,1388];slicemap (specval(S1HL), low,medLOW, MED, 
medHIGH, HIGH, S1HLx, S1HLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1FLx=[1652,1723,1905,1782]; 
S1FLz=[1181,1388,1297,1118];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1BFx=[1905,1782,1887,2067]; 
S1BFz=[1297,1118, 976,1054];slicemap (specval(S1BF), low,medLOW, MED, 
medHIGH, HIGH, S1BFx, S1BFz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[1887,2067,2106,1910]; 
S1ULz=[ 976,1054, 948, 898];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
S2x=[2106,1910,1918,1947,2126]; 
S2z=[ 948, 898, 819, 783, 784];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[1947,2126,2071,1982,1926]; 
Insz=[ 783, 784, 582, 594, 631];slicemap (specval(Ins), low,medLOW, 
MED, medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
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PirRx=[2071,1982,1926,1888,1835,1782,1811,1776,1877,1956,2008]; 
PirRz=[ 582, 594, 631, 558, 515, 490, 432, 313, 333, 389, 
449];slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, 
PirRz, Y); 
%receptorMap(specval(), x, z, Y) 
AAx=[1782,1811,1776,1614,1634,1708,1730]; 
AAz=[ 490, 432, 313, 373, 405, 459, 497];slicemap (specval(AA), 
low,medLOW, MED, medHIGH, HIGH, AAx, AAz, Y); 
%receptorMap(specval(), x, z, Y) 
MCPOx=[1614,1634,1708,1730,1661,1620,1574]; 
MCPOz=[ 373, 405, 459, 497, 527, 521, 388];slicemap (specval(MCPO), 
low,medLOW, MED, medHIGH, HIGH, MCPOx, MCPOz, Y); 
46 
%receptorMap(specval(), x, z, Y) 
DBx=[1574,1588,1537,1498,1489]; 
DBz=[388 , 471, 496, 474, 423];slicemap (specval(DB), low,medLOW, MED, 
medHIGH, HIGH, DBx, DBz, Y); 
%receptorMap(specval(), x, z, Y) 
Slx=[1620,1588,1521,1514]; 
Slz=[ 521, 471, 490, 573]; 
slicemap (specval(Sl), low,medLOW, MED, medHIGH, HIGH, Slx, Slz, Y); 
%receptorMap(specval(), x, z, Y) 
LPOx=[1514,1521,1498,1452,1460,1450,1354,1335,1397,1438,1490]; 
LPOz=[ 573, 490, 474, 491, 523, 552, 646, 705, 699, 658, 644];slicemap 
(specval(LPO), low,medLOW, MED, medHIGH, HIGH, LPOx, LPOz, Y); 
%receptorMap(specval(), x, z, Y) 
MPAx=[1295,1343,1354,1452,1419,1295]; 
MPAz=[ 708, 703,730, 491, 459, 438]; 
slicemap (specval(MPA), low,medLOW, MED, medHIGH, HIGH, MPAx, MPAz, 
Y); 
%receptorMap(specval(), x, z, Y) 
STx=[1511,1583,1545,1518,1537,1515,1400,1397,1438]; 
STz=[ 628, 652, 701, 809, 895, 915,801 , 699, 658]; 
slicemap (specval(ST), low,medLOW, MED, medHIGH, HIGH, STx, STz, Y); 
%receptorMap(specval(), x, z, Y) 
EAx=[1511,1583, 1610,1514]; 
EAz=[628 , 652, 537, 573];slicemap (specval(EA), low,medLOW, MED, 
medHIGH, HIGH, EAx, EAz, Y); 
%receptorMap(specval(), x, z, Y) 
LSx=[1395,1295,1295,1389,1416,1481,1530,1512,1395]; 
LSz=[ 797, 797,1080,1092,1106,1070, 973, 914, 797];slicemap 
(specval(LS), low,medLOW, MED, medHIGH, HIGH, LSx, LSz, Y); 
%receptorMap(specval(), x, z, Y) 
MSx=[1395,1295,1295,1397]; 
MSz=[797, 797 , 707, 699];slicemap (specval(MS), low,medLOW, MED, 
medHIGH, HIGH, MSx, MSz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1271, 
1426,1444,1678,1778,1834,1910,1882,1902,1897,1832,1707,1635,1489,1389,1295]; 
WMz=[1116, 1161,1224,1175,1122,1077, 898, 664,764 , 
847,1004,1109,1140,1140,1092,1080];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap(specval(), x, z, Y) 
VPx=[1603,1781,1784,1717,1661,1610]; 
VPz=[ 598, 540, 501, 500, 527, 537]; 
slicemap (specval(VP), low,medLOW, MED, medHIGH, HIGH, VPx, VPz, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1416,1481,1528,1489]; 
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Vz=[1106,1070, 973,1140]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
47 
DMSx=[1528,1489,1707,1710,1512]; 
DMSz=[973,1140 ,1109, 885, 914]; 
slicemap (specval(DMS), low,medLOW, MED, medHIGH, HIGH, DMSx, DMSz, 
Y); 
%receptorMap(specval(), x, z, Y) 
DLSx=[1710,1885,1837,1707]; 
DLSz=[ 885, 845, 999,1109]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y); 
%receptorMap(specval(), x, z, Y) 
VMSx=[1703,1718,1645,1606,1554]; 
VMSz=[ 882,543 , 568, 594, 883]; 
slicemap (specval(VMS), low,medLOW, MED, medHIGH, HIGH, VMSx, VMSz, 
Y); 
%receptorMap(specval(), x, z, Y) 
VLSx=[1703,1718,1781,1879,1897]; 
VLSz=[ 882, 543, 540, 668, 847];slicemap (specval(VLS), low,medLOW, 
MED, medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
Clx=[1921,1911,1869,1926,1949]; 
Clz=[ 820, 727, 654, 631, 748];slicemap (specval(Cl), low,medLOW, MED, 
medHIGH, HIGH, Clx, Clz, Y); 
%receptorMap(specval(), x, z, Y) 
ENx=[1926,1875,1788,1795,1888]; 
ENz=[ 631, 662, 551, 500, 558];slicemap (specval(EN), low,medLOW, MED, 
medHIGH, HIGH, ENx, ENz, Y); 
%receptorMap(specval(), x, z, Y) 
GPx=[1590,1562,1539,1554,1628,1645,1650,1624]; 
GPz=[ 635, 680, 703,883 , 827, 787, 700, 649];slicemap (specval(GP), 
low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
%receptorMap(specval(), x, z, Y) 
l=30; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice31 
if Slicenum == 31; 
Y=31*3; 
Cgx=[1295,1433,1409,1295]; 
Cgz=[1408,1230,1155,1146];slicemap (specval(Cg), low,medLOW, MED, 
medHIGH, HIGH, Cgx, Cgz, Y); 
M1x=[1310,1431,1493,1522]; 
M1z=[1415,1231,1234,1449];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
S1HLx=[1493,1522,1692,1624]; 
48 
S1HLz=[1234,1449,1410,1203];slicemap (specval(S1HL), low,medLOW, MED, 
medHIGH, HIGH, S1HLx, S1HLz, Y); 
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S1FLx=[1692,1624,1750,1857]; 
S1FLz=[1410,1203,1154,1341];slicemap (specval(S1FL), low,medLOW, MED, 
medHIGH, HIGH, S1FLx, S1FLz, Y); 
S1BFx=[1750,1857,1999,2072,1891,1836]; 
S1BFz=[1154,1341,1220,1052,1003,1091];slicemap (specval(S1BF), 
low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, Y); 
S1ULx=[2072,1891,1917,2109]; 
S1ULz=[1052,1003, 919, 966];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
S2x=[1917,2109,2145,1929]; 
S2z=[ 919, 966, 788, 780];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
Insx=[2145,1929,1934,2093]; 
Insz=[ 788, 780, 646, 609];slicemap (specval(Ins), low,medLOW, MED, 
medHIGH, HIGH, Insx, Insz, Y); 
PIRCx=[1934,2093,1913,1841,1840,1810]; 
PIRCz=[ 646, 609, 330, 305, 385, 451];slicemap (specval(PIRC), 
low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, Y); 
BAx=[1597,1844,1777,1638]; 
BAz=[ 482, 380, 502, 523];slicemap (specval(BA), low,medLOW, MED, 
medHIGH, HIGH, BAx, BAz, Y); 
Cox=[1597,1598,1741,1841,1844]; 
Coz=[482 , 387, 321, 305,380 ];slicemap (specval(Co), low,medLOW, MED, 
medHIGH, HIGH, Cox, Coz, Y); 
Cex=[1777,1638,1702,1767,1784]; 
Cez=[ 502, 523, 578, 579, 534];slicemap (specval(Ce), low,medLOW, MED, 
medHIGH, HIGH, Cex, Cez, Y); 
Mex=[1597,1598,1488]; 
Mez=[482 , 387, 422];slicemap (specval(Me), low,medLOW, MED, medHIGH, 
HIGH, Mex, Mez, Y); 
MCPOx=[1665,1591,1546,1543,1597]; 
MCPOz=[531 , 562, 532, 457, 482];slicemap (specval(MCPO), low,medLOW, 
MED, medHIGH, HIGH, MCPOx, MCPOz, Y); 
SOx=[1448,1379,1386,1435,1510,1533]; 
SOz=[ 422, 447, 475, 499, 474,440 ]; 
slicemap (specval(SO), low,medLOW, MED, medHIGH, HIGH, SOx, SOz, Y); 
LHx=[1295,1329,1405,1463,1562,1591,1546,1543,1452,1449,1414,1333,1344]; 
LHz=[ 725, 725, 715, 654, 620, 562, 532, 457, 497, 537, 589, 640, 
682]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
AHAx=[1295,1333,1414,1449,1450,1427,1386,1379,1351,1295]; 
AHAz=[ 604, 640, 589, 537, 496, 499, 475, 447, 440, 440]; 
slicemap (specval(AHA), low,medLOW, MED, medHIGH, HIGH, AHAx, AHAz, 
Y); 
SChx=[1351,1295,1295,1337]; 
SChz=[ 440, 440, 488, 479]; 
slicemap (specval(SCh), low,medLOW, MED, medHIGH, HIGH, SChx, SChz, 
Y); 
Rex=[1295,1357,1390,1342,1295]; 
Rez=[ 765, 787, 765, 728, 728]; 
slicemap (specval(Re), low,medLOW, MED, medHIGH, HIGH, Rex, Rez, Y); 
CMx=[1295,1357,1338,1295]; 
49 
CMz=[ 765, 787, 841, 839]; 
slicemap (specval(CM), low,medLOW, MED, medHIGH, HIGH, CMx, CMz, Y); 
PVAx=[1338,1295,1295,1345,1412,1402]; 
PVAz=[ 841, 839, 951, 987, 997, 920]; 
slicemap (specval(PVA), low,medLOW, MED, medHIGH, HIGH, PVAx, PVAz, 
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Y); 
Ax=[1412,1402,1339,1345,1412,1478,1504]; 
Az=[ 997, 920, 845, 803,770 , 859,1003]; 
slicemap (specval(A), low,medLOW, MED, medHIGH, HIGH, Ax, Az, Y); 
Rtx=[1504,1447,1508,1572,1546]; 
Rtz=[1003, 776, 747,1010,1042]; 
slicemap (specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
Vx=[1295,1345,1506,1549,1555,1462,1398,1295]; 
Vz=[951 ,987 ,1022,1041,1160,1147,1111,1111]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
%WMx=[]; 
%WMz=[];slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
%WM2x=[]; 
%WM2z=[];slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, 
Y); 
%WM3x=[]; 
%WM3z=[];slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, 
Y); 
DLSx=[1556,1549,1682,1903,1848,1728]; 
DLSz=[1161,1054, 852, 845,1003,1113]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y); 
VLSx=[1683,1903,1911,1870,1787,1602,1659,1687]; 
VLSz=[ 849, 845, 715, 619, 547, 659, 690, 744]; 
slicemap (specval(VLS), low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, 
Y); 
GPx=[1602,1659,1687,1683,1551,1587,1611,1654]; 
GPz=[ 659, 690, 744, 849, 699, 784, 925, 908]; 
slicemap (specval(GP), low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
Clx=[1926,1946,1903,1878]; 
Clz=[ 745, 694, 593, 635]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
ENx=[1903,1878,1787,1777,1805,1846,1880]; 
ENz=[ 593, 635, 547, 502, 450, 459,505 ]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
Pax=[1294,1333,1344,1303,1294]; 
Paz=[ 604, 640, 682, 725,727]; 
slicemap (specval(Pa), low,medLOW, MED, medHIGH, HIGH, Pax, Paz, Y); 
%QCcolor (Pax,Paz,31*3) 
l=31; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
50 
slice32 
if Slicenum ==32 ; 
Y=32*3; 
S1BFx=[1414,1270,1968,2078,1900,1838]; 
S1BFz=[1181,1373,1262,1077, 984,1098]; 
slicemap (specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, 
Y); 
Cgx=[1295,1354,1433,1427,1407,1295]; 
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Cgz=[1406,1451,1245,1187,1166,1156]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, Cgx, Cgz, Y); 
M1x=[1350,1436,1493,1522]; 
M1z=[1447,1245,1244,1458]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
S1HLx=[1493,1522,1696,1624]; 
S1HLz=[1244,1458,1414,1207]; 
slicemap (specval(S1HL), low,medLOW, MED, medHIGH, HIGH, S1HLx, S1HLz, 
Y); 
S1Shx=[1696,1624,1713,1797]; 
S1Shz=[1414,1207,1181,1373]; 
slicemap (specval(S1Sh), low,medLOW, MED, medHIGH, HIGH, S1Shx, S1Shz, 
Y); 
S1ULx=[2078,1900,1921,2121]; 
S1ULz=[1077, 984, 921, 966]; 
slicemap (specval(S1UL), low,medLOW, MED, medHIGH, HIGH, S1ULx, S1ULz, 
Y); 
S2x=[1921,2121,2153,1943]; 
S2z=[ 921, 966, 785, 781]; 
slicemap (specval(S2), low,medLOW, MED, medHIGH, HIGH, S2x, S2z, Y); 
Insx=[2153,1943,1939,2096]; 
Insz=[ 785, 781, 627, 591]; 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y); 
PirRx=[1939,2096,1914,1839,1827,1928]; 
PirRz=[ 627, 591, 310, 304, 406, 523]; 
slicemap (specval(PirR), low,medLOW, MED, medHIGH, HIGH, PirRx, PirRz, 
Y); 
Cox =[1838,1827,1594,1554]; 
Coz=[ 299 , 406, 516, 414]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
Cex=[1802,1648,1688,1721,1794,1830]; 
Cez=[ 494, 593, 629, 637, 621, 562]; 
slicemap (specval(Ce), low,medLOW, MED, medHIGH, HIGH, Cex, Cez, Y); 
AAx=[1630,1604,1552,1566]; 
AAz=[ 547, 382, 412, 472]; 
slicemap (specval(AA), low,medLOW, MED, medHIGH, HIGH, AAx, AAz, Y); 
EAx=[1657,1563,1483]; 
EAz=[ 600, 608, 702]; 
slicemap (specval(EA), low,medLOW, MED, medHIGH, HIGH, EAx, EAz, Y); 
51 
BAx=[1594,1827,1885,1876,1802,1648,1510,1552,1716,1702]; 
BAz=[ 516, 406, 472, 611, 494, 593, 716, 716, 677, 637]; 
slicemap (specval(BA), low,medLOW, MED, medHIGH, HIGH, BAx, BAz, Y); 
ENx=[1878,1931,1928,1885]; 
ENz=[ 615, 603, 523, 476]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
Clx=[1878,1931,1925,1889]; 
Clz=[ 615, 603, 705, 642]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
DLSx=[1830,1945,1917,1797,1795,1751,1806]; 
DLSz=[ 562, 743, 839, 850, 735, 642, 616]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y); 
VLSx=[1917,1797,1763,1657,1683,1576,1740,1789,1894]; 
VLSz=[ 839, 850, 938,1028,1037,1167,1116,1082, 928]; 
slicemap (specval(VLS), low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, 
Y); 
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GPx=[1714,1763,1793,1795,1748,1686,1716,1669,1702,1717,1714]; 
GPz=[ 975, 938, 868, 735, 651, 626, 677, 708, 751, 810, 970]; 
slicemap (specval(GP), low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
MCPOx=[1562,1650,1633,1560,1533,1535]; 
MCPOz=[ 602, 589, 551, 539, 564, 581]; 
slicemap (specval(MCPO), low,medLOW, MED, medHIGH, HIGH, MCPOx, MCPOz, 
Y); 
LHx=[1560,1562,1483,1304,1467]; 
LHz=[ 539, 602, 702, 697, 441]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
Rchx=[1443,1295,1295,1345]; 
Rchz=[ 391, 426, 390, 370]; 
slicemap (specval(Rch), low,medLOW, MED, medHIGH, HIGH, Rchx, Rchz, 
Y); 
AHAx=[1443,1295,1295,1351,1429,1461]; 
AHAz=[ 391, 426, 564,613 , 545, 440]; 
slicemap (specval(AHA), low,medLOW, MED, medHIGH, HIGH, AHAx, AHAz, 
Y); 
Pax=[1295,1351,1362,1305,1295]; 
Paz=[ 564,613 , 650, 701, 701]; 
slicemap (specval(Pa), low,medLOW, MED, medHIGH, HIGH, Pax, Paz, Y); 
Rex=[1295,1406,1446,1362,1295]; 
Rez=[701 , 704, 750, 786, 750]; 
slicemap (specval(Re), low,medLOW, MED, medHIGH, HIGH, Rex, Rez, Y); 
CMx=[1362,1295,1295,1346]; 
CMz=[ 786, 750, 847, 847]; 
slicemap (specval(CM), low,medLOW, MED, medHIGH, HIGH, CMx, CMz, Y); 
PVAx=[1295,1346,1425,1423,1349,1295]; 
PVAz=[ 847, 847, 941,1003, 988, 946]; 
slicemap (specval(PVA), low,medLOW, MED, medHIGH, HIGH, PVAx, PVAz, 
Y); 
Ax=[1346,1336,1446,1514,1516,1573,1517,1423,1425,1382]; 
Az=[ 847, 812, 750, 776, 890,1006,1037,1003, 941, 879]; 
slicemap (specval(A), low,medLOW, MED, medHIGH, HIGH, Ax, Az, Y); 
VAx=[1514,1516,1573,1595,1549,1522]; 
VAz=[ 776, 890,1006, 952, 814, 779]; 
slicemap (specval(VA), low,medLOW, MED, medHIGH, HIGH, VAx, VAz, Y); 
52 
Rtx=[1573,1595,1549,1522,1401,1484,1552,1638,1639,1684,1564,1517]; 
Rtz=[1006, 952, 814, 779, 720, 703, 716, 851, 953,1011,1068,1037]; 
slicemap (specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
Vx=[1564,1462,1349,1295,1295,1347,1475,1547]; 
Vz=[1068,1009, 988, 946,1020,1021,1065,1056]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
CMx=[1282,1362,1336,1346,1233]; 
CMz=[ 766, 786, 812, 847,851]; 
slicemap (specval(CM), low,medLOW, MED, medHIGH, HIGH, CMx, CMz, Y); 
WMx=[1019,924 ,906,1027 ,1118,1250,1295,1295,1198,1111]; 
WMz=[1161,1080,1036,1068,1064,1020,1020,1110,1119,1164]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WMx=[1295,1391,1478,1575,1740,1864,1923,1868,1856,1803,1870,1880,1945,1921,18
38,1713,1445,1427,1407,1295]; 
WMz=[1110,1119,1164,1167,1116, 928, 734, 652, 588, 512, 577, 642, 743, 
924,1098,1181,1250,1187,1166,1156]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WMx=[1639,1638,1554,1587,1650,1702,1713,1677]; 
WMz=[ 953, 851, 725, 680, 692, 751,1000,1018]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
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WMx=[1443,1554,1633,1598,1560,1461]; 
WMz=[ 391, 414, 549, 559, 539, 440]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%QCcolor (CMx,CMz,3*32) 
l=32; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 33 
if Slicenum == 33; 
Y=33*3 
WMx=[1295,1404,1875,1949,1933,1876,1835,1718,1459,1435,1401,1295]; 
WMz=[373, 359 , 611, 779, 920,1072,1120,1198,1275,1271,1186,1186]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
RSRx=[1295,1324,1361,1435,1423,1401,1249]; 
RSRz=[1415,1445,1462,1271,1208,1186,1177]; 
slicemap (specval(RSR), low,medLOW, MED, medHIGH, HIGH, RSRx, RSRz, 
Y); 
M1x=[1361,1433,1494,1521]; 
M1z=[1462,1264,1262,1459]; 
slicemap (specval(M1), low,medLOW, MED, medHIGH, HIGH, M1x, M1z, Y); 
S1HLx=[1521,1496,1538,1625,1694]; 
S1HLz=[1459,1263,1241,1229,1421]; 
slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, S1HLx, S1HLz, Y); 
S1Shx=[1625,1694,1790,1715]; 
S1Shz=[1229,1421,1390,1196]; 
53 
slicemap (specval(S1Sh), low,medLOW, MED, medHIGH, HIGH, S1Shx, S1Shz, 
Y); 
S1BFx=[1790,1715,1835,1916,2079,1976]; 
S1BFz=[1390,1196,1120,1002,1079,1257]; 
slicemap (specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, 
Y); 
S1ULx=[1916,2079,2125,1933]; 
S1ULz=[1002,1076, 976, 920]; 
slicemap (specval(S1UL), low,medLOW, MED, medHIGH, HIGH, S1ULx, S1ULz, 
Y); 
S2x=[2125,1933,1947,2156]; 
S2z=[ 976, 920, 781, 787]; 
slicemap (specval(S2), low,medLOW, MED, medHIGH, HIGH, S2x, S2z, Y); 
Insx=[1947,2156,2097,1986,1911]; 
Insz=[ 781, 787, 591, 601, 637]; 
slicemap (specval(Ins), low,medLOW, MED, medHIGH, HIGH, Insx, Insz, 
Y); 
PIRCx=[2097,1957,1902,1825,1807,1820,1911,1986]; 
PIRCz=[ 591, 330, 296, 301, 351, 413, 637, 601]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
Clx=[1910,1939,1929,1895,1875]; 
Clz=[ 607, 687, 715, 670, 611]; 
slicemap (specval(Cl), low,medLOW, MED, medHIGH, HIGH, Clx, Clz, Y); 
ENx=[1910,1875,1895,1929,1939]; 
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ENz=[607 , 611, 670, 715, 687]; 
slicemap (specval(EN), low,medLOW, MED, medHIGH, HIGH, ENx, ENz, Y); 
BAx=[1634,1868,1888,1820,1825,1563,1566]; 
BAz=[ 554, 588, 492, 404, 301, 421, 454]; 
slicemap (specval(BA), low,medLOW, MED, medHIGH, HIGH, BAx, BAz, Y); 
Cox=[1566,1809,1739,1563]; 
Coz=[ 454, 335, 326, 421]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
Mex=[1592,1563,1566,1634]; 
Mez=[ 405, 421, 454, 554]; 
slicemap (specval(Me), low,medLOW, MED, medHIGH, HIGH, Mex, Mez, Y); 
Cex=[1797,1829,1810,1766,1690,1653]; 
Cez=[ 509, 605, 642, 660, 639, 558]; 
slicemap (specval(Ce), low,medLOW, MED, medHIGH, HIGH, Cex, Cez, Y); 
VLSx=[1829,1907,1915,1817,1809,1785]; 
VLSz=[ 605, 713, 842, 821, 725, 656]; 
slicemap (specval(VLS), low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, 
Y); 
DLSx=[1663,1817,1915,1864,1755]; 
DLSz=[1101, 821, 842,1000,1125]; 
slicemap (specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, 
Y); 
GPx=[1771,1812,1809,1791,1720,1687,1737,1778]; 
GPz=[ 950, 885, 725, 654, 650, 664, 712, 814]; 
slicemap (specval(GP), low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
DGdx=[1295,1324,1374,1446,1375,1316,1295]; 
DGdz=[1131,1139,1091,1075,1036,1066,1066]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
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CA3Dx=[1324,1388,1466,1538,1599,1629,1596,1536,1446,1374]; 
CA3Dz=[1139,1140,1182,1190,1173,1117,1093,1094,1075,1091]; 
slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
Vx=[1316,1295,1295,1360]; 
Vz=[1066,1066,1007,1037]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
PVAx=[1295,1295,1314,1327,1317]; 
PVAz=[1007, 933, 948,1003,1025]; 
slicemap (specval(PVA), low,medLOW, MED, medHIGH, HIGH, PVAx, PVAz, 
Y); 
Hbx=[1340,1375,1407,1415,1362,1327,1321]; 
Hbz=[1050,1036,1051,1003, 986,1003,1030]; 
slicemap (specval(Hb), low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
MDx=[1327,1362,1406,1352,1335,1314]; 
MDz=[1003, 986, 989, 874, 937, 948]; 
slicemap (specval(MD), low,medLOW, MED, medHIGH, HIGH, MDx, MDz, Y); 
CMx=[1314,1295,1295,1352,1335]; 
CMz=[ 948, 933, 846, 874, 937]; 
slicemap (specval(CM), low,medLOW, MED, medHIGH, HIGH, CMx, CMz, Y); 
Ax=[1295,1354,1403,1392,1446,1493,1551,1530,1469,1449,1430,1295]; 
Az=[ 846, 876, 955,1042,1075,1043,1051,1004, 951, 906, 802, 784]; 
slicemap (specval(A), low,medLOW, MED, medHIGH, HIGH, Ax, Az, Y); 
LDx=[1466,1446,1493,1554,1575,1495]; 
LDz=[1084,1075,1043,1052,1094,1087]; 
slicemap (specval(LD), low,medLOW, MED, medHIGH, HIGH, LDx, LDz, Y); 
Rex=[1295,1439,1412,1419,1295]; 
Rez=[ 673, 722, 752, 794, 784]; 
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slicemap (specval(Re), low,medLOW, MED, medHIGH, HIGH, Rex, Rez, Y); 
VMx=[1436,1414,1412,1439,1514,1558,1486]; 
VMz=[ 812, 787, 752, 722, 729, 753, 766]; 
slicemap (specval(VM), low,medLOW, MED, medHIGH, HIGH, VMx, VMz, Y); 
VAx=[1436,1486,1558,1614,1540,1517,1499,1469,1449,1453]; 
VAz=[ 812, 766, 753, 793, 855, 895, 980, 951, 906, 845]; 
slicemap (specval(VA), low,medLOW, MED, medHIGH, HIGH, VAx, VAz, Y); 
VLx=[1507,1548,1616,1658,1652,1605,1540,1517]; 
VLz=[ 979,1030,1003, 928, 855, 788, 855, 895]; 
slicemap (specval(VL), low,medLOW, MED, medHIGH, HIGH, VLx, VLz, Y); 
Rtx=[1554,1575,1622,1632,1684,1708,1695,1657,1582,1439,1514,1608,1652,1658,16
16,1562,1557]; 
Rtz=[1052,1094,1112,1063,1003, 948, 841, 774, 703, 722, 729, 787, 855, 
928,1003,1029,1071]; 
slicemap (specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
ZIRx=[1305,1377,1466,1578,1439]; 
ZIRz=[ 673, 652, 667, 701, 722]; 
slicemap (specval(ZIR), low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, 
Y); 
Pax=[1295,1311,1380,1353,1288]; 
Paz=[655 , 567, 629, 663, 676]; 
slicemap (specval(Pa), low,medLOW, MED, medHIGH, HIGH, Pax, Paz, Y); 
Vx=[1295,1308,1311,1295]; 
Vz=[655 , 566, 436, 396]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
AHAx=[1308,1309,1355,1401,1410,1466,1450,1407,1380,1311]; 
AHAz=[ 566, 511, 525, 500, 451, 505, 588, 629, 629, 567]; 
55 
slicemap (specval(AHA), low,medLOW, MED, medHIGH, HIGH, AHAx, AHAz, 
Y); 
VMHx=[1309,1311,1346,1402,1418,1401,1339]; 
VMHz=[ 511, 436, 398, 423, 450, 500, 525]; 
slicemap (specval(VMH), low,medLOW, MED, medHIGH, HIGH, VMHx, VMHz, 
Y); 
Arcx=[1295,1311,1321,1338,1230,1295]; 
Arcz=[ 396, 436, 437, 396,373 , 373]; 
slicemap (specval(Arc), low,medLOW, MED, medHIGH, HIGH, Arcx, Arcz, 
Y); 
Rchx=[1295,1338,1392,1463,1404,1317]; 
Rchz=[ 373, 396, 410, 387, 359, 367]; 
slicemap (specval(Rch), low,medLOW, MED, medHIGH, HIGH, Rchx, Rchz, 
Y); 
LHx=[1392,1410,1466,1407,1380,1377,1466,1605,1686,1656,1615,1540,1498,1463]; 
LHz=[410 , 451, 505, 629, 629, 652, 667, 668, 674, 560, 550, 486, 435, 
387]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
l=33; 
load('plotable.mat') 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
PVAx=[1291,1314,1327,1317,1293]; 
PVAz=[ 933, 948,1003,1025,1007]; 
slicemap (specval(PVA), low,medLOW, MED, medHIGH, HIGH, PVAx, PVAz, 
Y); 
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%QCcolor(PVAx,PVAz,33*3) 
l=33; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
Slice34 
if Slicenum == 34; 
Rex=[1292,1329,1436,1401,1375,1215]; 
Rez=[ 694, 683, 722, 750, 789,792];slicemap (specval(Re), low,medLOW, 
MED, medHIGH, HIGH, Rex, Rez, Y); 
%receptorMap(specval(), x, z, Y) 
RSRx=[1295,1362,1434,1385,1295,]; 
RSRz=[1425,1462,1270,1200,1177];slicemap (specval(RSR), low,medLOW, 
MED, medHIGH, HIGH, RSRx, RSRz, Y); 
56 
%receptorMap(specval(), x, z, Y) 
M1x=[1362,1429,1494,1520]; 
M1z=[1462,1275,1276,1466];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
%receptorMap(specval(), x, z, Y) 
S1HLx=[1494,1520,1693,1626]; 
S1HLz=[1276,1466,1429,1243];slicemap (specval(S1HL), low,medLOW, MED, 
medHIGH, HIGH, S1HLx, S1HLz, Y); 
%receptorMap(specval(), x, z, Y) 
S1Shx=[1693,1626,1717,1790]; 
S1Shz=[1429,1243,1210,1392];slicemap (specval(S1Sh), low,medLOW, MED, 
medHIGH, HIGH, S1Shx, S1Shz, Y); 
%receptorMap(specval(), x, z, Y) 
S1BFx=[1717,1790,1896,2015,2082,1913,1874,1822]; 
S1BFz=[1210,1392,1336,1207,1081,1000,1087,1146];slicemap 
(specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, Y); 
%receptorMap(specval(), x, z, Y) 
S1ULx=[2082,1913,1944,2136]; 
S1ULz=[1081,1000, 920, 976];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
%receptorMap(specval(), x, z, Y) 
S2x=[1944,2136,2165,1968]; 
S2z=[920, 976 , 836, 815];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
%receptorMap(specval(), x, z, Y) 
Insx=[2165,1968,1945,2096]; 
Insz=[ 836, 815, 628, 580];slicemap (specval(Ins), low,medLOW, MED, 
medHIGH, HIGH, Insx, Insz, Y); 
%receptorMap(specval(), x, z, Y) 
PIRCx=[1945,2096,1956,1884,1796]; 
PIRCz=[ 628, 580, 310, 284, 321];slicemap (specval(PIRC), low,medLOW, 
MED, medHIGH, HIGH, PIRCx, PIRCz, Y); 
%receptorMap(specval(), x, z, Y) 
Cox=[1792,1589,1574,1788]; 
Coz=[321 , 421, 471, 356];slicemap (specval(Co), low,medLOW, MED, 
medHIGH, HIGH, Cox, Coz, Y); 
%receptorMap(specval(), x, z, Y) 
CONFIDENTIAL | 257 
 
Cex=[1714,1755,1809,1865]; 
Cez=[ 623, 654, 663, 607];slicemap (specval(Ce), low,medLOW, MED, 
medHIGH, HIGH, Cex, Cez, Y); 
%receptorMap(specval(), x, z, Y) 
BAx=[1574,1788,1868,1888,1865,1699]; 
BAz=[ 471, 356, 366, 445, 607,620 ];slicemap (specval(BA), low,medLOW, 
MED, medHIGH, HIGH, BAx, BAz, Y); 
%receptorMap(specval(), x, z, Y) 
Mex=[1698,1607,1574]; 
Mez=[ 607, 411, 471];slicemap (specval(Me), low,medLOW, MED, medHIGH, 
HIGH, Mex, Mez, Y); 
%receptorMap(specval(), x, z, Y) 
Cex=[1694,1888,1865,1792]; 
Cez=[ 604, 470, 607, 671];slicemap (specval(Ce), low,medLOW, MED, 
medHIGH, HIGH, Cex, Cez, Y); 
%receptorMap(specval(), x, z, Y) 
Lax=[1888,1865,1904,1938]; 
57 
Laz=[ 470, 607, 656, 670];slicemap (specval(La), low,medLOW, MED, 
medHIGH, HIGH, Lax, Laz, Y); 
%receptorMap(specval(), x, z, Y) 
VLSx=[1793,1844,1879,1868,1929,1947,1865]; 
VLSz=[ 671, 699, 796, 836, 827, 678,607 ];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
%receptorMap(specval(), x, z, Y) 
GPx=[1779,1844,1879,1868,1837,1834,1816,1763]; 
GPz=[ 666, 699, 796, 836, 864, 801, 743, 663];slicemap (specval(GP), 
low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
%receptorMap(specval(), x, z, Y) 
DLSx=[1790,1881,1929,1878,1868,1837,1808,1760,1674,1667]; 
DLSz=[1126,1000, 827, 823, 836, 864,1015,1077,1094,1177];slicemap 
(specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
%receptorMap(specval(), x, z, Y) 
LHx=[1718,1562,1541,1536,1424,1389,1597]; 
LHz=[ 631, 524, 486, 439, 359, 677, 678];slicemap (specval(LH), 
low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
%receptorMap(specval(), x, z, Y) 
VMHx=[1307,1337,1383,1417,1431,1419,1302]; 
VMHz=[ 511, 518, 507, 472, 427, 384,421 ];slicemap (specval(VMH), 
low,medLOW, MED, medHIGH, HIGH, VMHx, VMHz, Y); 
%receptorMap(specval(), x, z, Y) 
AHAx=[1338,1337,1417,1443,1431,1389]; 
AHAz=[ 683, 518, 472, 504, 628, 677];slicemap (specval(AHA), 
low,medLOW, MED, medHIGH, HIGH, AHAx, AHAz, Y); 
%receptorMap(specval(), x, z, Y) 
Rchx=[1326,1424,1419,1372]; 
Rchz=[ 362, 359, 384, 396];slicemap (specval(Rch), low,medLOW, MED, 
medHIGH, HIGH, Rchx, Rchz, Y); 
%receptorMap(specval(), x, z, Y) 
Arcx=[1326,1372,1306,1295,1295]; 
Arcz=[ 362, 396, 426, 426, 362];slicemap (specval(Arc), low,medLOW, 
MED, medHIGH, HIGH, Arcx, Arcz, Y); 
%receptorMap(specval(), x, z, Y) 
DMx=[1295,1338,1352,1331,1308,1295]; 
DMz=[ 698, 683, 653, 518, 511, 511];slicemap (specval(DM), low,medLOW, 
MED, medHIGH, HIGH, DMx, DMz, Y); 
%receptorMap(specval(), x, z, Y) 
Vx=[1295,1309,1302,1295]; 
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Vz=[ 658, 593, 421,421 ];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
ZIRx=[1338,1436,1631,1579,1389]; 
ZIRz=[ 683, 722, 702, 682, 677];slicemap (specval(ZIR), low,medLOW, 
MED, medHIGH, HIGH, ZIRx, ZIRz, Y); 
%receptorMap(specval(), x, z, Y) 
VMx=[1373,1435,1556,1585,1584,1436]; 
VMz=[ 789, 805, 788, 749, 716, 722];slicemap (specval(VM), low,medLOW, 
MED, medHIGH, HIGH, VMx, VMz, Y); 
%receptorMap(specval(), x, z, Y) 
VPLx=[1584,1642,1727,1738,1676,1634,1625,1660,1653]; 
VPLz=[ 716, 725, 809, 859,1037,1045, 993, 885, 841];slicemap 
(specval(VPL), low,medLOW, MED, medHIGH, HIGH, VPLx, VPLz, Y); 
%receptorMap(specval(), x, z, Y) 
58 
VLx=[1676,1634,1625,1660,1653,1624,1536,1509,1507]; 
VLz=[1037,1045, 993, 885, 841, 797, 875, 945, 995];slicemap 
(specval(VL), low,medLOW, MED, medHIGH, HIGH, VLx, VLz, Y); 
%receptorMap(specval(), x, z, Y) 
VAx=[1373,1435,1556,1585,1624,1536,1509,1524,1450]; 
VAz=[ 789, 805, 788, 749, 797, 875, 945,1002, 951];slicemap 
(specval(VA), low,medLOW, MED, medHIGH, HIGH, VAx, VAz, Y); 
%receptorMap(specval(), x, z, Y) 
Rtx=[1600,1725,1785,1777,1631,1642,1727,1738,1676,1607]; 
Rtz=[1086,1058, 896, 826, 702, 725, 809, 859,1037,1054];slicemap 
(specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
%receptorMap(specval(), x, z, Y) 
LDx=[1607,1633,1569,1460,1471,1533]; 
LDz=[1054,1097,1097,1054,1027,1024];slicemap (specval(), low,medLOW, 
MED, medHIGH, HIGH, LDx, LDz, Y); 
%receptorMap(specval(), x, z, Y) 
Ax=[1295,1375,1447,1530,1432,1422,1295]; 
Az=[ 792, 789, 951,1013,1042, 919, 816];slicemap (specval(A), 
low,medLOW, MED, medHIGH, HIGH, Ax, Az, Y); 
%receptorMap(specval(), x, z, Y) 
Rex=[1295,1295,1330,1436,1375]; 
Rez=[792, 690 , 685, 722, 789];slicemap (specval(Re), low,medLOW, MED, 
medHIGH, HIGH, Rex, Rez, Y); 
%receptorMap(specval(), x, z, Y) 
CMx=[1295,1356,1355,1295]; 
CMz=[ 816, 861, 938, 915];slicemap (specval(CM), low,medLOW, MED, 
medHIGH, HIGH, CMx, CMz, Y); 
%receptorMap(specval(), x, z, Y) 
PVAx=[1335,1292,1281,1313]; 
PVAz=[ 938, 932,1011,1003];slicemap (specval(PVA), low,medLOW, MED, 
medHIGH, HIGH, PVAx, PVAz, Y); 
%receptorMap(specval(), x, z, Y) 
MDx=[1313,1335,1356,1404,1430,1354,]; 
MDz=[1003, 938, 861, 888, 987, 981];slicemap (specval(MD), low,medLOW, 
MED, medHIGH, HIGH, MDx, MDz, Y); 
%receptorMap(specval(), x, z, Y) 
Hbx=[1354,1430,1416,1383,1350,1302]; 
Hbz=[ 981, 987,1025,1030,1039,1017];slicemap (specval(Hb), low,medLOW, 
MED, medHIGH, HIGH, Hbx, Hbz, Y); 
%receptorMap(specval(), x, z, Y)Hb 
Vx=[1295,1341,1316,1295]; 
Vz=[1011,1043,1066,1066];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
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%receptorMap(specval(), x, z, Y) 
DGdx=[1316,1295,1293,1317,1359,1431,1468,1475,1432,1417,1425,1455,1358]; 
DGdz=[1066,1066,1129,1143,1118,1133,1127,1111,1094,1074,1058,1052,1037];slice
map 
(specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, Y); 
%receptorMap(specval(), x, z, Y) 
CA3Dx=[1293,1317,1359,1431,1468,1475,1432,1417,1425,1539,1695,1700,1650,1503,
1391]; 
CA3Dz=[1129,1143,1118,1133,1127,1111,1094,1074,1058,1091,1100,1137,1189,1213,
1161];(specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1295,1391,1503,1667,1790,1883,1943,1928,1885,1960,1968,1874,1715,1459,14
29,1385,1294]; 
59 
WMz=[1129,1161,1213,1177,1126,1003, 824, 667, 481, 676, 
815,1087,1209,1291,1275,1200,1177];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
WMx=[1540,1589,1574,1720,1562,1541]; 
WMz=[ 440, 421, 471, 625, 524, 486];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
WMx=[1607,1720,1755,1834,1808,1760,1666,1725,1749,1740,1785,1777,1715,1597]; 
WMz=[ 632, 637, 654, 801,1015,1077,1094,1058,1003, 942,896 , 826, 748, 
678];slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, 
Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
%QCcolor (Rex,Rez,34*3) 
l=34; 
%%Slicefeed(l); 
%template\(0.0)/ 
% %receptorMap (specval(index), x, z, Y) 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice35 
if Slicenum == 35; 
S2x=[1967,2167,2134,2055,1938,1968]; 
S2z=[ 827, 849,1021,1000, 961, 832];slicemap (specval(S2), low,medLOW, 
MED, medHIGH, HIGH, S2x, S2z, Y); 
%QCcolor (S2x,S2z,35*3) 
l=35; 
RSRx=[1295,1376,1443,1383,1295]; 
RSRz=[1438,1474,1300,1215,1193];slicemap (specval(RSR), low,medLOW, 
MED, medHIGH, HIGH, RSRx, RSRz, Y); 
M1x=[1376,1443,1504,1534]; 
M1z=[1474,1300,1284,1475];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
S1Trx=[1504,1534,1765,1700]; 
S1Trz=[1284,1475,1411,1233];slicemap (specval(S1Tr), low,medLOW, MED, 
medHIGH, HIGH, S1Trx, S1Trz, Y); 
S1BFx=[1765,1700,1796,1893,2067,1863]; 
S1BFz=[1411,1233,1182,1059,1144,1362];slicemap (specval(S1BF), 
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low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, Y); 
S1ULx=[1893,2067,2134,1938]; 
S1ULz=[1059,1144,1021, 961];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
Insx=[1967,2167,2173,2102,1943]; 
Insz=[ 827, 849, 792, 566, 619];slicemap (specval(Ins), low,medLOW, 
MED, medHIGH, HIGH, Insx, Insz, Y); 
60 
PIRCx=[2102,1943,1878,1825,1768,1776,1903,1970]; 
PIRCz=[ 566, 619, 399, 382, 387, 341, 291, 301];slicemap 
(specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, Y); 
Cox=[1768,1776,1560,1552,1570,1784]; 
Coz=[ 392, 341, 444, 475, 517, 392];slicemap (specval(Co), low,medLOW, 
MED, medHIGH, HIGH, Cox, Coz, Y); 
Cex=[1867,1867,1666,1723,1777,1828]; 
Cez=[ 617, 580, 580, 639, 654, 646,];slicemap (specval(Ce), 
low,medLOW, MED, medHIGH, HIGH, Cex, Cez, Y); 
Mex=[1867,1666,1567,1552,1560,1608]; 
Mez=[ 580, 580, 543, 475, 444, 415];slicemap (specval(Me), low,medLOW, 
MED, medHIGH, HIGH, Mex, Mez, Y); 
BAx=[1608,1867,1940,1866,1825,1789]; 
BAz=[ 415, 617, 618, 391, 382, 390];slicemap (specval(BA), low,medLOW, 
MED, medHIGH, HIGH, BAx, BAz, Y); 
Lax=[1867,1768,1844,1877,1929]; 
Laz=[ 617, 392, 383, 406, 677];slicemap (specval(La), low,medLOW, MED, 
medHIGH, HIGH, Lax, Laz, Y); 
VLSx=[1784,1874,1926,1945,1864,1874,1863,1830]; 
VLSz=[ 660, 616, 679, 836, 825, 769, 727, 683];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
GPx=[1864,1874,1863,1830,1784,1740,1817,1855]; 
GPz=[ 825, 769, 727, 683, 660, 644, 729, 843];slicemap (specval(GP), 
low,medLOW, MED, medHIGH, HIGH, GPx, GPz, Y); 
DLSx=[1855,1870,1938,1928,1815,1768,1709,1788,1771,1822,1854]; 
DLSz=[ 843, 829, 836, 918,1118,1160,1179,1110,1072,1003, 917];slicemap 
(specval(DLS), low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
LHx=[1594,1536,1425,1334,1362,1468]; 
LHz=[ 677, 440, 363, 508, 627, 636];slicemap (specval(LH), low,medLOW, 
MED, medHIGH, HIGH, LHx, LHz, Y); 
WMx=[1536, 
1594,1730,1791,1794,1771,1704,1609,1771,1854,1870,1817,1740,1669,1570,1560]; 
WMz=[440 , 677 , 757, 835, 938,1003,1070,1082,1072, 917, 829, 729, 
644, 579, 517, 444];slicemap (specval(WM), low,medLOW, MED, medHIGH, 
HIGH, WMx, WMz, Y); 
WMx=[1295,1390,1488,1618,1768,1815,1928,1945,1926,1967,1939,1872,1796,1666,14
40,1383,1294]; 
WMz=[1153,1181,1232,1216,1160,1118, 918, 836, 502, 827, 
959,1103,1182,1248,1302,1215,1193];slicemap (specval(WM), low,medLOW, 
MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
VMHx=[1325,1293,1350,1391,1426,1435,1424,1384]; 
VMHz=[ 510, 367, 353, 350, 357, 415, 462, 500];slicemap (specval(VMH), 
low,medLOW, MED, medHIGH, HIGH, VMHx, VMHz, Y); 
Arcx=[1295,1305,1313,1345,1350,1295]; 
Arcz=[ 418, 418, 427, 412, 353, 359];slicemap (specval(Arc), 
low,medLOW, MED, medHIGH, HIGH, Arcx, Arcz, Y); 
VPMx=[1641,1066,1585,1573]; 
VPMz=[ 948, 874, 746, 796];slicemap (specval(VPM), low,medLOW, MED, 
medHIGH, HIGH, VPMx, VPMz, Y); 
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CMx=[1295,1303,1350,1340,1295]; 
CMz=[ 786, 786, 840, 881, 881];slicemap (specval(CM), low,medLOW, MED, 
medHIGH, HIGH, CMx, CMz, Y); 
ZIRx=[1295,1364,1468,1618,1583,1437,1366]; 
61 
ZIRz=[ 644, 627, 636, 696, 711, 698, 675];slicemap (specval(ZIR), 
low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, Y); 
VMx=[1335,1374,1585,1590,1435]; 
VMz=[ 755, 676, 711, 751, 796];slicemap (specval(VM), low,medLOW, MED, 
medHIGH, HIGH, VMx, VMz, Y); 
VLx=[1293,1335,1435,1585,1609,1442,1415,1350]; 
VLz=[ 776, 755, 796, 746, 860, 906, 877, 840];slicemap (specval(VL), 
low,medLOW, MED, medHIGH, HIGH, VLx, VLz, Y); 
VPLx=[1657,1753,1762,1706,1661,1585,1590,1666,1635]; 
VPLz=[1051, 946, 873, 771, 734, 711, 751, 874,1007];slicemap 
(specval(VPL), low,medLOW, MED, medHIGH, HIGH, VPLx, VPLz, Y); 
Rtx=[1657,1753,1762,1706,1661,1585,1590,1624,1730,1791,1794,1771,1704,1604,16
16]; 
Rtz=[1051, 946, 873, 771, 734, 711, 751, 699, 757, 835, 
938,1003,1070,1087,1059];slicemap (specval(Rt), low,medLOW, MED, 
medHIGH, HIGH, Rtx, Rtz, Y); 
LDx=[1615,1599,1519,1490,1466,1460,1562]; 
LDz=[1090,1051, 989, 986,1003,1054,1096];slicemap (specval(LD), 
low,medLOW, MED, medHIGH, HIGH, LDx, LDz, Y); 
Rex=[1294,1374,1335,1295]; 
Rez=[ 638, 676, 755, 763];slicemap (specval(Re), low,medLOW, MED, 
medHIGH, HIGH, Rex, Rez, Y); 
MDx=[1448,1466,1450,1416,1368,1335,1321,1295,1295,1340,1359,1415]; 
MDz=[ 913,1003,1049, 987, 975, 992, 939, 920, 887, 881, 850, 
877];slicemap (specval(MD), low,medLOW, MED, medHIGH, HIGH, MDx, MDz, 
Y); 
Pox=[1448,1466,1490,1519,1599,1657,1631,1641,1606]; 
Poz=[ 913,1003, 986, 989,1051,1051, 993, 948, 861];slicemap 
(specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
PVAx=[1295,1324,1335,1295]; 
PVAz=[ 920, 938, 992,1009];slicemap (specval(PVA), low,medLOW, MED, 
medHIGH, HIGH, PVAx, PVAz, Y); 
Hbx=[1295,1368,1416,1432,1359,1335,1295]; 
Hbz=[1009, 975, 987,1042,1036,1058,1032];slicemap (specval(Hb), 
low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
Vx=[1295,1341,1323,1295]; 
Vz=[1032,1050,1084,1088];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
DGdx=[1295,1323,1363,1443,1448,1417,1440,1604,1611,1565,1372,1330,1312,1295]; 
DGdz=[1088,1084,1035,1045,1070,1089,1109,1134,1174,1180,1131,1133,1147,1140];
slicemap 
(specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, Y); 
CA1Dx=[1312,1330,1372,1565,1619,1488,1390,1308]; 
CA1Dz=[1147,1133,1131,1180,1217,1232,1181,1160];slicemap 
(specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, Y); 
CA2x=[1587,1618,1687,1626]; 
CA2z=[1178,1216,1194,1155];slicemap (specval(CA2), low,medLOW, MED, 
medHIGH, HIGH, CA2x, CA2z, Y); 
CA3Dx=[1418,1490,1562,1772,1782,1705,1604,1487,1440,1417]; 
CA3Dz=[1069,1075,1096,1090,1120,1185,1134,1126,1109,1089];slicemap 
(specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
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hold all 
62 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice36 
if Slicenum == 36; 
PHDx=[1290,1348,1368,1353,1332,1295]; 
PHDz=[ 513, 525, 614, 680, 689, 676]; 
%QCcolor (PHDx,PHDz,36*3) 
l=36; 
WMx=[1295,1379,1442,1551,1724,1829,1905,1964,1912,1295]; 
WMz=[1206,1226,1320,1287,1234,1165,1041, 851, 450, 450];slicemap 
(specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
RSRx=[1295,1333,1402,1435,1442,1379,1295]; 
RSRz=[1424,1460,1481,1480,1320,1226,1206];slicemap (specval(RSR), 
low,medLOW, MED, medHIGH, HIGH, RSRx, RSRz, Y); 
M1x=[1435,1449,1551,1583]; 
M1z=[1480,1322,1287,1466];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
S1Trx=[1551,1583,1788,1727]; 
S1Trz=[1287,1466,1399,1234];slicemap (specval(S1Tr), low,medLOW, MED, 
medHIGH, HIGH, S1Trx, S1Trz, Y); 
S1BFx=[1788,1727,1829,1906,2086,]; 
S1BFz=[1399,1234,1165,1042,1123,];slicemap (specval(S1BF), low,medLOW, 
MED, medHIGH, HIGH, S1BFx, S1BFz, Y); 
S1ULx=[1906,2086,2143,1944]; 
S1ULz=[1042,1123,1003, 953];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
S2x=[2143,1944,1964,2164]; 
S2z=[1003, 953, 851, 887];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
Aux=[1964,2164,2164,1958]; 
Auz=[ 851, 887, 730, 734];slicemap (specval(Au), low,medLOW, MED, 
medHIGH, HIGH, Aux, Auz, Y); 
PRhx=[2164,1958,1935,1992,2106]; 
PRhz=[ 730, 734, 621, 572, 536];slicemap (specval(PRh), low,medLOW, 
MED, medHIGH, HIGH, PRhx, PRhz, Y); 
PIRCx=[1935,1992,2106,1993,1934,1762,1761,1783,1912,1931]; 
PIRCz=[ 621, 572, 536, 309, 298, 352, 380, 409, 450, 497];slicemap 
(specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, Y); 
Cox=[1781,1762,1551,1567]; 
Coz=[ 405, 352, 450, 505];slicemap (specval(Co), low,medLOW, MED, 
medHIGH, HIGH, Cox, Coz, Y); 
Mex=[1738,1634,1567,1551,1630]; 
Mez=[ 613, 563, 505, 450, 412];slicemap (specval(Me), low,medLOW, MED, 
medHIGH, HIGH, Mex, Mez, Y); 
Cex=[1717,1843,1836,1783]; 
63 
Cez=[ 605, 591, 617, 622];slicemap (specval(Ce), low,medLOW, MED, 
medHIGH, HIGH, Cex, Cez, Y); 
BAx=[1630,1743,1829,1843,1775]; 
BAz=[450 , 614, 621, 591, 402];slicemap (specval(BA), low,medLOW, MED, 
medHIGH, HIGH, BAx, BAz, Y); 
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Lax=[1781,1853,1899,1932,1931,1878]; 
Laz=[ 405, 595, 649, 667, 497, 426];slicemap (specval(La), low,medLOW, 
MED, medHIGH, HIGH, Lax, Laz, Y); 
VLSx=[1738,1791,1846,1918,1958,1934,1813]; 
VLSz=[ 618, 623, 609, 662, 729, 798, 673];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
DLSx=[1950,1965,1868,1862,1883,1872]; 
DLSz=[ 800, 850,1046,1003, 873, 788];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
LHx=[1573,1551,1503,1443,1421,1367,1357,1368,1427]; 
LHz=[ 631, 450, 431, 369, 431, 451, 525, 614, 580];slicemap 
(specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
DMx=[1295,1356,1376,1367,1295]; 
DMz=[ 507, 523, 503, 451, 451];slicemap (specval(DM), low,medLOW, MED, 
medHIGH, HIGH, DMx, DMz, Y); 
PMx=[1295,1305,1367,1421,1443,1381,1296]; 
PMz=[457, 457 , 451, 431, 369, 350, 350];slicemap (specval(PM), 
low,medLOW, MED, medHIGH, HIGH, PMx, PMz, Y); 
Arcx=[1295,1332,1372,1381,1295]; 
Arcz=[ 401, 408, 390, 350, 350];slicemap (specval(Arc), low,medLOW, 
MED, medHIGH, HIGH, Arcx, Arcz, Y); 
ZIRx=[1360,1523,1615,1656,1578,1427,1392]; 
ZIRz=[ 656, 656, 700, 678, 633, 580, 587];slicemap (specval(ZIR), 
low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, Y); 
VMx=[1360,1523,1615,1460,1365]; 
VMz=[ 656, 656, 700, 753, 720];slicemap (specval(VM), low,medLOW, MED, 
medHIGH, HIGH, VMx, VMz, Y); 
Rex=[1365,1353,1324,1293,1295,1330]; 
Rez=[ 720, 680, 689, 677, 759, 759];slicemap (specval(Re), low,medLOW, 
MED, medHIGH, HIGH, Rex, Rez, Y); 
VLx=[1292,1373,1418,1468,1588,1598,1452,1365,1330,1295]; 
VLz=[ 773, 797, 832, 889, 847, 711, 753, 720, 759, 759];slicemap 
(specval(VL), low,medLOW, MED, medHIGH, HIGH, VLx, VLz, Y); 
VPLx=[1730,1662,1780,1783]; 
VPLz=[1012, 711, 821, 958];slicemap (specval(VPL), low,medLOW, MED, 
medHIGH, HIGH, VPLx, VPLz, Y); 
VPMx=[1730,1662,1598,1581,1629,1673]; 
VPMz=[1012, 711, 711, 797, 931, 969];slicemap (specval(VPM), 
low,medLOW, MED, medHIGH, HIGH, VPMx, VPMz, Y); 
Rtx=[1658,1782,1822,1814,1656,1615,1705,1780,1783,1732,1652]; 
Rtz=[1075,1003, 932, 835, 678, 700, 732, 821, 958,1019,1029];slicemap 
(specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
LPx=[1652,1658,1546,1437,1471,1519]; 
LPz=[1029,1075,1092,1043,1002,1004];slicemap (specval(LP), low,medLOW, 
MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1470,1652,1732,1727,1673,1629,1588,1469]; 
Poz=[ 996,1029,1019, 984, 969, 931, 847, 900];slicemap (specval(Po), 
low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
64 
CMx=[1295,1350,1366,1295]; 
CMz=[ 866, 847, 800, 773];slicemap (specval(CM), low,medLOW, MED, 
medHIGH, HIGH, CMx, CMz, Y); 
PVAx=[1295,1326,1332,1286,1295]; 
PVAz=[ 914, 936, 984,1007,1024];slicemap (specval(PVA), low,medLOW, 
MED, medHIGH, HIGH, PVAx, PVAz, Y); 
Hbx=[1286,1332,1384,1429,1412,1380,1336,]; 
Hbz=[1007, 984, 974,1003,1037,1036,1060,];slicemap (specval(Hb), 
low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
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Vx=[1295,1336,1313,1295]; 
Vz=[1024,1060,1091,1095];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
DGdx=[1295,1313,1375,1437,1546,1670,1696,1637,1305,1295]; 
DGdz=[1095,1091,1037,1043,1092,1115,1136,1185,1166,1166];slicemap 
(specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, Y); 
CA1Dx=[1305,1322,1364,1589,1683,1716,1610,1507,1449,1379]; 
CA1Dz=[1166,1137,1130,1192,1164,1203,1238,1251,1237,1178];slicemap 
(specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, Y); 
CA2x=[1683,1720,1788,1703]; 
CA2z=[1164,1202,1164,1136];slicemap (specval(CA2), low,medLOW, MED, 
medHIGH, HIGH, CA2x, CA2z, Y); 
CA3Dx=[1420,1425,1532,1605,1670,1703,1780,1833,1803,1761,1523,1455]; 
CA3Dz=[1085,1111,1148,1144,1115,1136,1163,1114,1070,1059,1104,1075];slicemap 
(specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice37 
if Slicenum == 37; 
PHDx=[1290,1348,1368,1353,1332,1295]; 
PHDz=[ 513, 525, 614, 680, 689, 676]; 
%QCcolor (PHDx,PHDz,36*3) 
l=37; 
WMx=[1295,1379,1442,1551,1724,1829,1905,1964,1912,1295]; 
WMz=[1206,1226,1320,1287,1234,1165,1041, 851, 450, 450];slicemap 
(specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
RSRx=[1295,1333,1402,1435,1442,1379,1295]; 
RSRz=[1424,1460,1481,1480,1320,1226,1206];slicemap (specval(RSR), 
low,medLOW, MED, medHIGH, HIGH, RSRx, RSRz, Y); 
M1x=[1435,1449,1551,1583]; 
M1z=[1480,1322,1287,1466];slicemap (specval(M1), low,medLOW, MED, 
medHIGH, HIGH, M1x, M1z, Y); 
S1Trx=[1551,1583,1788,1727]; 
65 
S1Trz=[1287,1466,1399,1234];slicemap (specval(S1Tr), low,medLOW, MED, 
medHIGH, HIGH, S1Trx, S1Trz, Y); 
S1BFx=[1788,1727,1829,1906,2086,]; 
S1BFz=[1399,1234,1165,1042,1123,];slicemap (specval(S1BF), low,medLOW, 
MED, medHIGH, HIGH, S1BFx, S1BFz, Y); 
S1ULx=[1906,2086,2143,1944]; 
S1ULz=[1042,1123,1003, 953];slicemap (specval(S1UL), low,medLOW, MED, 
medHIGH, HIGH, S1ULx, S1ULz, Y); 
S2x=[2143,1944,1964,2164]; 
S2z=[1003, 953, 851, 887];slicemap (specval(S2), low,medLOW, MED, 
medHIGH, HIGH, S2x, S2z, Y); 
Aux=[1964,2164,2164,1958]; 
Auz=[ 851, 887, 730, 734];slicemap (specval(Au), low,medLOW, MED, 
medHIGH, HIGH, Aux, Auz, Y); 
PRhx=[2164,1958,1935,1992,2106]; 
PRhz=[ 730, 734, 621, 572, 536];slicemap (specval(PRh), low,medLOW, 
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MED, medHIGH, HIGH, PRhx, PRhz, Y); 
PIRCx=[1935,1992,2106,1993,1934,1762,1761,1783,1912,1931]; 
PIRCz=[ 621, 572, 536, 309, 298, 352, 380, 409, 450, 497];slicemap 
(specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, Y); 
Cox=[1781,1762,1551,1567]; 
Coz=[ 405, 352, 450, 505];slicemap (specval(Co), low,medLOW, MED, 
medHIGH, HIGH, Cox, Coz, Y); 
Mex=[1738,1634,1567,1551,1630]; 
Mez=[ 613, 563, 505, 450, 412];slicemap (specval(Me), low,medLOW, MED, 
medHIGH, HIGH, Mex, Mez, Y); 
Cex=[1717,1843,1836,1783]; 
Cez=[ 605, 591, 617, 622];slicemap (specval(Ce), low,medLOW, MED, 
medHIGH, HIGH, Cex, Cez, Y); 
BAx=[1630,1743,1829,1843,1775]; 
BAz=[450 , 614, 621, 591, 402];slicemap (specval(BA), low,medLOW, MED, 
medHIGH, HIGH, BAx, BAz, Y); 
Lax=[1781,1853,1899,1932,1931,1878]; 
Laz=[ 405, 595, 649, 667, 497, 426];slicemap (specval(La), low,medLOW, 
MED, medHIGH, HIGH, Lax, Laz, Y); 
VLSx=[1738,1791,1846,1918,1958,1934,1813]; 
VLSz=[ 618, 623, 609, 662, 729, 798, 673];slicemap (specval(VLS), 
low,medLOW, MED, medHIGH, HIGH, VLSx, VLSz, Y); 
DLSx=[1950,1965,1868,1862,1883,1872]; 
DLSz=[ 800, 850,1046,1003, 873, 788];slicemap (specval(DLS), 
low,medLOW, MED, medHIGH, HIGH, DLSx, DLSz, Y); 
LHx=[1573,1551,1503,1443,1421,1367,1357,1368,1427]; 
LHz=[ 631, 450, 431, 369, 431, 451, 525, 614, 580];slicemap 
(specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
DMx=[1295,1356,1376,1367,1295]; 
DMz=[ 507, 523, 503, 451, 451];slicemap (specval(DM), low,medLOW, MED, 
medHIGH, HIGH, DMx, DMz, Y); 
PMx=[1295,1305,1367,1421,1443,1381,1296]; 
PMz=[457, 457 , 451, 431, 369, 350, 350];slicemap (specval(PM), 
low,medLOW, MED, medHIGH, HIGH, PMx, PMz, Y); 
Arcx=[1295,1332,1372,1381,1295]; 
Arcz=[ 401, 408, 390, 350, 350];slicemap (specval(Arc), low,medLOW, 
MED, medHIGH, HIGH, Arcx, Arcz, Y); 
66 
ZIRx=[1360,1523,1615,1656,1578,1427,1392]; 
ZIRz=[ 656, 656, 700, 678, 633, 580, 587];slicemap (specval(ZIR), 
low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, Y); 
VMx=[1360,1523,1615,1460,1365]; 
VMz=[ 656, 656, 700, 753, 720];slicemap (specval(VM), low,medLOW, MED, 
medHIGH, HIGH, VMx, VMz, Y); 
Rex=[1365,1353,1324,1293,1295,1330]; 
Rez=[ 720, 680, 689, 677, 759, 759];slicemap (specval(Re), low,medLOW, 
MED, medHIGH, HIGH, Rex, Rez, Y); 
VLx=[1292,1373,1418,1468,1588,1598,1452,1365,1330,1295]; 
VLz=[ 773, 797, 832, 889, 847, 711, 753, 720, 759, 759];slicemap 
(specval(VL), low,medLOW, MED, medHIGH, HIGH, VLx, VLz, Y); 
VPLx=[1730,1662,1780,1783]; 
VPLz=[1012, 711, 821, 958];slicemap (specval(VPL), low,medLOW, MED, 
medHIGH, HIGH, VPLx, VPLz, Y); 
VPMx=[1730,1662,1598,1581,1629,1673]; 
VPMz=[1012, 711, 711, 797, 931, 969];slicemap (specval(VPM), 
low,medLOW, MED, medHIGH, HIGH, VPMx, VPMz, Y); 
Rtx=[1658,1782,1822,1814,1656,1615,1705,1780,1783,1732,1652]; 
Rtz=[1075,1003, 932, 835, 678, 700, 732, 821, 958,1019,1029];slicemap 
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(specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
LPx=[1652,1658,1546,1437,1471,1519]; 
LPz=[1029,1075,1092,1043,1002,1004];slicemap (specval(LP), low,medLOW, 
MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1470,1652,1732,1727,1673,1629,1588,1469]; 
Poz=[ 996,1029,1019, 984, 969, 931, 847, 900];slicemap (specval(Po), 
low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
CMx=[1295,1350,1366,1295]; 
CMz=[ 866, 847, 800, 773];slicemap (specval(CM), low,medLOW, MED, 
medHIGH, HIGH, CMx, CMz, Y); 
PVAx=[1295,1326,1332,1286,1295]; 
PVAz=[ 914, 936, 984,1007,1024];slicemap (specval(PVA), low,medLOW, 
MED, medHIGH, HIGH, PVAx, PVAz, Y); 
Hbx=[1286,1332,1384,1429,1412,1380,1336,]; 
Hbz=[1007, 984, 974,1003,1037,1036,1060,];slicemap (specval(Hb), 
low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
Vx=[1295,1336,1313,1295]; 
Vz=[1024,1060,1091,1095];slicemap (specval(V), low,medLOW, MED, 
medHIGH, HIGH, Vx, Vz, Y); 
DGdx=[1295,1313,1375,1437,1546,1670,1696,1637,1305,1295]; 
DGdz=[1095,1091,1037,1043,1092,1115,1136,1185,1166,1166];slicemap 
(specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, Y); 
CA1Dx=[1305,1322,1364,1589,1683,1716,1610,1507,1449,1379]; 
CA1Dz=[1166,1137,1130,1192,1164,1203,1238,1251,1237,1178];slicemap 
(specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, Y); 
CA2x=[1683,1720,1788,1703]; 
CA2z=[1164,1202,1164,1136];slicemap (specval(CA2), low,medLOW, MED, 
medHIGH, HIGH, CA2x, CA2z, Y); 
CA3Dx=[1420,1425,1532,1605,1670,1703,1780,1833,1803,1761,1523,1455]; 
CA3Dz=[1085,1111,1148,1144,1115,1136,1163,1114,1070,1059,1104,1075];slicemap 
(specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
67 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice38 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 38; 
PAGx=[1294,1325,1345,1342,1301,1294]; 
PAGz=[ 703, 710, 750, 967,1003, 992]; 
%QCcolor (PAGx,PAGz,3*38) 
l=38; 
RSRx=[1292,1324, 1421,1456,1465,1432,1376,1294]; 
RSRz=[1431,1463, 1495,1492,1335,1340,1241,1223]; 
slicemap (specval(RSR), low,medLOW, MED, medHIGH, HIGH, RSRx, RSRz, 
Y); 
Ptx=[1456,1465,1517,1636,1753,1832,1662,1496]; 
Ptz=[1492,1335,1313,1292,1237,1385,1447,1489]; 
slicemap (specval(Pt), low,medLOW, MED, medHIGH, HIGH, Ptx, Ptz, Y); 
S1BFx=[1832,1753,1919,2064]; 
S1BFz=[1385,1237,1072,1191]; 
slicemap (specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, 
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Y); 
S2x=[1919,2064,2124,1947]; 
S2z=[1072,1191,1095,1014]; 
slicemap (specval(S2), low,medLOW, MED, medHIGH, HIGH, S2x, S2z, Y); 
Aux=[2124,1947,1984,2183,2166]; 
Auz=[1095,1014, 750, 751, 997]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
PRhx=[1983,2183,2128,1959]; 
PRhz=[ 754, 751, 568, 612]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2128,1959,1955,2115]; 
Entz=[ 568, 612, 573, 527]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[1955,2115,2018,1836,1839,1890,1944,]; 
PIRCz=[ 573, 527, 322, 368, 434, 450, 494,]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
Cox=[1839,1650,1596,1688,1766,1819]; 
Coz=[ 434, 506, 476, 403, 352, 346]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
BAx=[1839,1650,1864,1938,1928,1895,1850]; 
BAz=[ 434, 506, 583, 567, 459, 449, 445]; 
slicemap (specval(BA), low,medLOW, MED, medHIGH, HIGH, BAx, BAz, Y); 
Lax=[1864,1938,1960,1907,1910,1894]; 
Laz=[ 583, 567, 698, 738, 688, 622]; 
68 
slicemap (specval(La), low,medLOW, MED, medHIGH, HIGH, Lax, Laz, Y); 
CA3Vx=[1907,1910,1894,1864,1651,1617,1598,1804,1862]; 
CA3Vz=[ 738, 688, 622, 583, 510, 514, 554, 716, 741]; 
slicemap (specval(CA3V), low,medLOW, MED, medHIGH, HIGH, CA3Vx, CA3Vz, 
Y); 
DGvx=[1592,1617,1647,1596,1554,1557]; 
DGvz=[ 546, 514, 504, 476, 478, 507]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
WMx=[ 
1558,1557,1596,1804,1877,1907,1960,1938,1983,1977,1946,1919,1824,1824,1636,15
17,1432,1376,1295,1295]; 
WMz=[ 476, 507, 553, 716, 742, 738, 698, 567, 691, 
913,1016,1072,1188,1188,1292,1313,1340,1241,1223, 476]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
LGx=[1676,1780,1791,1744,1669]; 
LGz=[1053,1003, 968, 955,1017]; 
slicemap (specval(LG), low,medLOW, MED, medHIGH, HIGH, LGx, LGz, Y); 
Rtx=[1693,1653,1761,1800,1814,1797,1744]; 
Rtz=[ 981, 770, 759, 810,917 , 973, 955]; 
slicemap (specval(Rt), low,medLOW, MED, medHIGH, HIGH, Rtx, Rtz, Y); 
WMx=[1679,1742,1748,1710,1595,1680,1745,1770,1739]; 
WMz=[ 950, 892, 852, 799, 727, 762, 807, 870, 926]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
ZIRx=[1422,1488,1758,1683,1579]; 
ZIRz=[ 629, 516,757 , 760, 719]; 
slicemap (specval(ZIR), low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, 
Y); 
SThx=[1512,1533,1637,1503,1475,1469,1488]; 
SThz=[ 516,568 , 646, 607, 580, 539, 516]; 
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slicemap (specval(STh), low,medLOW, MED, medHIGH, HIGH, SThx, SThz, 
Y); 
LHx=[1511,1512,1469,1387,1367,1356,1369,1338,1383,1379,1427,1455]; 
LHz=[ 466, 516, 538, 699, 710, 670, 580, 532, 496, 469, 445, 408]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
PRx=[1422,1579,1535,1474,1446,1399,1395]; 
PRz=[629 , 719, 710,715 , 724, 695, 671]; 
slicemap (specval(PR), low,medLOW, MED, medHIGH, HIGH, PRx, PRz, Y); 
VPMx=[1464,1579,1656,1698,1695,1655,1621,1558]; 
VPMz=[ 717, 719, 769, 866, 936, 955, 935, 785]; 
slicemap (specval(VPM), low,medLOW, MED, medHIGH, HIGH, VPMx, VPMz, 
Y); 
VPLx=[1653,1698,1695,1742,1748]; 
VPLz=[ 770, 866, 936, 892, 852]; 
slicemap (specval(VPL), low,medLOW, MED, medHIGH, HIGH, VPLx, VPLz, 
Y); 
LPx=[1690,1688,1588,1484,1438,1432,1493,1615,1676,1669,1693]; 
LPz=[ 965, 966, 975, 950,1000,1057,1075,1066,1053,1017, 981]; 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1690,1688,1588,1501,1458,1464,1555,1587,1621,1655,1692]; 
Poz=[ 965, 966, 975, 837, 734, 717, 785, 828, 935, 955, 938]; 
slicemap (specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
Hbx=[1443,1436,1420,1382,1344,1301,1348,1411]; 
Hbz=[1064, 998, 978, 962, 973,1003,1058,1052]; 
slicemap (specval(Hb), low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
PFx=[1342,1345,1325,1402,1446,1485,1501,1484,1436,1422,1382,1342]; 
69 
PFz=[ 967, 750, 710, 695, 724, 773, 837, 950, 998, 975, 962, 967]; 
slicemap (specval(PF), low,medLOW, MED, medHIGH, HIGH, PFx, PFz, Y); 
Vx=[1295,1334,1310,1295]; 
Vz=[1003,1067,1104,1104]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
PAGx=[1295,1342,1345,1321,1295,]; 
PAGz=[1003, 967, 750, 710, 710]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
PHDx=[1295,1321,1367,1356,1369,1338,1295]; 
PHDz=[710 ,710 , 710, 670, 580, 532,515 ]; 
slicemap (specval(PHD), low,medLOW, MED, medHIGH, HIGH, PHDx, PHDz, 
Y); 
SUMx=[1295,1338,1383,1379,1295]; 
SUMz=[515, 532 , 496, 469, 469]; 
slicemap (specval(SUM), low,medLOW, MED, medHIGH, HIGH, SUMx, SUMz, 
Y); 
MMx=[1295,1379,1427,1449,1408,1295]; 
MMz=[ 469, 469, 445, 406, 394, 394]; 
slicemap (specval(MM), low,medLOW, MED, medHIGH, HIGH, MMx, MMz, Y); 
DGdx=[1422,1502,1555,1613,1715,1689,1617,1595,1493]; 
DGdz=[1057,1190,1210,1198,1142,1112,1097,1066,1075]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
CA1Dx=[1295,1348,1412,1502,1555,1613,1684,1759,1652,1521,1472,1379,1295]; 
CA1Dz=[1106,1058,1054,1190,1210,1198,1166,1188,1250,1271,1253,1161,1161]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
CA2x=[1683,1715,1721,1821,1762]; 
CA2z=[1160,1142,1124,1142,1190]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
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Y); 
CA3Dx=[1689,1821,1884,1883,1845,1748,1595,1617,1553,1564,1643]; 
CA3Dz=[1112,1142,1066,1006,1003,1052,1066,1097,1109,1139,1136]; 
slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice39 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 39; 
LPx=[1303,1311,1319,1351,1445,1448,1404,1341]; 
LPz=[ 955,1004,1025,1046,1044, 998, 959, 950]; 
70 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
%QCcolor(LPx,LPz,39*3) 
l=39; 
%%Slicefeed(l); 
WMx=[1295,1339,1410,1435,1534,1685,1810,1894,1972,2010,2014,1986,1892,1295]; 
WMz=[1216,1224,1269,1349,1312,1288,1221,1145,1004, 850, 709, 605, 498, 
498]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
RSCx=[1295,1521,1487,1435,1412,1339,1295]; 
RSCz=[1472,1472,1335,1349,1270,1224,1224]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
Ptx=[1521,1492,1534,1685,1808,1901]; 
Ptz=[1472,1332,1312,1288,1221,1337]; 
slicemap (specval(Pt), low,medLOW, MED, medHIGH, HIGH, Ptx, Ptz, Y); 
S1BFx=[1808,1901,2077,1946]; 
S1BFz=[1221,1337,1174,1072]; 
slicemap (specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, 
Y); 
Aux=[2077,1946,1975,2010,2014,2185]; 
Auz=[1174,1072, 997, 850, 774, 773]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
PRhx=[2014,2185,2130,1986]; 
PRhz=[ 774, 773, 570, 605]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2130,1986,1961,2116]; 
Entz=[ 570, 605, 570, 522]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[1961,2116,2116,1847]; 
PIRCz=[570, 522 , 380, 471]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
Cox=[1822,1844,1655]; 
Coz=[ 376, 431, 459]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
BAx=[1844,1655,1725,1879]; 
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BAz=[ 431, 459,515 , 492]; 
slicemap (specval(BA), low,medLOW, MED, medHIGH, HIGH, BAx, BAz, Y); 
Lax=[1725,1879,1981]; 
Laz=[515 , 492, 636]; 
slicemap (specval(La), low,medLOW, MED, medHIGH, HIGH, Lax, Laz, Y); 
VSx=[1655,1623,1658,1713]; 
VSz=[ 459, 498, 525, 506]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1658,1713,1950,1942,1913]; 
CA1Vz=[ 525, 506, 608, 731, 746]; 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH, CA1Vx, CA1Vz, 
Y); 
CA2x=[1939,1899,1960,1985,1983,1931]; 
CA2z=[ 706, 670, 618, 678, 698, 703]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
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CA3Vx=[1931,1983,1961,1933,1844,1737,1631,1658,1824,1913,1942]; 
CA3Vz=[ 703, 698, 780, 804, 736, 686, 574, 525, 652, 746, 731]; 
slicemap (specval(CA3V), low,medLOW, MED, medHIGH, HIGH, CA3Vx, CA3Vz, 
Y); 
DGvx=[1631,1658,1623,1571]; 
DGvz=[ 574, 525, 498, 486]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
LGx=[1693,1774,1815,1783,1717,1749,1754,1710,1681,1695]; 
LGz=[1058,1009, 902, 800, 792, 829, 875, 938,1003,1057]; 
slicemap (specval(LG), low,medLOW, MED, medHIGH, HIGH, LGx, LGz, Y); 
ZIRx=[1524,1663,1786,1765,1688,1650,1540]; 
ZIRz=[ 617, 765, 796, 766, 715, 664, 581]; 
slicemap (specval(ZIR), low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, 
Y); 
SThx=[1537,1650,1625,1548]; 
SThz=[ 570, 657, 603, 516]; 
slicemap (specval(STh), low,medLOW, MED, medHIGH, HIGH, SThx, SThz, 
Y); 
PRx=[1545,1477,1446,1402]; 
PRz=[ 606, 695, 697, 647]; 
slicemap (specval(PR), low,medLOW, MED, medHIGH, HIGH, PRx, PRz, Y); 
VPMx=[1531,1663,1688,1675,1647,1610,1546,1477]; 
VPMz=[ 632, 765, 873, 947, 935, 832, 752, 700]; 
slicemap (specval(VPM), low,medLOW, MED, medHIGH, HIGH, VPMx, VPMz, 
Y); 
VPLx=[1686,1688,1660,1730,1723,1675]; 
VPLz=[ 939, 873,775 , 856, 897, 947]; 
slicemap (specval(VPL), low,medLOW, MED, medHIGH, HIGH, VPLx, VPLz, 
Y); 
LPx=[1683,1695,1586,1535,1475,1435,1404,1435,1547]; 
LPz=[ 973,1057,1065,1070,1049,1044, 959, 937, 973]; 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1435,1496,1489,1446,1477,1555,1610,1684,1683,1576,1532]; 
Poz=[ 937, 845, 762, 697, 700, 758, 832, 939, 973, 975, 972]; 
slicemap (specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
PFx=[1339,1346,1320,1343,1402,1489,1496,1435,1404]; 
PFz=[ 948,811 , 726, 683, 647, 762, 845, 937, 959]; 
slicemap (specval(PF), low,medLOW, MED, medHIGH, HIGH, PFx, PFz, Y); 
Hbx=[1306,1341,1404,1446,1435,1337,1311,1297]; 
Hbz=[ 956, 950, 959,1000,1044,1037,1004, 944]; 
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slicemap (specval(Hb), low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
PAGx=[1295,1305,1339,1346,1320,1295]; 
PAGz=[ 937, 961, 948, 811,726 , 726]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
PHDx=[1320,1343,1353,1345,1295,1295]; 
PHDz=[ 726, 683, 593, 552, 552, 728]; 
slicemap (specval(PHD), low,medLOW, MED, medHIGH, HIGH, PHDx, PHDz, 
Y); 
LHx=[1343,1353,1345,1451,1524,1571,1532,1545,1343]; 
LHz=[ 683, 593, 552, 538, 473, 486, 533, 606, 683]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
SUMx=[1295,1348,1451,1524,1457,1378,1295]; 
72 
SUMz=[ 558, 558,538 , 473, 438, 491, 505]; 
slicemap (specval(SUM), low,medLOW, MED, medHIGH, HIGH, SUMx, SUMz, 
Y); 
MMx=[1457,1378,1295,1295,1395]; 
MMz=[ 438, 491, 505, 414, 408]; 
slicemap (specval(MM), low,medLOW, MED, medHIGH, HIGH, MMx, MMz, Y); 
NLx=[1295,1395,1295]; 
NLz=[ 414, 408, 373]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
ALx=[1395,1295,1405]; 
ALz=[ 408, 373, 380]; 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
CA1Dx=[1295,1295,1411,1480,1706,1866,1544,1454,1295]; 
CA1Dz=[1125,1165,1166,1245,1234,1107,1078,1045,1045]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
Vx=[1548,1460,1347,1311,1295,1295,1348,1398,1482,1539]; 
Vz=[1076,1046,1041,1004, 939,1125,1077,1062,1095,1085]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
DGdx=[1533,1551,1635,1818,1814,1657,1586]; 
DGdz=[1084,1140,1177,1094,1048,1066,1065]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
CA2x=[1818,1866,1898,1816]; 
CA2z=[1094,1107,1063,1048]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
CA3Dx=[1898,1816,1761,1647,1618,1665,1657,1850,1890,1938,1926,1901]; 
CA3Dz=[1063,1048,1096,1139,1112,1086,1066, 958, 898, 924,1005,1063]; 
slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice40 next 3 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 40; Y=Slicenum*3; 
PFx=[1430,1411,1401,1482,1535,1491,1450,1448]; 
PFz=[ 684, 712, 892, 872, 905, 797, 739, 696]; 
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slicemap (specval(PF), low,medLOW, MED, medHIGH, HIGH, PFx, PFz, Y); 
%QCcolor(PFx,PFz,40*3) 
l=40; 
%%Slicefeed(l); 
WMx=[1295,1430,1481,1525,1681,1774,1894,1948,1977,2013,1994,1952,1815,1563,12
95]; 
WMz=[1221,1351,1344,1319,1294,1249,1149,1074,1000, 711, 630, 571, 
507,483 , 483]; 
73 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
RSCx=[1295,1403,1510,1479,1441,1412,1295]; 
RSCz=[1434,1495,1483,1342,1356,1276,1221]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1510,1479,1718,1769]; 
V2z=[1483,1342,1279,1414]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Ptx=[1718,1769,1913,1835]; 
Ptz=[1279,1414,1313,1204]; 
slicemap (specval(Pt), low,medLOW, MED, medHIGH, HIGH, Ptx, Ptz, Y); 
S1BFx=[1913,1835,1948,2070]; 
S1BFz=[1313,1204,1074,1183]; 
slicemap (specval(S1BF), low,medLOW, MED, medHIGH, HIGH, S1BFx, S1BFz, 
Y); 
Aux=[1948,2070,2171,2185,2014,2010,1977]; 
Auz=[1074,1183,1003, 776,772 , 849,1000]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
PRhx=[2185,2014,1981,2130]; 
PRhz=[ 776,772 , 606, 568]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[1981,2130,2121,1952]; 
Entz=[ 606, 568, 523, 571]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[2121,1952,1810,1866,1961,2059]; 
PIRCz=[ 523, 571, 494, 429, 414, 374]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
Cox=[1866,1815,1668,1700,1814]; 
Coz=[ 437, 507, 475, 442, 404]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
VSx=[1724,1678,1644,1688]; 
VSz=[ 491, 543, 502, 475]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1724,1678,1859,1871,1881,1930,1986,1950,1810]; 
CA1Vz=[ 491, 543, 651, 706, 753, 753, 666, 570, 494]; 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH, CA1Vx, CA1Vz, 
Y); 
CA2x=[1932,1925,1986,1981]; 
CA2z=[ 729, 671, 699, 723]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
CA3Vx=[1626,1797,1837,1983,1962,1909,1810]; 
CA3Vz=[564 , 647, 730, 724, 786, 809,773 ]; 
slicemap (specval(CA3V), low,medLOW, MED, medHIGH, HIGH, CA3Vx, CA3Vz, 
Y); 
DGvx=[1626,1797,1837,1895,1898,1859,1830,1678,1644,1571]; 
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DGvz=[564 , 647, 730, 746, 745, 651, 615, 543, 502, 488]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
DGdx=[1546,1566,1630,1784,1862,1901,1887]; 
DGdz=[1080,1142,1176,1132,1063, 995, 962]; 
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slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
CA3Dx=[1665,1632,1660,1788,1887,1899,1945,1969,1956,1921,1878,1834,1825,1787]
; 
CA3Dz=[1062,1111,1138,1088, 962, 995, 992, 933, 846, 824, 882, 922, 
961,1003]; 
slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
CA2x=[1857,1901,1945,1906]; 
Ca2z=[1067, 995, 992,1066]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
CA1Dx=[1857,1906,1769,1576,1525,1471,1295,1295,1348,1398,1542,1549,1630,1784]
; 
CA1Dz=[1067,1066,1207,1268,1247,1188,1166,1300,1077,1062,1073,1112,1176,1132]
; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
Vx=[1295,1322,1379,1454,1527,1482,1398,1348,1295]; 
Vz=[ 937,1023,1047,1045,1070,1095,1062,1077,1166]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
Hbx=[1306,1328,1368,1398,1353,]; 
Hbz=[ 965,1030,1046,1023, 966,]; 
slicemap (specval(Hb), low,medLOW, MED, medHIGH, HIGH, Hbx, Hbz, Y); 
APTx=[1326,1405,1482,1550,1546,1496,1412,1383,1353]; 
APTz=[ 964, 884, 872, 943, 977,1055,1050,1000, 966]; 
slicemap (specval(APT), low,medLOW, MED, medHIGH, HIGH, APTx, APTz, 
Y); 
LPx=[1496,1544,1682,1665,1586,1542]; 
LPz=[1055, 969, 973,1062,1065,1073]; 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
LGx=[1665,1682,1778,1790,1735,1808,1841,1825,1745]; 
LGz=[1062, 973, 935, 821, 774, 791, 904, 961,1035]; 
slicemap (specval(LG), low,medLOW, MED, medHIGH, HIGH, LGx, LGz, Y); 
ZIRx=[1547,1543,1583,1735,1805,1759,1651,1561]; 
ZIRz=[ 637, 678, 715, 774, 787, 717, 670, 645]; 
slicemap (specval(ZIR), low,medLOW, MED, medHIGH, HIGH, ZIRx, ZIRz, 
Y); 
VPLx=[1750,1720,1782,1776]; 
VPLz=[ 941, 776, 862,905 ]; 
slicemap (specval(VPL), low,medLOW, MED, medHIGH, HIGH, VPLx, VPLz, 
Y); 
VPMx=[1750,1720,1543,1522,1600,1718]; 
VPMz=[ 941, 776, 678, 718, 766, 952]; 
slicemap (specval(VPM), low,medLOW, MED, medHIGH, HIGH, VPMx, VPMz, 
Y); 
Pox=[1718,1597,1532,1448,1544,1682]; 
Poz=[952 , 767, 720, 696, 969, 973]; 
slicemap (specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
PRx=[1548,1522,1430,1418]; 
PRz=[ 652, 718, 684, 629]; 
slicemap (specval(PR), low,medLOW, MED, medHIGH, HIGH, PRx, PRz, Y); 
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PFx=[1418,1405,1527]; 
PFz=[ 629, 878, 883]; 
slicemap (specval(PF), low,medLOW, MED, medHIGH, HIGH, PFx, PFz, Y); 
PAGx=[1295,1405,1411,1387,1381,1358,1295]; 
PAGz=[941 , 887, 716, 656, 699, 725, 725]; 
75 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
PHDx=[1387,1381,1358,1295,1295,1337,1367]; 
PHDz=[ 656, 699, 725, 725, 589, 589, 571]; 
slicemap (specval(PHD), low,medLOW, MED, medHIGH, HIGH, PHDx, PHDz, 
Y); 
SUMx=[1295,1337,1426,1442,1388,1316,1295]; 
SUMz=[589 , 589, 527, 471, 523, 538, 538]; 
slicemap (specval(SUM), low,medLOW, MED, medHIGH, HIGH, SUMx, SUMz, 
Y); 
MMx=[1295,1315,1388,1431,1393,1368,1295]; 
MMz=[ 538, 538, 523, 483, 481,452 , 452]; 
slicemap (specval(MM), low,medLOW, MED, medHIGH, HIGH, MMx, MMz, Y); 
NLx=[1295,1368,1388,1295]; 
NLz=[ 452, 452, 434, 390]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
ALx=[1388,1295,1295,1449,1494,1494,1463]; 
ALz=[ 434, 390, 351, 322, 341, 391, 422]; 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
LHx=[1367,1387,1439,1554,1484,1503,1442,1426]; 
LHz=[ 571,656 , 620, 625, 568, 466, 471, 527]; 
slicemap (specval(LH), low,medLOW, MED, medHIGH, HIGH, LHx, LHz, Y); 
SNCx=[1486,1504,1594,1529,1484]; 
SNCz=[ 511, 563, 655, 621, 568]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
SNRx=[1486,1504,1594,1631,1618,1559,1563,1503]; 
SNRz=[ 511, 563, 655, 661, 592, 524, 484, 466]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice41 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 41; 
CA2x=[2002,1912,1909,1989]; 
CA2z=[ 812, 806, 885, 894]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
%QCcolor(CA2x,CA2z,41*3) 
l=41; 
RSCx=[1105,1110,1179,1232,1258,1295,1295,1239]; 
RSCz=[1490,1343,1201,1169,1194,1194,1433,1477]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1492,1479,1521,1649,1717,1769]; 
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V2z=[1484,1342,1320,1303,1279,1414]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1717,1769,1897,1826]; 
V1z=[1279,1414,1356,1213]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
Ptx=[1897,1826,1922,2061]; 
Ptz=[1356,1213,1126,1216]; 
slicemap (specval(Pt), low,medLOW, MED, medHIGH, HIGH, Ptx, Ptz, Y); 
Aux=[1922,2061,2146,2190,2190,2040,2018,1988]; 
Auz=[1126,1216,1084, 888, 789, 783, 894,1003]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
Tex=[2190,2040,2022,2179]; 
Tez=[ 789, 783, 737, 741]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
PRhx=[2022,2179,2135,1991]; 
PRhz=[ 737, 741, 587, 626]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2135,1991,1924,2099]; 
Entz=[ 587, 626, 550, 442]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[1924,2099,2057,1904,1845]; 
PIRCz=[ 550, 442, 405, 453, 503]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
Cox=[1904,1845,1668,1737]; 
Coz=[ 453, 503, 475, 434]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
VSx=[1845,1751,1678,1640,1668,1696]; 
VSz=[ 503, 573, 543, 498, 475, 490]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1845,1751,1884,1912,2001,2004,1975,1924]; 
CA1Vz=[ 503, 573, 668, 806, 818, 705, 616, 550]; 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH, CA1Vx, CA1Vz, 
Y); 
CA2x=[1914,2001,1989,1909]; 
CA2z=[ 805, 818, 894, 887]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
CA1Dx=[1989,1909,1879,1771,1635,1573,1553,1415,1370,1359,1437,1498,1534,1531,
1583,1704,1786,1957]; 
CA1Dz=[ 894, 
887,1003,1122,1165,1139,1093,1091,1112,1143,1122,1125,1171,1227,1261,1236,119
7,1004]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
DSx=[1359,1437,1498,1534,1531,1472,1407]; 
DSz=[1154,1122,1125,1171,1227,1179,1201]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
DGdx=[1550,1663,1791,1807,1867,1909,1899,1837,1771,1635,1573]; 
DGdz=[1092,1054, 919, 837, 829, 829, 955,1064,1122,1165,1139]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
CA3Dx=[1662,1791,1807,1867,1861,1818,1743,1640,1636]; 
CA3Dz=[1054, 919, 837, 829, 912,1003,1083,1125,1099]; 
77 
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slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
CA3Vx=[1807,1873,1829,1770,1696,1625,1643]; 
CA3Vz=[ 837, 833, 730, 646, 580, 558, 599]; 
slicemap (specval(CA3V), low,medLOW, MED, medHIGH, HIGH, CA3Vx, CA3Vz, 
Y); 
DGvx=[1640,1884,1907,1909,1867,1770,1696,1613]; 
DGvz=[ 500,668 , 715, 829, 829, 646, 580, 537]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
WMx=[1437,1391,1407,1472,1583,1704,1861,]; 
WMz=[1330,1226,1201,1179,1261,1236,1139,]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
mRtx=[1295,1401,1439,1465,1480,1566,1653,1647,1295]; 
mRtz=[1060,1059,1038,1000, 903, 839, 730, 662, 551]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
PAGx=[1295,1327,1404,1394,1338,1312,1295]; 
PAGz=[ 996,1011, 961, 859, 736, 640, 564]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
RLix=[1295,1321,1338,1320,1308,1295]; 
RLiz=[ 757, 755, 736, 651, 551, 551]; 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLix, RLiz, 
Y); 
VTAx=[1320,1308,1387,1420,1362]; 
VTAz=[ 651, 551, 498, 594, 644]; 
slicemap (specval(VTA), low,medLOW, MED, medHIGH, HIGH, VTAx, VTAz, 
Y); 
PRx=[1423,1471,1484,1458,1422,1381,1369,1384]; 
PRz=[ 810, 788, 749, 703, 697, 718, 747, 793]; 
slicemap (specval(PR), low,medLOW, MED, medHIGH, HIGH, PRx, PRz, Y); 
SNCx=[1411,1624,1566,1420,1396]; 
SNCz=[ 536, 657, 671, 594, 552]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
NLx=[1200,1213,1291,1372,1391]; 
NLz=[ 460, 432, 403, 431, 462]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
ALx=[1295,1295,1408,1497,1528,1536,1513,1387,1372]; 
ALz=[ 403, 352, 323, 340, 383, 433, 459, 460, 431]; 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
SNRx=[1401,1405,1485,1592,1624,1526]; 
SNRz=[ 524, 485, 495, 542, 657, 627]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
Vx=[1295,1352,1354,1329,1295]; 
Vz=[1104,1139,1170,1194,1194]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
MPTx=[1295,1352,1370,1415,1401,1350,1295]; 
MPTz=[1104,1139,1112,1091,1059,1049,1060]; 
slicemap (specval(MPT), low,medLOW, MED, medHIGH, HIGH, MPTx, MPTz, 
Y); 
78 
LGx=[1657,1649,1652,1681,1649,1661,1783,1807,1791,1657]; 
LGz=[1041,1003, 951, 903, 734, 679, 768, 837, 919,1041]; 
slicemap (specval(LG), low,medLOW, MED, medHIGH, HIGH, LGx, LGz, Y); 
MGx=[1653,1736,1749,1690,1625,1609,1628]; 
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MGz=[ 730, 809, 856, 907, 865, 801, 754]; 
slicemap (specval(MG), low,medLOW, MED, medHIGH, HIGH, MGx, MGz, Y); 
LPx=[1673,1634,1569,1550,1593,1657,1649,1652]; 
LPz=[ 922, 919, 962,1092,1084,1041,1003, 951]; 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1569,1562,1529,1566,1604,1609,1625,1690,1675,1634,1589]; 
Poz=[ 966, 902, 866, 839, 770, 801, 865, 907, 920, 919, 940]; 
slicemap (specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
APTx=[1550,1571,1569,1562,1529,1480,1465,1401,1415]; 
APTz=[1092,1003, 963, 902, 866, 903,1000,1059,1091]; 
slicemap (specval(APT), low,medLOW, MED, medHIGH, HIGH, APTx, APTz, 
Y); 
%%Sl=[];icefeed(l); 
%l = 1;; %enter whatever slice you want 
hold all; 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice42 
if Slicenum == 42; 
MGx=[1631,1664,1665,1697,1772,1794,1748,1691,1625,1609]; 
MGz=[ 754, 714, 677, 718, 775, 829, 892, 903, 865, 801]; 
%QCcolor(MGx,MGz,42*3) 
l=42; 
RSCx=[1295,1311,1467,1455,1424,1482,1442,1378,1328,1295]; 
RSCz=[1424,1450,1488,1365,1334,1189,1109,1143,1223,1219]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1468,1455,1522,1658,1710]; 
V2z=[1489,1365,1328,1299,1433]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V2x=[1926,1839,1928,2056]; 
V2z=[1335,1217,1139,1214]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1658,1710,1926,1839,1764]; 
V1z=[1299,1433,1335,1217,1266]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
Aux=[1928,2056,2129,2170,2194,2042,2001]; 
Auz=[1139,1214,1118,1003, 797, 805,1000]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
Tex=[2035,2194,2182,2030]; 
Tez=[ 804, 797, 737, 739]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
79 
PRhx=[2182,2030,2002,2140]; 
PRhz=[ 737, 739, 642, 607]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2002,2140,2104,1930]; 
Entz=[ 642, 607, 470, 554]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[2104,1930,1842,1897,2049]; 
PIRCz=[ 470, 554,514 ,482 , 425]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
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Y); 
Cox=[1842,1897,1715,1687]; 
Coz=[514 ,482 , 440, 478]; 
slicemap (specval(Co), low,medLOW, MED, medHIGH, HIGH, Cox, Coz, Y); 
VSx=[1687,1662,1746,1830]; 
VSz=[ 478, 527, 570, 516]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1746,1830,1954,2005,2006,1914,1913,1889]; 
CA1Vz=[ 570, 516,568 , 670, 835, 824, 729, 668]; 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH, CA1Vx, CA1Vz, 
Y); 
CA2x=[1914,2006,1984,1912]; 
CA2z=[ 824, 835, 919, 913]; 
slicemap (specval(CA2), low,medLOW, MED, medHIGH, HIGH, CA2x, CA2z, 
Y); 
CA1Dx=[1984,1912,1814,1748,1699,1650,1579,1567,1756,1930,1973]; 
CA1Dz=[ 919, 913,1096,1145,1166,1170,1145,1217,1225,1085,1003]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
DSx=[1570,1579,1566,1506,1477,1452]; 
DSz=[1090,1145,1215,1185,1193,1108]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
DGdx=[1570,1692,1864,1919,1912,1814,1699,1650,1579]; 
DGdz=[1090,1031, 836, 825, 916,1096,1166,1170,1145]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
CA3Dx=[1692,1693,1663,1689,1820,1861,1856,1806,1791]; 
CA3Dz=[1031,1062,1116,1128,1003, 874, 832, 837,919 ]; 
slicemap (specval(CA3D), low,medLOW, MED, medHIGH, HIGH, CA3Dx, CA3Dz, 
Y); 
DGvx=[1659,1684,1889,1913,1914,1864,1841,1768,1722]; 
DGvz=[ 609, 551, 668, 729, 824, 836, 771, 666,630,]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
CA3Vx=[1864,1841,1768,1722,1659]; 
CA3Vz=[ 836, 771, 666, 630, 609]; 
slicemap (specval(CA3V), low,medLOW, MED, medHIGH, HIGH, CA3Vx, CA3Vz, 
Y); 
LGx=[1678,1791,1794,1748,1691,1660]; 
LGz=[1026, 919, 829, 892, 903, 948]; 
slicemap (specval(LG), low,medLOW, MED, medHIGH, HIGH, LGx, LGz, Y); 
LPx=[1551,1678,1674,1645,1569]; 
LPz=[1091,1026, 924, 917, 967]; 
80 
slicemap (specval(LP), low,medLOW, MED, medHIGH, HIGH, LPx, LPz, Y); 
Pox=[1569,1693,1625,1609,1629,1529]; 
Poz=[ 963, 903, 865, 801, 754, 866]; 
slicemap (specval(Po), low,medLOW, MED, medHIGH, HIGH, Pox, Poz, Y); 
MGx=[1625,1609,1629,1665,1772,1807,1748]; 
MGz=[ 865, 801, 754, 677, 775, 865, 892]; 
slicemap (specval(MG), low,medLOW, MED, medHIGH, HIGH, MGx, MGz, Y); 
APTx=[1529,1571,1571,1551,1442,1437,1401,1439,1465,1480]; 
APTz=[ 866, 924,1003,1091,1109,1079,1058,1038,1000, 903]; 
slicemap (specval(APT), low,medLOW, MED, medHIGH, HIGH, APTx, APTz, 
Y); 
MPTx=[1295,1364,1420,1437,1401,1350,1295]; 
MPTz=[1127,1167,1116,1079,1058,1049,1060]; 
slicemap (specval(MPT), low,medLOW, MED, medHIGH, HIGH, MPTx, MPTz, 
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Y); 
Vx=[1295,1362,1328,1295]; 
Vz=[1124,1171,1223,1223]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
mRtx=[1350,1295,1295,1654,1664,1604,1566,1480,1465,1439]; 
mRtz=[1049,1060, 619, 662, 714, 770, 839, 903,1000,1038]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
RPx=[1418,1450,1470,1445,1411,1370,1377,1410]; 
RPz=[ 762, 753, 712, 671, 669, 703, 741, 765]; 
slicemap (specval(RP), low,medLOW, MED, medHIGH, HIGH, RPx, RPz, Y); 
PAGx=[1299,1354,1401,1423,1425,1370,1352,1311,1295]; 
PAGz=[1014,1003, 969, 936, 899, 804, 728, 757, 757]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
RLix=[1352,1311,1295,1295,1322,1335]; 
RLiz=[ 728, 757, 757, 500, 500, 619]; 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLix, RLiz, 
Y); 
VTAx=[1322,1335,1394,1416,1400,1389]; 
VTAz=[ 500, 619, 620, 592, 526, 499]; 
slicemap (specval(VTA), low,medLOW, MED, medHIGH, HIGH, VTAx, VTAz, 
Y); 
SNCx=[1400,1469,1622,1558,1486,1416]; 
SNCz=[ 526, 589, 658, 673, 652, 592]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
SNRx=[1389, 1469,1625,1654,1577]; 
SNRz=[499 , 589, 657, 662, 495]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
NLx=[1295,1337,1386,1373,1295]; 
NLz=[ 462, 475, 472, 436, 403]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
ALx=[1386,1373,1295,1295,1435,1523,1542,1528]; 
ALz=[ 472, 436, 403, 352, 327, 367, 409, 453]; 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
81 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 43 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 43; 
PAGx=[1235,1339,1390,1424,1434,1416,1334,1326,1293]; 
PAGz=[1034,1037,1024, 996, 930, 875, 813, 748, 756]; 
%QCcolor(PAGx,PAGz,3*44) 
l=43; 
RSCx=[1404,1463,1437,1507,1561,1529,1406,1341,1308,1308,1332]; 
RSCz=[1478,1348,1313,1237,1216,1140,1179,1237,1330,1418,1450]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
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V1x=[1627,1568,1620,1738,1826,1929]; 
V1z=[1447,1312,1282,1245,1188,1318]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1627,1568,1525,1462,1417]; 
V2z=[1447,1312,1339,1346,1478]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V2x=[1929,1826,1941,2073]; 
V2z=[1318,1188,1079,1164]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Aux=[1941,2073,2172,2022]; 
Auz=[1079,1164, 918, 901]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
Tex=[2172,2022,2032,2180]; 
Tez=[ 918, 901, 820, 826]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
PRhx=[2032,2180,2181,2141,2019,2033]; 
PRhz=[ 820, 826, 764, 687, 718, 788]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2141,2019,1965,2046,2095,2119]; 
Entz=[ 687, 718, 613, 505, 522, 590]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[2046,1965,1813,1785]; 
PIRCz=[ 505, 613, 542, 500]; 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
VSx=[1785,1970,2014,2009,1894,1892,1803,1758,1716,1665,1734]; 
VSz=[ 500, 624, 744, 862, 864, 806, 716, 712, 731, 618, 501]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1894,2007,2013,1892]; 
CA1Vz=[ 864, 859, 739, 806]; 
82 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH,CA1Vx, CA1Vz, 
Y); 
DSx=[1800,1691,1611,1534,1561,1686,]; 
DSz=[1159,1011,1111,1141,1216,1210,]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
CA1Dx=[1894,2007,1956,1800,1739,1847,1893,1770]; 
CA1Dz=[ 864, 859,1000,1159,1079,1003, 911,1180]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
DGdx=[1691,1698,1749,1847,1893,1894,1742]; 
DGdz=[1011,1058,1077,1003, 911, 864, 869]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
DGvx=[1742,1894,1892,1803,1758,1716,1746]; 
DGvz=[ 869, 864, 806, 716, 712, 731, 813]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
MGx=[1674,1650,1647,1696,1701]; 
MGz=[ 936, 903, 825, 791, 892]; 
slicemap (specval(MG), low,medLOW, MED, medHIGH, HIGH, MGx, MGz, Y); 
Sux=[1436,1504,1565,1652,1677,1642,1406,1341,1324,1295,1295,1339,1390,1424]; 
Suz=[ 930, 877, 872, 909, 936,1088,1179,1237,1211,1211,1037,1037,1024, 
996]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
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mRtx=[1436,1504,1565,1652,1647,1670,1695,1670,1616,1423,1369,1324,1337,1334,1
416]; 
mRtz=[ 930, 877, 872, 909, 825, 796, 790, 725, 735, 590, 650, 652, 
688, 813, 875]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
SNRx=[1668,1626,1460,1397,1452,1554,1638]; 
SNRz=[ 711, 619, 493, 491, 583, 678, 714]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
VTAx=[1295,1365,1388,1421,1410,1369,1324]; 
VTAz=[ 632, 573, 534, 582, 617, 650, 652]; 
slicemap (specval(VTA), low,medLOW, MED, medHIGH, HIGH, VTAx, VTAz, 
Y); 
SNCx=[1388,1426,1546,1616,1670,1668,1638,1554,1452,1400]; 
SNCz=[ 534, 590, 699, 735, 725, 711, 714, 678, 583, 497]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
IPx=[1295,1365,1388,1401,1295]; 
IPz=[ 632, 573, 534, 500, 500]; 
slicemap (specval(IP), low,medLOW, MED, medHIGH, HIGH, IPx, IPz, Y); 
RLix=[1295,1324,1337,1331,1306,1295]; 
RLiz=[ 632, 652, 688, 736, 756, 756]; 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLix, RLiz, 
Y); 
PAGx=[1306,1295,1295,1339,1390,1424,1434,1416,1334]; 
PAGz=[ 756, 756,1037,1037,1024, 996, 930, 875, 813]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
ALx=[1385,1371,1295,1295,1519,1546,1527,1498]; 
ALz=[ 449, 418, 390, 352,353 , 433, 471, 480]; 
83 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
NLx=[1385,1371,1295,1295,1325]; 
NLz=[ 449, 418, 390, 451, 439]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 44 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 44; 
PAGx=[1235,1339,1390,1424,1434,1416,1334,1326,1293]; 
PAGz=[1034,1037,1024, 996, 930, 875, 813, 748, 756]; 
%QCcolor(PAGx,PAGz,3*44) 
l=44; 
RSCx=[1404,1463,1437,1507,1561,1529,1406,1341,1308,1308,1332]; 
RSCz=[1478,1348,1313,1237,1216,1140,1179,1237,1330,1418,1450]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V1x=[1627,1568,1620,1738,1826,1929]; 
V1z=[1447,1312,1282,1245,1188,1318]; 
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slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1627,1568,1525,1462,1417]; 
V2z=[1447,1312,1339,1346,1478]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V2x=[1929,1826,1941,2073]; 
V2z=[1318,1188,1079,1164]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Aux=[1941,2073,2172,2022]; 
Auz=[1079,1164, 918, 901]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
Tex=[2172,2022,2032,2180]; 
Tez=[ 918, 901, 820, 826]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
PRhx=[2032,2180,2181,2141,2019,2033]; 
PRhz=[ 820, 826, 764, 687, 718, 788]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2141,2019,1965,2046,2095,2119]; 
Entz=[ 687, 718, 613, 505, 522, 590]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
PIRCx=[2046,1965,1813,1785]; 
PIRCz=[ 505, 613, 542, 500]; 
84 
slicemap (specval(PIRC), low,medLOW, MED, medHIGH, HIGH, PIRCx, PIRCz, 
Y); 
VSx=[1785,1970,2014,2009,1894,1892,1803,1758,1716,1665,1734]; 
VSz=[ 500, 624, 744, 862, 864, 806, 716, 712, 731, 618, 501]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
CA1Vx=[1894,2007,2013,1892]; 
CA1Vz=[ 864, 859, 739, 806]; 
slicemap (specval(CA1V), low,medLOW, MED, medHIGH, HIGH,CA1Vx, CA1Vz, 
Y); 
DSx=[1800,1691,1611,1534,1561,1686,]; 
DSz=[1159,1011,1111,1141,1216,1210,]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
CA1Dx=[1894,2007,1956,1800,1739,1847,1893,1770]; 
CA1Dz=[ 864, 859,1000,1159,1079,1003, 911,1180]; 
slicemap (specval(CA1D), low,medLOW, MED, medHIGH, HIGH, CA1Dx, CA1Dz, 
Y); 
DGdx=[1691,1698,1749,1847,1893,1894,1742]; 
DGdz=[1011,1058,1077,1003, 911, 864, 869]; 
slicemap (specval(DGd), low,medLOW, MED, medHIGH, HIGH, DGdx, DGdz, 
Y); 
DGvx=[1742,1894,1892,1803,1758,1716,1746]; 
DGvz=[ 869, 864, 806, 716, 712, 731, 813]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
MGx=[1674,1650,1647,1696,1701]; 
MGz=[ 936, 903, 825, 791, 892]; 
slicemap (specval(MG), low,medLOW, MED, medHIGH, HIGH, MGx, MGz, Y); 
Sux=[1436,1504,1565,1652,1677,1642,1406,1341,1324,1295,1295,1339,1390,1424]; 
Suz=[ 930, 877, 872, 909, 936,1088,1179,1237,1211,1211,1037,1037,1024, 
996]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
mRtx=[1436,1504,1565,1652,1647,1670,1695,1670,1616,1423,1369,1324,1337,1334,1
416]; 
mRtz=[ 930, 877, 872, 909, 825, 796, 790, 725, 735, 590, 650, 652, 
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688, 813, 875]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
SNRx=[1668,1626,1460,1397,1452,1554,1638]; 
SNRz=[ 711, 619, 493, 491, 583, 678, 714]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
VTAx=[1295,1365,1388,1421,1410,1369,1324]; 
VTAz=[ 632, 573, 534, 582, 617, 650, 652]; 
slicemap (specval(VTA), low,medLOW, MED, medHIGH, HIGH, VTAx, VTAz, 
Y); 
SNCx=[1388,1426,1546,1616,1670,1668,1638,1554,1452,1400]; 
SNCz=[ 534, 590, 699, 735, 725, 711, 714, 678, 583, 497]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
IPx=[1295,1365,1388,1401,1295]; 
IPz=[ 632, 573, 534, 500, 500]; 
slicemap (specval(IP), low,medLOW, MED, medHIGH, HIGH, IPx, IPz, Y); 
RLix=[1295,1324,1337,1331,1306,1295]; 
RLiz=[ 632, 652, 688, 736, 756, 756]; 
85 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLix, RLiz, 
Y); 
PAGx=[1306,1295,1295,1339,1390,1424,1434,1416,1334]; 
PAGz=[ 756, 756,1037,1037,1024, 996, 930, 875, 813]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
ALx=[1385,1371,1295,1295,1519,1546,1527,1498]; 
ALz=[ 449, 418, 390, 352,353 , 433, 471, 480]; 
slicemap (specval(AL), low,medLOW, MED, medHIGH, HIGH, ALx, ALz, Y); 
NLx=[1385,1371,1295,1295,1325]; 
NLz=[ 449, 418, 390, 451, 439]; 
slicemap (specval(NL), low,medLOW, MED, medHIGH, HIGH, NLx, NLz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice45 
if Slicenum == 45; 
DGvx=[1731,1796,1858,1877,1860,1775,1729,1722,1741,1738]; 
DGvz=[ 815, 786, 817, 885, 956,1021, 997, 957, 902, 835]; 
%QCcolor (DGvx,DGvz,45*3) 
l=45; 
RSCx=[1555,1330,1338,1306,1311,1363,1472,1517]; 
RSCz=[1176,1251,1272,1356,1415,1453,1465,1326]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH,RSCx, RSCz, Y); 
V2x=[1472,1517,1572,1625]; 
V2z=[1465,1326,1315,1442]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1572,1625,1744,1876,1920,1819]; 
V1z=[1315,1442,1410,1347,1314,1179]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1920,1819,1940,2057]; 
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V2z=[1314,1179,1071,1186]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Aux=[1940,2057,2103,2141,2154,2019,1985]; 
Auz=[1071,1186,1104,1005, 915, 901,1003]; 
slicemap (specval(Au), low,medLOW, MED, medHIGH, HIGH, Aux, Auz, Y); 
Tex=[2154,2019,2029,2177]; 
Tez=[ 915, 901, 821, 821]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
PRhx=[2029,2177,2136,1987]; 
PRhz=[ 821, 821,686, 728]; 
slicemap (specval(PRh), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, 
Y); 
Entx=[2136,1987,1721,1678,1725,2093]; 
86 
Entz=[686, 728, 794, 664, 542, 575]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
VSx=[1731,1723,1781,1928,1978,2011,1968,1860,1877,1858,1796]; 
VSz=[ 815, 796, 728, 686, 722, 781, 976, 956, 885, 817, 786]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
DSx=[1722,1555,1574,1752,1844,1918,1966,1871]; 
DSz=[ 957,1176,1234,1176,1125,1059, 980, 956]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
DGvx=[1871,1877,1858,1796,1731,1741,1724,1753,1775]; 
DGvz=[ 956, 885, 817, 786, 815, 902, 959,1021,1021]; 
slicemap (specval(DGv), low,medLOW, MED, medHIGH, HIGH, DGvx, DGvz, 
Y); 
Sux=[1295,1330,1449,1555,1628,1710,1553,1440,1410,1350,1295]; 
Suz=[1222,1251,1231,1176,1094, 935, 864, 948,1003,1039,1039]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
mRtx=[1325,1333,1405,1440,1498,1553,1624,1710,1711,1674,1614,1545,1426,1359,1
311,1303,1336]; 
mRtz=[ 751, 811, 862, 948, 883, 864, 880, 935, 838, 732, 727, 692, 
594, 622, 620, 629, 675]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
RPx=[1449,1462,1456,1403,1389,1416]; 
RPz=[ 741, 710, 685, 674, 733, 752]; 
slicemap (specval(RP), low,medLOW, MED, medHIGH, HIGH, RPx, RPz, Y); 
SNCx=[1392,1426,1545,1614,1674,1655,1627,1555,1452,1404]; 
SNCz=[ 536, 594, 692, 727, 732, 711, 714, 680, 538, 507]; 
slicemap (specval(SNC), low,medLOW, MED, medHIGH, HIGH, SNCx, SNCz, 
Y); 
SNRx=[1655,1627,1555,1452,1404,1422,1496,1605]; 
SNRz=[ 711, 714, 680, 538, 507, 477, 509, 629]; 
slicemap (specval(SNR), low,medLOW, MED, medHIGH, HIGH, SNRx, SNRz, 
Y); 
VTAx=[1385,1428,1395,1359,1325]; 
VTAz=[ 532, 587, 617, 622, 605]; 
slicemap (specval(VTA), low,medLOW, MED, medHIGH, HIGH, VTAx, VTAz, 
Y); 
IPx=[1295,1325,1404,1315,1295]; 
IPz=[ 620, 605, 507,430 , 451]; 
slicemap (specval(IP), low,medLOW, MED, medHIGH, HIGH, IPx, IPz, Y); 
Pnx=[1315,1387,1491,1527,1527,1471,1359]; 
Pnz=[ 430, 495, 504, 443, 392, 355, 363]; 
slicemap (specval(Pn), low,medLOW, MED, medHIGH, HIGH, Pnx, Pnz, Y); 
RLix=[1295,1325,1336,1295]; 
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RLiz=[ 757, 751, 675, 620]; 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLix, RLiz, 
Y); 
PAGx=[1440,1410,1350,1295,1295,1325,1333,1405]; 
PAGz=[ 948,1003,1039,1039, 757, 751, 811, 862]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
87 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice46 next 3 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 46; 
ICx=[1565,1569,1636,1706,1711,1676,1612]; 
ICz=[ 798, 862, 886, 936, 874, 779, 763]; 
%QCcolor (ICx,ICz,46*3) 
l=46; 
RSCx=[1616,1592,1345,1313,1327,1475,1546]; 
RSCz=[1221,1156,1248,1320,1417,1461,1289]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1475,1546,1590,1642]; 
V2z=[1461,1289,1294,1427]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1590,1642,1746,1915,1808]; 
V1z=[1294,1427,1398,1302,1158]; 
slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1915,1808,1874,1989,2111]; 
V2z=[1302,1158,1110, 964,1025]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Tex=[2111,1989,2027,2158]; 
Tez=[1025, 964, 833, 837]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
PRhx=[2027,2158,2124,1998]; 
PRhz=[ 833, 837, 712, 737]; 
slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, PRhx, PRhz, Y); 
Entx=[2124,1998,1728,1686,1762,1979,2077]; 
Entz=[ 712, 737, 850, 689, 568, 553,605 ]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
VSx=[1729,1821,1867,1930,2003,2004,1962,1882,1731]; 
VSz=[ 853, 785, 679, 687, 745, 844, 955, 907, 912]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
DSx=[1962,1882,1731,1702,1592 ,1616,1885,1937]; 
DSz=[ 955, 907, 912, 999, 1156,1221,1060,1003]; 
slicemap (specval(DS), low,medLOW, MED, medHIGH, HIGH, DSx, DSz, Y); 
PAGx=[1295,1369,1419,1445,1428,1395,1341,1295]; 
PAGz=[1031,1046,1004, 887, 846, 825, 827, 861]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
DRx=[1341,1295,1295,1319,1320]; 
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DRz=[ 827, 861, 750, 750, 802]; 
slicemap (specval(DR), low,medLOW, MED, medHIGH, HIGH, DRx, DRz, Y); 
RLx=[1295,1319,1334,1332,1295]; 
RLz=[ 750, 750, 677, 626, 626]; 
slicemap (specval(RLi), low,medLOW, MED, medHIGH, HIGH, RLx, RLz, Y); 
88 
mRtx=[1341,1320,1334,1332,1352,1385,1430,1447,1493,1584,1676,1568,1470,1414]; 
mRtz=[ 827, 802, 677, 626, 556, 514, 535, 621, 654, 625, 779, 737, 
774, 831]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
PrCnx=[1414,1470,1568,1612,1569,1440]; 
PrCnz=[ 831, 774, 737, 763, 862, 939]; 
slicemap (specval(PrCn), low,medLOW, MED, medHIGH, HIGH, PrCnx, PrCnz, 
Y); 
ICx=[1569,1612,1676,1711,1708]; 
ICz=[ 862, 763, 779, 874, 932]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
MnRx=[1273,1332,1385,1390,1295]; 
MnRz=[ 634, 626, 514, 469, 469]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, MnRx, MnRz, 
Y); 
Pnx=[1295,1390,1588,1574,1468,1295]; 
Pnz=[469 , 469, 578, 383, 342, 365]; 
slicemap (specval(Pn), low,medLOW, MED, medHIGH, HIGH, Pnx, Pnz, Y); 
PTgx=[1430,1522,1587,1493,1447]; 
PTgz=[ 530, 556, 628, 654, 621]; 
slicemap (specval(PTg), low,medLOW, MED, medHIGH, HIGH, PTgx, PTgz, 
Y); 
fiveRx=[1588,1574,1634,1696,1686,1644]; 
fiveRz=[ 578, 383, 406, 509, 562, 578]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice47 star 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 47; 
DRx=[1295,1326,1340,1322,1291]; 
DRz=[ 861, 849, 828, 791,788]; 
%QCcolor (DRx,DRz,47*3) 
l=47; 
RSCx=[1343,1592, 1608,1754,1665,1559,1494,1358,1314,1301]; 
RSCz=[1415, 1265,1232,1135,1059,1190,1222,1260,1292,1359]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1343,1592,1611,1590,1443]; 
V2z=[1415,1265,1282,1434,1443]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1590,1611,1668,1823,1933,1761]; 
89 
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V1z=[1434,1282,1258,1126,1270,1376]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1823,1915,2038,1930]; 
V2z=[1126,1007,1070,1272]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Tex=[1915,2035,2103,2151,1982]; 
Tez=[1007,1072,1003, 859, 858]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
Entx=[2149,1981,1865,1808,1718,1709,1770,1872,1983,2078,2115,2175]; 
Entz=[ 860, 856, 900, 898, 937, 734, 637, 584, 580, 645, 733, 770]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
VSx=[1866,1808,1719,1702,1665,1735,1849]; 
VSz=[ 899, 898, 941,1003,1059,1147,1003]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
Sux=[1548,1466,1353,1317,1295,1295,1326,1374,1423,1437,1507,1560]; 
Suz=[1170,1220,1240,1217,1140,1031,1045,1045,1003, 957, 962,1077]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
ICx=[1548,1560,1507,1501,1519,1583,1689,1704,1685,1623]; 
ICz=[1170,1077, 962, 925, 873, 821, 806, 938,1003,1094]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
PrCnx=[1437,1436,1514,1583,1519,1501,1507]; 
PrCnz=[ 957, 862, 803, 821, 873, 925, 962]; 
slicemap (specval(PrCn), low,medLOW, MED, medHIGH, HIGH, PrCnx, PrCnz, 
Y); 
PAGx=[1437,1436,1406,1338,1295,1295,1326,1374,1423]; 
PAGz=[ 957, 862, 831, 820, 861,1031,1045,1045,1003]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
DRx=[1295,1322,1326,1295]; 
DRz=[ 788, 791, 849, 862]; 
slicemap (specval(DR), low,medLOW, MED, medHIGH, HIGH, DRx, DRz, Y); 
mRtx=[1322,1444,1478,1653,1689,1583,1433,1406,1338]; 
mRtz=[ 791, 758, 779, 695, 806, 821, 862, 831, 820]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
WMx=[1295,1322,1441,1413,1295]; 
WMz=[ 788, 791, 761, 745, 728]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WMx=[1653,1504,1456,1388,1407,1478,1639]; 
WMz=[ 695, 539, 502, 480, 425, 450, 625]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
PTgx=[1478,1644,1653,1581,1436]; 
PTgz=[ 779, 731, 702,612 , 740]; 
slicemap (specval(PTg), low,medLOW, MED, medHIGH, HIGH, PTgx, PTgz, 
Y); 
LLx=[1581,1436,1513]; 
LLz=[612 , 740, 541]; 
slicemap (specval(LL), low,medLOW, MED, medHIGH, HIGH, LLx, LLz, Y); 
PnOx=[1436,1513,1456,1388,1295]; 
PnOz=[ 740, 541, 502, 480, 728]; 
slicemap (specval(PnO), low,medLOW, MED, medHIGH, HIGH, PnOx, PnOz, 
Y); 
90 
MnRx=[1295,1295,1384,1388]; 
MnRz=[ 728, 436, 436, 480]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, MnRx, MnRz, 
Y); 
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Pnx=[1295,1384,1407,1478,1597,1562,1579,1515,1324,1295]; 
Pnz=[ 436, 436, 425, 450, 574, 440, 395, 350, 343, 356]; 
slicemap (specval(Pn), low,medLOW, MED, medHIGH, HIGH, Pnx, Pnz, Y); 
fiveRx=[1597,1562,1579,1673,1705,1687,1646]; 
fiveRz=[ 574, 440, 395, 463, 549, 578, 595]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice48 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 48; 
DRx=[1295,1326,1340,1322,1291]; 
DRz=[ 861, 849, 828, 791,788]; 
%QCcolor (DRx,DRz,47*3) 
l=48; 
Y=48*3; 
RSCx=[1343,1592, 1608,1754,1665,1559,1494,1358,1314,1301]; 
RSCz=[1415, 1265,1232,1135,1059,1190,1222,1260,1292,1359]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1343,1592,1611,1590,1443]; 
V2z=[1415,1265,1282,1434,1443]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1590,1611,1668,1823,1933,1761]; 
V1z=[1434,1282,1258,1126,1270,1376]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1823,1915,2038,1930]; 
V2z=[1126,1007,1070,1272]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Tex=[1915,2035,2103,2151,1982]; 
Tez=[1007,1072,1003, 859, 858]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
Entx=[2149,1981,1865,1808,1718,1709,1770,1872,1983,2078,2115,2175]; 
Entz=[ 860, 856, 900, 898, 937, 734, 637, 584, 580, 645, 733, 770]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
VSx=[1866,1808,1719,1702,1665,1735,1849]; 
VSz=[ 899, 898, 941,1003,1059,1147,1003]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
Sux=[1548,1466,1353,1317,1295,1295,1326,1374,1423,1437,1507,1560]; 
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Suz=[1170,1220,1240,1217,1140,1031,1045,1045,1003, 957, 962,1077]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
ICx=[1548,1560,1507,1501,1519,1583,1689,1704,1685,1623]; 
ICz=[1170,1077, 962, 925, 873, 821, 806, 938,1003,1094]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
PrCnx=[1437,1436,1514,1583,1519,1501,1507]; 
PrCnz=[ 957, 862, 803, 821, 873, 925, 962]; 
slicemap (specval(PrCn), low,medLOW, MED, medHIGH, HIGH, PrCnx, PrCnz, 
Y); 
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PAGx=[1437,1436,1406,1338,1295,1295,1326,1374,1423]; 
PAGz=[ 957, 862, 831, 820, 861,1031,1045,1045,1003]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
DRx=[1295,1322,1326,1295]; 
DRz=[ 788, 791, 849, 862]; 
slicemap (specval(DR), low,medLOW, MED, medHIGH, HIGH, DRx, DRz, Y); 
mRtx=[1322,1444,1478,1653,1689,1583,1433,1406,1338]; 
mRtz=[ 791, 758, 779, 695, 806, 821, 862, 831, 820]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
WMx=[1295,1322,1441,1413,1295]; 
WMz=[ 788, 791, 761, 745, 728]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WMx=[1653,1504,1456,1388,1407,1478,1639]; 
WMz=[ 695, 539, 502, 480, 425, 450, 625]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
PTgx=[1478,1644,1653,1581,1436]; 
PTgz=[ 779, 731, 702,612 , 740]; 
slicemap (specval(PTg), low,medLOW, MED, medHIGH, HIGH, PTgx, PTgz, 
Y); 
LLx=[1581,1436,1513]; 
LLz=[612 , 740, 541]; 
slicemap (specval(LL), low,medLOW, MED, medHIGH, HIGH, LLx, LLz, Y); 
PnOx=[1436,1513,1456,1388,1295]; 
PnOz=[ 740, 541, 502, 480, 728]; 
slicemap (specval(PnO), low,medLOW, MED, medHIGH, HIGH, PnOx, PnOz, 
Y); 
MnRx=[1295,1295,1384,1388]; 
MnRz=[ 728, 436, 436, 480]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, MnRx, MnRz, 
Y); 
Pnx=[1295,1384,1407,1478,1597,1562,1579,1515,1324,1295]; 
Pnz=[ 436, 436, 425, 450, 574, 440, 395, 350, 343, 356]; 
slicemap (specval(Pn), low,medLOW, MED, medHIGH, HIGH, Pnx, Pnz, Y); 
fiveRx=[1597,1562,1579,1673,1705,1687,1646]; 
fiveRz=[ 574, 440, 395, 463, 549, 578, 595]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
92 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice49 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 49; 
DRx=[1295,1326,1340,1322,1291]; 
DRz=[ 861, 849, 828, 791,788]; 
%QCcolor (DRx,DRz,47*3) 
l=49; 
Y=49*3; 
RSCx=[1343,1592, 1608,1754,1665,1559,1494,1358,1314,1301]; 
CONFIDENTIAL | 290 
 
RSCz=[1415, 1265,1232,1135,1059,1190,1222,1260,1292,1359]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
V2x=[1343,1592,1611,1590,1443]; 
V2z=[1415,1265,1282,1434,1443]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
V1x=[1590,1611,1668,1823,1933,1761]; 
V1z=[1434,1282,1258,1126,1270,1376]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1823,1915,2038,1930]; 
V2z=[1126,1007,1070,1272]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Tex=[1915,2035,2103,2151,1982]; 
Tez=[1007,1072,1003, 859, 858]; 
slicemap (specval(Te), low,medLOW, MED, medHIGH, HIGH, Tex, Tez, Y); 
Entx=[2149,1981,1865,1808,1718,1709,1770,1872,1983,2078,2115,2175]; 
Entz=[ 860, 856, 900, 898, 937, 734, 637, 584, 580, 645, 733, 770]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
VSx=[1866,1808,1719,1702,1665,1735,1849]; 
VSz=[ 899, 898, 941,1003,1059,1147,1003]; 
slicemap (specval(VS), low,medLOW, MED, medHIGH, HIGH, VSx, VSz, Y); 
Sux=[1548,1466,1353,1317,1295,1295,1326,1374,1423,1437,1507,1560]; 
Suz=[1170,1220,1240,1217,1140,1031,1045,1045,1003, 957, 962,1077]; 
slicemap (specval(Su), low,medLOW, MED, medHIGH, HIGH, Sux, Suz, Y); 
ICx=[1548,1560,1507,1501,1519,1583,1689,1704,1685,1623]; 
ICz=[1170,1077, 962, 925, 873, 821, 806, 938,1003,1094]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
PrCnx=[1437,1436,1514,1583,1519,1501,1507]; 
PrCnz=[ 957, 862, 803, 821, 873, 925, 962]; 
slicemap (specval(PrCn), low,medLOW, MED, medHIGH, HIGH, PrCnx, PrCnz, 
Y); 
PAGx=[1437,1436,1406,1338,1295,1295,1326,1374,1423]; 
PAGz=[ 957, 862, 831, 820, 861,1031,1045,1045,1003]; 
slicemap (specval(PAG), low,medLOW, MED, medHIGH, HIGH, PAGx, PAGz, 
Y); 
DRx=[1295,1322,1326,1295]; 
DRz=[ 788, 791, 849, 862]; 
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slicemap (specval(DR), low,medLOW, MED, medHIGH, HIGH, DRx, DRz, Y); 
mRtx=[1322,1444,1478,1653,1689,1583,1433,1406,1338]; 
mRtz=[ 791, 758, 779, 695, 806, 821, 862, 831, 820]; 
slicemap (specval(mRt), low,medLOW, MED, medHIGH, HIGH, mRtx, mRtz, 
Y); 
WMx=[1295,1322,1441,1413,1295]; 
WMz=[ 788, 791, 761, 745, 728]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
WMx=[1653,1504,1456,1388,1407,1478,1639]; 
WMz=[ 695, 539, 502, 480, 425, 450, 625]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
PTgx=[1478,1644,1653,1581,1436]; 
PTgz=[ 779, 731, 702,612 , 740]; 
slicemap (specval(PTg), low,medLOW, MED, medHIGH, HIGH, PTgx, PTgz, 
Y); 
LLx=[1581,1436,1513]; 
LLz=[612 , 740, 541]; 
slicemap (specval(LL), low,medLOW, MED, medHIGH, HIGH, LLx, LLz, Y); 
PnOx=[1436,1513,1456,1388,1295]; 
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PnOz=[ 740, 541, 502, 480, 728]; 
slicemap (specval(PnO), low,medLOW, MED, medHIGH, HIGH, PnOx, PnOz, 
Y); 
MnRx=[1295,1295,1384,1388]; 
MnRz=[ 728, 436, 436, 480]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, MnRx, MnRz, 
Y); 
Pnx=[1295,1384,1407,1478,1597,1562,1579,1515,1324,1295]; 
Pnz=[ 436, 436, 425, 450, 574, 440, 395, 350, 343, 356]; 
slicemap (specval(Pn), low,medLOW, MED, medHIGH, HIGH, Pnx, Pnz, Y); 
fiveRx=[1597,1562,1579,1673,1705,1687,1646]; 
fiveRz=[ 574, 440, 395, 463, 549, 578, 595]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Vx=[1295,1322,1343,1318,1295]; 
Vz=[1054,1038, 985, 898,873 ]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice50 star 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum ==50 ; 
Y = 50*3; 
Cbx =[1437,1295,1294,1385,1450,1503,1507]; 
Cbz =[991 , 991, 785, 785, 812, 886, 926]; 
94 
%QCcolor (Cbx,Cbz,50*3) 
V1x=[1470,1549,1643,1765,1705,1591,1490,1465]; 
V1z=[1376,1376,1359,1292,1174,1209,1261,1301]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1707,1766,1906,1837]; 
V2z=[1173,1291,1178,1092]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Ectx=[1906,1837,1957,2015]; 
Ectz=[1178,1092,1000,1003]; 
slicemap (specval(Ect), low,medLOW, MED, medHIGH, HIGH, Ectx, Ectz, 
Y); 
Entx=[1837,1957,2015,2039,2010,1884,1697,1648]; 
Entz=[1092,1000,1003, 853, 814, 830,1002,1075]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
RSCx=[1648,1837,1705,1591,1548]; 
RSCz=[1075,1092,1174,1209,1198]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
fourCbx=[1295,1352,1333,1339,1295]; 
fourCbz=[1333,1311,1276,1232,1232]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1339,1445,1556,1557,1485,1295]; 
threeCbz=[1232,1232,1103,1041,1002, 969, 986]; 
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slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
twoCbx=[1295,1485,1557,1613,1486,1355,1295]; 
twoCbz=[986 , 969,1002, 760, 823, 841, 790]; 
slicemap (specval(twoCb), low,medLOW, MED, medHIGH, HIGH, twoCbx, 
twoCbz, Y); 
fiveCbx=[1544,1648,1804,1794,1588]; 
fiveCbz=[1043,1075, 869, 815, 939]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
threeCbx=[1794,1588,1570,1617,1721,1796]; 
threeCbz=[ 815, 939, 924, 758, 753, 778]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
ICx=[1556,1627,1443,1352,1333,1339,1377,1445]; 
ICz=[1040,1086,1299,1311,1276,1232,1173,1103]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
CGx=[1295,1512,1486,1355,1294]; 
CGz=[712 ,712 , 823, 831, 790]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, CGx, CGz, Y); 
PBx=[1486,1615,1700,1669,1512]; 
PBz=[ 823, 757, 747, 703, 712]; 
slicemap (specval(PB), low,medLOW, MED, medHIGH, HIGH, PBx, PBz, Y); 
DMTgx=[1295,1512,1519,1365,1295]; 
DMTgz=[ 712,712 , 601, 618, 618]; 
slicemap (specval(DMTg), low,medLOW, MED, medHIGH, HIGH, DMTgx, DMTgz, 
Y); 
PnCx=[1519,1365,1295,1295,1375,1460,1592]; 
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PnCz=[ 601, 618, 618, 448, 435, 365, 431]; 
slicemap (specval(PnC), low,medLOW, MED, medHIGH, HIGH, PnCx, PnCz, 
Y); 
RtTgx=[1306,1354,1354,1295]; 
RtTgz=[ 548, 544, 496, 483]; 
slicemap (specval(RtTg), low,medLOW, MED, medHIGH, HIGH, RtTgx, RtTgz, 
Y); 
Tzx=[1295,1375,1460,1415,1295]; 
Tzz=[ 448, 435, 365, 311, 311]; 
slicemap (specval(Tz), low,medLOW, MED, medHIGH, HIGH, Tzx, Tzz, Y); 
WMx=[1295,1415,1410,1373,1288]; 
WMz=[311 , 311, 389, 389, 355]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
POIx=[1409,1543,1602,1589,1460]; 
POIz=[ 308, 295, 363, 395, 365]; 
slicemap (specval(POI), low,medLOW, MED, medHIGH, HIGH, POIx, POIz, 
Y); 
fiveRx=[1592,1666,1673,1733,1740,1710,1607,1589]; 
fiveRz=[ 431, 528, 610, 676, 565, 454, 367, 395]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Prsx=[1589,1583,1665,1666]; 
Prsz=[ 395, 538, 611, 528]; 
slicemap (specval(Prs), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
SubCx=[1589,1444,1486,1613,1512,1519,1583,1592]; 
SubCz=[ 395, 635, 823, 769, 712, 601, 538, 431]; 
slicemap (specval(SubC), low,medLOW, MED, medHIGH, HIGH, SubCx, SubCz, 
Y); 
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fiveNx=[1613,1512,1519,1583,1700]; 
fiveNz=[ 769, 712, 601, 538, 747]; 
slicemap (specval(fiveN), low,medLOW, MED, medHIGH, HIGH, fiveNx, 
fiveNz, Y); 
WMx=[1700,1583,1733,1797,1796]; 
WMz=[ 747, 538, 676, 760, 778]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
end 
slice51 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 51; 
Cbx=[1290,1337,1333,1363,1295,]; 
Cbz=[1257,1232,1276,1318,1333]; 
%QCcolor (Cbx,Cbz,51*3) 
V1x=[1470,1549,1643,1765,1705,1591,1490,1465]; 
V1z=[1376,1376,1359,1292,1174,1209,1261,1301]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1707,1766,1906,1837]; 
V2z=[1173,1291,1178,1092]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
96 
Ectx=[1906,1837,1957,2015]; 
Ectz=[1178,1092,1000,1003]; 
slicemap (specval(Ect), low,medLOW, MED, medHIGH, HIGH, Ectx, Ectz, 
Y); 
Entx=[1837,1957,2015,2039,2010,1884,1697,1648]; 
Entz=[1092,1000,1003, 853, 814, 830,1002,1075]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
RSCx=[1648,1837,1705,1591,1548]; 
RSCz=[1075,1092,1174,1209,1198]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
fourCbx=[1295,1352,1333,1339,1295]; 
fourCbz=[1333,1311,1276,1232,1232]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1339,1445,1556,1557,1485,1295]; 
threeCbz=[1232,1232,1103,1041,1002, 969, 986]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
twoCbx=[1295,1485,1557,1613,1486,1355,1295]; 
twoCbz=[986 , 969,1002, 760, 823, 841, 790]; 
slicemap (specval(twoCb), low,medLOW, MED, medHIGH, HIGH, twoCbx, 
twoCbz, Y); 
fiveCbx=[1544,1648,1804,1794,1588]; 
fiveCbz=[1043,1075, 869, 815, 939]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
threeCbx=[1794,1588,1570,1617,1721,1796]; 
threeCbz=[ 815, 939, 924, 758, 753, 778]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
ICx=[1556,1627,1443,1352,1333,1339,1377,1445]; 
ICz=[1040,1086,1299,1311,1276,1232,1173,1103]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
CGx=[1295,1512,1486,1355,1294]; 
CONFIDENTIAL | 294 
 
CGz=[712 ,712 , 823, 831, 790]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, CGx, CGz, Y); 
PBx=[1486,1615,1700,1669,1512]; 
PBz=[ 823, 757, 747, 703, 712]; 
slicemap (specval(PB), low,medLOW, MED, medHIGH, HIGH, PBx, PBz, Y); 
DMTgx=[1295,1512,1519,1365,1295]; 
DMTgz=[ 712,712 , 601, 618, 618]; 
slicemap (specval(DMTg), low,medLOW, MED, medHIGH, HIGH, DMTgx, DMTgz, 
Y); 
PnCx=[1519,1365,1295,1295,1375,1460,1592]; 
PnCz=[ 601, 618, 618, 448, 435, 365, 431]; 
slicemap (specval(PnC), low,medLOW, MED, medHIGH, HIGH, PnCx, PnCz, 
Y); 
RtTgx=[1306,1354,1354,1295]; 
RtTgz=[ 548, 544, 496, 483]; 
slicemap (specval(RtTg), low,medLOW, MED, medHIGH, HIGH, RtTgx, RtTgz, 
Y); 
Tzx=[1295,1375,1460,1415,1295]; 
97 
Tzz=[ 448, 435, 365, 311, 311]; 
slicemap (specval(Tz), low,medLOW, MED, medHIGH, HIGH, Tzx, Tzz, Y); 
WMx=[1295,1415,1410,1373,1288]; 
WMz=[311 , 311, 389, 389, 355]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
POIx=[1409,1543,1602,1589,1460]; 
POIz=[ 308, 295, 363, 395, 365]; 
slicemap (specval(POI), low,medLOW, MED, medHIGH, HIGH, POIx, POIz, 
Y); 
fiveRx=[1592,1666,1673,1733,1740,1710,1607,1589]; 
fiveRz=[ 431, 528, 610, 676, 565, 454, 367, 395]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Prsx=[1589,1583,1665,1666]; 
Prsz=[ 395, 538, 611, 528]; 
slicemap (specval(Prs), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
SubCx=[1589,1444,1486,1613,1512,1519,1583,1592]; 
SubCz=[ 395, 635, 823, 769, 712, 601, 538, 431]; 
slicemap (specval(SubC), low,medLOW, MED, medHIGH, HIGH, SubCx, SubCz, 
Y); 
fiveNx=[1613,1512,1519,1583,1700]; 
fiveNz=[ 769, 712, 601, 538, 747]; 
slicemap (specval(fiveN), low,medLOW, MED, medHIGH, HIGH, fiveNx, 
fiveNz, Y); 
l=51; 
WMx=[1700,1583,1733,1797,1796]; 
WMz=[ 747, 538, 676, 760, 778]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
end 
slice52 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 52; 
Cbx=[1290,1337,1333,1363,1295,]; 
Cbz=[1257,1232,1276,1318,1333]; 
%QCcolor (Cbx,Cbz,51*3) 
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V1x=[1470,1549,1643,1765,1705,1591,1490,1465]; 
V1z=[1531,1376,1359,1292,1174,1209,1261,1301]; 
slicemap (specval(V1), low,medLOW, MED, medHIGH, HIGH, V1x, V1z, Y); 
V2x=[1707,1766,1906,1837]; 
V2z=[1173,1291,1178,1092]; 
slicemap (specval(V2), low,medLOW, MED, medHIGH, HIGH, V2x, V2z, Y); 
Ectx=[1906,1837,1957,2015]; 
Ectz=[1178,1092,1000,1003]; 
98 
slicemap (specval(Ect), low,medLOW, MED, medHIGH, HIGH, Ectx, Ectz, 
Y); 
Entx=[1837,1957,2015,2039,2010,1884,1697,1648]; 
Entz=[1092,1000,1003, 853, 814, 830,1002,1075]; 
slicemap (specval(Ent), low,medLOW, MED, medHIGH, HIGH, Entx, Entz, 
Y); 
RSCx=[1648,1837,1705,1591,1548]; 
RSCz=[1075,1092,1174,1209,1198]; 
slicemap (specval(RSC), low,medLOW, MED, medHIGH, HIGH, RSCx, RSCz, 
Y); 
fourCbx=[1295,1352,1333,1339,1295]; 
fourCbz=[1333,1311,1276,1232,1232]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1339,1445,1556,1557,1485,1295]; 
threeCbz=[1232,1232,1103,1041,1002, 969, 986]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
twoCbx=[1295,1485,1557,1613,1486,1355,1295]; 
twoCbz=[986 , 969,1002, 760, 823, 841, 790]; 
slicemap (specval(twoCb), low,medLOW, MED, medHIGH, HIGH, twoCbx, 
twoCbz, Y); 
fiveCbx=[1544,1648,1804,1794,1588]; 
fiveCbz=[1043,1075, 869, 815, 939]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
threeCbx=[1794,1588,1570,1617,1721,1796]; 
threeCbz=[ 815, 939, 924, 758, 753, 778]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
ICx=[1556,1627,1443,1352,1333,1339,1377,1445]; 
ICz=[1040,1086,1299,1311,1276,1232,1173,1103]; 
slicemap (specval(IC), low,medLOW, MED, medHIGH, HIGH, ICx, ICz, Y); 
CGx=[1295,1512,1486,1355,1294]; 
CGz=[712 ,712 , 823, 831, 790]; 
slicemap (specval(Cg), low,medLOW, MED, medHIGH, HIGH, CGx, CGz, Y); 
PBx=[1486,1615,1700,1669,1512]; 
PBz=[ 823, 757, 747, 703, 712]; 
slicemap (specval(PB), low,medLOW, MED, medHIGH, HIGH, PBx, PBz, Y); 
DMTgx=[1295,1512,1519,1365,1295]; 
DMTgz=[ 712,712 , 601, 618, 618]; 
slicemap (specval(DMTg), low,medLOW, MED, medHIGH, HIGH, DMTgx, DMTgz, 
Y); 
PnCx=[1519,1365,1295,1295,1375,1460,1592]; 
PnCz=[ 601, 618, 618, 448, 435, 365, 431]; 
slicemap (specval(PnC), low,medLOW, MED, medHIGH, HIGH, PnCx, PnCz, 
Y); 
RtTgx=[1306,1354,1354,1295]; 
RtTgz=[ 548, 544, 496, 483]; 
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slicemap (specval(RtTg), low,medLOW, MED, medHIGH, HIGH, RtTgx, RtTgz, 
Y); 
Tzx=[1295,1375,1460,1415,1295]; 
Tzz=[ 448, 435, 365, 311, 311]; 
slicemap (specval(Tz), low,medLOW, MED, medHIGH, HIGH, Tzx, Tzz, Y); 
99 
WMx=[1295,1415,1410,1373,1288]; 
WMz=[311 , 311, 389, 389, 355]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
POIx=[1409,1543,1602,1589,1460]; 
POIz=[ 308, 295, 363, 395, 365]; 
slicemap (specval(POI), low,medLOW, MED, medHIGH, HIGH, POIx, POIz, 
Y); 
fiveRx=[1592,1666,1673,1733,1740,1710,1607,1589]; 
fiveRz=[ 431, 528, 610, 676, 565, 454, 367, 395]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Prsx=[1589,1583,1665,1666]; 
Prsz=[ 395, 538, 611, 528]; 
slicemap (specval(Prs), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
SubCx=[1589,1444,1486,1613,1512,1519,1583,1592]; 
SubCz=[ 395, 635, 823, 769, 712, 601, 538, 431]; 
slicemap (specval(SubC), low,medLOW, MED, medHIGH, HIGH, SubCx, SubCz, 
Y); 
fiveNx=[1613,1512,1519,1583,1700]; 
fiveNz=[ 769, 712, 601, 538, 747]; 
slicemap (specval(fiveN), low,medLOW, MED, medHIGH, HIGH, fiveNx, 
fiveNz, Y); 
l=52; 
WMx=[1700,1583,1733,1797,1796]; 
WMz=[ 747, 538, 676, 760, 778]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice53 star = 54 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 53; 
CGx=[1404,1410,1295,1291,1350]; 
CGz=[ 816, 726, 726, 768, 777]; 
%QCcolor (CGx,CGz,53*3) 
l=53; 
%%Slicefeed(l); 
fiveCbx=[1295,1391,1551,1858,1785,1295]; 
fiveCbz=[1365,1350,1280,1042,838 , 838]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
fourCbx=[1295, 1703,1782,1469,1358,1295]; 
fourCbz=[795 , 795, 832,1159,1220,1223]; 
100 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
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fourCbz, Y); 
threeCbx=[1295,1392,1505,1609,1472,1295]; 
threeCbz=[1071,1062,1007, 901, 954, 954]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
twoCbx=[1609,1472,1295,1295,1350,1477,1551,1644,1703]; 
twoCbz=[ 901, 954, 954, 768, 777, 844, 822, 748, 795]; 
slicemap (specval(twoCb), low,medLOW, MED, medHIGH, HIGH, twoCbx, 
twoCbz, Y); 
Simx=[1741,1785,1857,1871,1858]; 
Simz=[1161, 838, 919,1003,1042]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
PFIx=[1778,1922,1909,1857,1805,1779]; 
PFIz=[ 792, 803, 871, 919, 885, 829]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
FLx=[1778,1702,1733,1761,1825,1976,2012,2014,1922]; 
FLz=[ 792, 724, 707, 647, 623, 655, 675, 725, 803]; 
slicemap (specval(FL), low,medLOW, MED, medHIGH, HIGH, FLx, FLz, Y); 
WMx=[1778,1751,1663,1644,1658,1702]; 
WMz=[ 792, 815, 778, 748, 716, 724]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
VCAx=[1680,1733,1801,1810,1784,1699,1693,1722,1732]; 
VCAz=[ 711, 707, 620, 562, 503, 439, 469, 523, 597]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
fiveRx=[1678,1693,1722,1732]; 
fiveRz=[ 712, 469, 523, 597]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Pr5x=[1678,1699,1663,1611]; 
Pr5z=[ 712, 439, 398, 578]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
fiveNx=[1680,1611,1558,1521,1501,1505]; 
fiveNz=[ 711, 578, 582, 610, 665, 741]; 
slicemap (specval(fiveN), low,medLOW, MED, medHIGH, HIGH, fiveNx, 
fiveNz, Y); 
PBx=[1505,1680,1647,1551,1477,1447,1462,1505]; 
PBz=[741 , 711, 749, 822, 844, 838, 768, 741]; 
slicemap (specval(PB), low,medLOW, MED, medHIGH, HIGH, PBx, PBz, Y); 
LCx=[1447,1410,1441,1462,1463]; 
LCz=[ 838, 726, 733, 768, 806]; 
slicemap (specval(LC), low,medLOW, MED, medHIGH, HIGH, LCx, LCz, Y); 
CGx=[1295,1410,1447,1404,1350,1295]; 
CGz=[ 726, 726, 838, 816, 777, 768]; 
slicemap (specval(CG), low,medLOW, MED, medHIGH, HIGH, CGx, CGz, Y); 
SubCx=[1462,1441,1434,1633,1707,1611,1558,1521,1501,1505]; 
SubCz=[ 768, 733, 633, 398, 448, 578, 582, 610, 665, 741]; 
slicemap (specval(SubC), low,medLOW, MED, medHIGH, HIGH, SubCx, SubCz, 
Y); 
POIx=[1458,1693,1707,1589,1556,1511,1509]; 
POIz=[ 398, 469, 448, 355, 316, 296, 339]; 
101 
slicemap (specval(POI), low,medLOW, MED, medHIGH, HIGH, POIx, POIz, 
Y); 
DMTgx=[1295,1441,1434,1358,1295]; 
DMTgz=[ 733, 733, 633, 618, 618]; 
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slicemap (specval(DMTg), low,medLOW, MED, medHIGH, HIGH, DMTgx, DMTgz, 
Y); 
PnCx=[1295,1441,1663,1458,1295]; 
PnCz=[ 733, 733, 398, 398, 392]; 
slicemap (specval(PnC), low,medLOW, MED, medHIGH, HIGH, PnCx, PnCz, 
Y); 
RMgx=[1295,1339,1337,1295]; 
RMgz=[ 392, 407, 458, 482]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
Tzx=[1295,1339,1393,1458,1509,1511,1405]; 
Tzz=[ 392, 407, 420, 398, 334, 296, 302]; 
slicemap (specval(Tz), low,medLOW, MED, medHIGH, HIGH, Tzx, Tzz, Y); 
WMx=[1405,1334,1295,1295,1368,1405,1432,1428]; 
WMz=[ 302, 279, 294, 349, 377, 375, 344,322 ]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice54 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 54; 
CGx=[1404,1410,1295,1291,1350]; 
CGz=[ 816, 726, 726, 768, 777]; 
%QCcolor (CGx,CGz,53*3) 
Y=Slicenum*3; 
%%Slicefeed(l); 
fiveCbx=[1295,1391,1551,1858,1785,1295]; 
fiveCbz=[1365,1350,1280,1042,838 , 838]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
fourCbx=[1295, 1703,1782,1469,1358,1295]; 
fourCbz=[795 , 795, 832,1159,1220,1223]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1392,1505,1609,1472,1295]; 
threeCbz=[1071,1062,1007, 901, 954, 954]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
twoCbx=[1609,1472,1295,1295,1350,1477,1551,1644,1703]; 
102 
twoCbz=[ 901, 954, 954, 768, 777, 844, 822, 748, 795]; 
slicemap (specval(twoCb), low,medLOW, MED, medHIGH, HIGH, twoCbx, 
twoCbz, Y); 
Simx=[1741,1785,1857,1871,1858]; 
Simz=[1161, 838, 919,1003,1042]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
PFIx=[1778,1922,1909,1857,1805,1779]; 
PFIz=[ 792, 803, 871, 919, 885, 829]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
FLx=[1778,1702,1733,1761,1825,1976,2012,2014,1922]; 
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FLz=[ 792, 724, 707, 647, 623, 655, 675, 725, 803]; 
slicemap (specval(FL), low,medLOW, MED, medHIGH, HIGH, FLx, FLz, Y); 
WMx=[1778,1751,1663,1644,1658,1702]; 
WMz=[ 792, 815, 778, 748, 716, 724]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
VCAx=[1680,1733,1801,1810,1784,1699,1693,1722,1732]; 
VCAz=[ 711, 707, 620, 562, 503, 439, 469, 523, 597]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
fiveRx=[1678,1693,1722,1732]; 
fiveRz=[ 712, 469, 523, 597]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Pr5x=[1678,1699,1663,1611]; 
Pr5z=[ 712, 439, 398, 578]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
fiveNx=[1680,1611,1558,1521,1501,1505]; 
fiveNz=[ 711, 578, 582, 610, 665, 741]; 
slicemap (specval(fiveN), low,medLOW, MED, medHIGH, HIGH, fiveNx, 
fiveNz, Y); 
PBx=[1505,1680,1647,1551,1477,1447,1462,1505]; 
PBz=[741 , 711, 749, 822, 844, 838, 768, 741]; 
slicemap (specval(PB), low,medLOW, MED, medHIGH, HIGH, PBx, PBz, Y); 
LCx=[1447,1410,1441,1462,1463]; 
LCz=[ 838, 726, 733, 768, 806]; 
slicemap (specval(LC), low,medLOW, MED, medHIGH, HIGH, LCx, LCz, Y); 
CGx=[1295,1410,1447,1404,1350,1295]; 
CGz=[ 726, 726, 838, 816, 777, 768]; 
slicemap (specval(CG), low,medLOW, MED, medHIGH, HIGH, CGx, CGz, Y); 
SubCx=[1462,1441,1434,1633,1707,1611,1558,1521,1501,1505]; 
SubCz=[ 768, 733, 633, 398, 448, 578, 582, 610, 665, 741]; 
slicemap (specval(SubC), low,medLOW, MED, medHIGH, HIGH, SubCx, SubCz, 
Y); 
POIx=[1458,1693,1707,1589,1556,1511,1509]; 
POIz=[ 398, 469, 448, 355, 316, 296, 339]; 
slicemap (specval(POI), low,medLOW, MED, medHIGH, HIGH, POIx, POIz, 
Y); 
DMTgx=[1295,1441,1434,1358,1295]; 
DMTgz=[ 733, 733, 633, 618, 618]; 
slicemap (specval(DMTg), low,medLOW, MED, medHIGH, HIGH, DMTgx, DMTgz, 
Y); 
PnCx=[1295,1441,1663,1458,1295]; 
103 
PnCz=[ 733, 733, 398, 398, 392]; 
slicemap (specval(PnC), low,medLOW, MED, medHIGH, HIGH, PnCx, PnCz, 
Y); 
RMgx=[1295,1339,1337,1295]; 
RMgz=[ 392, 407, 458, 482]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
Tzx=[1295,1339,1393,1458,1509,1511,1405]; 
Tzz=[ 392, 407, 420, 398, 334, 296, 302]; 
slicemap (specval(Tz), low,medLOW, MED, medHIGH, HIGH, Tzx, Tzz, Y); 
WMx=[1405,1334,1295,1295,1368,1405,1432,1428]; 
WMz=[ 302, 279, 294, 349, 377, 375, 344,322 ]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
l=Slicenum; 
%l = 1; %enter whatever slice you want 
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hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice55 star 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 55; 
l=55; 
%%Slicefeed(l); 
sixCbx=[1295,1551,1575,1406,1295]; 
sixCbz=[1370,1316,1174,1281,1281]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
fiveCbx=[1295,1406,1575,1702,1630,1593,1523,1463,1385,1295]; 
fiveCbz=[1281,1281,1174, 921, 899, 922,1111,1155,1175,1175]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
fourCbx=[1593,1523,1463,1385,1295,1295]; 
fourCbz=[ 922,1111,1155,1175,1175, 922]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1360,1420,1483,1430,1321,1295]; 
threeCbz=[ 873, 884, 951, 978,1061,1084,1084]; 
oneCbx=[1295,1360,1389,1295]; 
oneCbz=[873, 884, 823, 739]; 
slicemap (specval(oneCb), low,medLOW, MED, medHIGH, HIGH, oneCbx, 
oneCbz, Y); 
Simx=[1551,1575,1675,1791,1990,1999,1902,1741]; 
Simz=[1316,1174, 915, 862, 910,1003,1148,1249]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
104 
Crus1x=[1990,1999,1902,1741,1791,1815]; 
Crus1z=[ 910,1003,1148,1249, 862, 900]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
PFIx=[1791,1815,1909,1990,1945,2080,2156,2140,2099,1977,1789,1758,1688,1672,1
710]; 
PFIz=[ 862, 900, 930, 910, 755, 758, 644, 585, 546, 553, 633, 687, 
732, 779, 810]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
Rx=[1671,1655,1753,1795,1790,1758,1688]; 
Rz=[ 776, 693, 508, 557, 632, 687, 732]; 
slicemap (specval(Fl), low,medLOW, MED, medHIGH, HIGH, Rx, Rz, Y); 
WMx=[1642,1599,1575,1489,1389,1360,1474,1546,1630,1702,1747,1791,1794,1771,17
02,1671]; 
WMz=[ 670, 674, 760, 819, 823, 884, 978, 982, 899, 921, 910, 862, 823, 
784, 811, 776]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
Latx=[1645,1602,1616,1652, 1673]; 
Latz=[ 876, 828, 768, 774, 827 ]; 
slicemap (specval(Lat), low,medLOW, MED, medHIGH, HIGH, Latx, Latz, 
Y); 
Intx=[1530,1494,1448,1390,1396,1489]; 
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Intz=[ 863, 835, 837, 865, 884, 889]; 
slicemap (specval(Int), low,medLOW, MED, medHIGH, HIGH, Intx, Intz, 
Y); 
Vex=[1389,1418,1599,1575,1536,1489]; 
Vez=[823 , 657, 674, 760, 800, 819]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
PCRtx=[1418,1534,1593,1534]; 
PCRtz=[ 657, 444, 494, 657]; 
slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
Prsx=[1593,1534,1611,1639]; 
Prsz=[ 494, 657, 669, 484]; 
slicemap (specval(Prs), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
fiveRx=[1611,1639,1689,1753,1656]; 
fiveRz=[ 669, 484, 413, 508, 698]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
VCAx=[1753,1656,1642,1731]; 
VCAz=[ 508, 698, 670, 486]; 
slicemap (specval(VCA), low,medLOW, MED, medHIGH, HIGH, VCAx, VCAz, 
Y); 
sevenNx=[1687,1688,1639,1593,1554,1531,1649]; 
sevenNz=[ 410, 449, 484, 494, 479, 412, 360]; 
slicemap (specval(sevenN), low,medLOW, MED, medHIGH, HIGH, sevenNx, 
sevenNz, Y); 
Olvx=[1531,1649,1600,1432,1438,1531]; 
Olvz=[ 412, 360, 321, 309,330 , 412]; 
slicemap (specval(Olv), low,medLOW, MED, medHIGH, HIGH, Olvx, Olvz, 
Y); 
Gigx=[1295,1438,1531,1535,1418,1295]; 
Gigz=[ 330, 330, 412, 447, 657, 657]; 
105 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
DPGIx=[1418,1295,1295,1398]; 
DPGIz=[ 657, 657, 739, 823]; 
slicemap (specval(DPGi), low,medLOW, MED, medHIGH, HIGH, DPGIx, DPGIz, 
Y); 
RMgx=[1295,1348,1351,1295]; 
RMgz=[ 448, 410, 353, 340]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
WMx=[1295,1371,1420,1438,1408,1338,1295]; 
WMz=[ 340, 361, 353, 330, 297, 279, 279]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice56 star 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 56; 
Intx=[1396,1429,1489,1530,1494,1448,1390]; 
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Intz=[ 884, 895, 889, 863, 835, 837, 865]; 
%QCcolor (Intx,Intz,3*56) 
l=56; 
%%Slicefeed(l); 
sixCbx=[1295,1551,1575,1406,1295]; 
sixCbz=[1370,1316,1174,1281,1281]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
fiveCbx=[1295,1406,1575,1702,1630,1593,1523,1463,1385,1295]; 
fiveCbz=[1281,1281,1174, 921, 899, 922,1111,1155,1175,1175]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
fourCbx=[1593,1523,1463,1385,1295,1295]; 
fourCbz=[ 922,1111,1155,1175,1175, 922]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1295,1360,1420,1483,1430,1321,1295]; 
threeCbz=[ 873, 884, 951, 978,1061,1084,1084]; 
oneCbx=[1295,1360,1389,1295]; 
oneCbz=[873, 884, 823, 739]; 
slicemap (specval(oneCb), low,medLOW, MED, medHIGH, HIGH, oneCbx, 
oneCbz, Y); 
Simx=[1551,1575,1675,1791,1990,1999,1902,1741]; 
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Simz=[1316,1174, 915, 862, 910,1003,1148,1249]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
Crus1x=[1990,1999,1902,1741,1791,1815]; 
Crus1z=[ 910,1003,1148,1249, 862, 900]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
PFIx=[1791,1815,1909,1990,1945,2080,2156,2140,2099,1977,1789,1758,1688,1672,1
710]; 
PFIz=[ 862, 900, 930, 910, 755, 758, 644, 585, 546, 553, 633, 687, 
732, 779, 810]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
Rx=[1671,1655,1753,1795,1790,1758,1688]; 
Rz=[ 776, 693, 508, 557, 632, 687, 732]; 
slicemap (specval(Fl), low,medLOW, MED, medHIGH, HIGH, Rx, Rz, Y); 
WMx=[1642,1599,1575,1489,1389,1360,1474,1546,1630,1702,1747,1791,1794,1771,17
02,1671]; 
WMz=[ 670, 674, 760, 819, 823, 884, 978, 982, 899, 921, 910, 862, 823, 
784, 811, 776]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
Latx=[1645,1602,1616,1652, 1673]; 
Latz=[ 876, 828, 768, 774, 827 ]; 
slicemap (specval(Lat), low,medLOW, MED, medHIGH, HIGH, Latx, Latz, 
Y); 
Intx=[1530,1494,1448,1390,1396,1489]; 
Intz=[ 863, 835, 837, 865, 884, 889]; 
slicemap (specval(Int), low,medLOW, MED, medHIGH, HIGH, Intx, Intz, 
Y); 
Vex=[1389,1418,1599,1575,1536,1489]; 
Vez=[823 , 657, 674, 760, 800, 819]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
PCRtx=[1418,1534,1593,1534]; 
PCRtz=[ 657, 444, 494, 657]; 
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slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
Prsx=[1593,1534,1611,1639]; 
Prsz=[ 494, 657, 669, 484]; 
slicemap (specval(Prs), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
fiveRx=[1611,1639,1689,1753,1656]; 
fiveRz=[ 669, 484, 413, 508, 698]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
VCAx=[1753,1656,1642,1731]; 
VCAz=[ 508, 698, 670, 486]; 
slicemap (specval(VCA), low,medLOW, MED, medHIGH, HIGH, VCAx, VCAz, 
Y); 
sevenNx=[1687,1688,1639,1593,1554,1531,1649]; 
sevenNz=[ 410, 449, 484, 494, 479, 412, 360]; 
slicemap (specval(sevenN), low,medLOW, MED, medHIGH, HIGH, sevenNx, 
sevenNz, Y); 
Olvx=[1531,1649,1600,1432,1438,1531]; 
Olvz=[ 412, 360, 321, 309,330 , 412]; 
slicemap (specval(Olv), low,medLOW, MED, medHIGH, HIGH, Olvx, Olvz, 
Y); 
107 
Gigx=[1295,1438,1531,1535,1418,1295]; 
Gigz=[ 330, 330, 412, 447, 657, 657]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
DPGIx=[1418,1295,1295,1398]; 
DPGIz=[ 657, 657, 739, 823]; 
slicemap (specval(DPGi), low,medLOW, MED, medHIGH, HIGH, DPGIx, DPGIz, 
Y); 
RMgx=[1295,1348,1351,1295]; 
RMgz=[ 448, 410, 353, 340]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
WMx=[1295,1371,1420,1438,1408,1338,1295]; 
WMz=[ 340, 361, 353, 330, 297, 279, 279]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice57 = 58 = 59 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 57; 
nx=[1485,1651,1686,1614,1543,1492,1471]; 
nz=[ 313, 327, 386, 421, 423, 397,360]; 
%QCcolor (nx,nz,57*3) 
l=57; 
sixCbx=[1295,1638,1578,1511,1445,1368,1295]; 
sixCbz=[1370,1297, 978,1135,1210,1241,1241]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
fiveCbx=[1578,1511,1445,1368,1295,1295,1385,1449]; 
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fiveCbz=[ 978,1135,1210,1241,1241,1033,1033,1003]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
fourCbx=[1295,1385,1449,1463,1655,1727,1668,1476,1385,1295]; 
fourCbz=[1033,1033,1003, 942, 911, 844, 837, 864, 897, 897]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1476,1385,1295,1295,1355]; 
threeCbz=[ 864, 897, 897, 801, 813]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
oneCbx=[1295,1355,1397,1295]; 
oneCbz=[ 801, 813, 766, 766]; 
108 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, oneCbx, 
oneCbz, Y); 
Medx=[1470,1450,1378,1355,1402]; 
Medz=[ 772, 832, 868, 813, 768]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, Medx, Medz, 
Y); 
Simx=[1578,1535,1638,1750,1779]; 
Simz=[ 985,1324,1297,1244, 954]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
Crus1x=[1750,1779,1773,1973,1975 ,1925]; 
Crus1z=[1244, 954, 884, 908, 1047,1128]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
PFIx=[1772,1973,1976,2040,2091,2148,2106,2023,1790,1743,1619,1668,1743]; 
PFIz=[ 883, 908, 838, 765, 747, 631, 534, 515, 636, 710, 748, 837, 
846]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
WMx=[1449,1779,1804,1749,1717,1655,1463,1440]; 
WMz=[1003, 954, 907, 851, 847, 911, 942, 969]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
Latx=[1574,1580,1642,1668,1662,1625]; 
Latz=[766, 826 , 873, 837, 802, 744]; 
slicemap (specval(Lat), low,medLOW, MED, medHIGH, HIGH, Latx, Latz, 
Y); 
Intx=[1470,1574,1586,1565,1508,1451]; 
Intz=[772, 766, 839, 860, 871, 850 ]; 
slicemap (specval(Int), low,medLOW, MED, medHIGH, HIGH, Intx, Intz, 
Y); 
Vx=[1295,1397,1295]; 
Vz=[ 677, 766, 766]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
DPGIx=[1295,1397,1393,1295]; 
DPGIz=[ 677, 766, 599, 599]; 
slicemap (specval(DPGi), low,medLOW, MED, medHIGH, HIGH, DPGIx, DPGIz, 
Y); 
Vex=[1397,1393,1551,1614,1547]; 
Vez=[ 766, 599, 614,599 , 772]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
FIx=[1619,1743,1744,1790,1790,1743]; 
FIz=[ 748, 631, 510, 559, 636, 710]; 
slicemap (specval(Fl), low,medLOW, MED, medHIGH, HIGH, FIx, FIz, Y); 
VCAx=[1619,1743,1718,1547]; 
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VCAz=[ 748, 631, 489, 772]; 
slicemap (specval(VCA), low,medLOW, MED, medHIGH, HIGH, VCAx, VCAz, 
Y); 
fiveRx=[1718,1619,1547,1686]; 
fiveRz=[ 489, 748, 772, 386]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Solx=[1551,1526,1537,1567,1614]; 
Solz=[614 , 563, 539, 518, 599]; 
109 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
Prsx=[1567,1614,1686,1574]; 
Prsz=[ 518, 599, 386, 425]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
sevenNx=[1686,1574,1491,1471,1485,1561]; 
sevenNz=[ 386, 425, 399, 360, 313, 327]; 
slicemap (specval(sevenN), low,medLOW, MED, medHIGH, HIGH, sevenNx, 
sevenNz, Y); 
PCRtx=[1551,1526,1537,1567,1614,1543,1492,1417,1393]; 
PCRtz=[614 , 563, 539, 518, 421, 423, 397, 479, 599]; 
slicemap(specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
Gigx=[1295,1393,1417,1491,1471,1485,1421,1295]; 
Gigz=[ 599, 599, 479, 399, 360, 313,300, 300]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
RMgx=[1295,1348,1351,1295]; 
RMgz=[440 , 410, 352, 338]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
WMx=[1295,1384,1434,1416,1295]; 
WMz=[ 338, 361, 341, 292, 276]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice58 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 58; 
nx=[1485,1651,1686,1614,1543,1492,1471]; 
nz=[ 313, 327, 386, 421, 423, 397,360]; 
%QCcolor (nx,nz,57*3) 
l=58; 
sixCbx=[1295,1638,1578,1511,1445,1368,1295]; 
sixCbz=[1370,1297, 978,1135,1210,1241,1241]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
fiveCbx=[1578,1511,1445,1368,1295,1295,1385,1449]; 
fiveCbz=[ 978,1135,1210,1241,1241,1033,1033,1003]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
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fiveCbz, Y); 
fourCbx=[1295,1385,1449,1463,1655,1727,1668,1476,1385,1295]; 
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fourCbz=[1033,1033,1003, 942, 911, 844, 837, 864, 897, 897]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1476,1385,1295,1295,1355]; 
threeCbz=[ 864, 897, 897, 801, 813]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
oneCbx=[1295,1355,1397,1295]; 
oneCbz=[ 801, 813, 766, 766]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, oneCbx, 
oneCbz, Y); 
Medx=[1470,1450,1378,1355,1402]; 
Medz=[ 772, 832, 868, 813, 768]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, Medx, Medz, 
Y); 
Simx=[1578,1535,1638,1750,1779]; 
Simz=[ 985,1324,1297,1244, 954]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
Crus1x=[1750,1779,1773,1973,1975 ,1925]; 
Crus1z=[1244, 954, 884, 908, 1047,1128]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
PFIx=[1772,1973,1976,2040,2091,2148,2106,2023,1790,1743,1619,1668,1743]; 
PFIz=[ 883, 908, 838, 765, 747, 631, 534, 515, 636, 710, 748, 837, 
846]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
WMx=[1449,1779,1804,1749,1717,1655,1463,1440]; 
WMz=[1003, 954, 907, 851, 847, 911, 942, 969]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
Latx=[1574,1580,1642,1668,1662,1625]; 
Latz=[766, 826 , 873, 837, 802, 744]; 
slicemap (specval(Lat), low,medLOW, MED, medHIGH, HIGH, Latx, Latz, 
Y); 
Intx=[1470,1574,1586,1565,1508,1451]; 
Intz=[772, 766, 839, 860, 871, 850 ]; 
slicemap (specval(Int), low,medLOW, MED, medHIGH, HIGH, Intx, Intz, 
Y); 
Vx=[1295,1397,1295]; 
Vz=[ 677, 766, 766]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
DPGIx=[1295,1397,1393,1295]; 
DPGIz=[ 677, 766, 599, 599]; 
slicemap (specval(DPGi), low,medLOW, MED, medHIGH, HIGH, DPGIx, DPGIz, 
Y); 
Vex=[1397,1393,1551,1614,1547]; 
Vez=[ 766, 599, 614,599 , 772]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
FIx=[1619,1743,1744,1790,1790,1743]; 
FIz=[ 748, 631, 510, 559, 636, 710]; 
slicemap (specval(Fl), low,medLOW, MED, medHIGH, HIGH, FIx, FIz, Y); 
VCAx=[1619,1743,1718,1547]; 
VCAz=[ 748, 631, 489, 772]; 
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slicemap (specval(VCA), low,medLOW, MED, medHIGH, HIGH, VCAx, VCAz, 
Y); 
fiveRx=[1718,1619,1547,1686]; 
fiveRz=[ 489, 748, 772, 386]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Solx=[1551,1526,1537,1567,1614]; 
Solz=[614 , 563, 539, 518, 599]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
Prsx=[1567,1614,1686,1574]; 
Prsz=[ 518, 599, 386, 425]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
sevenNx=[1686,1574,1491,1471,1485,1561]; 
sevenNz=[ 386, 425, 399, 360, 313, 327]; 
slicemap (specval(sevenN), low,medLOW, MED, medHIGH, HIGH, sevenNx, 
sevenNz, Y); 
PCRtx=[1551,1526,1537,1567,1614,1543,1492,1417,1393]; 
PCRtz=[614 , 563, 539, 518, 421, 423, 397, 479, 599]; 
slicemap(specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
Gigx=[1295,1393,1417,1491,1471,1485,1421,1295]; 
Gigz=[ 599, 599, 479, 399, 360, 313,300, 300]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
RMgx=[1295,1348,1351,1295]; 
RMgz=[440 , 410, 352, 338]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
WMx=[1295,1384,1434,1416,1295]; 
WMz=[ 338, 361, 341, 292, 276]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice59 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 59; 
nx=[1485,1651,1686,1614,1543,1492,1471]; 
nz=[ 313, 327, 386, 421, 423, 397,360]; 
%QCcolor (nx,nz,57*3) 
l=59; 
sixCbx=[1295,1638,1578,1511,1445,1368,1295]; 
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sixCbz=[1370,1297, 978,1135,1210,1241,1241]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
fiveCbx=[1578,1511,1445,1368,1295,1295,1385,1449]; 
fiveCbz=[ 978,1135,1210,1241,1241,1033,1033,1003]; 
slicemap (specval(fiveCb), low,medLOW, MED, medHIGH, HIGH, fiveCbx, 
fiveCbz, Y); 
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fourCbx=[1295,1385,1449,1463,1655,1727,1668,1476,1385,1295]; 
fourCbz=[1033,1033,1003, 942, 911, 844, 837, 864, 897, 897]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, fourCbx, 
fourCbz, Y); 
threeCbx=[1476,1385,1295,1295,1355]; 
threeCbz=[ 864, 897, 897, 801, 813]; 
slicemap (specval(threeCb), low,medLOW, MED, medHIGH, HIGH, threeCbx, 
threeCbz, Y); 
oneCbx=[1295,1355,1397,1295]; 
oneCbz=[ 801, 813, 766, 766]; 
slicemap (specval(fourCb), low,medLOW, MED, medHIGH, HIGH, oneCbx, 
oneCbz, Y); 
Medx=[1470,1450,1378,1355,1402]; 
Medz=[ 772, 832, 868, 813, 768]; 
slicemap (specval(MnR), low,medLOW, MED, medHIGH, HIGH, Medx, Medz, 
Y); 
Simx=[1578,1535,1638,1750,1779]; 
Simz=[ 985,1324,1297,1244, 954]; 
slicemap (specval(Sim), low,medLOW, MED, medHIGH, HIGH, Simx, Simz, 
Y); 
Crus1x=[1750,1779,1773,1973,1975 ,1925]; 
Crus1z=[1244, 954, 884, 908, 1047,1128]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
PFIx=[1772,1973,1976,2040,2091,2148,2106,2023,1790,1743,1619,1668,1743]; 
PFIz=[ 883, 908, 838, 765, 747, 631, 534, 515, 636, 710, 748, 837, 
846]; 
slicemap (specval(PFI), low,medLOW, MED, medHIGH, HIGH, PFIx, PFIz, 
Y); 
WMx=[1449,1779,1804,1749,1717,1655,1463,1440]; 
WMz=[1003, 954, 907, 851, 847, 911, 942, 969]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
Latx=[1574,1580,1642,1668,1662,1625]; 
Latz=[766, 826 , 873, 837, 802, 744]; 
slicemap (specval(Lat), low,medLOW, MED, medHIGH, HIGH, Latx, Latz, 
Y); 
Intx=[1470,1574,1586,1565,1508,1451]; 
Intz=[772, 766, 839, 860, 871, 850 ]; 
slicemap (specval(Int), low,medLOW, MED, medHIGH, HIGH, Intx, Intz, 
Y); 
Vx=[1295,1397,1295]; 
Vz=[ 677, 766, 766]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
DPGIx=[1295,1397,1393,1295]; 
DPGIz=[ 677, 766, 599, 599]; 
slicemap (specval(DPGi), low,medLOW, MED, medHIGH, HIGH, DPGIx, DPGIz, 
Y); 
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Vex=[1397,1393,1551,1614,1547]; 
Vez=[ 766, 599, 614,599 , 772]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
FIx=[1619,1743,1744,1790,1790,1743]; 
FIz=[ 748, 631, 510, 559, 636, 710]; 
slicemap (specval(Fl), low,medLOW, MED, medHIGH, HIGH, FIx, FIz, Y); 
VCAx=[1619,1743,1718,1547]; 
VCAz=[ 748, 631, 489, 772]; 
slicemap (specval(VCA), low,medLOW, MED, medHIGH, HIGH, VCAx, VCAz, 
Y); 
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fiveRx=[1718,1619,1547,1686]; 
fiveRz=[ 489, 748, 772, 386]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
Solx=[1551,1526,1537,1567,1614]; 
Solz=[614 , 563, 539, 518, 599]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
Prsx=[1567,1614,1686,1574]; 
Prsz=[ 518, 599, 386, 425]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Prsx, Prsz, 
Y); 
sevenNx=[1686,1574,1491,1471,1485,1561]; 
sevenNz=[ 386, 425, 399, 360, 313, 327]; 
slicemap (specval(sevenN), low,medLOW, MED, medHIGH, HIGH, sevenNx, 
sevenNz, Y); 
PCRtx=[1551,1526,1537,1567,1614,1543,1492,1417,1393]; 
PCRtz=[614 , 563, 539, 518, 421, 423, 397, 479, 599]; 
slicemap(specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
Gigx=[1295,1393,1417,1491,1471,1485,1421,1295]; 
Gigz=[ 599, 599, 479, 399, 360, 313,300, 300]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
RMgx=[1295,1348,1351,1295]; 
RMgz=[440 , 410, 352, 338]; 
slicemap (specval(RMg), low,medLOW, MED, medHIGH, HIGH, RMgx, RMgz, 
Y); 
WMx=[1295,1384,1434,1416,1295]; 
WMz=[ 338, 361, 341, 292, 276]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
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slice 60 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 60; 
Cbx=[1295,1383, 1500,1516,1231,]; 
Cbz=[ 877, 887, 858, 767, 784]; 
%receptorMap(specval(), x, z, Y) 
%QCcolor (Cbx,Cbz,60*3) 
l=60; 
Vx=[1295,1351,1342,1295]; 
Vz=[ 651, 687, 704, 704]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1446,1489,1539,1766,1724,1634,1470,1449]; 
WMz=[1093,1086,1022, 865, 862, 910,1037,1064]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
Crus1x=[1449,1665,1816,1870,1907,1814,1535,1489]; 
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Crus1z=[1092,1257,1198,1143,1075, 999,1025,1086]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
%receptorMap(specval(), x, z, Y) 
Crus2x=[1907,1814,1535,1766,1846,1921]; 
Crus2z=[1075, 999,1025, 865, 873, 892]; 
slicemap (specval(Crus2), low,medLOW, MED, medHIGH, HIGH, Crus2x, 
Crus2z, Y); 
%receptorMap(specval(), x, z, Y) 
PMIx=[1766,1846,1921,1920,1901,1778,1740,1749,1735,1665,1605,1543,1472,1464,1
470,1634,1724]; 
PMIz=[ 865, 873, 892, 826, 775, 700, 704, 745, 773, 778, 804, 888, 
953,1003,1037, 910, 862]; 
slicemap (specval(PMI), low,medLOW, MED, medHIGH, HIGH, PMIx, PMIz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Copx=[1473,1543,1605,1665,1735,1749,1740,1713,1663,1593,1517,1472]; 
Copz=[ 948, 888, 804, 778, 773, 745, 704, 685, 683, 715, 775, 946]; 
slicemap (specval(Cop), low,medLOW, MED, medHIGH, HIGH, Copx, Copz, 
Y); 
%receptorMap(specval(), x, z, Y) 
sixCbx=[1449,1665,1426,1295,1295,1362,1449]; 
sixCbz=[1092,1257,1331,1349,1110,1124,1092]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
%receptorMap(specval(), x, z, Y) 
sevenCbx=[1295,1362,1449,1449,1470,1464,1469,1401,1295]; 
sevenCbz=[1110,1124,1092,1064,1037,1003, 951, 975, 986]; 
slicemap (specval(sevenCb), low,medLOW, MED, medHIGH, HIGH, sevenCbx, 
sevenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
eightCbx=[1469,1401,1295,1295,1377,1492]; 
eightCbz=[ 951, 975, 986, 879, 887, 856]; 
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slicemap (specval(eightCb), low,medLOW, MED, medHIGH, HIGH, eightCbx, 
eightCb, Y); 
%receptorMap(specval(), x, z, Y) 
nineCbx=[1295,1377,1492,1516,1295]; 
nineCbz=[ 879, 887, 856, 777, 777]; 
slicemap (specval(nineCb), low,medLOW, MED, medHIGH, HIGH, nineCbx, 
nineCbz, Y); 
%receptorMap(specval(), x, z, Y) 
tenCbx=[1516,1295,1487,1354,1342,1295]; 
tenCbz=[ 777, 777,726 , 686, 704, 704]; 
slicemap (specval(tenCb), low,medLOW, MED, medHIGH, HIGH, tenCbx, 
tenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
Solx=[1380,1572,1517,1430]; 
Solz=[ 636, 618, 574, 581]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
%receptorMap(specval(), x, z, Y) 
%receptorMap(specval(), x, z, Y) 
Vex=[1380,1572,1585,1487,1420,1351,1295]; 
Vez=[ 636, 618, 704, 726, 697, 687, 651]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
%receptorMap(specval(), x, z, Y) 
fiveRx=[1572,1585,1664,1713,1759,1756]; 
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fiveRz=[ 618, 704, 667, 617, 537, 432]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%receptorMap(specval(), x, z, Y) 
Pr5x=[1572,1756,1712,1517]; 
Pr5z=[ 618, 432, 365, 574]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
%receptorMap(specval(), x, z, Y) 
PCRtx=[1712,1517,1466,1433,1524,1546]; 
PCRtz=[ 365, 574, 571, 586, 411, 302]; 
slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Gigx=[1433,1524,1546,1509,1295,1295,1380]; 
Gigz=[ 586, 411, 302, 285,285 , 651,636 ]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
%receptorMap(specval(), x, z, Y) 
IOx=[1286,1313,1321,1310,1295]; 
IOz=[ 615, 598, 520, 432, 396]; 
slicemap (specval(IO), low,medLOW, MED, medHIGH, HIGH, IOx, IOz, Y); 
%receptorMap(specval(), x, z, Y) 
Robx=[1295,1313,1373,1444,1485,1385,1295]; 
Robz=[351 , 373, 366, 327, 281,270 , 270]; 
slicemap (specval(Rob), low,medLOW, MED, medHIGH, HIGH, Robx, Robz, 
Y); 
%receptorMap(specval(), x, z, Y) 
%%Slicefeed(l); 
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%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 61 next 3 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 61; 
%QCcolor (Crus2x,Crus2z,61*3) 
l=61; 
Vx=[1295,1351,1342,1295]; 
Vz=[ 651, 687, 704, 704]; 
slicemap (specval(V), low,medLOW, MED, medHIGH, HIGH, Vx, Vz, Y); 
%receptorMap(specval(), x, z, Y) 
WMx=[1446,1489,1539,1766,1724,1634,1470,1449]; 
WMz=[1093,1086,1022, 865, 862, 910,1037,1064]; 
slicemap (specval(WM), low,medLOW, MED, medHIGH, HIGH, WMx, WMz, Y); 
%receptorMap (specval(174), WMx, WMz, Y) 
Crus1x=[1449,1665,1816,1870,1907,1814,1535,1489]; 
Crus1z=[1092,1257,1198,1143,1075, 999,1025,1086]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
%receptorMap(specval(), x, z, Y) 
Crus2x=[1907,1814,1535,1766,1846,1921]; 
Crus2z=[1075, 999,1025, 865, 873, 892]; 
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slicemap (specval(Crus2), low,medLOW, MED, medHIGH, HIGH, Crus2x, 
Crus2z, Y); 
%receptorMap(specval(), x, z, Y) 
PMIx=[1766,1846,1921,1920,1901,1778,1740,1749,1735,1665,1605,1543,1472,1464,1
470,1634,1724]; 
PMIz=[ 865, 873, 892, 826, 775, 700, 704, 745, 773, 778, 804, 888, 
953,1003,1037, 910, 862]; 
slicemap (specval(PMI), low,medLOW, MED, medHIGH, HIGH, PMIx, PMIz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Copx=[1473,1543,1605,1665,1735,1749,1740,1713,1663,1593,1517,1472]; 
Copz=[ 948, 888, 804, 778, 773, 745, 704, 685, 683, 715, 775, 946]; 
slicemap (specval(Cop), low,medLOW, MED, medHIGH, HIGH, Copx, Copz, 
Y); 
%receptorMap(specval(), x, z, Y) 
sixCbx=[1449,1665,1426,1295,1295,1362,1449]; 
sixCbz=[1092,1257,1331,1349,1110,1124,1092]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
%receptorMap(specval(), x, z, Y) 
sevenCbx=[1295,1362,1449,1449,1470,1464,1469,1401,1295]; 
sevenCbz=[1110,1124,1092,1064,1037,1003, 951, 975, 986]; 
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slicemap (specval(sevenCb), low,medLOW, MED, medHIGH, HIGH, sevenCbx, 
sevenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
eightCbx=[1469,1401,1295,1295,1377,1492]; 
eightCbz=[ 951, 975, 986, 879, 887, 856]; 
slicemap (specval(eightCb), low,medLOW, MED, medHIGH, HIGH, eightCbx, 
eightCb, Y); 
%receptorMap(specval(), x, z, Y) 
nineCbx=[1295,1377,1492,1516,1295]; 
nineCbz=[ 879, 887, 856, 777, 777]; 
slicemap (specval(nineCb), low,medLOW, MED, medHIGH, HIGH, nineCbx, 
nineCbz, Y); 
%receptorMap(specval(), x, z, Y) 
tenCbx=[1516,1295,1487,1354,1342,1295]; 
tenCbz=[ 777, 777,726 , 686, 704, 704]; 
slicemap (specval(tenCb), low,medLOW, MED, medHIGH, HIGH, tenCbx, 
tenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
Solx=[1380,1572,1517,1430]; 
Solz=[ 636, 618, 574, 581]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
%receptorMap(specval(), x, z, Y) 
%receptorMap(specval(), x, z, Y) 
Vex=[1380,1572,1585,1487,1420,1351,1295]; 
Vez=[ 636, 618, 704, 726, 697, 687, 651]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
%receptorMap(specval(), x, z, Y) 
fiveRx=[1572,1585,1664,1713,1759,1756]; 
fiveRz=[ 618, 704, 667, 617, 537, 432]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%receptorMap(specval(), x, z, Y) 
Pr5x=[1572,1756,1712,1517]; 
Pr5z=[ 618, 432, 365, 574]; 
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slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
%receptorMap(specval(), x, z, Y) 
PCRtx=[1712,1517,1466,1433,1524,1546]; 
PCRtz=[ 365, 574, 571, 586, 411, 302]; 
slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Gigx=[1433,1524,1546,1509,1295,1295,1380]; 
Gigz=[ 586, 411, 302, 285,285 , 651,636 ]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
%receptorMap(specval(), x, z, Y) 
IOx=[1286,1313,1321,1310,1295]; 
IOz=[ 615, 598, 520, 432, 396]; 
slicemap (specval(IO), low,medLOW, MED, medHIGH, HIGH, IOx, IOz, Y); 
%receptorMap(specval(), x, z, Y) 
Robx=[1295,1313,1373,1444,1485,1385,1295]; 
Robz=[351 , 373, 366, 327, 281,270 , 270]; 
118 
slicemap (specval(Rob), low,medLOW, MED, medHIGH, HIGH, Robx, Robz, 
Y); 
%receptorMap(specval(), x, z, Y) 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 62 star 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 62; 
%receptorMap(specval(), x, z, Y) 
%QCcolor (Cbx,Cbz,62*3) 
Crus1x=[1460,1900,1903,1877,1807,1725,1572,1558]; 
Crus1z=[1141, 890,1003,1099,1178,1228,1269,1240]; 
slicemap (specval(Crus1), low,medLOW, MED, medHIGH, HIGH, Crus1x, 
Crus1z, Y); 
%receptorMap(specval(), x, z, Y) 
Crus2x=[1460,1900,1856,1458]; 
Crus2z=[1141, 890, 764,1077]; 
slicemap (specval(Crus2), low,medLOW, MED, medHIGH, HIGH, Crus2x, 
Crus2z, Y); 
%receptorMap(specval(), x, z, Y) 
PMIx=[1856,1458,1459,1600,1724,1747]; 
PMIz=[ 764,1077,1014, 818, 746, 690]; 
slicemap (specval(PMI), low,medLOW, MED, medHIGH, HIGH, PMIx, PMIz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Copx=[1699,1652,1511,1456]; 
Copz=[ 675, 678, 762,1012]; 
slicemap (specval(Cop), low,medLOW, MED, medHIGH, HIGH, Copx, Copz, 
Y); 
%receptorMap(specval(), x, z, Y) 
sixCbx=[1295,1384,1459,1572,1481,1460,1295]; 
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sixCbz=[1330,1330,1293,1269,1176,1141,1154]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
%receptorMap(specval(), x, z, Y) 
sevenCbx=[1460,1295,1295, 1450]; 
sevenCbz=[1141,1154,1063, 1052]; 
slicemap (specval(sevenCb), low,medLOW, MED, medHIGH, HIGH, sevenCbx, 
sevenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
eightCbx=[1295, 1450,1471,1295]; 
eightCbz=[1063, 1052, 911, 911]; 
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slicemap (specval(eightCb), low,medLOW, MED, medHIGH, HIGH, eightCbx, 
eightCbz, Y); 
%receptorMap(specval(), x, z, Y) 
nineCbx=[1471,1295,1295,1490]; 
nineCbz=[ 911, 911, 800, 800]; 
slicemap (specval(nineCb), low,medLOW, MED, medHIGH, HIGH, nineCbx, 
nineCbz, Y); 
%receptorMap(specval(), x, z, Y) 
tenCbx=[1295,1490,1511,1456,1295]; 
tenCbz=[ 800, 800, 762, 720, 711]; 
slicemap (specval(tenCb), low,medLOW, MED, medHIGH, HIGH, tenCbx, 
tenCbz, Y); 
%receptorMap(specval(), x, z, Y) 
Solx=[1377,1569,1519,1430]; 
Solz=[ 645, 623, 580, 586]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Vex=[1377,1569,1600,1520,1448,1350]; 
Vez=[ 645, 623, 694, 720, 703, 700]; 
slicemap (specval(Ve), low,medLOW, MED, medHIGH, HIGH, Vex, Vez, Y); 
%receptorMap(specval(), x, z, Y) 
fiveRx=[1569,1600,1694,1756,1767]; 
fiveRz=[ 623, 694, 638, 553, 480]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%receptorMap(specval(), x, z, Y) 
Pr5x=[1767,1569,1519,1706]; 
Pr5z=[ 480, 623, 580, 359]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
%receptorMap(specval(), x, z, Y) 
PCRtx=[1519,1706,1549,1525,1475,1430,1472]; 
PCRtz=[ 580, 359, 293, 413, 523, 586, 576]; 
slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
%receptorMap(specval(), x, z, Y) 
Gigx=[1295,1350,1377,1475,1525,1549,1485,1364,1295]; 
Gigz=[668 , 700, 645, 523, 413, 293, 273, 265, 277]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
%receptorMap(specval(), x, z, Y) 
IOx=[1364,1295,1295,1319,1385,1459,1485]; 
IOz=[ 265, 277, 351, 374, 361, 315, 273]; 
slicemap (specval(IO), low,medLOW, MED, medHIGH, HIGH, IOx, IOz, Y); 
%receptorMap(specval(), x, z, Y) 
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Robx=[1295,1313,1321,1295]; 
Robz=[621 , 598, 520, 393]; 
slicemap (specval(Rob), low,medLOW, MED, medHIGH, HIGH, Robx, Robz, 
Y); 
%receptorMap(specval(), x, z, Y) 
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l=62; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
slice 63 
%slicemap (specval(), low,medLOW, MED, medHIGH, HIGH, x, z, Y); 
if Slicenum == 63; 
Crus2x=[1512,1457,1445,1715,1798,1867,1878,1841,1762,1666,1500]; 
Crus2z=[1261,1164,1092, 885, 857, 862, 977,1099,1185,1234,1263]; 
slicemap (specval(Crus2), low,medLOW, MED, medHIGH, HIGH, Crus2x, 
Crus2z, Y); 
%receptorMap(specval(Crus2), Crus2x, Crus2z, Y) 
PMIx=[1445,1715,1798,1867,1797,1738,1621,1462]; 
PMIz=[1092, 885, 857, 862, 738, 695, 790,1019]; 
slicemap (specval(PMI), low,medLOW, MED, medHIGH, HIGH, PMIx, PMIz, 
Y); 
%receptorMap(specval(PMI), PMIx, PMIz, Y) 
Copx=[1462,1503,1630,1703,1738,1621,1482,]; 
Copz=[1019, 756, 683, 674, 695, 790,1003,]; 
slicemap (specval(Cop), low,medLOW, MED, medHIGH, HIGH, Copx, Copz, 
Y); 
%receptorMap(specval(Cop), Copx, Copz, Y) 
sixCbx=[1295,1370,1512,1481,1295]; 
sixCbz=[1317,1317,1261,1203,1214]; 
slicemap (specval(sixCb), low,medLOW, MED, medHIGH, HIGH, sixCbx, 
sixCbz, Y); 
%receptorMap(specval(sixCb), sixCbx, sixCbz, Y) 
sevenCbx=[1481,1295,1295,1445,1457]; 
sevenCbz=[1203,1214,1101,1095,1164]; 
slicemap (specval(sevenCb), low,medLOW, MED, medHIGH, HIGH, sevenCbx, 
sevenCbz, Y); 
%receptorMap(specval(sevenCb), sevenCbx, sevenCbz, Y) 
eightCbx=[1295,1445,1462,1295]; 
eightCbz=[1101,1095,956 , 967]; 
slicemap (specval(eightCb), low,medLOW, MED, medHIGH, HIGH, eightCbx, 
eightCb, Y); 
%receptorMap(specval(eightCb), eightCbx, eightCbz, Y) 
nineCbx=[1462,1295,1295,1489]; 
nineCbz=[956 , 967, 798, 805]; 
slicemap (specval(nineCb), low,medLOW, MED, medHIGH, HIGH, nineCbx, 
nineCbz, Y); 
%receptorMap(specval(nineCb), nineCbx, nineCbz, Y) 
tenCbx=[1295,1489,1512,1295]; 
tenCbz=[ 805,805, 731, 707]; 
slicemap (specval(tenCb), low,medLOW, MED, medHIGH, HIGH, tenCbx, 
tenCbz, Y); 
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%receptorMap(specval(tenCb), tenCbx, tenCbz, Y) 
Solx=[1326,1383,1451,1497,1518,1512]; 
Solz=[690 , 639, 621, 629, 667, 715]; 
slicemap (specval(Sol), low,medLOW, MED, medHIGH, HIGH, Solx, Solz, 
Y); 
%receptorMap(specval(Sol), Solx, Solz, Y) 
fiveRx=[1515,1681,1730,1756]; 
fiveRz=[ 716, 638, 582, 494]; 
slicemap (specval(fiveR), low,medLOW, MED, medHIGH, HIGH, fiveRx, 
fiveRz, Y); 
%receptorMap(specval(5R), fiveRx, fiveRz, Y) 
Pr5x=[1756,1756,1730,1515]; 
Pr5z=[494 ,432 , 380,716 ]; 
slicemap (specval(Pr5), low,medLOW, MED, medHIGH, HIGH, Pr5x, Pr5z, 
Y); 
%receptorMap(specval(), x, z, Y) 
PCRtx=[1383,1451,1497,1518,1512,1515,1730,1550,1536,1470]; 
PCRtz=[ 639, 621, 629, 667, 715,716 , 380, 278, 376, 527]; 
slicemap (specval(PCRt), low,medLOW, MED, medHIGH, HIGH, PCRtx, PCRtz, 
Y); 
%receptorMap(specval(PCR), PCRx, PCRz, Y) 
Gigx=[1550,1536,1470,1383,1326,1295,1295,1435]; 
Gigz=[ 278, 376, 527, 639, 690, 680, 277, 255]; 
slicemap (specval(Gig), low,medLOW, MED, medHIGH, HIGH, Gigx, Gigz, 
Y); 
%receptorMap(specval(Gig), Gigx, Gigz, Y) 
IOx=[1295,1435,1487,1449,1374,1314,1293]; 
IOz=[ 277, 255,266 , 307, 374, 354, 332]; 
slicemap (specval(IO), low,medLOW, MED, medHIGH, HIGH, IOx, IOz, Y); 
%receptorMap(specval(IO), IOx, IOz, Y) 
Robx=[1295,1321,1313,1295]; 
Robz=[ 393, 546, 598, 620]; 
slicemap (specval(Rob), low,medLOW, MED, medHIGH, HIGH, Robx, Robz, 
Y); 
%receptorMap(specval(Rob), Robx, Robz, Y) 
%QCcolor (Copx,Copz,63*3) 
l=63; 
%%Slicefeed(l); 
%l = 1; %enter whatever slice you want 
hold all 
for t = 1:plotable{l,2}%slice31 
plot3(plotable{l,1}{t}{1}, plotable{l,1}{t}{3}, 2000- 
plotable{l,1}{t}{2}, 'k-') 
end 
end 
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Appendix R: “slicemap” Program 
 
function slicemap (specval, low,medLOW, MED, medHIGH, HIGH, xpoints, 
zpoints, Y) 
hold all 
ypoints = zpoints; 
xpointmirror = xpoints; 
len = length(ypoints); 
for i =1:length(xpoints); 
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xpointmirror(i) = ((1295*2)-(xpoints(i))) ; 
end 
for i=1:len 
ypoints(i) = Y; 
end 
if specval <= (low) 
fill3(xpoints,ypoints,zpoints,[1,1,1]) 
fill3(xpointmirror,ypoints,zpoints,[1,1,1]) 
%<plot white color> 
end 
if specval >= (low) 
fill3(xpoints,ypoints,zpoints,[1,1,0]) 
fill3(xpointmirror,ypoints,zpoints,[1,1,0]) 
%<plot yellow color> 
end 
if specval >= (medLOW) 
hold all 
fill3(xpoints,ypoints,zpoints,[1,0.7,0]) 
fill3(xpointmirror,ypoints,zpoints,[1,0.7,0]) 
%<plot yellow-orange color> 
end 
if specval >= (MED) 
hold all 
fill3(xpoints,ypoints,zpoints,[1,0.6,0]) 
fill3(xpointmirror,ypoints,zpoints,[1,0.6,0]) 
%<plot orange color> 
end 
if specval >= (medHIGH) 
hold all 
fill3(xpoints,ypoints,zpoints,[1,0.4,0]) 
fill3(xpointmirror,ypoints,zpoints,[1,0.4,0]) 
%<plot red-orange color> 
end 
if specval >= (HIGH) 
hold all 
fill3(xpoints,ypoints,zpoints,[1,0,0]) 
fill3(xpointmirror,ypoints,zpoints,[1,0,0]) 
%<plot red color> 
end 
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Appendix S: “receptorMap” Program 
 
function receptorMap (specval, xpoints, zpoints, Y) 
low = 1%0.903305;%1.269407; %1 for receptor, else use cutoff values 
 from percentiles 
medLOW = 2; %1.374403; %2 for receptor 
MED = 3;%1.435702; %3 for receptor 
medHIGH =4; %1.533658; %4 for receptor 
HIGH = 5;%1.671788; %5 for receptor 
hold all 
%5=[0,1,1] 
%4=[0,0.8,0.8] 
%3=[0,0.6,0.6] 
%2=[0,0.4,0.4] 
%1=[0,0.2,0.2] 
%0=[0,0,0] 
ypoints = xpoints; 
xpointmirror = xpoints; 
len = length(zpoints); 
for i =1:length(xpoints); 
xpointmirror(i) = ((1295*2)-(xpoints(i))) ; 
end 
for i=1:len 
ypoints(i) = Y; 
end 
if specval == (0) 
     fill3(xpoints,ypoints,zpoints,[0,0,0]) 
        fill3(xpointmirror,ypoints,zpoints,[0,0,0]) 
%<plot black color> 
end 
if specval == (low) 
     fill3(xpoints,ypoints,zpoints,[0,.2,.2]) 
        fill3(xpointmirror,ypoints,zpoints,[0,0.2,0.2]) 
%<plot low color> 
end 
 if specval== (medLOW) 
        hold all 
         fill3(xpoints,ypoints,zpoints,[0,0.4,0.4]) 
            fill3(xpointmirror,ypoints,zpoints,[0,0.4,0.4]) 
%<plot med-low color> 
    end 
  if specval == (MED) 
         hold all 
      fill3(xpoints,ypoints,zpoints,[0,0.6,0.6]) 
      fill3(xpointmirror,ypoints,zpoints,[0,0.6,0.6]) 
%<plot mid color> 
    end 
 if specval == (medHIGH) 
         hold all 
    fill3(xpoints,ypoints,zpoints,[0,0.8,0.8]) 
 
fill3(xpointmirror,ypoints,zpoints,[0,0.8,0.8]) 
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%<plot med-high color> 
end  
    ypoints = zpoints; 
xpointmirror = xpoints; 
len = length(ypoints); 
for i =1:length(xpoints); 
xpointmirror(i) = ((1295*2)-(xpoints(i))) ; 
end 
for i=1:len 
ypoints(i) = Y; 
end 
 if specval == (HIGH) 
         hold all 
fill3(xpoints,ypoints,zpoints,[0,1,1]) 
fill3(xpointmirror,ypoints,zpoints,[0,1,1]) 
%<plot high color> 
end  
low = 1  
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